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Historically, diagnosis has relied on clinical signs of disease, microscopy and serological testing.  
However, these approaches have a number of drawbacks for example, differential diagnosis, low 
sensitivity (microscopy) and the inability to differentiate past from current infections (serology).  In 
the past decade the use of molecular techniques, such as the polymerase chain reactions (PCR) have 
gained favour. Many research groups have used these techniques to study the molecular epidemiology 
of diseases in sub-Saharan Africa.  Such methodologies rely on the detection of genetic materials and 
as such are reliant on the specificity of their components and the quality of the starting materials.  It is 
the aim of this thesis is to demonstrate improvements that can be made to sample collection that will 
help to enhance the reliability of these tests and highlight the importance of the diagnostic parameters. 
The model that I will use to demonstrate these improvements are African trypanosomes, these are the 
causative agents of sleeping sickness in humans and nagana in animals, and are wide spread across 
much of sub-Saharan Africa. My work will be presented as three main sections:  
Firstly, a comparison of the suitability of various different approaches to cattle blood sample 
collection – including the genetic materials prepared directly in the field and the use of Whatman 
FTA®cards – in terms of the provision of appropriate materials for molecular screening will be 
presented.  It was found that uneven distribution of genetic materials occurs across the surface of the 
FTA®cards due to the matrix chemistry. Therefore suggestions for improvements for the preparation 
of materials to be stored on these cards and their downstream application are made. 
Secondly, a comparison between the specificity of the pan-Trypanosoma ITS-PCR reaction and the 
species-specific reactions is made.  The ITS-PCR has gained favour in recent years as it is reported to 
be capable of identifying a wide range of trypanosomes, as this is a single nested PCR reaction the 
reduction in time and cost has been very appealing to researchers in this field.  My work suggests that 
this test is not reliable in terms of the accurate detection of trypanosomes species, and in fact on a 
direct comparison of 969 samples, 37 parasitic events where identified by this approach compared to 
197 when species-specific tests were applied. 
Thirdly, based on my findings from the previous two chapters I present two case studies, the first of 
which looks to evaluate the impact on the prevalence of trypanosome species in cattle after drug 
treatment during the Ugandan, Stamp Out Sleeping sickness (www.sleepingsickness.com) campaign.  
The results of this case study highlight the importance of understanding the relationship that occurs 
between trypanosome species in mixed infections, my second case study therefore looks to 
quantifying the infection load of Trypanosoma brucei and T. congolense within the midgut of their 
insect vector (Glossina morsitans morsitans) using qPCR. 
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Diagnosis is an essential element in the management of disease, both at the level of individual patient 
care and at the level of disease-control in populations. Diagnostic tests should be simple, rapid, 
specific and highly sensitive. They also should ideally differentiate between closely related parasites, 
especially if the disease syndromes they cause require different management approaches. They should 
be suitable for field application and the cost for these tests should be within the means of the 
communities affected by the disease (Nantulya, 1991). 
The aetiology of infectious diseases has traditionally been investigated through the establishment of 
Koch’s postulates (Poxton, 2005). The postulates state that an organism is causal if: 
1- It is present in all cases of the disease 
2- It does not occur in another disease as a fortuitous and non-pathogenic parasite 
3- It is isolated in pure culture from an animal, is repeatedly passaged and induces the same 
disease in other animals (Koch, 1882).  
Although these postulates were the basics to understand the infectivity of the causative organism, they 
have limitations in dealing with asymptomatic carriers. Asymptomatic carriers are those carrying the 
infectious agent without having clinical signs. 
The diagnosis of the asymptomatic carrier is crucial because they act as a reservoir of the disease, 
leading to transmission and spread of the infectious agent amongst population (Falkow, 2004). 
Moreover, the transition from asymptomatic carrier to clinically sick is related to failure in the host 
immune response rather than an increase in pathogenicity of the infectious agent (Evans, 1991; 
Poxton, 2005).  
Blood borne parasites were traditionally diagnosed using microscopy to directly observe the causative 
agent within blood or through the use of serological approaches for the detection of either antibodies 
to or antigens from the pathogen in the host serum. However, recently the explosion of new 
techniques, due to rapid advances in molecular biology, has provided a battery of novel approaches 
and technologies, which can be applied to more practical issues such as diagnosis and research studies 
(Hide and Tait, 1991; Nantulya, 1991). 
The use of molecular approaches such as polymerase chain reaction (PCR) is important for the 
detection of low levels of infectious agents circulating in the blood and more importantly for the 
identification of asymptomatic carriers. An example of this would be the identification of animals 
carrying human infective Trypanosoma brucei rhodesiense which is non pathogenic for the animal 
host, but fatal to human (Eisler et al., 2004).   
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This chapter summarises the development of diagnostic tools for the detection and characterisation of 
the infectious agent. The second part of this chapter describes the development of diagnostic strategies 
for three blood borne parasites (Plasmodium, Leishmania and Trypanosoma cruzi) from the traditional 
approaches of microscopy and serology to the most recent molecular tools used for diagnosis and 
identification of such agents. 
1.2 Microscopical diagnosis 
The main approach for diagnosing blood borne parasites is the examination of blood samples by 
microscopy. The definition of particular species within a genus is dependant on morphological criteria 
(Prichard and Tait, 2001). Microscopy can be performed quickly, but accuracy depends on the 
experience of the microscopist and quality of equipment. 
Different blood films have been used for this purpose, including wet blood films and thick or thin 
fixed blood films stained with Giemsa stain. Using the wet blood film approach, a drop of blood can 
be examined directly using a microscope. Thick and thin blood smears fixed with methanol or acetone 
and stained with Giemsa are examined in the laboratory to detect blood parasites and determine the 
species involved in the infection (Hoare, 1972). Phase contrast microscopy is used to examine the 
details of the cells which are undetectable using bright field microscopy. The inability of the light 
microscope to examine the details of cells is due to the lack of contrast between structures with similar 
transparency and insufficiency of natural pigmentation.   
Although widely used, these methods are considered to have low sensitivity and are also time 
consuming; therefore, these drawbacks were the main reason for research to be directed toward the 
detection of antibodies against the infectious agents for the diagnosis of infections.  
1.3 Serology 
Serodiagnosis of diseases depends mainly on antigen-antibody reaction in the blood serum. The 
essential element in immunodiagnosis is the availability of species-specific test antigens and/or highly 
specific antibodies. Because parasites contain thousands of potentially antigenic polypeptides, 
glycoproteins and glycolipids, many of which are shared with unrelated species and even with 
bacteria, there has been great difficulty in developing sufficiently specific immunodiagnostic tests 
(Nantulya, 1991). The advantage of using a robust serological test is that they can be used for mass 
screening without the need for expensive analytical equipments. However, the main drawback of 
serological tests is the inability of these tests to differentiate current from previous infection since 
antibodies frequently persist far longer than the infectious agent within the host.  
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1.3.1 Complement fixation test (CFT) 
Complement fixation test is one of the widely used immunodiagnostic tests for the detection of 
antibodies or antigens for a variety of blood borne parasites. Complement is a biological substance 
present in the sera of normal humans and animals helping in the clearance of invading pathogens 
(Male et al., 2006). CFT uses sheep red blood cells (RBC) as an indicator system, meaning that in a 
positive test, the complement is bound to the antigen-antibody complex and is not free to interact with 
sheep RBC which in turn settle to the bottom of the well forming a button shape. Alternatively, in a 
negative reaction, the complement remains free due to the absence of antigen-antibody reaction and 
react with the sheep RBC leading to lyses and the serum colour turns pink (Male et al., 2006), as 
shown in Figure 1.1. This test is considered the official diagnostic test for infectious diseases such as 
babesiosis, brucellosis and piroplasmosis due to ease of application and suitability for in field 
screening (Bashiruddin et al., 1999; Herr et al., 1985; Luckins, 1992). However, the main drawback of 
this test is the lack of sensitivity especially during the late stages of disease and the difficulty 
encountered during the preparation of reagents.  
 
Figure 1.1: Complement fixation test results in serum sample (positive results: button shape 
RBC, negative results: pink color of serum)  
(virology-online.com/general/Test3.htm)  
1.3.2 Agglutination tests 
In agglutination tests, the reaction of antibody with the antigen can be detected by agglutination or 
clumping of the antigen. Specific infectious agent antigen applied to the card can be used for the 
identification of antibodies produced against such infectious agent by observing the agglutination 
produced from the antigen-antibody reaction (Male et al., 2006). For instance, antibodies against 
Neospora caninum (causes hind and forelimb paresis) and Sarcocystis neurona (causes myelitis and 
encephalitis), which are both protozoa, were determined in serum samples of 501 domestic cats from 
Brazil using the agglutination test (Dubey et al., 2002). The test detected Neospora caninum in 11.9% 
of the tested sera, whereas, Sarcocystis neurona could not be identified. 
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1.3.3 Indirect fluorescent antibody test (IFAT) 
In this test, blood films from infected laboratory animals are fixed and used as a source of infectious 
agent antigens to which antibodies in test sera may bind specifically. Bound antibodies are visualised 
using anti-host species immunoglobulin conjugated to a fluorescent dye using a fluorescent 
microscope (Luckins and Mehlitz, 1978). An example of using IFAT in the screening of blood borne 
parasitic infections was the diagnosis of Theileria equi and Babesia caballi in domestic horses, 
southwest Mongolia (Ruegg et al., 2007). The test was able to detect 78.8% and 65.7% of the 
examined animals to be infected with the two parasites, respectively. 
1.3.4 Enzyme linked immunosorbent assay (ELISA) 
Another important widely used immunodiagnostic test for the detection of antibodies or antigens of 
blood borne parasites diagnosis is ELISA; developed in 1971 by Engvall and Perlman for the 
measurements of antibodies for the diagnosis of different diseases (Engvall and Perlman, 1971).  
Two types of ELISA have been developed depending on the target to be detected, the indirect ELISA 
is used for the detection of antibodies in a serum sample, based on the adhesion of a known antigen to 
the surface of a 96-well microtitre plate followed by the addition of the patient serum sample from 
which the antibodies will bind to the antigens if prior exposure has taken place. Finally, a second 
antibody labelled with an enzyme that catalyse the conversion of a colourless substrate to a visible 
coloured product are added (Engvall and Perlman, 1971; Voller et al., 1976).  
The other type is the direct ELISA such as antigen-ELISA or the double sandwich ELISA; used for 
antigen detection in which specific antibodies adhere to the surface of the microtitre plate. The sample 
to be examined is then applied and any antigen present is bound by the antibodies. Finally, the 
labelled antibodies with the enzyme are attached (Voller et al., 1976). Figure 1.2 illustrates the 
indirect and sandwich direct ELISA.  
 6 
 
Figure 1.2: Indirect and sandwich direct ELISA 
Ab-ELISA was used to detect anti-Toxoplasma gondii antibodies in 1258 small ruminants in Ghana 
and the results were compared to IFAT which was used as a reference test (van der Puije et al., 2000). 
The ELISA test was found to be both highly sensitive (92%) and specific (91%) in the identification 
of the parasite antibodies in the examined animals. Similar sensitivity and specificity (90.2% and 
92%, respectively) were also obtained using ELISA when comparing with IFAT in diagnosing T. 
gondii in pig serums from Ghana (Arko-Mensah et al., 2000). 
1.4 Molecular diagnosis 
Molecular diagnostic testing is now firmly established as a routine diagnostic tool for infectious 
diseases. However, molecular tests have broader applications including use in epidemiological 
investigations, therapeutic strategies decisions and predicting the development of diseases (Caliendo 
and Dumler, 2001). Examples for the use of molecular tools in the diagnosis of blood borne parasitic 
diseases are fully discussed in section 1.5 of this chapter.    
1.4.1 DNA hybridization 
In eukaryotes, repeated Deoxyribo-nucleic acid (DNA) sequences known as “satellite DNA” have no 
known cellular function and typically contain a simple consensus sequence that is repeated thousands 
if not millions of times (Nantulya, 1991). These satellite repetitive DNA sequences give good 
sensitivity when used as hybridization probes for detection of complementary sequences in small 
amounts of test DNA.  
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The principle of DNA hybridization is that a single stranded DNA fragment containing the infectious 
agent species-specific sequences, is identified and purified, then labelled with a tracer (often 
radioisotope) and used to probe purified infectious agent DNA or whole organisms. Prior to 
application of the probe, the test DNA is treated with denaturing agents and split into single strands 
and immobilized on nitro-cellulose or nylon filters. When the probe is applied to the specimen, the 
sequences in the probe will hybridize with complementary DNA sequences (Figure, 1.3). The bound 
label can then be revealed by autoradiography (if the probe was labelled with a radioisotope). 
 
Figure 1.3: DNA hybridization using labelled probes (L: ladder, S: Samples), protocol adopted 
from Southern (1992) 
Such procedures could form the basis of a diagnostic test because quantities of DNA down to 10-100 
pg can be detected; this is equivalent to 102-103 protozoa per ml such as trypanosomes (Nantulya, 
1991).  The major constraint for field application of DNA probes are the preparation of specimens, 
hybridization of the probe and most importantly, the requirement of the radiolabel and the subsequent 
detection of the hybridization signal by autoradiography (Hide and Tait, 1991; Nantulya, 1991).  
1.4.2 Restriction Fragment Length Polymorphism (RFLP) 
Molecular methods have the advantage of the ability to examine DNA sequences which show 
variation between individuals or group of individuals using RFLP (Saiki et al., 1985). The variation in 
DNA sequence in specific genes can be detected using a series of restriction enzymes which cut the 
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DNA at specific sequences. The variation is then assessed by examining the electrophoretically 
separated banding patterns of DNA digested with restriction enzymes after transfer onto nitrocellulose 
membrane using Southern blot technique followed by hybridization on the filter with a radio-labelled 
DNA probe. DNA polymorphism and variation can be detected by observing differences in banding 
patterns when comparing total DNA isolated from different organism stocks (Hide and Tait, 1991; 
Saiki et al., 1985; Southern, 1992).   
The limitation of this protocol is the low sensitivity especially if a single or low copy number gene is 
used for the assay and the use of Southern blotting which requires preparation of probes, radio-
labelling and visualisation by autoradiography. Therefore, the use of RFLP has been used on the 
products from PCR in different fields for the study of the variation between individuals (Wolf et al., 
1999). PCR-RFLP was used for diagnosing filarial infection in 52 domestic cats in Thailand. Infection 
was demonstrated in 9.5% of the examined cats using PCR-RFLP which was able to detect two 
additional cases that were not detected using microscopy (Nuchprayoon et al., 2006).     
1.4.3 Nucleic acid amplification 
Nucleic acid amplification is one of the most valuable tools in virtually all life science fields, 
including in field applications such as clinical medicine that requires diagnosis of infectious diseases 
(Notomi et al., 2000). Several methods for amplifying target nucleic acid have been invented, such as 
Nucleic Acid Sequence Based Amplification (NASBA), Self-Sustained Sequence Replication (3SR), 
Strand Displacement Amplification (SDA) and PCR. PCR depends on heat denaturation of DNA to be 
subjected to the action of polymerase enzyme for amplification, whereas, the other three 
aforementioned protocols depend on another innovation to initiate new rounds of DNA synthesis. 
Briefly, NASBA and 3SR eliminate heat denaturation by using a set of transcription and reverse 
transcription reactions to amplify the target sequence (Compton, 1991; Guatelli et al., 1990; Notomi et 
al., 2000). While, SDA eliminates the heat denaturation step and employs a set of restriction enzyme 
digests and strand displacement for DNA synthesis with modified nucleotides as substrate. NASBA, 
3SR and SDA methods lack specificity hindering them from being of wide scale use (Notomi et al., 
2000; Walker et al., 1992). 
PCR based assays currently constitute the main molecular diagnostic approach of researchers and 
health professionals. PCR allows the production of large quantities of a specific DNA from a complex 
DNA template in a simple enzymatic reaction; polymerases catalyse the synthesis of long 
polynucleotide chains using a single strand as a template (Newton and Graham, 1997). The hypothesis 
of replicating a piece of DNA using two primers was initially described by Kleppe et al. (1971), but 
progress was limited by primer synthesis and polymerase purification issues. In 1980s, Mullis and 
colleagues discovered a way to start and stop a polymerase based reaction at specific points along a 
single strand of DNA with the exponential amplification of the target sequence (Mullis et al., 1986). 
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The basic amplification technique depends on an initial denaturation of the double stranded DNA at 
95ºC for 3 minutes, followed by repeated cycles of denaturation, annealing and extension. Annealing 
of the synthesized primers to the specified regions in the target of interest occurs by decreasing the 
temperature to 50-60ºC. Extension of the target by activation of the polymerase at 72ºC utilises the 
annealed primers to synthesise a second strand of DNA on the single stranded template DNA (Figure 
1.4). During this cycle, if the efficiency is perfect, the number of copies of the target DNA has 
doubled, depending on the number of the reaction cycles, the target DNA sequence can be amplified 
2n times where (n) is the number of reaction cycles (Hide and Tait, 1991; Newton and Graham, 1997). 
However, in reality, reactions do not maintain perfect efficiency because reactants within the PCR are 
consumed after many cycles, inactivation of polymerase and due to the self-annealing of the 
accumulating product after the copy number reaches high levels (Valasek and Repa, 2005). 
In Mullis’s original PCR process, Escherichia coli heat liable polymerase was used in vitro. The 
double stranded DNA was separated into two single strands by heating it to 95ºC leading to 
destruction of the enzyme, meaning that the enzyme had to be replenished after the heating stage of 
each cycle (Mullis et al., 1986; Mullis and Faloona, 1987). In contrast, thermostable enzymes such as 
Taq polymerase which is derived from Thermus aquaticus, can be added at the beginning of the 
amplification process without further additions during the reaction (Newton and Graham, 1997). 
 
Figure 1.4: Diagram illustrating the basic PCR technique (protocol adopted from Newton and 
Graham (1997)) 
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PCR based strategies have propelled molecular biology forward by enabling researchers to manipulate 
DNA easily (Valasek and Repa, 2005). Several distinct PCR formats are available that may be broadly 
be classified into (“high-tech”, “mid-tech” and “low-tech”) approaches (Reithinger and Dujardin, 
2007). The most widely used approaches are those categorised as “Mid-tech”, comprising  
conventional PCR assays in which PCR amplicons are resolved by electrophoresis and visualised after 
ethidium bromide staining. These assays are performed with several pieces of laboratory equipments 
such as thermocycler, power supply, electrphoresis tank, UV transilluminator and a camera 
(Reithinger and Dujardin, 2007; Singh et al., 2005). 
The category “High-tech” includes approaches in which PCR products are analysed during their 
amplification (real-time quantitative PCR, qPCR) utilising staining with a fluorescent dye (Reithinger 
and Dujardin, 2007). These assays are performed with a single all-in setup, and the detection of 
fluorescence is done within a closed tube decreasing the risk of contamination. Moreover, these 
applications are rapid and of high throughput, however, the equipment is comparatively expensive and 
the working costs remain high (Espy et al., 2006; Reithinger and Dujardin, 2007). Quantitative PCR 
represents yet another technological leap forward that has opened up new and powerful applications 
for researchers throughout the world. This is in part because the enormous sensitivity of PCR has been 
coupled to the precision afforded by real-time monitoring of PCR products as they are generated. The 
basic goal of qPCR is to precisely distinguish and measure (quantify) specific nucleic acid sequences 
in a sample, even if there is only a very small quantity, by monitoring the amplification progress using 
fluorescent technology (Valasek and Repa, 2005). 
Low-tech approaches refer to simplified PCR methods for use in laboratory settings with minimal 
equipments. Simplification can potentially be done at the two main steps of the PCR protocol that 
include target amplification and detection of the PCR products. Loop-mediated isothermal 
amplification (LAMP) represents a promising avenue for both steps requiring only a simple water bath 
for amplification and detection can be done visually by using SYBR Green I dye, which turns green in 
the presence of amplified products and remains orange in their absence (Reithinger and Dujardin, 
2007). 
LAMP was developed by Notomi et al. (2000) to amplify a few copies of DNA to 109 in less than an 
hour under isothermal conditions (constant temperature) and with high specificity. This method 
depends on auto-cycling strand displacement DNA synthesis using Bacillus stearothermophilus (Bst) 
DNA polymerase with high strand displacement activity. The products are a mixture of stem-loop 
DNAs with various sizes of stem and cauliflower-like structures with multiple loops. The main 
advantages of LAMP are the use of low-technology for the performance of the protocol especially in 
field conditions; this is mainly due to the use of a water bath because the reaction is performed at 
65ºC. Additionally, LAMP was found to be highly sensitive and able to detect few copies of DNA (six 
copies) in the reaction mixture, the presence of non-target DNA in the reaction mixture had no 
significant effect on LAMP reactions. Moreover, visualization of the results can be done by noticing 
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turbidity or by using dyes such as SYBR Green I, making LAMP easier for practical in field use and 
less prone to contamination because the handling of the samples is minimized (Notomi et al., 2000). 
Recently, the use of a real-time thermal cycler or real-time turbidimeter has been developed for the 
potential to quantify template DNA by the real-time monitoring of LAMP reaction using the increased 
intensity of fluorescence emitted from the used fluorescent reporter (Aoi et al., 2006; Mori et al., 
2004). 
1.5 Examples for the development of diagnostic strategies in 
three blood borne parasitic diseases 
The main focus of this work is to study a variety of sample preparations (Chapters, III and IV) and 
molecular tools for the diagnosis of African trypanosomes (Chapter V). Trypanosomes are studied as 
a model for blood borne parasites, which occur in the blood stream as an extracellular parasite 
(outside blood cells). In the following section, the different diagnostic tools used for three other blood 
borne parasites are summarised. They were chosen based on their location either intracellular or 
extracellular in blood. Plasmodium was chosen as an example to an organism occurring intracellular 
within RBC, Leishmania was chosen as an example of an organism occurring intracellular within the 
white blood cells (WBC). Finally, Trypanosoma cruzi was used to exemplify organisms occurring 
extracellular or between blood cells. The aim of this literature search was to discuss specific sample 
preparation techniques used to detect each protozoon and to look at the different diagnostic 
approaches used for each organism. 
1.5.1 Intracellular parasites in the red blood cells (Plasmodium 
species) 
Malaria is a disease which can be transmitted to people of all ages through the bite of an infected 
mosquito. Approximately, 40% of the world’s population, mostly those living in the world’s poorest 
countries, are at risk of malaria with more than 500 million people becoming severely ill with malaria 
every year. The early diagnosis of malaria is the basic element for the control of this disease (WHO, 
2007). The control, prophylaxis and eradication of this disease depends on the availability of sensitive, 
simple and inexpensive diagnostic means of detecting parasites in order to identify foci of infection 
and to evaluate the effect of various control programmes (Barker et al., 1986). Although malaria is a 
frequently encountered disease in many developing countries, it is difficult to make the right diagnosis 
based on clinical signs; these include fever, headache, chills and vomiting. Such symptoms are not 
specific and could be found in many other diseases such as brucellosis and flu, so it is important to 
confirm the clinical suspicious using a good laboratory test in order to prevent unnecessary anti-
malarial treatment (Mens et al., 2007; WHO, 2007). 
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1.5.1.1 Diagnosis 
There are four types of human malaria, Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. 
P. falciparum and P. vivax are the most common (WHO, 2007). Malaria cases caused by the most 
deadly type of malaria,  P. falciparum have been estimated in 2004 to be within a range of 300-660 
million cases (Snow et al., 2005). 
Direct microscopic examination of blood smears continues to be the method of choice (gold standard) 
for diagnosing acute malaria. This method is both sensitive and specific since malaria can be 
differentiated from other potential infectious agents, moreover, the various Plasmodium species can be 
readily distinguished. It is, however, time consuming to examine each slide, and a trained technician is 
required for accurate identification when low numbers of parasites are present (Barker et al., 1986). 
Thick and thin blood films stained with Giemsa stain can be prepared for microscopy; thick blood 
films concentrate the layers of RBC on a small surface providing enhanced sensitivity for the 
detection of low levels of parasitaemia and reappearance of circulating parasites during infection 
recrudescence or relapse. Thin blood films (Figure 1.5) enable the fixation of RBC for morphological 
identification of the parasite to the species level and counting of the parasites to estimate the 
parasitaemia.  
 
Figure 1.5: Human red blood cells infected with Plasmodium falciparum  
(www.sciencedaily.com/images/2006/06/060620080915.jpg) 
The sensitivity of blood films in diagnosing malaria was found to be 50 parasites/µl, although, 
examination of 100-400 microscopic fields is required before declaring the sample negative (Jonkman 
et al., 1995; Mens et al., 2007; Moody, 2002; Reyburn et al., 2004). False positive diagnosis of 
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Plasmodium species using microscopy has been reported due to poor blood film preparation that 
generates artifacts leading to mistaken malaria diagnosis, these include bacteria, fungi, stain 
preparations, dirt and cell debris (Wongsrichanalai et al., 2007). 
Immunodiagnostic procedures such as ELISA for detecting malaria antibodies have been developed 
and tested providing important information with regard to exposure to malaria. The main drawback of 
this technique is the persistence of the antibodies after the disappearance of the malaria parasites from 
the blood following treatment, hindering the discrimination between present and past infections 
(Avraham et al., 1982).  
Assays depending on the detection of the parasite antigens have been developed to identify present 
infections; however, antibody for malaria antigen from a past infection may interfere with this assay 
causing false positive results (Avraham et al., 1982; Barker et al., 1986; Mackey et al., 1982). The 
antigen based tests are termed by the World Health Organization (WHO) as Rapid Diagnostic Tests 
(RDT), they can detect 100 parasites/µl in a small amount of blood (5-15 µl) using an immuno-
chromatographic assay with monoclonal antibodies impregnated on a test strip and directed against 
the target parasite antigen. Although the sensitivity of RDT remains a problem, the test is usually easy 
to perform without the need of any experience to interpret the coloured line on the test strip (Figure 
1.6) and results can be obtained in five to twenty minutes without requiring capital investments or 
electricity (Wongsrichanalai et al., 2007). However, parasite densities above 100 parasites/µl should 
be detected with confidence because the average parasitaemia seen in patients attending hospitals is 
between 50-5000 parasites/µl (Moody, 2002). 
 
Figure 1.6: RDT test for malaria diagnosis (black line indicates positive results and grey line 
indicates negative results) 
(www.fda.gov/Cber/blood/malaria071206sk9.gif) 
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The malaria antigens targeted by RDT are Histidine rich protein (HRT-1,2,3) and parasite specific 
lactate dehydrogenase enzyme (pLDH). These tests are not suited for follow-up after treatment 
because of the persistence of the antigens, therefore the specificity of these tests decreases (Mens et 
al., 2007; Moody, 2002). The current market price of RDT in developing countries is ranging between 
US$0.55-US$1.50 compared with a range of US$0.12-US$0.40 per malaria smear to be examined by 
microscopy. Although, the cost of RDT is higher than microscopy, RDT is cost effective due to the 
rise in anti-malrial therapy costs that desperately requires accurate and rapid diagnosis 
(Wongsrichanalai et al., 2007). 
Diagnostic probes based on repetitive satellite DNA sequences are currently used for Plasmodium 
diagnosis. The probe is a DNA fragment containing a sequence of 21 bp that are repeated several 
thousand times in the malaria parasite genome. The technique is sensitive enough to detect 10 pg of 
purified Plasmodium DNA which is equivalent to 100 parasites. In the field, it has been observed that 
this technique can detect approximately 40 parasites/µl blood (Barker et al., 1986). The advantages of 
this approach include the detection of current infection, results can be quantified and this method can 
be adapted to field use in blood samples obtained from a finger prick and applied directly to 
nitrocellulose paper without the need of DNA extraction (Barker et al., 1986; Holmberg and Wigzell, 
1987; Nantulya, 1991). In a study to evaluate the use of a DNA probe and microscopy for field 
diagnosis of malaria in Thailand, 20.4% of 632 patients were diagnosed to be positive using DNA 
probe, while, 19.1% were detected by microscopy. Subsequent examination of duplicate slides, from 
the cases diagnosed only with DNA probe, by expert microscopists confirmed that microscopy missed 
those cases (Wirth et al., 1989).   
The major advantage of using probes compared to microscopy, is the batch wise analysis of samples, 
meaning that one technician can examine 60 samples per day using microscopy, while, 1000 samples 
can be tested using probes per day (Barker et al., 1986). Another large scale study was conducted by 
Barker and colleagues (1994) in Thailand to examine the applicability of DNA probe-based method 
for in field diagnosis of P. falciparum compared with microscopy. The results revealed that between 
four and eight persons/day were required to obtain results from each set of 5000 samples by DNA 
probe analysis, whereas, microscopic examination required 150 persons/day. Approximate costs were 
US$ 0.17 per sample for DNA probe analysis, and US$ 0.36 for microscopic examination. In 
conclusion, the DNA probe method offers significant advantages when large numbers of samples must 
be surveyed (Barker et al., 1994). 
Quantitative nucleic acid sequence based amplification (QT-NASBA) can detect parasites at a level as 
low as 0.02 parasites/µl, and allow precise quantification of the parasite load in a range of 20-108 
parasites/ml blood (Mens et al., 2007; Schneider et al., 2005). A cross sectional field study was 
reported by Ouedraogo et al. (2007) to validate the use of QT-NASBA in diagnosing and quantifying 
P. falciparum in 412 samples collected from Burkina Faso and comparing the sensitivity with 
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microscopy. The results revealed that the more sensitive QT-NASBA technique gave estimates of P. 
falciparum prevalence 3.3 fold higher than microscopy (Ouedraogo et al., 2007). 
PCR is said to have a detection limit of between 0.7 and 0.02 Plasmodium parasites/µl (Hänscheid and 
Grobusch, 2002; Hermsen et al., 2001; Mens et al., 2007). This reaction is used for the qualitative 
detection of the parasites regardless of the quantity of the infective species. A study conducted in a 
Brazilian amazon basin aimed to detect the prevalence of P. malariae using microscopy and PCR of 
the parasite after extracting the DNA from the blood sample applied onto filter paper. Microscopic 
examination of blood films showed prevalence of 1.2%, while, PCR revealed a prevalence of 11.9% 
(Scopel et al., 2004).  
In another study, PCR revealed 34.8% prevalence of malaria infected individuals in Lao People’s 
Democratic Republic compared with only 17.3% detected by microscopy (Toma et al., 2001). 
Moreover, PCR was especially sensitive for detection of 27 mixed infections with different malaria 
species but only two were detected by microscopy. In this study, extraction of DNA from 100 µl of 
heparinised blood using GFX (genomic blood DNA purification kits) were used as PCR template 
(Toma et al., 2001). Another study conducted in Tanzania and Kenya, Mens et al. (2007) assessed the 
use of microscopy, RDT and molecular biology in malaria diagnosis. The authors confirmed the 
higher sensitivity of molecular tests including PCR and QT-NASBA in diagnosing malaria suspicious 
clinical cases. However, the drawback of using the molecular based techniques in diagnosing malaria 
is that they are expensive, complicated to perform and not widely available due to limited resources 
such as electricity and inadequate laboratory infrastructures in developing countries. Moreover, the 
impact of molecular tools in areas with low incidence is higher than in areas with higher malaria 
incidence (Hänscheid and Grobusch, 2002; Mens et al., 2007). 
Recently, qPCR has been developed and reported for quantification of low number of Plasmodium 
species, reaching 10 parasites per ml (Hermsen et al., 2001). Although PCR based tools are sensitive, 
specific and able to detect very low parasitaemia, the costs and infrastructure needed to run and 
maintain PCR are not practical in most field settings where even intermittent electrical supply is a 
luxury (Boonma et al., 2007). 
Attempts for conducting simple and inexpensive molecular test to detect the highly conserved 18S 
ribosomal RNA gene of P. falciparum using LAMP technology have been described by Poon et al. 
(2006). The authors reported that the assay did not cross react with DNA from other Plasmodium 
species and indicated high specificity in diagnosing malaria when compared with PCR and 
microscopy. To reduce the cost and turnaround time of the LAMP test, the blood samples were 
prepared by heating at 99ºC for 10 minutes instead of utilising DNA extraction methods. More 
positive cases were reported using LAMP rather than PCR from the pre-heated samples, this might be 
attributed to the impact of proteins within this preparation having a greater inhibitory effect on the Taq 
polymerase of the PCR reaction. The LAMP test for the detection of P. falciparum is simple, cheap 
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and robust, moreover, there is no need for highly experienced staff to interpret the results, can be 
performed in the field with resource limited situations and not time consuming (Poon et al., 2006). 
Preparation of the samples prior to the application of PCR diagnostic methodology is an important 
issue to consider. In case of malaria parasites, the presence of the parasites intracellular in the RBC 
requires the release of the parasites from the cells and to remove the inhibitors that are present in 
blood. Distilled water was added to blood samples to lyse the blood cells in a study conducted in 
Nigeria for the detection of malaria using PCR (Uzoegwu and Onwurah, 2003). The use of DNA 
extraction kits on samples for malaria diagnosis was reported where lyses solution to lyse RBC 
releasing the malaria parasites is an essential step (Aslan et al., 2007).  Application of the blood 
sample onto filter paper and extraction of DNA using Chelex®100 was used in a large scale field study 
to characterise P. falciparum in the Republic of Cabo Verde using PCR (Alves et al., 2006). The 
impact of lysing cells and using Chelex®100 in DNA extraction is fully discussed in Chapter VI. 
1.5.2 Intracellular parasites in the WBC (Leishmania) 
Leishmaniasis is a disease caused by Leishmania parasites, that are located intracellulary in 
macrophages (Figure 1.7), and transmitted to mammals including humans through the bite of 
phlebotomine sand flies. It is estimated that worldwide there are an annual 1.5 to 2 million cases with 
up to 350 million people at risk of infection.  
 
Figure 1.7: Blood film showing Leishmania intracellularly within macrophages 
(www.nature.com/bmt/journal/v40/n4/images/1705728f2.jpg) 
Diagnosis of leishmaniasis is considered a challenge because of the wide spectrum of clinical 
manifistations including, ulcerative skin lesions developing at the site of sand fly bite (localised 
cutaneous leishmaniasis), multiple non-ulcerative nodules (diffuse cutaneous form), destructive 
mucosal inflammation form and disseminated fatal visceral form (Murray et al., 2005; Reithinger and 
Dujardin, 2007). Epidemiological studies carried out in the last few decades show that leishmaniasis is 
 17 
a zoonotic disease because at least 15 Leishmania species (Table 1.1) found in mammals are infective 
for humans (Hide and Tait, 1991). 
Table 1.1: Leishmania species and sub-species with the disease form caused (Hide and Tait, 
1991) 
Species Sub-species Disease form 
brasiliensis Muco-cutaneous form 













Leishmania major  Cutaneous 
Leishmania tropica  Cutaneous 
Leishmania aethiopica  Cutaneous 
 
1.5.2.1 Diagnosis 
In recent decades, surveillance data indicates that the number of cases with leishmaniasis has 
increased; such an increase could be attributed to the improved diagnosis resulting in increased case 
reporting beside other factors such as inadequate vector control resulting in an absolute increase in 
disease incidence (Reithinger and Dujardin, 2007). The broad clinical spectrum of leishmaniasis 
makes the diagnosis more difficult and complicated, however, it should be accurate and differential 
because diseases caused by other etiological agents with clinical manifestations similar to those 
caused by Leishmania parasites are present at the same area such as skin diseases that might be 
diagnosed as cutaneous form (Reithinger and Dujardin, 2007). Moreover, the importance of accurate 
and differential diagnosis of leishmaniasis arises from the need to prescribe the highly toxic drugs 
only to patients affected with the more pathogenic species such as those causing the visceral form of 
the disease (Hide and Tait, 1991). 
Microscopy of Giemsa stained smears (from blood, cutaneous lesion or visceral biopsy) is still the 
gold standard diagnostic approach in different health levels in endemic areas as more sophisticated 
techniques are currently expensive and rarely available (Herwaldt, 1999). The sensitivity of 
microscopy tends to be low and can be highly variable depending on the number and dispersion of 
parasites in biopsy samples, the sampling procedure and most importantly, the technical skills of the 
personnel (Herwaldt, 1999; Murray et al., 2005; Reithinger and Dujardin, 2007). 
Several serological approaches are commonly used in visceral form diagnosis, in particular, freeze-
dried antigen-based direct agglutination tests and commercially available immunochromatographic 
dipstick tests due to their high sensitivity, ease of use and minimal laboratory and technological 
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expertise requirements (Chappuis et al., 2006). However, serological tests are rarely used in cutaneous 
form because sensitivity can be variable and the number of circulating parasites tends to be low, as in 
cases of previous administration of chemotherapy. The specificity can also be variable, especially in 
areas where cross-reacting parasites such as Trypanosoma cruzi are prevalent (Chappuis et al., 2006; 
Reithinger and Dujardin, 2007). 
DNA hybridization technique has been found to be useful as a diagnostic procedure using labelled 
minicircle kDNA as a diagnostic probe (Nantulya, 1991). The minimum number of parasites detected 
by this technique was 102-103. Genomic DNA probes also exist but most are probes directed against 
single copy sequences, which are not generally suitable for diagnosis (Barker, 1987). Field application 
of DNA probes in diagnosing leishmaniasis was reported in Brazil for the identification of the 
parasites in 68 patients, of which, 94.1% belonged to L. braziliensis complex and 5.9% belonged to L. 
mexicana complex (Andrade et al., 2005). 
Practical applications of molecular methods for leishmaniasis diagnosis may be used to answer 
different clinical and biological questions (Reithinger and Dujardin, 2007). The first question is the 
detection of the parasite before initiating therapy; this includes analysis to the species or genus level. 
In this case, PCR has been shown to be better than microscopy, particularly in samples with low 
parasitaemia levels. Secondly, quantification of the parasite load may be highly relevant for 
monitoring disease progression and outcome of anti-Leshmanial therapy, qPCR with high analytical 
sensitivity reaching 0.0125 parasites per ml of blood has been reported with different Leishmania 
species. Although the higher sensitivity and accurate quantification achieved using qPCR, the cost of 
such tests remains higher than the conventional assays. It has been estimated that the cost per sample 
analysed using qPCR assays is $12, and $2.5 for analysis using PCR-RFLP assays (Reithinger and 
Dujardin, 2007). 
The prevalence of leishmaniasis was studied using sero-diagnosis and PCR of blood samples collected 
from 100 dogs. The results revealed sero-prevalence of 26%, whilst, 63% were positive using PCR 
indicating higher sensitivity of PCR in diagnosing leishmaniasis (Solano-Gallego et al., 2001). 
Field samples collected for the diagnosis of the disease include cutaneous lesions, visceral biopsies 
and blood samples. PCR on blood samples for diagnosis depends mainly on the preparation of the 
blood sample. Extraction of DNA from blood was conventionally done using organic solvents 
(phenol-chloroform extraction), although this method is low cost if compared with commercial DNA 
extraction kits, it takes three hours to obtain the DNA (Alhassan et al., 2007). Moreover, the organic 
solvents are known to persist in DNA extracts and can inhibit the PCR and require appropriate 
chemical disposal (Reithinger et al., 2000).  
Guanidine blood lysates have been used for lysing the blood cells to release the parasite from inside 
the macrophage cells (Reithinger et al., 2000). Moreover, guanidine HCl is also suitable for storing 
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the samples at 4ºC or even at room temperature because it keeps the integrety of DNA for months. 
However, guanidine HCl might inhibit PCR because it is a salt, therefore, dilutions of extracted DNA 
might be required for successful amplification (Reithinger et al., 2000). 
In conclusion, compared to the standard microscopy and cell culture approach for leishmania 
diagnosis, the molecular approaches remain expensive and require technological expertise, and efforts 
should be made to make PCR simpler and cost-effective especially in remote areas where 
leishmaniasis is endemic (Reithinger and Dujardin, 2007). 
1.5.3 Extracellular parasites (Trypanosoma cruzi) 
The blood protozoa Trypanosoma cruzi (Figure 1.8) is the causative agent of Chagas’ disease 
(American trypanosomiasis) which is transmitted to mammals by insect vectors called triatomine bugs 
(CDC, Fact sheet, 2007). These insects are commonly found in Latin America, especially in rural 
areas where poverty is widespread. The disease is named after the Brazilian physician Carlos Chagas 
who described the disease and the transmission cycle in 1909. The disease is acquired through 
contamination of the conjunctiva or any skin abrasion with the faeces of the infected bugs. The 
disease is the most important zoonotic parasitic disease in Latin America infecting more than 10 
million people and about 50,000 chagasic patients die each year from the disease (CDC, Fact sheet, 
2007; Miles et al., 2003; Oelemann et al., 1998). 
 
Figure 1.8: T. cruzi extracellular C- shape in blood film  
(workforce.cup.edu/buckelew/Trypanosoma%20cruzi%20amastigotes%20in%20heart.htm)  
The parasite is also transmitted through blood transfusion and congenital transmission as well as 
accidental ingestion of the vector faeces (Oelemann et al., 1998). Clinically, at the site of exposure to 
infected faeces, local lesions in form of unilateral conjunctivitis and oedema (Romaña’s sign) or 
cutaneous chagoma are developed. After the acute clinical manifestations disappear, the infection rests 
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with a long period of latency, called the indeterminate form period, which may last throughout life or 
evolve to a chronic phase (Chagas, 1922).  The chronic phase is characterised by heart disease 
especially aneurysm of the apex of left ventricle because the parasite multiplies in heart muscle (Miles 
et al., 2003; Tanowitz et al., 1992). Gastrointestinal involvement also is a characteristic of the chronic 
phase. 
1.5.3.1 Diagnosis 
In areas where Chaga’s disease is endemic, T. cruzi may infect as many as 74% of the general 
population (Pless et al., 1992). Economic difficulties in such endemic areas are considered as a risk 
for the disease spread and the increased number of undiagnosed subclinical cases due to poor housing 
which is suitable for vector habitat (Garcia et al., 1995). Therefore, sensitive, rapid and specific 
diagnostic assays are greatly needed for the acute Chagas’ disease because early drug treatment of the 
acute form is presumed to be beneficial. The first approach for T. cruzi diagnosis is microscopic 
examination of blood films from suspicious patients (Kirchoff et al., 1996). Xenodiagnosis, (meaning, 
in this context, feeding of laboratory bred triatomine on the patient followed by dissection of the 
insect looking for T. cruzi) and intensive blood cultures are used for diagnosing chronic phase patients 
due to low parasitaemia which is far below the threshold for microscopic detection (Miles et al., 2003; 
Tanowitz et al., 1992). Microscopic diagnosis of the vector hind gut is the gold standard method 
which is essential for vector control strategies; the usual standard for microscopic examination for 
parasite prevalence is based on the observation of 50 fields. The examination depends mainly on the 
detection of the parasite motility under the microscope which requires the examination of fresh 
samples (Pizarro et al., 2007).  
Serological assays such as IFAT, indirect hemagglutination, CFT and ELISA are used for diagnosis of 
T. cruzi infections due to their simplicity, low cost and good performance (Andersson, 2004). These 
tests depend on the detection of antibodies directed against the parasite; however, two tests should be 
used for the confirmation of the results because IFAT and hemagglutination often lead to false 
positive or false negative results due to antigenic cross reactivity with other parasites such as 
Leishmania and Trypanosoma rangeli, therefore ELISA is usually combined with these tests to 
confirm the results (Avila et al., 1991; Garcia et al., 1995; Oelemann et al., 1998). 
T. cruzi contains nuclear and kDNA, both of which contain many repetitive sequences that are highly 
suitable for PCR detection (Virreira et al., 2003). A repetitive genomic DNA sequence has been used 
as a diagnostic probe (Nantulya, 1991). This probe consists of 195 bp repeating unit that constitutes 
9% of the parasite genome. The sensitivity of this assay permits the detection of phenol-extracted 
DNA of 30 parasites genome equivalent from mammalian blood or tissues. 
PCR based detection of T. cruzi from vector gut and from mammalian host blood is widely used for 
treatment and control purposes. Several primers complementary to the 330 bp conserved region of the 
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kinetoplast-minicircle part of the mitochondrial DNA have been used in PCR based assays (Moser et 
al., 1989b). However, such PCR targeting the kDNA minicircle region require partial disruption of the 
dense kinetoplast minicircle with either a nuclease or by boiling the sample in the presence of strong 
chaotropic agent such as guanidine chloride to release the linear and amplifiable kDNA fragments. 
Moreover, the kDNA minicircle target has some sequence similarity to kDNA minicircle regions in 
other trypanosomatids such as Leishmania and other trypanosomes, decreasing the specificity of the 
target sequence. Primers amplifying a 188 bp repetitive nuclear sequence were found to be more 
sensitive in the parasite detection because this sequence was found in 1.8 times as many copies in T. 
cruzi genome as there are of the minicircle kDNA target, allowing the detection of low numbers of 
parasites. These primers amplify a target which is specific for T. cruzi parasites making it an ideal 
target for primer directed amplification of T. cruzi DNA without any pre-treatment of the sample 
(Moser et al., 1989b; Pizarro et al., 2007; Virreira et al., 2003). 
A study has been conducted to evaluate the performance of PCR amplification in the diagnosis of 
chronic Chagas’ disease from whole blood and compared to serology (Avila et al., 1993). The results 
indicated that the PCR amplification method has 100% sensitivity compared with serological testing. 
Nested PCR (the target DNA undergoes the first run of PCR using first set of primers, then the 
product from the first reaction undergoes a second run using a second set of primers) has also been 
designed for the amplification of flagellar protein gene (Tc-24) which directly demonstrates the 
presence of T. cruzi (Andersson, 2004; Vera-Cruz et al., 2003). The authors argued that nested PCR is 
a good way to assess T. cruzi persistence because the second PCR step is considered as a confirmation 
that the appropriate parasite DNA is amplified. 
A cross sectional study to determine the prevalence of T. cruzi infection among dogs in Oklahoma 
using PCR revealed that 3.6% of the examined dogs were infected (Bradley et al., 2000). Another 
large field study has been performed in Bolivia with the aim of comparing PCR with other diagnostic 
methods for Chaga’s disease. The results showed that PCR is highly sensitive when compared with 
ELISA and microscopy. The blood samples were lysed using guanidine to release the linear kDNA for 
amplification using PCR (Wincker et al., 1997). 
Quantitative PCR was developed by Cummings and Tarleton (2003) using SYBR Green I assay in 
order to demonstrate the utility of qPCR for quantitative measurement of tissue parasitic load in 
experimental T. cruzi infection. The authors optimised two specific primer sets, the first set that 
amplifies the tandemly repeated satellite DNA sequence exhibited greater sensitivity than the primer 
set amplifying kDNA (Cummings and Tarleton, 2003; Virreira et al., 2006). 
Piron et al. (2007) recently developed and evaluated the efficacy of qPCR assay to detect and quantify 
T. cruzi in blood of chagasic patients, using a TaqMan probe to guarantee the specificity of the 
measured signal. The qPCR is designed to amplify a 166 bp fragment in the satellite DNA of T. cruzi 
which has been shown to be specific, with a sensitivity of 7.8 down to 0.06 epimastigotes/ml. The 
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authors concluded that this new qPCR system was simpler, faster and more reliable than conventional 
PCR with a possibility of quantification and reduced risk of contamination. 
LAMP reaction has been developed for the detection of T. cruzi using primer sets targeting the 18S 
rRNA gene (Thekisoe et al., 2007). The primers have been shown to be highly specific because only 
the target DNA was amplified. Moreover, the sensitivity of the reaction was quantified using serial 
dilution of T. cruzi DNA starting from 10 ng down to 1 fg which is equivalent to DNA from 0.01 
trypanosomes. The primers showed high sensitivity while detecting the protozoa DNA down to 1 fg, 
indicating that LAMP has the potential to be used as an alternative molecular diagnostic method 
especially at the under resourced laboratories because it takes only one hour for amplification, 
requires simple instruments (water bath) and it can produce large amounts of DNA that can be 
visualised by the naked eye because it depends on turbidity or colour detection (Thekisoe et al., 2007). 
1.6 Aims and outline of the thesis 
The overall aim of the thesis is to investigate molecular diagnosis of trypanosomiasis as a model for 
blood borne infectious diseases. The approach adopted in the thesis is outlined below. 
• Chapter II reviews the taxonomy and lifecycle of trypanosomes in vertebrate host and insect 
vector. Diagnosis of trypanosomes using different approaches starting from visualisation of 
the parasite by microscopy to different molecular tools is fully described. 
•  Chapter III validates the use of different sample preparations in the molecular diagnosis of 
trypanosome species. 
• Chapter IV describes trials to improve the preparation of blood samples from paper based 
system (FTA®cards). 
• Chapter V evaluates different PCR reactions in use for the molecular diagnosis of 
trypanosomes highlighting the advantages and drawbacks of each reaction.  
• Chapter VI describes the application of the improved sample processing from FTA®cards and 
species-specific PCR reactions in field in a case study of the impact of the Stamp Out 
Sleeping sickness (SOS) mass treatment programme in the prevalence of different 
trypanosome species in new sleeping sickness foci, Uganda.  
• Chapter VII aims to evaluate qPCR for quantifying Trypanosom. brucei brucei and T. 
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Trypanosomiasis is a disease occurring in Sub-Saharan Africa, caused by blood borne parasites of the 
genus Trypanosoma that are transmitted cyclically by Glossina species (Hoare, 1972). Trypanosomes 
have been reported in 38 African countries where they cause diseases of medical and veterinary 
importance (Masiga et al., 1996; WHO, 2001, , 2006). Human African trypanosomiasis (sleeping 
sickness) is caused by the parasites T. brucei rhodesiense and T. brucei gambiense; it is estimated that 
300,000-500,000 people are currently infected, resulting in an estimated 100,000 deaths per annum 
(Cattand, 2001). However, the actual number is unknown because those infected with trypanosomes 
tend to live in areas with little or no medical care (El-Sayed et al., 2000). Moreover, sleeping sickness 
is likely to be highly under-reported because outbreaks tend to occur mainly among the rural poor and 
during civil strife when control measures are difficult to apply (Odiit et al., 2005).  
It is estimated that three million cattle die annually from trypanosomiasis, T. vivax and T. congolense 
are regarded as major pathogens of cattle and other ruminants causing a disease called Nagana (Aksoy 
et al., 2003; Hoare, 1972). T. brucei affects all livestock, with particularly severe effects in equines 
and dogs, while, T. simiae causes high mortality in domestic pigs. 
The greatest impact of animal trypanosomiasis is on the nutrition of millions of people living in the 
most highly endemic areas and on the agricultural economies of their countries as it renders vast areas 
of semi-arid savannah land in Africa unsuitable for raising domestic animals that are the source of 
dairy and meat products (El-Sayed et al., 2000). 
2.1.1 Historical background 
“It is tempting to believe that stages of a true trypanosome were first seen in 1680 by Antony van 
Leeuwenhoek (the Father of Protozoology) who described organisms seen by him in the gut of horse 
flies, which might have been the developmental stages of the bovine parasite T. theileri. However, 
serious attention to the trypanosomes of mammals was drawn by the work of Timothy Lewis (1878, 
1879) on a parasite of Indian rats (T. lewisi). The discovery of the causative agent of Surra (T. evansi) 
in local horses and camels in India (1880) was the starting point of all subsequent investigations which 
incriminated trypanosomes in the aetiology of a series of diseases affecting man and livestock. The 
most important contribution to this subject was made by David Bruce (1880) who proved that the 
disease Nagana in livestock of Zululand was caused by a trypanosome (T. brucei) and also 
demonstrated that the disease was transmitted by tsetse flies and wild game animals acted as 
reservoirs of infection” (Hoare, 1972). 
“The clinical signs of sleeping sickness were described during the 14th century in the historical 
writings of Al-Qalqashandi, who recorded that the Sultan of the Mali died from the disease in 1373-4 
(Lumsden, 1974). Arab merchants and slave traders recognised the characteristic sign of the disease 
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(swollen cervical gland) making them reject slaves (Cattand, 2001). In 1902, trypanosomes were 
discovered in a human in West Africa by Dutton, and in the following year, similar trypanosomes 
were seen by Castellani (1903) in cerebro-spinal fluid (CSF) of a sleeping sickness patient in Uganda. 
Bruce had shown in 1903 that the mild infections observed in West Africa and sleeping sickness in 
East Africa were phases of the same disease. In 1909, the German investigator Kleine made the 
important discovery that T. brucei had to undergo cyclical development in tsetse flies (Glossina) 
before it became infective to a new mammalian host” (Hoare, 1972). 
2.1.2 Structure of trypanosomes 
Trypanosomes are blood borne parasites with a single nucleus, single flagellum and a leaf like or 
rounded body (Figure 2.1). The trypanosomes are members of the order Kinetoplastida characterised 
by the presence a kinetoplast (a DNA containing organelle) which is a part of the only mitochondria 
within the cell (Marquardt et al., 2000). 
 
Figure 2.1: Trypanosome cell structure showing single flagellum and the kinetoplast   
(www.gsbs.utmb.edu/microbook/ch077.htm) 
2.1.3 Taxonomy of trypanosomes 
The genus Trypanosoma is divided into Stercoraria and Salivaria groups (Figure 2.2). The first group, 
the Stercoraria, trypanosomes develop in the hindgut of the vector and are then transmitted to the host 
through faecal contamination (the insect defecates after taking the blood meal). The second group, the 
Salivaria, the majority of trypanosomes are transmitted from the vector to the host during the act of 
blood feeding (Hoare, 1972). 
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For most species of Salivaria group, the vector for transmission is the tsetse fly. The two exceptions of 
this are T. evansi which is transmitted mechanically by tabanid flies, and T. equiperdum which is 
transmitted by direct sexual contact between equine hosts (Levine et al., 1980; Marquardt et al., 
2000). Recently, Claes et al. (2005) hypothesized that some T. equiperdum strains are actually T. b. 
brucei or members of a subspecies of T. brucei (T. b. equiperdum) and that all other T. equiperdum 
strains are misidentified and are, in fact, T. evansi. This hypothesis was based on the existence of only 
small number of T. equiperdum laboratory strains after 100 years of research and the history of most 
of the strains is unknown. Moreover, the disease caused by T. equiperdum (dourine) has no definitive 
diagnosis based on serological or molecular methods, and only clinical signs are pathognomonic. The 
authors now propose to investigate their hypothesis by performing experimental infections in horses 
with T. equiperdum and comparing the produced clinical signs with the pathology of confirmed T. b. 
brucei and T. evansi strains (Claes et al., 2005). 
 
Figure 2.2: Taxonomy of trypanosomes (classification is based on Hoare (1972) and Marquardt 
et al. (2000)) 
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2.1.4 Animal African Trypanosomiasis 
2.1.4.1 Overview 
The burden of animal trypanosomiasis is due to the direct losses resulting from mortality, morbidity 
and infertility of infected animals and the costs of controlling the disease (Hoare, 1972). Also, due to 
the indirect losses which include the exclusion of livestock and animal power-based crop production 
from the extensive tsetse flies infested areas (FAO, 1998,cited after (Kidanemariam et al., 2002)). It is 
estimated that three million cattle die annually from trypanosomiasis causing shortage in sources of 
animal protein. Therefore, the disease contidbutes to protein deficiency problems  in tropical Africa 
(Marquardt et al., 2000). 
2.1.4.2 Vertebrate host 
Table 2.1 shows the host range of African trypanosomes in domestic animals.  In the second column 
the list of livestock species is tentatively ranked in descending order of importance as an indication of 
pathogenicity (Uilenberg, 1998). 
Table 2.1: Species of African trypanosomes with their hosts (Uilenberg, 1998) 
Species Domestic animal host Reservoir 
T. b. brucei Horses, camels, dogs, sheep, goats, cattle, pigs Several groups of wild mammals 
 
T. b. rhodesiense Horses, camels, dogs, sheep, goats, cattle, pigs Several groups of wild mammals 
 
T. b. gambiense 
 
Horses, camels, dogs, sheep, goats, cattle, pigs Several groups of wild mammals 
 
T. congolense Cattle, camels, horses, dogs, sheep, goats, pigs Several groups of wild mammals 
 









2.1.4.3 Life cycle 
Trypanosomes transmission has two phases (Figure 2.3). One phase is inside the vertebrate host, while 




Figure 2.3: Life cycle of Trypanosomiasis in the vertebrate and invertebrate host 
(www.dpd.cdc.gov/DPDX/HTML/ImageLibrary/SZ/TrypanosomiasisAfrican/body_TrypanosomiasisAfrican_il5.ht) 
2.1.4.3.1 Inside the insect vector 
The tsetse fly becomes infected with bloodstream trypomastigotes when taking a bloodmeal from an 
infected mammalian host. In the fly’s midgut, the parasites transform into procyclic trypomastigotes 
that multiply by binary fission, leaving the midgut and transform into epimastigotes (Uilenberg, 
1998). The epimastigotes reach the fly’s salivary glands (in case of Trypanozoon) or mouthparts (in 
case of Nannomonas) and continue multiplication by binary fission giving rise to the infective 
metacyclics. In case of Dutonella species, trypanosomes mature in the proboscis of the fly but do not 
undergo a midgut maturation stage (Desquesnes and Dia, 2003). The period from ingesting infected 
blood to the appearance of the infective metacyclics varies according to the trypanosome species. It 
varies from five days in flies infected with T. vivax , two to three weeks in flies infected with T. 
congolense, while, three to five weeks is required in flies infected with T. brucei s.l (Vickerman et al., 
1988). 
2.1.4.3.2 Inside the vertebrate host 
During a bloodmeal on the mammalian host, an infected tsetse fly injects metacyclics into skin tissue. 
The metacyclics undergo development and multiplication at the site of infection where a swelling or 
chancre may be detected in the skin. The mature bloodstream trypomastigotes are released via lymph 
vessels and lymph nodes into blood circulation. Trypomastigotes multiply by binary fission in various 
body fluids such as blood, lymph and spinal fluids (Uilenberg, 1998). 
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2.1.4.4 Factors affecting the disease severity 
A number of host factors including physiological status of the host, nutritional and environmental 
factors have an important effect on the pathogenicity and determine the severity of the disease 
(Uilenberg, 1998). The pathogenicity of different species differs according to the host, for example, T. 
vivax is severely pathogenic to cattle, while T. b. brucei causes mild infection. The severity is also 
related to the geographical distribution, meaning that some East African isolates of T. vivax may cause 
an acute haemorrhagic disease in cattle, while, most West African T. vivax isolates cause a milder 
non-haemorrhagic disease. T. congolense is severely pathogenic to cattle and camels, while, 
moderately pathogenic to goats, sheep, horse and dogs (Taylor and Authie, 2004). Classically, in West 
Africa, acute T. vivax infection has been considered more important than T. congolense, whereas, in 
central or East Africa, T. congolense is considered the more important parasite (Eisler et al., 2004). 
2.1.4.5 Pathogenesis 
Infection of animals with T. congolense, T. vivax or T. b. brucei causes a disease known as Nagana, it 
is a chronic deblitating disease characterised by anaemia, roughness of hair coat, abortion, reduced 
milk yield, intermittent pyrexia, depression and gradual loss of condition (Figure 2.4), leading to 
extreme emaciation and death of the animal (Eisler et al., 2004; Hoare, 1972).  
The lesion at the site of penetration is characterised by congestion and oedema. Plasma cells, 
lymphocytes and macrophages accumulate in this lesion then the parasites move into the lymphatic 
and circulatory systems (Uilenberg, 1998). Because of high parasitaemia, the body temperature rises 
to 39-41ºC, and the immune response of the body is directed toward the invading parasites leading to 
enlargement of the lymph nodes and the spleen.  
 
Figure 2.4: Emaciated cattle with nagana  
(www.dfid-ahp.org.uk/images/projectphotos/009-R8214.jpg) 
Protection from the host immune response is afforded by variable surface glycoproteins (VSGs) which 
are glycosyl-phosphatidyl-inositol (GPI) anchored molecules that form a dense monolayer of identical 
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epitopes protecting against complement mediated lysis (Barry and Carrington, 2004). VSGs are only 
expressed in specialised telomeric loci called expression sites (ES) (Berriman et al., 2005). A small 
membrane portion of VSGs bearing limited antigen epitopes are exposed, these epitopes exhibit a high 
degree of variability between different VSGs. Meaning that switching VSG expression offers a 
mechanism to evade any antibody response that the host immune system may have developed. This 
mechanism is observed when waves of parasitaemia in infected patients occur due to the expression of 
different VSGs, resulting in the escape of small number of parasites from the host immune response 
(reviewed in Pays, 2006). 
2.1.4.6 The zoonotic potential of trypanosomiasis 
Animals are considered as an important source of food and transport for man. However, they are also 
an important source of many diseases that can be directly or indirectly transmitted to human 
(Seimenis, 1998). These diseases are zoonotic, and constitute a public health problem throughout the 
world (Coulibaly and Yameogo, 2000). The best agreed definition of zoonoses used by the WHO is 
that “they are those diseases and infections which are naturally transmitted between vertebrate animals 
and humans” (Shakespear, 2002).  
The causative agents of zoonoses include prions, viruses, bacteria, protozoa, fungi and helminthes. It 
has been estimated that 62% of all human pathogens are classified as zoonotic (Taylor et al., 2001). It 
is well documented that T. b. rhodesiense is a zoonosis that is transmitted from a wide range of 
domestic and wild animals to human through the bite of tsetse flies. In particular, cattle are believed to 
be the important reservoir host for T. b. rhodesiense (Hide et al., 1996). In contrast, T. b. gambiense is 
not considered to be a zoonotic disease, however, recently a variety of wild animals and pigs were 
reported to harbour the pathogen (Njiokou et al., 2006; Simo et al., 2006) 
2.1.5 Human African Trypanosomiasis 
2.1.5.1 Overview 
Human African Trypanosomiasis (HAT), known as sleeping sickness, remains a significant public 
health problem in sub-Saharan Africa. The disease has two forms, Gambian sleeping sickness (in 
central and western Africa) caused by T. b. gambiense and Rhodesian sleeping sickness (in eastern 
Africa) caused by T. b. rhodesiense resulting in chronic and acute forms, respectively (Apted, 1970). 
The obvious distinction of the two forms is that the Rhodesian form may be fatal within a few months 
due to central nervous system (CNS) involvement, damage to the heart and/or viscera, whereas the 
Gambian form may progress for years before death due to central nervous system damage. Sleeping 
sickness is placed third behind malaria and schistosomiasis in terms of the burden of parasitic diseases 
in sub-Saharan Africa (Cattand, 2001). 
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The incidence of T. b. rhodesiense sleeping sickness is characterised by short epidemics interspersed 
between long periods of low undetectable endemicity (Hide et al., 1996). One possible mechanism for 
the generation of an epidemic is the introduction of new strains of parasites which may be more 
virulent or have a higher level of transmissibility through the human population. The possible 
explanations for the introduction of such new strains could be the change in the ecology resulting in a 
higher transmission of existing human infective trypanosomes from reservoir hosts to humans, genetic 
exchange or the appearance of new strains from other regions (Hide et al., 1996). 
2.1.5.2 Disease stages 
2.1.5.2.1 First stage 
Human African Trypanosomiasis is characterised by two stages; the first stage is the haemolymphatic 
stage which corresponds to the invasion of lymph, blood and other tissues by trypanosomes. At the 
site of the fly bite, a trypanosomal chancre (Figure 2.5) may appear after 5-15 days of infection, other 
early signs include itching, erythema, swelling and pain. After three to four weeks, the chancre usually 
heals with overlying desquamation. Invasion of the blood stream by the trypanosomes leads to fever, 
headache and general malaise. 
 
Figure 2.5: Trypanosomal chancre at the site of the fly bite 
(www.cdc.gov/ncidod/eid/vol8no1/images/01-0130ab.jpg) 
Other clinical signs include adenopathy especially enlarged neck gland causing Winterbottom’s sign 
(only in case of Gambian form) (Figure 2.6); skin rash, oedematous swelling of the lower eyelids and 
puffy swollen appearance of the face. Moreover, cardiovascular disturbances such as arrhythmia and 
hypotension are early signs of the acute phase (Barrett et al., 2003; Buscher and Lejon, 2004). 
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Figure 2.6: Winterbottom’s sign (enlarged neck gland in Gambian sleeping sickness) 
(commons.wikimedia.org/wiki/Image:Winterbottom's_sign.jpg) 
2.1.5.2.2 Second stage 
The second stage is the meningo-encephalitic stage, which occurs due to crossing of the blood brain 
barrier by the parasite. This stage occurs within a few weeks of infection with T. b. rhodesiense but 
over a period lasting between several months or years with T. b. gambiense. Signs of nervous system 
injury become more obvious especially in the Gambian form due to long duration of the disease. As 
this stage progresses, headaches become severe and sleep disorders begin to manifest. This stage is 
also characterised by disorders of tonus, motility and abnormal movement behaviour. However, in the 
Rhodesian form the marked neurological symptoms are often not clear because death occurs more 
rapidly (Barrett et al., 2003; Buscher and Lejon, 2004). 
2.1.6 Vector 
2.1.6.1 Introduction 
African trypanosomes are transmitted between vertebrate hosts by tsetse flies that belong to genus 
Glossina of family Glossinidae (Figure 2.7). Tsetse flies are restricted to sub-Saharan Africa between 
latitudes 5oN and 20oS in an area of 8.5 million km2 which represents more than 40% of the total land 
area of 38 African countries (Allsopp, 2001), except for a report early in the 20th century from the 
Arabian Peninsula where small tsetse pockets were reported in the southwest part (Barrett et al., 
2003). They breed along different habitates such as rivers, streams and bush; being active during the 
day and feed exclusively on blood. Unlike most biting flies, where only females are bloodsuckers, 
both male and female tsetse flies require bloodmeals. The fly is characterised by the wings overlaping 
one another at rest and the presence of “a hatchet cell” in the centre of the wing (Marquardt et al., 
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2000; Uilenberg, 1998). After trypanosomes develop in the tsetse host, the fly remains infective over 
its life span, which is around five to six weeks in the field (Welburn and Maudlin, 1999). 
 
Figure 2.7: Tsetse fly feeding on blood  
(www.dfid-ahp.org.uk/images/gallery/target133.html) 
2.1.6.2 Taxonomy of the vector 
Tsetse have been divided into three sub-genera, Glossina, Nemorhina and Austenina, that are 
commonly called morsitans, palpalis and fusca groups, respectively (Pepin and Meda, 2001). The 
species and subspecies are listed in Table 2.2. 
Table 2.2: Taxonomy of the vector (Rogers and Robinson, 2004; Uilenberg, 1998) 
Morsitans group Palpalis group Fusca group 
Species Sub-species Species Sub-species Species Sub-species 
G. m. morsitans G. p. palpalis G. f.  fusca 
G. m. submorsitans G. palpalis G. p. gambiensis 
G. fusca 
G. fusca congolense 
 
G. morsitans 
G. m.  centralis G. f. fuscipes G. n. nigrofusca 
G. pallidipes  G. f.  martini 
G. nigrofusca 
G. n.  hopkinsi 
G. swynnertoni  
 
G. fuscipes 
G. f. quanzensis G. brevipalpis  
G. austeni  G. p. pallicera G. fuscipleuris  
G. longipalpis  
G. pallicera 
G. p.  newsteadi G. haningtoni  
  G. caliginea  G. longipennis  
  G. tachinoides  G. medicorum  
    G. nashi  
    G. severini  
    G. schwetzi  
    G. tabaniformis  
    G. vanhoofi  






The classification of tsetse is based on morphological criteria dividing the species into the 
aforementioned three groups. The geographical distribution of these groups is shown in Figure 2.8. In 
summary, the fusca group flies tend to occur in the lowland rainforests of West and Central Africa 
(Figure 2.8a). While, palpalis group flies occupy similar forest habitats throughout Africa and extend 
into riverine and lakeside forests or the moist areas between such forests (Figure 2.8b). Finally, the 
morsitans group of flies occurs in a variety of savannah habitats lying between the forest edges and 
deserts (Figure 2.8c) (Rogers and Robinson, 2004). 
  
a) Distribution of fusca group b) Distribution of palpalis group 
 
c) Distribution of morsitans group 
Figure 2.8: Distribution of tsetse groups  
(http://ergodd.zoo.ox.ac.uk/livatl2/tsetse.htm) 
Host preference of the vector was investigated by Weitz (1963) who analysed over 22,000 tsetse blood 
meals collected from all over Africa using precipitin test. The authors categorised the tsetse according 
to their feeding preference in to five groups as shown in Table 2.3. 
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Table 2.3: Feeding preference of Glossina species (Uilenberg, 1998) 
Group Glossina species Host preferred 
1 G. swynnertoni, G. austeni, G. tabaniformis and G. fuscipleuris Mainly Suidae 
2 G. m. morsitans and G. m. submorsitans Equally feed on Suidae and Bovidae 
3 G. pallidipes, G. longipalpis and G. fusca Mainly Bovidae 
4 G. brevipalpis and G. longipennis Mainly mammalian species other 
than Suidae and Bovidae 
5 G. p. palpalis, G. f. fuscipes and G. tachinoides Most available hosts and man 
 
2.1.7 Control 
2.1.7.1 Tsetse control strategies 
Vector control is considered an important approach to control both human and animal 
trypanosomiasis. The female fly produces a single egg over a period of 12-14 days that develops 
inside the uterus into a larva that weighs more than the female (Hargrove, 2004). This means that a 
female produces no more than eight to 10 eggs in a lifetime of 14 weeks. This low reproductive rate 
allows the control programmes targeting the flies to be more effective resulting in reduction of the 
vector number. 
Until the development of organochlorine insecticides such as Dichlorodiphenylethans (DDT) in 
1940s, the principle means of tsetse control were the extermination of game and the destruction of 
bush (Swynnerton, 1921). Although these methods have been used successfully in the past to control 
tsetse, they are no longer used due to their ecological implications (Grant, 2001). 
The application of insecticides can be done from air or from the ground. Ground application aims to 
apply a deposit of residual insecticides to resting sites of tsetse on vegetation where it remains lethal 
to tsetse beyond the maximum pupal period of about 60 days (Holmes, 1997). This method is the only 
proven method of large-scale tsetse eradication, for example the elimination of tsetse from 200,000 
km2 of Nigeria (Jordan, 1978). In the past, DDT has been commonly used; however, the use of 
residual insecticides is now environmentally and politically unacceptable. Recently, pyrethroids such 
as deltamethrin (Vectocid®) have been applied using the ground application method. Problems have 
been encountered with this method such as developing adequate access, maintaining a fleet of vehicles 
and spraying items, and supervising large numbers of spray teams (Holmes, 1997). 
In order to overcome the drawbacks of ground spraying, aerial spraying was increasingly adopted 
during the 1970s and 1980s using the sequential aerosol technique. This approach applies very low 
doses of insecticides as aerosols either from low flying aircraft or helicopters at intervals timed to kill 
newly emerged flies before they could reproduce to deposit larvae in the soil. The sequential 
application of five sprayings is found to be sufficient and has no residual effect due to the very low 
doses used. This method has advantages over ground spraying as a result of reduced labour demands 
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and the centralisation of activities and support facilities. However, it is expensive and requires 
substantial funding at national and international level (Grant, 2001; Holmes, 1997). 
In the early 1970s, bi-conical traps (Figure 2.9) made from blue and black materials that attract tsetse 
flies, were developed and successfully used against riverine species such as G. palpalis palpalis 
(Allsopp, 1984). However, a study conducted at the same time in Zimbabwe, demonstrated that the 
traps failed to catch many of the tsetse that visited them and most of the tsetse were instead attracted 
to a stationary animal in response to the host’s odour (Vale, 1980). Therefore, different attractants 
such as carbon dioxide, acetone, butanone, 4-methylphenol and 3-n propylphenol have been used to 
attract tsetse flies to the traps. The use of the aforementioned attractants increased the catch of the trap 
by 20-fold for some species of tsetse. Moreover, cheaper and simpler targets have been developed, 
they are insecticide treated cloth screens baited with synthetic odours. The flies come in contact with 
the target and pick up a lethal dose of insecticide. Targets have the advantage of being relatively more 
effective and cheaper than traps, although traps have the distinct advantage of displaying dead tsetse 
flies, which helps to motivate local people to participate in schemes using this technique (Grant, 2001; 
Holmes, 1997). 
  
Figure 2.9: Bi-conical tsetse traps 
(www.nri.org/tsetse/FAQ/Pics/ph_biconique2.jpg) 
In recent years, the use of insecticide sprays, dips or pour-on for cattle, have been applied as live bait 
application in areas infested with tsetse flies. Pyrethroides are the chemical of choice for this 
application, the scheme has been proved to be successful and major reduction in tsetse populations 
have been achieved in different areas such as Tanzania, Burkina Faso and Ethiopia (Bauer et al., 
1995; Fox et al., 1993; Holmes, 1997; Rowlands et al., 2001). 
Another method for tsetse control is the use of sterile insect technique (SIT) that depends on the 
release of irradiated sterile males into the environment. The sterile males mate normally with females 
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preventing them from producing any offspring resulting in reduction of the tsetse population 
(Hargrove and Williams, 1998). This technique has been successfully used in the island of Zanzibar, 
although the situation in Zanzibar differs than the other African countries because this island is small 
and geographically isolated from other countries reducing the chance of re-infestation from 
neighbouring areas (Bailey, 1998; Vale and Terr, 2004). 
2.1.7.2 Drugs 
2.1.7.2.1 Treating the animal host 
The application of drugs has been the main control strategy against trypanosomiasis for more than 40 
years. There are currently only three trypanocides available for controlling tsetse transmitted 
trypanosomiasis in animals. These drugs are isometamedium chloride (trade name; Samorin®, 
Trypamidium®, Veridium®) and homidium (chloride salt; Novidium®; bromide salt or ethidium 
bromide; Ethidium®), both having curative and prophylactic effect. The third drug is diminazene 
aceturate (trade names; Azidine®, Berenil®, and Veriben®) has only therapeutic properties (Browning 
et al., 1938).  
Isometamedium chloride and homidium are phenanthridinium compounds, whose antitrypanosomal 
activity was first demonstrated in 1938. Their mode of action is mainly blockage of nucleic acid 
synthesis through intercalation between DNA base pairs and inhibition of DNA and RNA 
polymerases (Browning et al., 1938; Kinabo, 1993). Both isometamedium chloride and homidium are 
active against T. congolense and T. vivax, moreover, isometamedium is of value against infections 
caused by T. brucei s.l (Kinabo, 1993). Isometamidium is routinely administered intra muscular (i.m) 
at doses of 0.25-0.5 mg/kg for therapeutic purposes, and 0.5-1 mg/kg for prophylactic purposes for 
two to three months, with a maximum dose for resistant cases of 2 mg/kg. Homidium is recommended 
for i.m use at a dose of 1 mg/kg (Kinabo, 1993; Sinyangwe et al., 2004). The recommended dose of 
diminazene aceturate is 3.5 mg/kg by i.m route, however, twice this dosage is recommended for T. 
brucei s.l. infections. The trypanocidal activity of diminazene aceturate is mainly due to its ability to 
inhibit kDNA replication and cause alterations in ribosomes, cytoplasmic membranes and amino-acid 
transport mechanisms (Peregrine and Mamman, 1993). 
The emergence of drug resistant trypanosomes has been reported in many African countries (Geerts et 
al., 2001). It is estimated that 35 million doses of trypanocide drugs are used in Africa each year with 
about 50-70 million animals at risk from trypanosomiasis (Geerts and Holmes, 1998). In the past, the 
availability of trypanocides was strictly controlled in most African countries by Government 
Veterinary Departments. However, recently, with the privatization of veterinary services and a general 
trend towards deregulation of markets, trypanocides have become widely available increasing the risk 




2.1.7.2.2 Treating the human cases 
The type of treatment depends on the stage of the disease. In the first stage of the disease, the drug 
used is less toxic, easier to administer and more effective. Treatment success in the second stage 
depends on a drug that can cross the blood-brain barrier to reach the parasite; such drug is quite toxic 
and complicated to administer (WHO, 2006). There are four drugs available for treating human 
African trypanosomiasis; these include Pentamidine, Suramin, Melarsoprol and Eflornithine. Most of 
these drugs are toxic and encounter parasite resistance (Docampo and Moreno, 2003). With the 
exception of Eflornithine (registered in 1990) no new drugs have been developed for sleeping sickness 
in 60 years (Pepin and Meda, 2001).  Table 2.4 summarizes the use, application and dosage of those 
drugs (Burchmore et al., 2002; Docampo and Moreno, 2003). 
Table 2.4: Drugs used against Human African Trypanosomiasis (Burchmore et al., 2002; 
Docampo and Moreno, 2003) 
Drug Pentamidine Suramin Melarsoprol Eflornithine 
Chemistry Diamidine Sulphated 
naphthylamine 
Arsenical Difluoromethylornithine 
Solubility Water soluble Water soluble Poorly soluble in water, 
ether or alcohol 
 
Application I/M Repeated slow I/V 
injections 
I/V I/V 





Early & Late stage 
T.b.rhodesiense 
T.b.gambiense 
Early & Late stage 
T.b.gambiense 
Dosage 4mg/kg body wt* 
once daily for 7 days 
5mg/kg body wt on day 1 
followed by 5 injections 
of 20mg/kg body wt on 
days 3, 10, 17, 24 and 31. 
3-4 daily injections of 
3.6mg/kg body wt 
separated by rest 
periods of 7-10 days 
400mg/kg body wt (100mg 
every 6 hours) for 14 days 
Side effect Injection sites are 
very tender and sterile 
gluteal abscesses may 
occur 
-Mild renal toxicity 




Highly toxic  
Notes Poor penetration to 
CNS 
Poor penetration CNS  -expensive 




Rapid and accurate diagnosis is necessary in any clinical conditions. In the context of animal and 
human trypanosomiasis in the field, the rapidity and accuracy of any technique or a combination of 
techniques is vital if the treatment of any individual is to be effective, or if chemotherapeutic control 
of a selected group of animals is to be attempted (Molyneux, 1975). The primary reason for 
trypanosomiasis diagnosis is the appropriate application of therapeutic and sometimes prophylactic 
measures. In order to design rational control strategies and for research purposes, knowledge of the 
epidemiology of the disease is imperative, which in turn depends on the sensitivity and specificity of 
the selected methods of trypanosome diagnosis (Hutchinson et al., 2003).  
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2.2.1 Clinical diagnosis 
Diagnosis of trypanosomiasis on the basis of clinical signs is difficult because there are no specific 
pathognomonic symptoms. The clinical signs in humans (section, 2.1.5.2) could be mis-diagnosed 
with other diseases causing cutaneous lesions, such as leishmaniasis; however, the pathognomonic 
disturbance of the sleep is usually obvious at late stage of the disease, where cure from the disease 
becomes more complicated. In animals (section, 2.1.4.5) the clinical signs are not specific and could 
be mis-diagnosed with other diseases such as fasciolosis, schistosomiasis and haemonchosis (Catley et 
al., 2001).  
2.2.2 Parasitological diagnosis 
Microscopical examination of wet or Geimsa stained thin and thick blood films (Figure 2.10) is 
considered the traditional method for trypanosome diagnosis in the field. Although being widely used, 
these techniques are not considered sensitive enough to detect the low parasite levels especially in 
chronic cases. Therefore, these methods have been modified using concentration techniques to 
improve the sensitivity of the microscopic based methods (Luckins, 1977, , 1992). 
The most commonly used concentration method is the haematocrit centrifugation technique (HCT) 
developed by Woo (1970) using centrifugation of microhaematocrit capillary tubes containing the 
blood sample and examination of the buffy coat/plasma junction (Figure 2.11) under the microscope. 
In a positive diagnosis, trypanosomes are found wriggling at the junction of the buffy layer and the 
plasma (Woo, 1970). 
 










Improvement of the HCT was achieved by cutting the capillary tube 1 mm below the buffy coat and 
expressing the buffy coat/plasma interface on a microscope slide for examination using dark-ground 
or phase contrast microscopy (Murray, 1977). This method is known as the buffy coat technique 
(BCT). A biproduct of this approach is the calculation of the packed red cell volume (PCV) in 
advance to buffy coat aspirationas. The PCV can be used as a measure of anaemia as a useful 
indicator of trypanosome infection.  
Parasitological techniques commonly applied in the detection of trypanosome infections have 
inherently poor sensitivity, and therefore fail to detect a high proportion of chronic and often 
aparasitemic infections (Masake et al., 2002). Even using techniques to concentrate the parasite for 
microscopical diagnosis, the sensitivity is still low. Paris et al. (1982) compared the use of 
parasitological techniques for the diagnosis of African trypanosomiasis in cattle and found that the 
BCT was the most sensitive followed by HCT, Giemsa stained thick blood film; Giemsa stained thin 
blood film and then wet blood films. The analytical sensitivity of the BCT in detecting trypanosomes 
was found to be 2.5x102, 5x102 and 5x103 for T. congolense, T. vivax and T. brucei, respectively 
(Eisler et al., 2004; Paris et al., 1982). Furthermore, the sensitivity of HCT and BCT for T. vivax 
detection using microscopy was estimated by Desquences (1997) to be at 102-103 trypanosomes/ml 
blood. 
Application of parasitological techniques in field has been widely used for the diagnosis of African 
trypanosomiasis in both the vertebrate (domestic and wildlife) and invertebrate hosts. Blood samples 
from randomly selected dairy and beef cattle from Tanzania were examined for the presence of 
different trypanosome species. Fifty two animals (13.3%) were diagnosed as harbouring trypanosomes 
by examining wet, thick and thin blood films prepared from buffy coat content after centrifugation of 
the blood sample (Mugittu et al., 2001). Goossens et al. (2006) screened blood samples collected from 
cattle population of Mafia Island, Tanzania, using BCT. Microscopy revealed that 3.9% of the 
examined animals were infected with trypanosomes. Wildlife has been found to be infected with 
trypanosomes (38.3%), in a study conduced in Tanzania by Geigy et al. (1971) using examination of 
thick and thin blood smears. While Majiwa et al. (1994) examined 3044 flies caught from Kenya and 
Uganda for the natural infection with trypanosome species using microscopy. The results revealed that 
156 (5.1%) flies were infected with trypanosomes. The identified species were 71 Nannomonas type 
or immature Trypanozoon type (gut and mouthparts) infections and 85 had T. vivax type (mouthparts 






2.2.3 Sub-inoculation methods 
Sub-inoculation refers to methods where trypanosomes are transferred from a suspected case by 
inoculating the blood into another susceptible animal, invertebrate host or in vitro culture system. 
Rodent sub-inoculation  
Rodent sub-inoculation has been widely used for diagnosis and preparation of trypanosome stabilates. 
Immunosuppressants (such as cyclophosphamide) are used to increase the susceptibility of the rodents 
to infections. This method has been found to be more effective for trypanosomes in Trypanozoon 
species and T. congolense rather than T. vivax which fail to grow in laboratory animals. Therefore, 
sub-inoculation using domestic small ruminants (sheep and goat) may be recommended for the 
isolation of T. vivax (Eisler et al., 2004; Molyneux, 1975).  
A field study was conducted in Lambwe Valley area, Kenya, to evaluate the currently available 
trypanosome diagnostic techniques in domestic animals (Robson and Ashkar, 1972a). The study 
revealed that among the infected animals; T. brucei s.l. infections were diagnosed using the mouse 
inoculation method rather than the blood examination techniques (94.8% and 5.2%, respectively). 
However, more T. congolense were diagnosed using the blood examination methods than with the 
mouse inoculation method (87.5% and 43.3%, respectively). Moreover, T. vivax was only diagnosed 
by blood examination (20.2%) rather than by mouse inoculation (Robson and Ashkar, 1972a). The 
drawbacks of the sub-inoculation technique are mainly the time taken for trypanosomes to show in the 
inoculated laboratory animals, the need for groups at least six animals which makes this technique 
expensive and ethical considerations (Molyneux, 1975). 
Xenodiagnosis 
The other sub-inoculation method is xenodiagnosis which is feeding of a clean susceptible Glossina 
species on a suspected case of trypanosomiasis. Afterwards the fly is either dissected and examined 
for the presence of trypanosomes or allowed to feed on a clean animal which in turn is examined for 
the presence of trypanosomes. Although this method is found to be sensitive, it is rarely used due to 
the scarcity of laboratory reared Glossina species. This method is also time consuming and not likely 
to be a practical field technique (Eisler et al., 2004; Frezil, 1971; Molyneux, 1975).  
In vitro isolation 
A culture medium (Cunningham’s medium) based on the amino-acid composition of tsetse 
hemolymph and containing 20% (v/v) foetal bovine serum was designed for the cultivation of various 
trypanosomatida (Cunningham, 1977). It was reported that Cunningham’s media does not support the 
transformation of bloodstream forms from rodent blood to the procyclic phase (Bienen et al., 1980). 
However, the transformation was achieved using the natural cycle in the vector by feeding infected 
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blood to susceptible laboratory reared tsetse flies (Dukes et al., 1989). These findings were then 
investigated by Bass and Wang (1992) who showed that T. brucei s.l. was found to differentiate 
directly from the long slender bloodstream form to the procyclic form in Cunningham’s medium at 
26ºC without going through either the intermediary or the short-stumpy stage.   
The development of a kit for the in vitro isolation of trypanosomes (KIVI) that allowed direct 
introduction of blood into culture medium, with the subsequent transformation and multiplication of 
procyclic trypanosomes solved this problem (Aerts et al., 1992). These kits were developed for the 
isolation of T. b. gambiense with a remarkable efficiency when compared with the rodent isolation 
procedure (Truc et al., 1992). 
McNamara et al. (1995a) evaluated the in field use of KIVI for the isolation of T. b. gambiense in a 
sleeping sickness focus in northern Uganda. Blood samples positive for T. b. gambiense using 
serological tests were used for the isolation of the parasite using the kits. Only 80% of the isolates 
were able to grow in the culture kits. The authors explained the reported KIVI failures (20%) with the 
existence of certain T. b. gambiense strains that were unable to become established in the culture 
medium. Moreover, this could be also due to the insufficient stumpy forms present in the inoculum 
(McNamara et al., 1995a). Although the reported failure percentage of the kits, the authors 
recommended the use of KIVI for the isolation of the parasites as it is undoubtedly the best method 
available. 
Field application of KIVI was reported also by Truc et al. (1997) who examined 122 wild mammals in 
Cote d’Ivoir for the identification of T. b. gambiense. The results revealed that 88 animals (72.1%) 
were positive using KIVI kits confirming the potential value of these kits as a diagnostic test for 
trypanosome infection. Moreover, out of 74 patients in a sleeping sickness focus of Cote d’Ivoir, 43 T. 
b. gambiense were isolated using KIVI kits (Jamonneau et al., 2004). 
Although these kits were designed for the isolation of T. b. gambiense, they have been proven useful 
for detecting T. brucei and T. congolense in man or animals (McNamara et al., 1995b; Truc et al., 
1992). Moreover, a study conducted by Verloo et al. (2000) suggested that KIVI is an excellent tool 
for isolation of T. theileri from cattle in Belgium. However, the easy growth of T. theileri might 
render KIVI less efficacious for the isolation of pathogenic trypanosomes (Verloo et al., 2000). This 
method is not practical for in field diagnosis of bovine trypanosomiasis due to the long pre-patent 
period (two to four weeks) before the culture becomes positive by microscopy and  they are relatively 
expensive (Aerts et al., 1992; Eisler et al., 2004; Truc, 1996). 
2.2.4 Immunodiagnostic techniques 
Direct demonstration of trypanosomes in the infected animal or patient gives conclusive proof of 
infection. However, the limitations of parasitological diagnosis in terms of low sensitivity have been 
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the driving force for a great deal of research into alternative techniques that provide an indirect 
evidence of infection, namely immunodiagnostic techniques (Luckins, 1992). 
2.2.4.1 Complement fixation test  
Complenet fixation test (CFT) was used successfully in the control and eradication of dourine disease 
(caused by T. equiperdium in horses) in North America and surra disease (caused by T. evansi in 
buffaloes) in the Philippines, in which trypanosomes are rarely detected in blood or body fluids (Eisler 
et al., 2004; Luckins, 1992). This assay has not been found useful for the diagnosis of other 
trypanosome infections due to problems in reagent preparations, standardisation and anti-
complementary activity in sera from several animal species (Luckins, 1992). 
2.2.4.2 Indirect fluorescent antibody test  
Indirect fluorescent antibody test (IFAT) has been used extensively in the detection of trypanosomal 
antibodies in animals and humans (Luckins, 1992). This test has been proven to be specific and 
sensitive for detecting trypanosome antibodies in infected cattle (Luckins and Mehlitz, 1978) and 
camels (Luckins et al., 1979). The major drawback of the IFAT is the occurrence of cross-reactions 
between different trypanosome species. This was clearly noticed from a study conducted by Ashkar 
and Ochilo (1972) who applied IFAT test for trypanosomiasis diagnosis in samples collected from 
cattle in the Lambwe Valley, Kenya. They found that more than 85% of examined cattle infected with 
T. vivax or T. congolense reacted with T. brucei s.l. antigen (Ashkar and Ochilo, 1972). Additionally, 
the requirement of sophisticated microscopy for the detection of fluorescence is considered an 
obstacle for using IFAT for field application (Luckins, 1992).  
2.2.4.3 Card agglutination trypanosomiasis test  
The card agglutination trypanosomiasis test (CATT) has been widely used for in field diagnosis of 
infections with T. b. gambiense because it is considered a rapid, cheap and practical serological test 
(Chappuis et al., 2004; Magnus et al., 1978). The antigens originate from particular variable antigen 
types (VATs) of T. b. gambiense that are highly conserved across the range of this species and they 
are expressed early with infection. Therefore, the majority of infected individuals develop antibodies 
that cause visible agglutination when whole blood or serum is mixed with the antigen on the card 
(Eisler et al., 2004; Luckins, 1992; Magnus et al., 1978). The sensitivity of the test for T. b. 
gambiense varies between 87% and 98%, with an average of 95% (Robays et al., 2004). 
The test was used by Inojosa et al. (2006) for diagnosing human African trypanosomiasis in Angola. 
The authors screened 14,446 people using CATT; the results revealed that 1.7% reacted positive for 
the test. Although this low prevalence, the authors concluded that CATT is useful for initial screening 
but because the drug used for treatment is toxic, CATT should not be used alone for the treatment 
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decision (Inojosa et al., 2006). This test has also been used for the diagnosis of T. evansi  (Njiru et al., 
2004a) but unlikely to be of use for T. vivax or T. congolense due to the difficulty of identifying 
suitable variable antigens of these species (Luckins, 1992). 
2.2.4.4 Enzyme linked immunosorbent assay  
Enzyme linked immunosorbant assay (ELISA) has been used as a diagnostic test for trypanosomiasis 
caused by the different trypanosome species (Luckins, 1977, , 1992; Luckins et al., 1979; Luckins and 
Mehlitz, 1978). The use of ELISA for field diagnosis was based on the fact that the test may be 
performed without specialised equipment making it adaptable to inexpensive versions for use in the 
field or in under-resourced laboratories (Eisler et al., 2004; Luckins, 1992). 
It was shown that Ab-ELISA is able to detect specific antibodies in trypanosome infected cattle with 
more detection of serologically positive cattle than the IFAT. However, similarly to IFAT, cross 
reactivity between the three major trypanosomes causing trypanosomiasis (T. brucei s.l., T. 
congolense and T. vivax) also occurred in Ab-ELISA (Eisler et al., 2004; Luckins, 1992; Luckins and 
Mehlitz, 1978). Evaluation of Ab-ELISA was done using antigen preparations for the diagnosis of T. 
evansi infection in cattle, the results revealed that the reaction was specific for this species although 
the sensitivity was low (Reid and Copeman, 2002). 
Since the detection of antibodies does not necessarily indicate an active infection (because antibodies 
frequently persist far longer than the infectious agent); Ab-ELISA could not be used solely for 
diagnosis and instead another test is required at the same time. In cattle, antibodies were shown to 
persist inside the host for six to 13 months after the clearance of trypanosome infection (Eisler et al., 
2004; Luckins, 1992; Van den Bossche et al., 2000). In the last decade, interest in the Ab-ELISA for 
bovine trypanosomiasis has focused on use as an epidemiological tool for mapping and quantifying 
trypanosomiasis prevalence and risk. In this context, Ab-ELISA will provide information on the 
aggregated level of trypanosome challenge over a prolonged period prior to the survey. 
Alternatively, detection of the parasite itself rather than antibodies is important for identifying active 
infection; Ag-ELISA achieves this purpose by detecting the parasite antigen using the double 
sandwich ELISA method. Ag-ELISA was shown to detect T. congolense and T. evansi within 10-14 
days of infection and these antigens disappeared from the animal within 21 days of trypanocidal drugs 
treatment (Rae and Luckins, 1984). Ag-ELISA was shown to have a high diagnostic sensitivity; more 
than 90% and 95% in cattle and camels, respectively (Nantulya, 1990). 
For the ELISA to be used more widely, it will be necessary to provide training programmes providing 
a standardised assay protocol and reference preparations including suitable and defined control sera 
(Luckins, 1992). 
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2.2.5 Molecular diagnosis 
The detection and identification of trypanosomes by molecular means should be based upon genetic 
markers that are able to reveal the presence of the parasite irrespective of the developmental stage of 
the parasite at the time of identification (Moser et al., 1989a).  
The genetic material of the trypanosome (Figure 2.12) is composed of nuclear DNA (nDNA) that is 
organised in chromosomes and kinetplastid DNA (kDNA). The nDNA content of T. brucei s.l. is 
about 35 Mb that probably harbours about 12,000 genes (El-Sayed et al., 2000). The chromosomal 
DNA is grouped in three classes according to size. These groups are the megabase chromosomes (one 
to six Mb), intermediate chromosomes (200-900 kb) and the mini-chromosomes (50-150 kb). The 
kDNA represents about 20% of the total DNA and is organised in mini and maxi-circles. The mini-
circles are 1 kb in size and found in 5000-20,000 copies, while, the maxi-circles are about 20 kb in 
size and found in 20-50 copies (Desquesnes and Davila, 2002; El-Sayed et al., 2000). The nuclear and 
kDNA content of T. brucei s.l. was determined to be 0.097 and 0.004 pg, respectively (Borst et al., 
1982). 
 
Figure 2.12: Composition of the African trypanosome genome (Desquesnes and Davila, 2002; 
El-Sayed et al., 2000) 
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2.2.5.1 DNA hybridization 
Identification of infectious agents using DNA probes has become a technique readily available for 
field epidemiologists and control organisers (ole-MoiYoi, 1987). The application of DNA probe 
technology has been a major breakthrough in the molecular diagnosis of trypanosomes, although it has 
revealed greater complexity than previously thought due to the discovery of new species and sub-
species (Gibson, 2002). The important criteria for an identification method are sensitivity and 
specificity, realised in DNA probes based on species-specific repetitive DNA satellite sequences 
(Gibson, 2002; Sloof et al., 1983a). The satellite DNA is so-called because it bands separately from 
the bulk of the nuclear DNA in density centrifugation due to its high Adenosine+ Thymine (A+T) 
content (Gibson et al., 1988). 
T. brucei s.l. complex 
As mentioned above, in relation to the trypanosome genome, the T. brucei s.l. mini-chromosomes are 
linear mini-chromosomal DNA molecules of 50-150 kb. They are comprised predominantly of an 
internal tandem array of a 177 bp repeat (satellite DNA), which constitutes >90% of the sequence in 
some mini-chromosomes, over 10,000 copies of this repeated sequence were found to be present per 
trypanosome genome (El-Sayed et al., 2000; Sloof et al., 1983a; Sloof et al., 1983b). The analysis of 
satellite DNA from T. brucei s.l. revealed that the Guanidine+Cytocine (G+C) content is 29% and 
71% A+T content (Sloof et al., 1983a). A T. brucei probe prepared by Gibson et al. (1988) based on 
the 177 bp repetitive sequence was tested against DNA from a range of trypanosome stocks. However, 
it hybridized to every Trypanozoon stock tested including T. b. gambiense and T. evansi due to the 
close similarity of species and sub-species within this sub-genera (Gibson et al., 1988). 
T. congolense species 
Enzyme polymorphism was used extensively to investigate sub-specific diversity and the genetics of a 
wide variety of organisms, such methods revealed a distinct enzyme polymorphism in T. congolense 
(Young and Godfrey, 1983). Two stocks of T. congolense isolated from a sheep and a goat on the 
Kenya coast were found to be distinctly different from 112 other stocks of the same species after 
comparing by isoenzyme electrophoresis. This difference indicated a marked genetic distinction that 
may be of epidemiological significance (Gashumba, 1986). Knowles et al. (1988) reported the 
elecrophoretic variation of enzymes found in stocks of T. congolense taken from two areas on the 
Kilifi area of the Kenya coast. Moreover, the DNA from the Kilifi parasites contained a repetitive 
DNA sequence that was absent from other stocks of T. congolense.  
The main groupings of T. congolense based on isoenzyme electrophoresis were reported by Gashumba 
et al. (1988) who summarised these groups to three, Savannah group (has two subgroups: East African 
Savannah and East/West African Savannah), Riverine/Forest group and the Kenya coast group. 
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Furthermore, differences in the molecular karyotypes, repetitive DNA sequences and the kDNA 
sequences suggested that there are some trypanosome populations that are classified as T. congolense 
based on the morphological features, but differ significantly from each other at the molecular level 
(Majiwa et al., 1986; Majiwa et al., 1985).  
In order to determine and compare the pathological effects induced by the three types, Majiwa et al. 
(1985) and Bengaly et al. (2002)  experimentally infected three groups of Zebu cattle with the 
different species. The study revealed that T. congolense Savannah was of high pathogenicity that led 
to progress of the disease and ended by death within four to seven days post infection. The low 
pathogenicity of Forest type was observed with a self-cure by clearing the infection that suggested the 
ability of cattle to eliminate this trypanosome type. Moreover, the Kilifi type was found to be 
asymptomatic suggesting the ability of the host to control this type of infection.  
The mini-chromosomes of T. congolense Savannah are characterised by being very small in size, that 
they are 25-50 kb (Gibson and Borst, 1986). They contain many repeats of a satellite DNA sequence 
of 369 bp that constitutes an estimated 5% of the nDNA. This implies that the repetitive sequences are 
present at about 5400 copies in a single parasite if the genome size is 4x107 (Gibson et al., 1987; 
Katakura et al., 1997; Masiga et al., 1992; Moser et al., 1989a). The DNA sequence of the satellite 
DNA from T. congolense Savannah was found to have 65% A+T content (Masiga et al., 1992). DNA 
probes specific for T. congolense Savannah, T. congolense Forest and T. congolense Kilifi targeting 
369 bp, 350 bp and 400 bp fragments, respectively, were described by Gibson et al. (1988). These 
probes were specific for the corresponding species and there was no cross hybridization with 
trypanosomes of other species (Gibson et al., 1988). 
T. vivax species  
A T. vivax DNA probe was prepared by Kukla et al. (1987) using purified T. vivax DNA. The purified 
DNA was digested with the restriction enzyme EcoRI and the fragments were then cloned at the 
EcoRI site of the bacteriophage lambda gtWES. The recombinant phages were propagated in E. coli 
strain and transferred on to nitrocellulose filters and hybridised to radio-isotope labelled homologous 
total T. vivax DNA. This probe was used to hybridise with T. vivax infected flies by examining the 
proboscis of the flies. The target for such probe is the satellite DNA sequence which does not exist in 
all T. vivax isolates. Therefore, Masake et al. (1994) designed another probe targeting a fragment of 
the gene encoding T. vivax specific antigen which occurs in all T. vivax isolates examined by the 
authors. 
T. simiae species  
DNA probe targeting the 200 bp satellite sequence of T. simiae was described by Gibson et al. (1988) 
and showed hybridization to the specific species without cross reaction with other species. 
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Applications of DNA probes 
Application of DNA probes for the identification of trypanosome infections in wild tsetse flies has 
been reported from the Gambia (McNamara et al., 1989). The probes identified 17 flies out of 52 
examined (33%) to be infected, the species were diagnosed to be T. simiae (11 out of 17) and six T. 
congolense. McNamara and Snow (1990) collected flies from the same area surveyed by McNamara 
et al. (1989) for the identification of trypanosome species using DNA probes. Twenty eight infections 
(78%) were identified using DNA probes specific for Trypanozoon, T. simiae and the three types of T. 
congolense (McNamara and Snow, 1990). In Cote d’Ivoir, McNamara et al. (1995b) examined 
midguts of 30 flies for the presence of trypanosomes using DNA probes specific for Trypanozoon, the 
three types of T. congolense and T. simiae. Probe hybridization detected only one single infection with 
T. congolense Forest, 10 double infections and 19 triple infections with the three types of T. 
congolense species. 
2.2.5.2 PCR 
In recent years, PCR has been developed and became widely used for the detection of trypanosomes. 
This approach has overcome the constraints of parasitological and serological techniques (Gonzales et 
al., 2003; Moser et al., 1989a). PCR has proven to be highly sensitive and specific for trypanosome 
detection (Becker et al., 2004). The use of PCR in detecting the trypanosome DNA is reported to be 
the most reliable and accurate technique to assess and followup the efficacy of trypanosomiasis 
treatment (Njiokou et al., 2004; Truc et al., 1999). In a study to compare the use of Ag-ELISA and 
PCR in detecting trypanosomes in experimentally infected flies, Ouma et al. (2000) showed that Ag-
ELISA and PCR detected 71.4% and 96% of T. congolense and 98.4% and 97.6% of T. brucei s.l. 
infections, respectively, indicating a high sensitivity of detecting trypanosomes using PCR. 
It was observed that PCR can detect the DNA equivalent of one trypanosome/10 ml of host (cattle) 
blood (Masake et al., 2002), while, in human blood, the detection limit of PCR is 25 trypanosomes/ml 
(Kanmogne et al., 1996). The presence of human DNA is an important factor that interferes with the 
reaction yield of the PCR; this was described by Contamin et al. (1995) who noticed a decrease of the 
PCR sensitivity in identifying malaria parasites in human blood by 10 fold due to the presence of 
human DNA compared to amplification of purified parasite DNA. 






2.2.5.2.1 Species-specific PCR reactions 
T. brucei s. l. 
Many studies were conducted to design primers targeting DNA sequences or genes specific for 
Trypanozoon species identification. Table 2.5 summarises the different primers used with the size of 
the amplified product and the type of the target. 
Table 2.5: T. brucei s.l. different primers for PCR 




TBR1:5’-CGA ATG AAT ATT 
AAA CAA TGC GCA GT-3’ 
(Moser et al., 1989a) 177 bp repetitive 
satellite sequence 
Trypanozoon 173 bp 
TBR2: 5’-AGA ACC ATT TAT 
TAG CTT TGT TGC-3’  
TBR1: 5’- GAA TAT TAA 
ACA ATG CGC AG-3’ 
(Masiga et al., 1992) 177 bp repetitive 
satellite sequence 
Trypanozoon 164 bp 
TBR2: 5’- CCA TTT ATT 
AGC TTT GTT GC-3’ 
Tb177F: 5’- AAC AAT GCG 
CAG TTA ACG CTA T-3’ 
(Becker et al., 2004) 177 bp repetitive 
satellite sequence 
Trypanozoon 134 bp 
Tb177R: 5’- ACA TTA AAC 
ACT AAA GAA CAG CGT 
TG-3’ 
ILO342: 5’-GAT CCG CAG 
CCG GGC CTG-3’ 
(Majiwa et al., 1994) 5.2 kb repetitive ingi 
sequence 
Trypanozoon 1500 bp 
ILO343: 5’-CCG CGG TGG 
CTC CTT CCC-3’ 
Museq1: 5’-GCG TTA GCA 
GCA GCT GCA GCT GGG-3’ 
(Kabiri et al., 1999) ESAG 6 and 7 T. brucei s. l. 286 bp 
Museq2: 5’-CCT CCT CGG 
ATA TTT TCC GCA CCC-3’ 
ORPHON5J-u: 5’- GAT CCC 
TCT CCA CCA ATC CG-3’ 
(de Almeida et al., 
1998a) 
1.4 kb DNA sequence 
encoding mRNA 
spliced leader 
Trypanozoon  246 bp 
ORPHON5J-1: 5’- AAC TGC 
CCC GAC CTC CGC AGT-3’ 
5’-CAC AAT GGC ACC TCG 
TTC CC-3’ 
(Artama et al., 1992) Procyclin gene repeat Trypanozoon 300-400 bp 
5’- TTA GAA TGC GGC AAC 
GAG A-3’ 
5’- TAG CGT TAG TTG AAA 
GC-3’ 
(Artama et al., 1992) 1.35 kb DNA 
sequence encoding 
mRNA spliced leader 
Trypanozoon 1350 bp 
5’- TAT TAT TAG AAC AGT 
TTC TGT AC-3’ 
PLC1: 5’- CGC TTT GTT GAG 
GAG CTG CAA GCA-3’ 
(Picozzi et al., 2008) PLC gene Trypanozoon 324 bp 
PLC2: 5’- TGC CAC CGC 
AAA GTC GTT ATT TCG-3’ 
 
As mentioned before, a satellite DNA sequence of 177 bp length specific for Trypanozoon was 
described by Sloof et al. (1983a) and used as a target for the identification of this genus by PCR. This 
target was the most favourable targets due to the high copy number (10,000) thus increasing the 
chance that the trypanosome DNA would be amplified (Desquesnes and Davila, 2002). Moser et al. 
(1989a) reported that TBR universal primers that are used to prime the amplification of 177 bp 
sequences from Trypanozoon genomic DNA, are able to detect 0.1 pg of parasite DNA, this is about 
the amount of DNA calculated to be in a single trypanosome. Moreover, weak bands containing the 
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amplification product could be detected when the DNA content was 0.01 pg which is equivalent to 
1/10th that of a single parasite. This is in agreement with Clausen et al. (1998) who found that T. 
brucei s.l. specific nuclear repeat primers amplified 177 bp satellite sequence are able to detect as little 
as one femtogram purified DNA which is equivalent to about 1% of the genome content of one 
parasite.  
Different primers targeting this satellite sequence were designed to target specific regions of the 
target. For instance, primers amplifying 173 bp product of the target were described by Moser et al. 
(1989a) and other primers were published by Masiga et al. (1992) amplifying 164 bp of the same 
target sequence. Becker et al. (2004) re-designed the primers previously designed by Moser et al. 
(1989a) to get rid of the tendency of the primers to form secondary structures to be used in qPCR. 
The primers targeting the repetitive 177 bp sequence are considered universal and have been used in 
different studies for the identification of T. brucei s.l. in animal hosts (Clausen et al., 1998; Gonzales 
et al., 2003; McOdimba, 2006; Picozzi et al., 2002) and vector (Boid et al., 1999; Morlais et al., 
1998b; Morlais et al., 1998a; Njiru et al., 2004b).  
Another sequence specific for Trypanozoon reported by Kimmel et al. (1987) was used as a target for 
PCR amplification. This sequence is a repetitive element of 5.2 kb named ingi which has the 
Kiswahili root adjective meaning many. This target is present in 200 copy numbers in the 
Trypanozoon genome and believed to be specific for Trypanozoon only as it has not been detected in 
isolates of other genera such as T. congolense and T. vivax  (Kimmel et al., 1987). Primers targeting 
these sequences were designed by Majiwa et al. (1994) and used for detection of Trypanozoon 
infections in the saliva of tsetse flies and buffy coat samples from cattle. The designed primers 
amplified a product of 1500 bp length (Majiwa et al., 1994). 
In T. brucei s.l. there are 20 copies of the expression site associated genes (ESAG) 6 and 7 in the 
trypanosome genome (Kabiri et al., 1999). These targets are utilised by PCR for the detection and 
identification of T. brucei s. l. The detection limit of PCR using these primers was reported to amplify 
a parasite DNA content equivalent to 1/10th that of a single trypanosome in the reaction. This 
detection limit is equivalent to the detection of 40 trypanosomes/ml blood. These primers were used 
for the detection of T. b. gambiense in blood samples collected from patients suspected of having 
sleeping sickness in Equatorial Guinea and Angola (Kabiri et al., 1999). 
The ORPHON5J primers targeting 246 bp fragment of 1.4 kb DNA sequence that encodes mRNAs 
termed spliced leader (Parsons et al., 1986) occurring in all Trypanozoon species were designed by de 
Almeida et al. (1998b). The target element was reported to be located in 100-200 copy number as 
tandemly repeated units in the genome (Parsons et al., 1986). The problem encountered with these 
primers was the cross-reactivity with T. vivax, whereas they do not react with T. congolense. The 
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authors argued that the more conventional T. brucei s.l. primers described by Moser et al. (1989) react 
with T. vivax and T. congolense stocks they examined (de Almeida et al., 1998b). 
Artama et al. (1992) described primers to amplify two different repetitive regions in the T. brucei s.l. 
nDNA. Firstly, primers targeting a tandem repeat of two similar adjacent procyclin genes were 
designed to amplify 300-400 bp products representing different procyclin genes. The procyclin gene 
target is reported to be found three times in the nDNA (Clayton et al., 1990). Surprisingly, PCR 
product was detected in T. evansi despite the fact that procyclin is not known to be required during the 
mechanically transmitted T. evansi infections (Artama et al., 1992). The second is the 1.35 kb repeat 
containing the spliced leader gene of which there are approximately 200-250 copies in the 
Trypanozoon nuclear DNA (Dorfman and Donelson, 1984). 
The variant surface glycoprotein (VSG) of the mammalian bloodstream form of T. brucei was 
amongst the first proteins to be reported to be attached to the plasma membrane by a glycosyl-
phosphatidylinositol (GPI) anchor linked to the C-terminal α-carboxyl group through ethanolamine 
(Carrington et al., 1989). Specific phospholipases that convert GPI-anchored proteins from membrane 
attached to soluble forms have been isolated from T. brucei s.l. (Hereld et al., 1986). Primers targeting 
the single copy PLC gene (Mensa-Wilmot et al., 1990) specific for Trypanozoon were reported by 
Picozzi et al. (2008) where they were used as an internal control using a multiplex PCR in 
combination with primers targeting the serum resistance associated gene (SRA) for the identification 
of T. b. rhodesiense. 
T. b. rhodesiense 
It is important to differentiate between T. b. rhodesiense and other T. brucei s.l sub species due to the 
inability to differentiate them morphologically. The aforementioned PCR reactions amplify different 
targets in T. brucei s.l. and Trypanozoon genomes but cannot differentiate between the different sub 
species. Human serum is lytic to T. b. brucei, however T. b. rhodesiense and T. b. gambiense are 
resistant to lysis by human serum enabling them to stablish and cause the diseases in this host.  
De Greef et al. (1989) reported the presence of laboratory strains that were sensitive to lysis by human 
serum. The only molecular difference between the resistant and sensitive forms was a 1.5 kb mRNA, 
cDNA screening identified the gene, termed the serum resistant associated gene (SRA) in the resistant 
strains (De Greef et al., 1989; Xong et al., 1998).  This gene alone was sufficient to confer human 
serum resistance on T. b. brucei by transfection (Xong et al., 1998). The resistance of T. b. 
rhodesiense to the lytic factor is determined by the N-terminal α-helix of SRA which is involved in 
coil-coiling with the trypanolytic factor by strong and specific binding to the C-terminal α-helix of 
apoL-I (Pays, 2006).  
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SRA has been shown to be a robust and ubiquitous marker for T. b. rhodesiense to distinguish this 
isolate from T. b. brucei and other trypanosomes of subgenus Trypanozoon (Gibson, 2002; Welburn et 
al., 2001). Different primers have been designed for the amplification of SRA gene (Table 2.6).  
Table 2.6: Different primers used to prime the amplification of SRA gene for T. b. rhodesiense 
identification 
Reference Size of amplified 
product 
Primer sequence 
B537: 5’- CCA TGG CCT TTG ACG AAG AGC CCG-3’ (Welburn et al., 2001) SRA: 743 bp 
VSG: 1121 bp B538: 5’-CTC GAG TTT GCT TTT CTG TAT TTT TCC C-
3’ 
SRA A: 5’-GAC AAC AAG TAC CTT GGC GC-3’ (Gibson, 2002) 1.2 kb 
SRA B: 5’-CAG CAA CCA TAT TCA GAG CC-3’ 
F: 5’-ATA GTG ACA AGA TGC GTA CTC AA CGC-3’ (Radwanska et al., 2002a) 284 bp 
R: 5’-AAT GTG TTC GAG TAC TTC GGT CAC GCT-3’ 
02: 5’- GGA GCC AAA ACC AGT GGG CAC ATC-3’ 
03: 5’- AAG TAG CGC TGT CCT GTA GAC GCT TC-3’ 
651: 5’- GAA GAG CCC GTC AAG AAG GTT TG-3’ 
(Picozzi et al., 2008) PLC: 239 bp 
SRA: 669 bp 
VSG: > 1 kb 
652: 5’- TTT TGA GCC TTC CAC AAG CTT GGG-3’ 
 
Welburn et al. (2001) designed primers that amplified 743 bp sequences in the SRA gene to validate 
the use of the single copy SRA gene as a diagnostic indicator of T. b. rhodesiense. SRA gene is very 
similar to that of the VSG, but has an internal deletion of 378 bp that encodes the central part of 
variable surface glycoprotein N-terminal domain. These primers were designed to amplify across this 
deletion to distinguish the SRA product from any SRA-related variable surface glycoprotein (1121 bp) 
(Welburn et al., 2001). The authors identified the SRA gene in 29 samples collected from patients 
with sleeping sickness in Tororo district, Uganda. Moreover, of 200 cattle sampled in Soroti district, 
18% were found infected with T. b. rhodesiense.  
Radwanska et al. (2002a) evaluated the SRA gene as a tool for identification of T. b. rhodesiense 
strains using PCR. Twenty five previously identified T. b. rhodesiense isolates using the human serum 
resistance test were assessed using SRA-PCR. Twenty four isolates were identified as T. b. 
rhodesiense using SRA primers that prime the amplification of 284 bp sequence of the SRA gene. 
However, one strain was negative and was thought to be misidentification of the strain (Radwanska et 
al., 2002a). The primers designed by Gibson et al. (2002) to amplify 1.2 kb sequence of SRA gene 
were evaluated for the identification of T. b. rhodesiense from 264 trypanosome isolates from human, 
different animals and tsetse flies collected from 1964-2001 from sleeping sickness foci in East Africa 
(Njiru et al., 2004c). In total, 75 T. brucei s.l. isolates were found to have SRA gene confirming that 
SRA gene is a specific marker for T. b. rhodeisense hence offering an opportunity to detect the animal 
host and targeting them using different trypanocidal drugs.  
In another study, the primers designed by Radwanska et al. (2002) and Gibson et al. (2002) were 
evaluated for the amplification of SRA in samples collected during a cross sectional study in Uganda 
(Enyaru et al., 2006). SRA was identified in 28 (80%) of the 35 T. b. rhodesiense isolates from 
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parasitologically confirmed sleeping sickness cases, using primers designed by Radwanska et al. 
(2002). While, the gene was identified in 27 (77.1%) of the same 35 T. b. rhodesiense isolates using 
the primers designed by Gibson et al. (2002).         
The fact that SRA is a single copy gene makes the interpretation of a negative result difficult, as in 
such cases, negative result is either due to absence of SRA gene or the low level of parasitaemia 
(Katunguka-Rwakishaya, 1996). To overcome this problem, a multiplex PCR was developed by 
Picozzi et al. (2008). The reaction contains two different sets of primers to amplify two products 
within the same reaction from the same starting material. The primers target both SRA gene for the 
diagnosis of T. b. rhodesiense and GPI-PLC which is found in T. brucei s.l. genome as an internal 
control. Positive amplification of GPI-PLC indicates sufficient T. brucei s.l. genomic material is 
present to detect a single copy gene and the presence or absence of SRA determines whether T. b. 
rhodesiense is present (Picozzi et al., 2008). The amplification of GPI-PLC only indicates that the 
sample is negative for T. b. rhodesiense, whereas, it might be positive for T. b. brucei, T. b. gambiense 
or T. evansi. However, concerning both the host range and geographic distribution of these parasites, 
the assumption that the absence of the SRA amplicon indicates the presence of T. b. brucei is made. 
T. b. gambiense 
T. b. gambiense is so closely related to the rest of the T. brucei s.l. complex, therefore, no T. b. 
gambiense-specific DNA probe has been reported (Bromidge et al., 1993). However, certain VSG 
genes, for example LiTat 1.3, the antigen used in the serological card agglutination test, was used for 
identification of T. b. gambiense (Magnus et al., 1978). In Gambian sleeping sickness foci, PCR 
reactions targeting Trypanozoon subgenus markers (Table 2.7 ) were used, however, these results 
were not satisfactory due to inability to distinguish between T. brucei s.l. species (Kabiri et al., 1999; 










Table 2.7: Primers designed for PCR identification of T. b. gambiense 




AnTA: 5’-CAC AGA CGA CAG AAG CGA 
TA-3’ 
(Bromidge et al., 1993) AnTat 11.17 VSG gene 653 bp 
AnTB: 5’-GAA AGT GGG AGT TGT TGC 
TC-3’ 
MDF: 5’- CGC CCA TAA GAT TTC CGG 
TT-3’ 
 
(Mathieu-Daude et al., 
1994) 
Non conserved sequence 
of kDNA 
930 bp 
MDR: 5’- GGT GTA ATA CTC ACC CGG 
TT-3’ 
MDF: 5’- CGC CCA TAA GAT TTC CGG 
TT-3’ 
 
MDR: 5’- GGT GTA ATA CTC ACC CGG 
TT-3’ 
(Schares and Mehlitz, 
1996) 
Non conserved sequence 
of kDNA 
930 bp 
MDN: 5’-CGA GGT ACT TCG AAA GGG 
TT-3’ 
Sense primers: 5’- GCT GCT GTG TTC GGA 
GAG C-3’ 
(Radwanska et al., 2002b) TgsGP 308 bp 
Anti-sense primers: 5’- GCC ATC GTG CTT 
GCC GCT C-3’ 
 
PCR reaction was developed by Bromidge et al. (1993) to detect the AnTat 11.17 VSG gene which is 
capable of distinguishing T. b. gambiense from other T. brucei s.l. group trypanosomes in most foci of 
Gambian sleeping sickness. However, this target gene was absent in six stocks collected from the 
Moyo focus in West Uganda meaning the difficulty of using VSG genes as target markers for the 
identification due to instability of these genes. 
As shown previously in Figure 2.12, the one kilobase minicircles (10,000 copies) contain 177 bp 
sequences that appear to be conserved within T. brucei s.l. These minicircles contain also non-
conserved sequence (hypervariable region, HVR) that is heterogenous within a single organism (200-
300 different sequence classes of HVR). They were used to design specific probes for T. cruzi (Veas 
et al., 1990), therefore, HVR were used in the same manner to design specific markers for T. b. 
gambiense using PCR (Mathieu-Daude et al., 1994). However, this technique has been used only with 
large parasite number (103 trypanosomes per reaction) obtained after in vitro cultivation of procyclic 
trypanosomes and was not evaluated for use with in field blood samples. Therefore, Schares and 
Mehlitz (1996) used nested PCR for the amplification of kDNA non-conserved sequence from blood 
samples isolated from animals and patients in sleeping sickness foci in Zaire. The primers used were 
the forward and reverse ones designed by Mathieu-Daude et al. (1994) and another primer set for the 
nested reaction. The results showed that one parasite per reaction volume was able to produce a strong 
amplicon in the nested PCR and the samples collected from the field were successfully identified as T. 
b. gambiense infected using the nested reaction.   
The sequence of the T. b. gambiense specific glycoprotein (TgsGP) which encodes a flagellar pocket 
glycoprotein, were found to be diagnostic for T. b. gambiense only (Berberof et al., 2001). Primers 
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targeting this sequence were designed by Radwanska et al. (2002b) and were found to be specific for 
the amplification of TgsGP of T. b. gambiense when tested against non-T. b. gambiense populations 
revealing negative results. The detection limit of the reaction was evaluated; it reached 1000 
trypanosomes/ml of blood after a single PCR. This detection limit was increased to 10 
trypanosomes/ml of blood when the TgsGP PCR was repeated using aliquot of the first PCR product. 
The diagnostic potential of the TgsGP-PCR was evaluated on a collection of human blood samples 
from Cote d’Ivoire and Belgium. Of 41 CATT-positive samples from Cote d’Ivoire, 14 were positive 
and they were confirmed using parasitological methods. 
T. congolense 
The satellite sequence specific for the three sub species of T. congolense have been used to identifiy 
these trypanosomes using PCR. The primers targeting the satellite fragments of T. congolense 
Savannah, T. congolense Forest and T. congolense Kilifi are summarised in Table 2.8. 
Table 2.8: Primer sequences used to target satellite DNA marker of T. congolense 
Reference Target Size of amplified product Primer sequence 
 
TCS1: 5’-CGA GAA CGG 
GCA CTT TGC GA-3’ 
(Masiga et al., 1992; Moser 
et al., 1989) 
Satellite DNA of T. 
congolense Savannah 
316 bp 
TCS2: 5’-GGA CAA ACA 
AAT CCC GCA CA-3’ 
TCF1: 5’- GGA CAC GCC 
AGA AGG TAC TT-3’ 
(Masiga et al., 1992) Satellite DNA of T. 
congolense Forest 
350 bp 
TCF2: GTT CTC GCA CCA 
AAT CCA AC-3’ 
TCK1: 5’-GCT GCA GGT 
CGA CGG ATC-3’ 
(Majiwa et al., 1994) Satelite DNA of T. 
congolense Kilifi 
400 bp 
TCK2: 5’- CCC TCG AGA 
ACG AGC A-3’ 
 
The Savannah group is the most widespread, in terms of both geographical and host range, 
overlapping with the Forest and Kenya Coast sub-species where they occur in the humid parts of West 
and Central Africa and Kenya, respectively (Gibson et al., 1988; Masiga et al., 1996; Reifenberg et 
al., 1997b; Young and Godfrey, 1983).  
The sensitivity of the universal primers in detecting T. congolense Savannah was found to be 0.1 pg of 
parasite DNA which is about the amount of DNA calculated to be in a single trypanosome. Moreover, 
weak bands containing the amplification product could be detected when the DNA content was 0.01 
pg which is equivalent to 1/10th that of a single parasite (Moser et al., 1989a). Although the similarity 
in the sequence of satellite DNA of T. congolense Savannah compared with T. brucei s.l. and T. vivax 
(44 and 37%, respectively), this doesn’t affect the specificity of the primers to detect the target 
sequence (Masiga et al., 1992). This was studied by Gibson et al. (1987) who introduced the mini-
chromosomes from T. congolense Savannah into T. brucei s.l. using electroporation. They were able 
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to detect both satellite sequences indicating that these sequences are ideal for use to distinguish 
trypanosome species and subspecies. 
In field, the primers specific for the three T. congolense sub species were used to identify infections in 
tsetse flies in Cameroon (Morlais et al., 1998b; Morlais et al., 1998a). PCR for detecting T. 
congolense Savannah and T. congolense Kilifi were used on samples collected from saliva of tsetse 
flies and buffy coat from aparasitaemic cattle (Majiwa et al., 1994). Also, these primers were used to 
detect the T. congolense sub species in blood samples collected from cattle in Uganda (Clausen et al., 
1998; McOdimba, 2006). Njiru et al. (2004b) identified the three sub species of T. congolense using 
PCR in 3826 Glossina species collected from Kenya. The different primers identified 1.2% infections 
with T. congolense Savannah, 0.7% T. congolense Kilifi and 0.6% T. congolense Forest infections. 
Moreover, PCR was able to identify mixed infections with different T. congolense sub species which 
is not possible using microscopy. 
T. vivax 
The natural home for T. vivax is tropical Africa where it is prevalent in most parts of West, Central, 
East and South Africa (Hoare, 1972). This species represents a remarkable instance of a tsetse-borne 
trypanosome that has spread far beyond its original area of distribution to distant areas such as West 
Indies, Central and South America through imported cattle from Africa (Hoare, 1972). In addition to 
tsetse flies, which are the true vectorial hosts of T. vivax, it is readily transmitted by mechanical 
inoculators represented by other bloodsucking Dipetra, especially Tabanid flies (Desquesnes and Dia, 
2003; Desquesnes and Dia, 2004; Hoare, 1972).  
The diagnosis of T. vivax based on the presence of specific insect vectors is limited due to the ease of 
transmission by a variety of insect vectors in addition to the tsetse fly. Diagnosis using clinical picture 
of the disease and using microscopy is also limited due to the absence of a consistent set of clinical 
signs (hemorrhagic form in Kenya cost and sub clinical infection in West Africa) and the often very 
low parasitemia of infections (Masake et al., 1997). Infection of cattle with certain stocks of East 
African T. vivax has been associated with varying degrees of an intravascular coagulation-like 
syndrome which is occasionally accompanied by severe haemorrhage (Masake et al., 1994). The 
American isolates induce a disease generally more severe than those from Africa (Gardiner, 1989). 
T. vivax has a similar molecular karyotype to other salivarian trypanosomes, with chromosomal DNA 
ranging in size from approximately 50-6000 kb. However, unlike the other salivarian trypanosomes 
which have an estimated 100 mini-chromosomes of 50-150 kb, T. vivax has only one or two mini-
chromosomes which are characterised by the presence of a highly repetitive G+C rich (64%) satellite 
DNA of 180 bp in size (Dickin and Gibson, 1989; Stevens and Brisse, 2004). The kDNA mini-circles 
of T. vivax are approximately half the size of the other salivarian trypanosomes, while, the relative 
amount of maxi-circle DNA is at least twice that of T. brucei s.l. 
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Diagnosis of T. vivax infection using molecular markers has been subjected to a number of researches 
(Desquesnes, 1997; Masake et al., 1997; Masake et al., 1994; Masiga et al., 1992; Morlais et al., 
1998b; Morlais et al., 1998a; Morlais et al., 2001). The satellite DNA sequence of T. vivax that is 
positioned in the mini-chromosomes has been used to identify infections with T. vivax (Dickin and 
Gibson, 1989; Masiga et al., 1992). However, it has been shown that this DNA sequence is not present 
in some T. vivax isolates; consequently, universal primers targeting a fragment of the gene encoding T. 
vivax specific antigen have been described by Masake et al. (1994).  
The antigen is recognised by a monoclonal antibody (Tv27) in an Ag-ELISA, the cloned gene was 
found to be highly tandemly repeated with a length of 900 bp in the genome of all T. vivax isolates 
from diverse geographic locations in Africa and South America (Masake et al., 1994). Several primer 
pairs were tested for their capacity to amplify a segment of the repeat unit of the gene fragment (1870 
bp long) but only one was able to amplify a segment of DNA from all the T. vivax tested isolates. The 
primer set was named ILO1264 and ILO1265 that amplified a segment of 400 bp (Masake et al., 
1997). Table 2.9 summarises the sequences of the primers specific for T. vivax amplification. 
Table 2.9: Primer sequences and amplified target sizes specific for T. vivax 




TVW1: 5’-GTG CTC CAT GTG CCA 
CGT TG-3’ 
(Masake et al., 1994; Masiga 
et al., 1992) 
Satellite DNA 175 bp 
TVW2: 5’-CAT ATG GTC TGG GAG 
CGG GT-3’ 
ILO1264: 5’- CAG CTC GGC GAA 
GGC CAC TTC GCT GGG GTG-3’ 
(Masake et al., 1997) Gene encoding specific 
antigen 
400 bp 
ILO1265: 5’- TCG CTA CCA CAG 
TCG CAA TCG TCG TCT CAA GG-3’ 
 
A study comparing the sensitivity of primers targeting the 400 bp fragment of the species-specific 
antigen (ILO) and those targeting the satellite DNA (TVW) in the identification of T. vivax was 
conducted by Morlais et al. (2001). The ILO and TVW primers were used to identify T. vivax in 36 
tsetse with mouthpart infections. The results revealed that ILO primer set identified T. vivax infections 
in 31 of the 36 mouthpart infections (86%), while TVW primers wrongly classified 16 (44%) of these 
infections as negative, indicating better sensitivity of ILO primers. These results demonstrate that the 
DNA sequence targeted by TVW primer set is not conserved in all T. vivax isolates, concluding that 
ILO primers are universal primers suitable for T. vivax diagnosis in hosts and vectors from different 
geographic areas. Moreover, in a study to compare the ability of ILO and TVW primers to detect the 
target sequences using T. vivax strains from West Africa, Lefrancois et al. (1998) clarified that 
primers used for amplifying diagnostic antigen sequence specific for T. vivax (ILO) are more specific 
and universal than the satellite sequence primers (TVW) that were unable to amplify DNA of all 
Duttonella stocks circulating in West Africa.  
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This is in agreement with the results obtained by Morlais et al. (1998a) who used TVW primers to 
amplify T. vivax strains infecting tsetse flies examined in Cameroon. The primers could not detect the 
parasite and the authors contributed this to the fact that these primers are designed from sequenced 
isolates of West African origin, and they may not anneal if different subtypes of T. vivax occur in 
Cameroon. Additionally, Malele et al. (2003) found that the use of the universal T. vivax primers 
rather than the primer set designed for the West African isolates doubled their detection of the parasite 
from tsetse flies collected in Tanzania. In Kenya, the detection of T. vivax using the universal primers 
improved the results obtained by Njiru et al. (2004b) who screened 3826 tsetse flies for trypanosome 
infections. The detection rate was improved from 0.2% to 0.7% indicating the occurrence of genetic 
variation of T. vivax in Kenya and the accurate detection using the universal primers compared to the 
West African isolates primers.  
Conversely, Gonzales et al. (2003) reported that some stocks of T. vivax from Bolivia (South 
America) were unable to give a product using ILO primers suggesting that these strains do not have 
this sequence in their DNA, however, using TVW primers resulted in the detection of such stocks 
concluding the presence of the sequence targeted by TVW primers in the isolates occurring in Bolivia. 
This difference in the data from Bolivia in the sensitivity of the ILO primers could be due to variation 
in the processing of samples or technical problems in the procedure (Masake et al., 1997). In 
conclusion, by targeting a species-specific antigen, the ILO primer set showed better sensitivity and 
seems to provide a more reliable marker for T. vivax identification (Morlais et al., 2001).  
2.2.5.2.2 Internal transcribed spacer-PCR as a pan-trypanosome reaction 
In trypanosomes, as in other eukaryotic organisms, the ribosomal RNA (rRNA) genes are transcribed 
as a large primary transcript, which is processed by stepwise endonucleolytic cleavage to yield the 
18S, 5.8S and 28S units (Urakawa and Majiwa, 2001). These RNAs interact with ribosomal proteins 
to form the ribosomes. Ribosomal RNA genes are highly conserved and have been proven to be useful 
in comparisons of more closely related species. Eukaryotic rRNA genes are found as tandem repeat of 
units separated by non-transcribed spacers (NTS) region and internal transcribed spacer regions (ITS). 
The ITS regions are relatively small, show variability among related species and are flanked by highly 
conserved segments to which PCR primers can be designed (Cupolillo et al., 1995). The inter-species 
length variation makes the ITS region a useful marker for species differentiation in trypanosomes 
(Cox et al., 2005; Desquesnes et al., 2001; McLaughlin et al., 1996; Njiru et al., 2005). At least, five 
PCR reactions using species-specific primers would be required for each sample depending on the 
host species and the geographic distribution of the trypanosome species compared to the convenience 
of a single test. Trials have been conducted to combine the species-specific primers in a multiplex 
reaction, but these trials have been shown to be less sensitive with some combinations of primers 
inducing the synthesis of non-specific and un expected size products (Desquesnes et al., 2001).  
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The most important obstacle of using species-specific primers is the lack of specific primers for all 
trypanosome species, leading to the inability of identifying new trypanosome species. For example, in 
a tsetse survey conducted in Tanzania, Lehane et al. (2000) failed to identify 13% of infections 
detected by microscopy using the available species-specific PCR. Similar studies have shown higher 
percentage of unidentified trypanosomes, 42% infected flies in Cameroon and Zimbabwe had 
unidentified trypanosomes (Morlais et al., 1998b; Woolhouse et al., 1996). The unidentified species 
may be pathogenic mammalian trypanosomes or more importantly, may be of zoonotic importance. 
These findings strengthened the need for a universal primer set for identification of species of both 
veterinary and zoonotic importance. The development of the ITS region as a universal target for the 
diagnosis of different trypanosome species occurring in either the vertebrate host or the invertebrate 
vector, aimed to decrease the number of species-specific PCR reactions required for diagnosis and 
allowed for the identification of new species infecting both the vector and vertebrate host. 
The copy number of the rRNA locus varies from 100-200 copies per genome and each transcribed unit 
is composed of 18S, 5.8S and 28S rRNA genes as well as several ITS flanked by NTS. Eukaryotes 
have two ITS spacers, ITS1 which is located between the small subunit 18S gene and the large subunit 
5.8S gene, and ITS2 which is located between the two large subunits 5.8S and 28S genes. The only 
species having an 18S rRNA G+C content of 55.4% (higher than other trypanosomes by 3%) is T. 
vivax (Stevens and Brisse, 2004). 
Kin primers have been designed to react with kinetoplastid species, annealing in the conserved regions 
of the 18S and 5.8S rRNA to amplify the ITS1, the sequence of which is usually 300-800 bp in length 
(McLaughlin et al., 1996). Desquesens et al. (2001) used Kin primers to evaluate their sensitivity in 
the detection of African livestock trypanosome DNA through a single PCR. The results showed the 
ability of the Kin primers to detect and discriminate all livestock trypanosome species through a single 
PCR reaction producing different amplified product for each species (Table 2.10). The sensitivity of 
kin primers to detect T. congolense Savannah was 85% of that of the species-specific PCR. In 
addition, the authors described that the sensitivity of Kin primers to amplify ITS1 region of T. vivax is 
low, attributing this to the fact that T. vivax target sequences have only 75 and 90% identity to the 
forward and reverse Kin primers, respectively. Moreover, with T. vivax, a non-specific product of 610 
bp was observed and with the use of excess DNA, extra non-specific bands of more than 900 bp have 
been observed. By evaluating the detection of mixed DNA samples, all the PCR products expected 
were observed with mixing two to three of the DNA from T. congolense types together or with T. 
vivax or Trypanozoon DNA. It was interesting to notice that when mixing T. brucei s.l. and T. vivax, 
the T. vivax product sometimes became weak or indicating lower sensitivity for the detection of T. 
vivax DNA in the presence of T. brucei s.l. DNA. The authors recommended the requirement of 
improvement and investigation of new primers design in order to enhance the sensitivity of the test 
especially for detection of T. vivax DNA.  
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Table 2.10: Band sizes and Kin primers sequence (Desquesnes, 1997) 
Trypanosome species Obtained band size 
T. brucei s.l. 540 bp 
T. congolense Kilifi 680 bp 
T. congolense Forest 780 bp 
T. congolense Savannah 750 bp 
T. vivax 305 bp 
T. theileri 455 bp 
T. simiae 435 bp 
T. equiperdium 540 bp 
T. evansi 540 bp 
Kin1 5’-GCG TTC AAA GAT TGG GCA AT-3’ Primers 
Kin2 5’-CGC CCG AAA GTT CAC C-3’ 
 
Several attempts have been made to improve the design of primers amplifying the ITS1 locus for 
trypanosomes diagnosis using either semi-nested or nested PCR reactions. Geysen et al. (2003) stated 
that 18S ribosomal sub-unit is an ideal target sequence which is highly conserved, has sufficient 
polymorphism, and species specific sequences present in a multi-copy locus. The authors described a 
semi-nested PCR assay associated with restriction fragment length polymorphism assay (RFLP) using 
restriction enzymes to characterise all important bovine trypanosome species.  
The use of PCR-RFLP was aimed to increase the sensitivity and specificity of the test and to 
distinguish different trypanosomes, because the amplified region encompasses such a polymorphic 
area in the 18S locus that specific restriction enzymes (Msp1 and Eco571) can be found for each 
trypanosome species. The first amplification was done on the 18S gene using the forward primer 18ST 
nF2 and the reverse primer 18ST nR3. The second amplification was done using the forward primer 
18ST nF2 and the reverse primer 18ST nR2 (Table 2.11). The primers were designed to amplify small 
sub-unit rRNA (ssu-rRNA) giving clear differences among the important trypanosome species 
infecting cattle. 
Table 2.11: Band sizes and semi-nested PCR primers sequence (Geysen et al., 2003) 
Trypanosome species  Obtained band size 
T. brucei s.l 660 bp 
T. congolense Kilifi 711 bp 
T. congolense Forest 674 bp 
T. congolense Savannah 671 bp 
T. vivax 616 bp 
T. theileri 626 bp 
T. simiae 629 bp 
T. evansi 660 bp 
18ST nF2 5’-CAA CGA TGA CAC CCA TGA ATT GGG GA-3’ 
18ST nR3 5’-TGC GCG ACC AAT AAT TGC AAT AC-3’ 
Primers 
18ST nR2 5’-GTG TCT TGT TCT CAC TGA CAT TGT AGT G-3’ 
  
The primers showed a high target homology for all trypanosome sequences and increased the 
sensitivity 100-fold for T. vivax as compared to the test described by Desquesnes et al. (2001). The 
detection limit of the test on blood applied to filter papers in the case of single infections is one 
 61 
trypanosome/40 µl blood. The authors documented that the inability to differentiate T. brucei s.l. from 
T. evansi (660 bp, each) is of less importance due to the geographical separation of their occurrence 
except in a few overlapping regions. Moreover, there was lack of differentiation between T. simiae 
and T. theileri using the two restriction enzymes. However, the authors reported that this had no 
repercussions for epidemiological surveys in cattle as T. simiae does usually not occur in cattle, 
whereas, this would be important in differentiating the trypanosomes infecting small ruminants and 
tsetse. This differentiation could be further investigated using MboII digestion of the same 
amplification product. The increases in cost and time, together with the low sensitivity, indicated the 
need of designing more specific primers targeting the ITS1 region with increased sensitivity (Geysen 
et al., 2003). The same primers have been used by Delespaux et al. (2003) to evaluate their capacity in 
detecting mixed infections in vitro and in vivo. The results revealed that the restriction profiles of the 
different trypanosome species are easily recognised because the profile of each individual species is 
not overlapping with the profile of other species except for T. congolense and T. theileri. In this case, 
it is difficult to differentiate a single infection with T. congolense from a mixed infection of T. 
congolense/T. theileri.  
Previously identified trypanosomes have been classified using primers designed to amplify the ssu 
rRNA region (Maslov et al., 1996). The primers were evaluated by Malele et al. (2003) who used the 
species-specific primers to confirm the identification of different trypanosomes in microscopically 
positive tsetse flies collected from Tanzania. The species-specific primers were able to identify 24% 
with trypanosome infection, whereas, a high proportion of the microscopically examined flies (about 
75%) had unidentified trypanosome species. To investigate these unidentified samples, the authors 
used primers complementary to the conserved regions of trypanosomal ssu rRNA genes to amplify 
variable segments of the gene. Initial attempts using C and H primers resulted in recovery of ssu 
rRNA sequences with high similarity to Dipetran genes on database together with the desired 
trypanosomal genes. This was probably due to the close similarity of the primers to the tsetse ssu 
rRNA genes. Consequently, primer C was paired with primers (J and I) of low similarity to Dipetran 
ssu rRNA genes (Table 2.12). 
Table 2.12: Primers sequence and PCR product length (Malele et al., 2003; Maslov et al., 1996) 
Approximate length of PCR product (bp) Primer code Primer sequence 
C-J C-I C-H 
C 5’- CCG CGG TAA TTC CAG CTC C-3’ 
H 5’- CGT CAA TTT CTT TAA GTT TC-3’ 
I 5’- GAC TAC AAT GGT CTC TAA TC-3’ 








The amplified DNA fragments using the ssu rRNA primers were then cloned, sequenced and 
compared with ssu rRNA genes on database of known trypanosome species. The results revealed the 
identification of two new trypanosomes, one related to T. vivax and the other related to T. godfreyi 
(Malele et al., 2003). 
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In Kenya, new ITS-based primers (ITS-CF an ITS-BR) have been evaluated for their use as universal 
set for trypanosomes diagnosis by amplifying ITS1 region (Njiru et al., 2005).  Table 2.13 shows the 
sequence of ITS-CF and ITS-BR primers with the band size of the obtained products. 
Table 2.13: Band sizes and ITS-CF, ITS-BR primers sequence (Njiru et al., 2005) 
Trypanosome species Obtained band size 
T. brucei s.l. 480 bp 
T. congolense Kilifi 620 bp 
T. congolense Forest 700 bp 
T. congolense Savannah 700 bp 
T. vivax 250 bp 
T. simiae 400 bp 
T. equoperdium 480 bp 
T. evansi 480 bp 
ITS-CF 5’-CCG GAA GTT CAC CGA TAT TG-3’ Primers 
ITC-BR 5’-TTG CTG CGT TCT TCA ACG AA-3’ 
 
The authors used serial dilutions of trypanosome DNA to test the sensitivity of the ITS-CF, ITS-BR 
and KIN primers together with the sensitivity of the species-specific primers, Table 2.14 summarises 
the results. 
Table 2.14: Sensitivity of ITS based primers (CF and BR) and KIN primers compared with 
species-specific primers (Njiru et al., 2005) 
Sensitivity Trypanosome species 
Species specific primers ITS (CF and BR) KIN 
T. evansi 0.1 pg* 10 pg 10 pg 
T. brucei gambiesnse 0.1 pg 10 pg 10 pg 
T. brucei rhodesiense 0.1 pg 10 pg 10 pg 
T. congolense savannah 0.1 pg 10 pg 100 pg 
T. congolense forest 0.1 pg 10 pg 100 pg 
T. congolense kilifi 0.1 pg 10 pg 100 pg 
T. godfreyi 10 pg 100 pg 1 ng 
T. simiae 1 pg 100 pg 1 ng 
T. vivax 1 pg 10 pg 1 ng 
*(0.1 pg = one trypanosome, 1 pg = 10 trypanosomes, 10 pg = 100 trypanosomes, 100 pg = 1000 trypanosomes, 1 ng= 0.01 
trypanosomes) 
Table 2.14 shows that the species-specific primers are more sensitive in trypanosomes detection than 
using rRNA target due to the higher copy number of the specific targets. Concerning the T. 
congolense subgroups, it is clear that ITS (CF and BR) primers are more sensitive compared with KIN 
primers in detecting the different T. congolense sub-species. In field application, 357 cattle samples 
collected from Kenya were examined using the different primer sets, for the samples positive using 
species-specific primers, ITS (CF and BR) were able to detect 84.9% compared with 67.4% using 
KIN primers. Although KIN primers were highly sensitive in detecting T. vivax (West African isolate) 
using the reference DNA, they were unable to detect any of the T. vivax species from field samples 
that were detected using species-specific primers and ITS (CF and BR).  
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From the above results, ITS (CF and BR) showed a higher diagnostic sensitivity than that previously 
described using KIN primers. The major difference between ITS (CF and BR) and KIN primers, is the 
ability of ITS (CF and BR) to detect T. vivax in field samples. This may be due to the 100% homology 
shown using ITS (CF and BR) with the available T. vivax sequence, while KIN primers showed only 
75-90%. Despite the improved detection rates of T. vivax using ITS (CF and BR) primers, the authors 
identified only 77.4% of T. vivax from field samples in Kenya (East Africa). This fact may be related 
to low target DNA or the existence of T. vivax genetic variants (Masake et al., 1997; Masiga et al., 
1992; Morlais et al., 2001).  
The specificity of ITS (CF and BR) (no amplification with host and vector DNA) and capability of 
detecting all pathogenic trypanosomes in a single PCR indicates a great potential for this system as a 
universal test for pathogenic trypanosomes. However, the greatest challenge facing ITS-based tests is 
diagnostic sensitivity, because ITS1 has approximately 100-200 copies compared to 10,000 copies of 
species-specific tests targeting satellite DNA of T. brucei s.l. for instance (Desquesnes and Davila, 
2002).   
The development of a simple nested PCR method which detects the inter-specific length variation of 
the ITS regions of ribosomal genes producing a unique size of PCR product for each species has been 
reported by Cox et al. (2005). The authors compared the sensitivity of the nested ITS-PCR with the 
single PCR using KIN primers in detecting different trypanosomes using genomic DNA diluted with 
water and bovine blood. The sensitivity of KIN primers to detect trypanosomes using genomic DNA 
was found to be more than 70 trypanosomes/µl and 350-3000 trypanosomes/µl when whole 
trypanosomes were diluted with bovine blood. This indicates that blood has an inhibitory effect on 
PCR. However, the sensitivity of the nested ITS-PCR was a single trypanosome/µl using both the 
genomic DNA diluted in water and the whole trypanosome diluted in bovine blood.  
The decision to use a nested PCR was based on increasing the sensitivity limit of the reaction with the 
increase in the target amount and potential dilution of the inhibitory factors (Cox, 2007). The nested 
ITS-PCR developed by Cox et al. (2005) has greatly simplified epidemiological studies involving cost 
reduction by a factor of four making the test a simple, cost effective, robust and reliable tool for 
investigating the complex epidemiology of African trypanosomiasis. Table 2.15 summarises the 







Table 2.15: ITS1 primers sequence and band sizes (Cox et al., 2005) 
Trypanosome species Obtained band size 
T.congolense Forest 1513 bp 
T.congolense Kilifi 1422 bp 
T.congolense Savannah 1413 bp 
T.congolense Tsavo 954 bp 
T.brucei s.l. 1207-1224 bp 
T.simiae 850 bp 
T.vivax 611 bp 
T.theileri 988 bp 
ITS1 5'-GAT TAC GTC CCT GCC ATT TG-3' Outer primers 
ITS2 5'-TTG TTC GCT ATC GGT CTT CC-3' 
ITS3 5'-GGA AGC AAA AGT CGT AAC AAG G-3' 
Primers 
Inner primers 
ITS4 5'-TGT TTT CTT TTC CTC CGC TG-3' 
 
The aforementioned studies using generic primers to amplify the ITS1 region have concentrated on 
identifying only those trypanosomes causing the disease in cattle, whereas the range of trypanosomes 
infecting tsetse flies is far wider. Consequently, the study conducted by Adams et al. (2006) aimed to 
design generic primers in highly conserved areas to amplify the internal transcribed spacer (ITS) 
region of the rRNA repeat regions to enable species identification by inter-species size variation. The 
nested PCR developed is composed of two rounds of 35 cycles each using the outer primers in the first 
round and the inner primers in the second round. The produced band sizes varied from 150-750 bp 
according to the species (Table 2.16).  
Table 2.16: ITS1 primers sequence and band sizes (Adams et al., 2006) 
Trypanosome species Obtained band size 
T. brucei s.l. 430 bp 
T. congolense kilifi 560 bp 
T. congolense Forest 640 bp 
T. congolense Savannah 640 bp 
T. vivax 180 bp 
T. simiae Tsavo 380 bp 
T. simiae 380 bp 
T. grayi 380 bp 
T. godfreyi 240 bp 
TRYP1 5’-TGC AAT TAT TGG TCG CGC-3’ Outer primers 
TRYP2 5’-CTT TGC TGC GTT CTT-3’ 
TRYP3 5’- AAG CCA AGT CAT CCA TCG-3’ 
 
 
Primers Inner primers 
TRYP4 5’- TAG AGG AAG CAA AAG-3’ 
 
It is noticeable that some species have the same band size such as T. congolense Savannah/T. 
congolense Forest, T. brucei s.l/T. evansi and T. simiae/T. grayi. For tsetse examination, an additional 
species-specific PCR test is needed to distinguish these species. However, from my point of view, if 
this reaction is being used to screen samples collected from cattle, there is no need for further species-
specific reaction to distinguish between the aforementioned species because it is easier to differentiate 
between these species depending on geographic distribution and the host range.  
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The sensitivity of this reaction is similar to that developed by Cox et al. (2005), both reported to detect 
0.1 pg DNA (one trypanosome), but the sensitivity of the PCR test using the new generic primers 
(Adams et al., 2006) was reduced when dilution series with and without midgut tissues were 
compared. The authors collected wild tsetse samples from Tanzania in order to examine them using 
the new primers. The test was not able to identify a high proportion of samples (43.1%), they 
attributed this failure of identification to the presence of inhibitors in the midgut (proteases or haem-
moieties) or that DNA storage method was not optimum. Moreover, the encountered failiure might be 
attributed to the unbounding of all trypanosome DNA effectively onto FTA®card matrix due to the 
presence of midgut material. The primers designed by Cox et al. (2005) were able to amplify the non 
pathogenic T. theileri which is transmitted mainly by Tabanids, while, the new primers designed by 
Adams et al. (2006) didn’t amplify the ITS region for this trypanosome species because the authors 
were interested more with tsetse transmitted trypanosomes. The main drawbacks of using nested PCR 
are contamination issues related to the necessity of reagent and product handling before first round 
PCR, second round PCR and once again before gel electrophoresis (Boonma et al., 2007).  
As a further development in the diagnosis of trypanosomes using the length variation of multiple 
fragments within the 18S and 28S rRNA genes, Adams et al. (2008) have developed a new generic 
PCR method using fluorescent primers with the subsequent sizing of the products accurately and 
rapidly using an automated DNA sequencer. The authors have compared the use of the new 
fluorescent fragment length bar-coding (FFLB) (Hamilton et al., 2007) and the previously described 
method using ITS primers (Adams et al., 2006) in examining midgut samples collected from 
Tanzania. The comparison revealed that using ITS primers, 78% of the examined flies were identified 
to be infected with different trypanosome species, while, using FFLB, 97% were found to be infected. 
The authors documented that the FFLB system is accurate, quick and has an extremely high level of 
identification of infection. Moreover, FFLB revealed the existence of a putative new species of 
trypanosomes that is most related to T. brucei s.l. by phylogenetic analysis. However, the only 
obstacle of this new technique is the requirement of expensive equipment and trained technical staff 
for application.  
In the current study, the different species-specific primers for the three major pathogenic trypanosmes 
T. brucei s.l., T. congolense Savannah and T. vivax are evaluated and compared to the use of ITS-
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Polymerase chain reaction (PCR) has been used to amplify trypanosome DNA from genetic material 
isolated from both blood (Garcia et al., 1995; Njiru et al., 2004a) and buffy coat preparations  
(Mugittu et al., 2001).  Rapid, efficient and reproducible procedures for isolating DNA before PCR 
amplification are essential for confirmation of infection (Alhassan et al., 2007). However, the 
protocols to extract the DNA from samples are expensive, require specific instruments and kits and 
are time consuming. The transport of the collected fresh samples including blood, body fluids and 
tissues from animals and humans from the collection point to the laboratory may involve leakage risks 
because these samples are considered a potential biohazard to humans, animals or the environment. 
This is because they contain biological organisms such as viruses, bacteria, fungi and parasites and 
their toxins (WHO, 2005). Moreover, the transport of the samples may involve degradation of the 
genomic material due to temperature variation (Smith and Burgoyne, 2004).     
Blood and buffy coat samples have been routinely collected on ordinary filter paper for analysis and 
detection of different blood pathogens such as Theileria parva (Geysen et al., 1999), trypanosomes 
(Boid et al., 1999; de Almeida et al., 1998a; Delespaux et al., 2003; Gonzales et al., 2003; Goossens 
et al., 2006; Katakura et al., 1997; Mahama et al., 2004), Plasmodium species (Wooden et al., 1993) 
and human immunodeficiency virus (Panteleeff et al., 1999.).  Although collection of blood samples 
on filter paper for large scale sampling seems to be more convenient than other sampling procedures 
such as in situ DNA extraction (de Almeida et al., 1998), these filter papers are not suitable for long 
term storage, as they do not protect the sample from spoiling and degradation (Smith and Burgoyne, 
2004). For instance, in a study conducted by Katakura et al. (1997), blood samples from cattle 
collected on filter paper (stored at room temperature and at -20ºC for three months) were tested for the 
presence of trypanosome DNA by PCR. The authors observed 1000-fold decrease in the sensitivity of 
DNA detection from the filter paper stored at room temperature compared to those stored at -20ºC, 
confirming the inability of ordinary filter papers in protecting the genomic material for long periods 
when stored at room temperature.  
Flinders Technology- Australia (FTA) technology has improved upon this paper based system. The 
FTA®card has been designed to fix and store nucleic acids directly from tissues, allowing the 
collection and archiving of nucleic acids (Belgrader et al., 1995; Picard-Meyer et al., 2007). The FTA 
matrix is impregnated with protein denaturants that cause lysis of cells and any organisms on contact. 
Moreover, these chemicals inhibit saprophytes during drying to ensure the safe handling of cards with 
out risk of biohazards (Belgrader et al., 1995; Rogers and Burgoyne, 1997). FTA technology also 
includes chelating agents and a free- radical trap designed to deal with atmospheric pollutants, thus 
protecting the entrapped nucleic acids for at least six years at room temperature (Rogers and 
Burgoyne, 1997). Although FTA®cards can protect DNA against acid gases and free radical 
generating pollutants in the atmosphere, it is reasonable to enhance the storage times of the DNA in 
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FTA®cards by inhibiting the atmospheric circulation by keeping them in specific envelopes with 
desiccants (Smith and Burgoyne, 2004). In conclusion, the advantages of using FTA®cards technology 
over other methods are due to the low sample volume (100 µl), safe handling, immobilization of the 
DNA, less storage space, ease of transportation and cheaper costs (Gutierrez-corchero et al., 2002).  
FTA®cards have been used for blood storage (Devost and Choy, 2000; Gutierrez-corchero et al., 
2002), detecting bacterial pathogens (Lampel et al., 2000; Rogers and Burgoyne, 1997), detection of 
plant genes (Lin et al., 2000), detection of viral genomes (Ndunguru et al., 2005; Owor et al., 2007; 
Picard-Meyer et al., 2007) and in forensic human biology (Hsiao et al., 1999). The use of FTA®cards 
has been extended to include DNA detection from pathogenic protozoa and pathogenic organisms 
isolated from foods and clinical specimens using PCR (Orlandi and Lampel, 2000).  
The feasibility of FTA®cards for the shipment, storage and detection of RNA rabies virus has recently 
been evaluated by Picard-Meyer et al. (2007). The authors concluded that the chemicals impregnated 
in the filter paper have made the samples no longer infectious; subsequently the samples do not induce 
any biohazards especially during shipment. Moreover, Owor et al. (2007) reported that the use of 
FTA®cards facilitates the large scale field sampling of viruses infecting plants, and yields DNA with 
sufficient stability, quantity and quality for further screening over time of storage at room temperature. 
The authors successfully extracted the viral DNA from FTA®cards stored at room temperature for 
nine months. 
In trypanosome diagnosis, FTA®cards have been used for the storage of many materials including 
blood, buffy coat and extracted DNA for the detection of trypanosomes using PCR (Becker et al., 
2004; Cox et al., 2005; Kaare et al., 2006; Picozzi et al., 2005; Picozzi et al., 2002). The use of 
FTA®cards for tsetse flies midgut storage has been documented by  Adams et al. (2006, 2008), who 
noticed a lower trypanosome detection using PCR (56.9%) than was expected. They attributed this to 
different reasons including the sub-optimum binding of trypanosome DNA to the FTA®cards and the 
un-even binding of the trypanosome DNA throughout the card due to competition with midgut 
material. Also, the lower trypanosome detection was due to the high level of PCR inhibitors such as 
proteases and haem-moeties. The results have been improved reaching 78% after storage of the 
midgut samples in 100% ethanol and purification of DNA using ammonium acetate precipitation. 
Although FTA®cards are reliable medium for storage and transport of blood samples for PCR-based 
assays, long-term storage (>9 months) has been shown to prevent the complete removal of blood from 
discs by washing (Becker et al., 2004).  
3.2 Objectives 
The aim of this study is to validate different sample preparations in trypanosome diagnosis. This aim 
will be achieved by comparing different sample preparations collected in 2001-2002 by PCR in order 
to study the suitability of such preparations for the accurate diagnosis. The PCR screening of these 
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samples collected on FTA®cards will give an idea about the suitability of FTA®cards to sustain the 
integrity of DNA over long periods. 
3.3 Study area 
3.3.1 Overview 
Uganda is a landlocked country in East Africa, bordered to the east by Kenya, to the north by Sudan, 
to the west by Republic of Congo and Tanzania to the south. The southern part of the country includes 
a substantial portion of Lake Victoria (Figure 3.1). The country is mostly plateau (900 meters altitude 
above the sea level and 800 kilometres inland from the Indian Ocean) and is suitable for both arable 
and livestock farming.  
 
Figure 3.1: Uganda map with the studied two districts highlighted in purple 
The two districts studied, Tororo and Busia, (highlighted in purple, Figure 3.1) are located in the East 
of Uganda. The main economic activity in both districts is agriculture. The predominant tsetse species 
in the study area is Glossina fuscipes fuscipes. Glossina pallidipes is present but to a lesser extent 
(Lancien et al., 1990). 
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3.3.2 Selected villages 
3.3.2.1 Busia district villages 
The selected villages include Buyimini village which lies to the east of the district. It is located a little 
further away from the nearest swamp compared to the other villages, with a surrounding forest cover. 
Kubo village lies in the mid-western part of the district, at the forest edge within the mixed farmland. 
It is also in close proximity to open Savannah grassland and a swamp. The third one is Nanjeho 
village, which lies to the southeast of the district; in close proximity to a swamp and a forest cover.  
3.3.2.2 Tororo district villages 
Three villages were selected from Tororo district; the first was Hitunga village lying to the north-west 
of the district at the edge of a swamp. It has open Savannah grassland with minimum forest cover. The 
second selected village was Magogi lying to the western part of the district in close proximity to a 
swamp with papyrus type of vegetation. It lies also in close proximity to woodland vegetation with 
trees of approximately four meters in height. The third village is Ojilai, which lies to the south-
western part of the district in close proximity to a swamp with open savannah. Tropical high forests 
are also present to the north of the village. 
3.3.3 Sample selection 
The samples used in the current study were selected from samples collected within a longitudinal 
study carried out in Busia and Tororo districts – Uganda, in 2001 and 2002 by Kim Picozzi. For each 
animal, blood samples were collected for preparation of different materials including blood and buffy 
coat applied on FTA®cards and DNA extracted from whole blood and buffy coat preparations. 
Different sample preparations for 84 animals were selected in the current study to be analysed using 
PCR.  
Selection of the samples in the current study was based on reported positive identification of 
infectious agent by microscopy, a reported low packed red cell volume (PCV), lower than 25, or a 
recorded poor condition score. The selection of these animals was also based on the availability of at 
least four sample preparations for each animal in order to make a comparison between these different 
preparations. The DNA samples were stored at -20ºC, while the FTA®card samples were stored at 
room temperature in envelopes with desiccant until the analysis was done in 2006 during the current 
research. Table 3.1, shows the number of cattle collected from each village. Figure 3.2, shows the 




Table 3.1: The number of samples in each village 









Total  84 
 
 
Figure 3.2: Different sample preparations collected from the selected animals (n: number of 
available material) 
3.4 Material and methods 
The samples used in the current study were collected and prepared by Kim Picozzi during a 
longitudinal study carried out in Busia and Tororo districts – Uganda, in 2001 and 2002.  
3.4.1 Recording data   
Data including the village name, age/sex/breed and body condition of the animal were recorded. Body 
condition scoring is a measure of the extent to which fat is stored or the muscle mass has declined. 
This can be measured by observing and examining the depth of the sub-lumbar fossa to assess the 
extent of emaciation (Nicholson and Butterworth, 1986). During sampling, Zebu and Ankole cattle 
were scored for the body condition as follows: Fat (F), Medium (M) or Lean (L). 
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3.4.2 Collection of heparinised whole blood 
Blood was collected from the jugular vein into heparinised vacutainers for the preparation of buffy 
coat and for microscopic examination by thin and thick smears. Before the preparation of buffy coat 
samples, 100 µl of blood was spotted upon arrival to the laboratory on FTA®cards. Buffy coat samples 
were prepared by centrifugation of heparinised venous blood (4 ml) in a centrifuge at 3000 rpm. The 
buffy coat preparation was then collected from the interface between the packed red cells and the 
plasma and 100 µl was spotted on FTA®card for further analysis. 
3.4.3 DNA preparation 
3.4.3.1 Amershams GFX blood DNA purification kit 
GFX purification uses a chaotropic agent (causes disruption of the molecular structure) to extract 
nucleated cells. The agent facilitates the binding of the genomic DNA to a glass fiber matrix contained 
in a MicroSpin column. Contaminants are removed with ethanolic washes and the purified DNA is 
eluted in a low ionic strength buffer. 
Red Blood Cells (RBCs) lysis 
To extract DNA from 300 µl whole blood, 900 µl RBC lysis solution (3x the sample volume) was 
added to 1.5 ml micro-centrifuge tube containing the blood sample. After inverting the tubes several 
times for thorough mixing, they were incubated at room temperature for five minutes. Centrifugation 
of the tubes at 12,000 rpm for 20 seconds was done to pellet the cells. 
The supernatant was removed by aspiration without disturbing the white blood cell pellet. Some 
residual fluid remained on the sides of the tube to be used in re-suspending the cells before extraction.   
Extraction 
Vigorous vortexing of the cells in the residual supernatant (20-50 µl) was carried out to re-suspend 
them. Before the cells settled completely, 500 µl of extraction solution was added to the suspended 
cells. The mixture was then vigorously vortexed and incubated at room temperature for five minutes. 
DNA binding 
The entire extraction mixture was transferred to the GFX column and centrifuged at 8000 rpm for one 
minute. The flow-through was discarded by emptying the collection tube and then the GFX column 




The DNA was extracted by adding 500 µl of extraction solution to the column. The mixture was 
centrifuged at 8000 rpm for one minute, and then the flow-through was discarded by emptying the 
collection tube. The contaminants were washed by adding 500 µl of wash solution and centrifugation 
of the mixture was carried out at 12,000 rpm for three minutes. The collection tube was discarded and 
the GFX column was transferred to a fresh 1.5 ml micro-centrifuge tube. 
Elution 
Pre-heated elution buffer (100 µl) was applied directly to the glass fiber matrix in the GFX column. 
The mixture was incubated at room temperature for one minute and then centrifuged at 8000 rpm for 
one minute to recover the purified DNA. The DNA yield using this method is 4.5-7.5 µg from 300 µl 
whole blood. 
3.4.3.2 DNeasy®Blood and Tissue Extraction kit 
For each sample, 200 µl buffy coat was collected from spinning down 1 ml whole blood. The DNA 
was extracted from this buffy coat amount by using DNeasy®Blood and Tissue Extraction kits 
(Qiagen). 
Extraction 
Proteinase K (20 µl) was pipetted into the bottom of a 1.5 ml micro-centrifuge tube containing 100 µl 
of buffy coat (each sample was divided into two and each half was processed separately). The volume 
was then adjusted to 200 µl with phosphate buffer solution (PBS). Extraction buffer (AL) was added 
in a volume of 200 µl, and then the tubes were thoroughly mixed by vortexing. Ethanol (200 µl) was 
added to the sample, the mixture was then vortexed thoroughly and pipetted into the DNeasy Mini 
spin column placed in a 2 ml collection tube. Centrifugation of the tubes was carried out at 8000 rpm 
for one minute, and then the flow-through and collection tubes were discarded. 
Washing 
The DNeasy Mini spin was placed in a new 2 ml collection tube. Contaminants were removed from 
the tubes by adding 500 µl washing buffer (AW1); the samples were then centrifuged at 8000 rpm for 
one minute. The same washing step was repeated but by using washing buffer (AW2) and 
centrifugation at 14,000 rpm for 3 minutes. The flow-through and collection tubes were discarded for 





The DNeasy Mini spin was placed in a clean 1.5 ml micro-centrifuge tube. DNA was eluted from the 
sample by pipetting 200 µl of the elution buffer (AE) directly on the DNeasy membrane. The tubes 
were incubated at room temperature for one minute, and then centrifuged at 8000 rpm for one minute. 
The final yield of DNA from 100 µl buffy coat sample is 3-12 µg. 
3.4.4 FTA®cards 
Preparation of the discs for the PCR reaction was done during the current study using the previously 
archived samples collected on FTA®cards during the longitudinal study in 2001-2002.   
3.4.4.1 Preparation of discs from FTA®cards 
For the three types of samples applied on FTA®cards, the same procedure for preparaing and washing 
the discs was applied. FTA®cards were placed on a cutting mat, using a puncher (Harris Micro Punch) 
a 0.2 mm disc was cut from the card. The number of discs to be examined were cut and placed 
together into a micro-centrifuge tube for washing. To avoid cross contamination between samples, an 
equivalent number of discs were taken from a blank filter paper after each sample. 
3.4.4.2 Washing the discs  
The discs were washed twice, 15 minutes each, in 200 µl (for each disc) of Whatman FTA purification 
reagent. This washing step removes materials such as haemoglobin which inhibits the PCR reaction, 
while the DNA is remained bound to the disc. The discs were then washed twice for 15 minutes in 200 
µl (for each disc) 1 mM TE buffer (10mM Tris-HCL pH 8.0; 1mM EDTA pH 8.0) to remove the FTA 
purification reagent from the card. The discs were then transferred to PCR tubes and left to dry at 
room temperature for at least 90 minutes (Picozzi et al., 2002). To detect any cross-contamination that 
may occur during sample washing, discs of a blank FTA®cards were washed with each batch of 
samples processed, and used as negative controls in the PCR. 
3.4.5 Diagnosis by microscopy 
Microscopic examination of heparinised blood samples for the presence of trypanosomes was done by 
Kim Picozzi using the haematocrit centrifugation technique (HCT) and buffy-coat phase contrast 
methods. The data of the microscopical examination was collected from the records of the 
longitudinal study conducted in 2001-2002.  
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3.4.5.1 Haematocrit centrifugation technique 
Heparinised capillary tubes were filled with blood and one end of each tube was sealed with 
plasticine. The sealed capillary tubes were then centrifuged for four minutes at 12,000 rpm. After 
centrifugation, the capillary tubes were placed in a capillary tube holder along with a drop of 
immersion oil and examined under the microscope (Woo, 1970).  
3.4.5.2 Buffy coat phase contrast method 
Buffy coat samples were prepared by centrifugation of heparinised blood collected in capillary tubes. 
The capillary tube was cut with a diamond pointed pen 1 mm below the buffy-coat to include the 
uppermost layer of RBCs and 3 cm above to include the plasma. Using a micro-haematocrit capillary 
tube holder, the contents of the capillary tube were gently expressed on to a slide, mixed and covered 
with 22x22 mm cover slip. The slides were then examined by using phase contrast microscope at 
250X magnification (Murray, 1977). 
3.4.6 PCR 
3.4.6.1 Primers and sizes of amplified products  
The PCR reaction used in this chapter was Internal Transcribed Spacer PCR (ITS-PCR) to amplify 
ITS region of different trypanosome species. The primer sequences and the size of the amplified 
products related to each trypanosome species are summarised in Tables 3.2 and 3.3, respectively. The 
primers were re-suspended in water to a working concentration of 100 µM and stored frozen at -20ºC. 
The working stock was then diluted to a concentration of 10 µM before use and stored at 4ºC. 
Table 3.2: Primer sequences for ITS-PCR reaction 
Primer Sequence Reference 
ITS1 5'-GAT TAC GTC CCT GCC ATT TG-3' Outer primers 
ITS2 5'-TTG TTC GCT ATC GGT CTT CC-3' 
ITS3 5'-GGA AGC AAA AGT CGT AAC AAG G-3' Inner primers 
ITS4 5'-TGT TTT CTT TTC CTC CGC TG-3' 








Table 3.3: Amplified product sizes for each trypanosome species 
Trypanosome species Product size 
(bp) 
Reference 
T.congolense Forest 1513 
T.congolense Kilifi 1422 
T.congolense Savannah 1413 
T.congolense Tsavo 954 







(Cox et al., 2005) 
 
*ITS-PCR results with amplicon size more than 1400 bp were classified as T. congolense due to the difficulty in 
classifying the sizes of the three sub species 
3.4.6.2 The reaction conditions 
The reaction volume of 25 µl contained the following components, Super Taq PCR buffer (HT 
Biotechnology Ltd, UK) (final concentrations of 10 mM Tri-HCL, pH 9.0, 1.5 mM MgCl2, 50 mM 
KCL, 0.1% Triton X-100 and 0.01% (w/v) stabilizer), 0.2 µM of each outer primer ITS1 and ITS2, 1 
mM total dNTP’s (Bioline, London, UK) and 1.25 units of Biotaq (Bioline, London, UK). 
Trypanosome DNA was amplified from 1 µl of extracted DNA from whole blood and buffy-coat, 
while, one disc from samples applied on FTA®cards was used for the DNA amplification. One 
positive control (genomic DNA) and one negative control were run with each PCR.  
The reaction conditions were as follows: 1 cycle of 95ºC for seven minutes followed by 35 cycles of 
94ºC for one minute, 55ºC for one minute and 72ºC for two minutes. The reaction was carried out in a 
DNA Engine DYADTM Peltier Thermal Cycler. 
For the ITS-PCR second round reaction, 1 µl of the PCR product from the first round reaction was 
placed in a fresh tube and 24 µl of the reaction mixture was added as detailed for the outer primers 
with the exception of the substitution of the outer primers with the inner primers ITS3 and ITS4. The 
reaction conditions were the same as in the first round. 
3.4.7 Gel electrophoresis 
3.4.7.1 Principle 
The principle of gel electrophoresis is that at neutral pH, DNA has a negative charge, when it is 
loaded at the cathode, it moves toward the anode. The DNA fragments migrate through the gel with a 





Amplification products were resolved in 1% (w/v) agarose gels along with 100 bp molecular weight 
Superladder (ABgene, Epsom, Surrey, UK). The agarose gel was prepared in 1 x TBE (89 mM Tris-
Borate, 2 mM EDTA, and pH 8.3) (Sigma-Aldrich, Poole, Dorset, UK) stained with 5 µM ethidium 
bromide which intercalates between DNA bases and fluoresces under Ultra Violet light. The gels were 
run in 1xTBE, 5 µM ethidium bromide for at least 45 minutes at 100 volts. 
3.4.7.3 Visualisation 
The amplified DNA bands were visualized under Ultra Violet transilluminator (Gel-Doc 2000, Bio-
Rad). Exposure was optimised and pictures were stored with the aid of Bio-Rad Software (Quantity 
One, Bio-Rad). 
When the amplification reaction gave a signal of the expected size (Table 3.3) according to the set of 
primers used without any signal in the negative control, infection was considered to be confirmed. A 
positive control was used to be sure that the reaction mixture was working. Figure 3.3 shows gel 
picture of positive ITS-PCR results.  
 
Figure 3.3: Example of ITS-PCR results in 1% agarose (A: T. simiae, B: T. vivax, C: T. 
congolense/T. vivax mixed infection, D: T. brucei s.l., E: T. theileri (100 bp ladder) 
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3.4.8 Statistical analysis 
The difference in trypanosome detection between the different sample preparations used was analysed 
using Chi-squared test (degree of freedom were noted as a subscript to the χ2 –statistic) that was 
computed using Minitab version 15 (Minitab, Inc.). Differences were considered to be significant at 
p<0.05. For the tested values containing expected frequencies of less than five, Fisher’s exact test was 
used instead of Chi-squared test. 
The sensitivity of a test is defined as the proportion of true positives detected by the test; representing 
the probability of the test to produce true positive result when compared with the gold standard 
(reference test). On the other hand, specificity of a test is the proportion of true negatives that are 
detected by the test; representing the probability of the test to produce true negative result with the 
gold standard.  
The positive predictive value of a test is the probability that the positive result is a true positive. 
While, the negative predictive value of the test is the probability that the negative result is a true 
negative. Unlike sensitivity and specificity, the predictive value of a test varies depending upon the 
prevalence of the condition being tested in a specific population. 
Table 3.4 shows the outcomes of a test in relation to the gold standard and the equations to calculate 
the sensitivity, specificity, positive predictive value and negative predictive value (Thrusfield, 1986). 
Table 3.4: Outcomes of a diagnostic test and equations (Thrusfield, 1986) 
 Gold standard 
 Positive Negative Total 
Positive TP FP TP+FP 















Negative predictive value (NPV)= TN/(TN+FN) 
TP: True positive, FP: False positive, TN: True negative, FN: False negative 
The Kappa value was used to determine the level of agreement between the diagnostic test and the 
gold standard. The Kappa value lies between 0 and 1, where 0.8-1 means a very good agreement 
between tests and 0 means that the association is no better than expected from chance alone. Kappa 
value >0-0.2 indicates poor agreement, >0.2-0.4 indicates fair agreement, >0.4-0.6 means moderate 
agreement and >0.6-0.8 means good agreement.  A negative Kappa value indicates that the two tests 
agree less than would be expected by chance (Altman, 1991; Avila et al., 1991). Kappa value is 
calculated by the formula: (A-E)/ (N-E) where A is the sum of agreements defined as the sum of 
positives and negatives common to both techniques. E is the sum of expected occurrences defined as 
the sum of all positives divided by N plus the sum of all negatives divided by N. While, N is the 
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number of animals examined by both methods. The agreement of test results was based on the 
analysis of the Kappa statistics using the computer programme Win Episcope 2.0. 
Kappa value= (A-E)/ (N-E) 
A=∑all positives and negatives common to both techniques 
E= ((∑positives)/N+ (∑negatives)/N) 
N= the total number of animals examined by both techniques. 
3.5 Results 
In 2001/2002; a longitudinal study was carried out to observe the impact of block treatment of cattle 
with drugs against trypanosomiasis and East Coast Fever (ECF). At the last collection point, both 
DNA and blood samples were collected. This chapter focuses on 84 animals selected on the basis of 
reported positive identification of infectious agent by microscopy, a reported low PCV (lower than 25) 
or a recorded poor condition score. These animals were also selected on the basis of the existence of at 
least four analytical samples namely whole blood on FTA®cards and DNA extracted directly from 
whole blood, and buffy coat on FTA®cards as well as DNA extracted from buffy coat. For 49 animals, 
DNA was also stored on FTA®cards. This information is summarised in Figure 3.2.  
3.5.1 Data collected from microscopical examination of the 
selected animals 
The microscopy results obtained from the records of the longitudinal study indicated a total of 15.5% 
animals were infected with different trypanosome species in single and mixed infection. Table 3.5 
summarises the proportion of different trypanosome species identified by microscopy in the examined 
animals. 
Table 3.5: Proportion of trypanosome species detected by microscopy [% (fraction; 95% CI)] 
Parasitic events* Number of animals examined 
T. brucei s.l. 
 
T. congolense T. vivax 
 










*Includes parasite species existing in single and mixed infections 
The results in Table 3.5 show the proportion of parasitic events identified by microscopy; in the case 
of mixed infection with more than one species, the parasites in the combination were categorised 
according to the species. For instance, an animal infected with T. brucei s.l./T. vivax mixed infection, 
T. brucei s.l. was included in the column of T. brucei s.l. single parasitic event and T. vivax was 
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included in the column of T. vivax single parasitic event. This explains why the overall incidence of 
the parasitic events exceeds the overall infected animals.  
The results show that the proportion of T. brucei s.l., T. congolense and T. vivax diagnosed by 
microscopy, was 2.4%, 1.2% and 13.1%, respectively. The identification of T. vivax by microscopy 
was significantly higher than T. brucei s.l. (χ1
2=6.8, p=0.009) and T. congolense (χ1
2=8.7, p=0.003).    
3.5.2 PCR results from examining the selected animals  
The PCR reaction used in this study was ITS-PCR which targets internal transcribed spacer in the 
trypanosome genome. The reaction was used to amplify trypanosome genomic material from different 
sample preparations collected from 84 selected animals (Figure 3.2). The preparations included 
examining five discs from each material applied on FTA®cards; each disc was examined by a separate 
ITS-PCR. Moreover, 1 µl from DNA extracted from both whole blood and buffy coat was also 
examined.  
For the PCR results, the true infection status of the 84 animals, was defined as positive if at least one 
of the different examined materials was positive by PCR (Picozzi et al., 2002). ITS-PCR identified 
72.6% of the sampled animals to be infected with different trypanosome species including single and 
mixed infections with pathogenic (T. brucei s.l., T. congolense and T. vivax) and non-pathogenic 
species (T. theileri). Table 3.6 shows the proportion of parasitic events diagnosed by ITS-PCR of 
different sample preparations from the selected animals. 
Table 3.6: Proportion of trypanosome species detected by ITS-PCR [% (fraction; 95% CI)] 
Parasitic events* Proportion of animals 
infected with any 
trypanosomes 
 
Proportion of animals 






























*Includes parasite species existing in single and mixed infections  
The results in Table 3.6 show the proportion of parasitic events diagnosed by ITS-PCR. The 
proportion of T. brucei s.l., T. congolense, T. vivax and T. theileri diagnosed by PCR was 13.1%, 
7.1%, 8.3% and 53.6%, respectively. The prevalence of T. theileri species identified by ITS-PCR was 
significantly higher than the other pathogenic species (χ1
2=10.8, p=0.001).  
Excluding the non-pathogenic species T. theileri from the overall prevalence of the parasitic events 
would help to precisely compare the level of PCR sensitivity with microscopy. This exclusion was 
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based on the inability of microscopy to identify this species due to characteristic low parasitemia 
level.    
3.5.3 Evaluation of PCR versus microscopy in trypanosome 
diagnosis 
Table 3.7 shows the results of microscopy compared to ITS-PCR in identifying animals infected with 
trypanosomes.  
Table 3.7: ITS-PCR versus microscopy in diagnosing animals infected with trypanosomes 
ITS-PCR 
All trypanosome species Pathogenic trypanosomes 
 
Positive Negative Total Positive Negative Total 
Positive 12 1 13 6 7 13 
Negative 49 22 71 17 54 71 
Microscopy 
Total 61 23 84 23 61 84 
 
The results in Table 3.7 show that comparing PCR and microscopy in detecting any trypanosome 
species (pathogenic and non-pathogenic) 12 animals were found to be positive for trypanosomes by 
both microscopy and PCR, 49 were positive by PCR but negative by microscopy. One animal was 
identified by microscopy to have infection but missed by PCR, while 22 animals were found negative 
by both methods.  
The detection of trypanosomes in the examined animals by either microscopy or ITS-PCR was 
compared to a gold standard (defined as a positive PCR and/or microscopy result in each examined 
animal) and tested for the agreement using Kappa test. The sensitivity of microscopy in detecting any 
trypanosomes compared to the gold standard was found to be 21% (95% CI: 10.8-31.1), while the 
sensitivity of ITS-PCR compared to the gold standard was found to be 98.4% (95% CI: 95.3-100). 
The diagnostic predictive value showed that the probability of microscopy detecting animals negative 
for trypanosomes was 31% (95% CI: 20.2-41.7). The Kappa value was determined to be 0.1 indicating 
poor agreement between the gold standard and microscopy in identifiying any trypanosome infections. 
The negative diagnostic predictive value of ITS-PCR was calculated to be 95.7% (95% CI: 87.3-100) 
compared to the gold standard with a Kappa value of 0.9 indicating very good agreement. The results 
show also that PCR proving to be significantly 4.7 times more sensitive than microscopy in 
identifying any trypanosomes (χ1
2=72.1, p<0.001). 
Looking at the overall prevalence of pathogenic species results after excluding the non-pathogenic T. 
theileri, the sensitivity of microscopy in identifying pathogenic species was 43.3% (95% CI: 25.6-
61.1) compared to the gold standard. The negative predictive value of microscopy for diagnosing 
animals infected with pathogenic trypanosomes was 76.1% (95% CI: 66.1-86). ITS-PCR was shown 
to be 1.7 times more sensitive than microscopy in diagnosing pathogenic species with 76.7% (95% CI: 
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61.5-91.8) sensitivity compared to the gold standard. However, this was not statistically significant 
(χ1
2=3.5, p=0.06). The negative diagnostic predictive value of ITS-PCR was calculated to be 88.5% 
(95% CI: 80.5-96.5); ITS-PCR did not detect seven infected animals diagnosed positive by 
microscopy. The Kappa value for the agreement between PCR and the gold standard in detecting 
pathogenic trypanosomes was 0.8 (very good agreement) while 0.5 for microscopy (moderate 
agreement).   
For more specific evaluation of ITS-PCR and microscopy sensitivity in the diagnosis of 
trypanosomes, the data were further broken down to compare the two protocols in diagnosing each 
species. Table 3.8 shows the results comparing ITS-PCR and microscopy in diagnosing T. brucei s.l., 
T. congolense and T. vivax.  
Table 3.8: ITS-PCR versus microscopy in diagnosing animals infected with pathogenic 
trypanosomes 
ITS-PCR 
T. brucei s.l. T. congolense T. vivax 
 
Positive Negative Total Positive Negative Total Positive Negative Total 
Positive 0 2 2 1 0 1 4 7 11 
Negative 11 71 82 6 77 83 3 70 73 
Microscopy 
Total 11 73 84 7 77 84 7 77 84 
  
The results in Table 3.8 show that there was less agreement than would be expected by chance 
between ITS-PCR and microscopy in detecting T. brucei s.l. species (Kappa value=-0.04). Moreover, 
poor agreement was observed between the two tests in diagnosing T. congolense and T. vivax, Kappa 
value was 0.2 and 0.4, respectively. Sensitivity of ITS-PCR in amplifying T. congolense genomic 
material was seven times higher than the detection by microscopy (p=0.06) and this was statistically 
insignificant. While, the sensitivity of microscopy in detecting T. vivax was 1.7 times higher than the 
identification of the species using ITS-PCR but this was statistically insignificant (χ1
2=0.99, p=0.3).  
3.5.4 Suitability of various sample preparations for the accurate 
diagnosis of trypanosome infected animals 
3.5.4.1 Diagnosis of any trypanosome species 
A total of 84 animals were examined for the presence of trypanosome DNA in different sample 
preparations using ITS-PCR. The sample preparations included whole blood, buffy coat and DNA 
applied on FTA®cards, also, extracted DNA from blood and buffy coat in homogenous solution 
(Figure 3.2). 
Using a gold standard (defined as positive PCR result from amplifying trypanosome DNA from 
FTA®cards and/or positive PCR result from amplifying trypanosome DNA in homogenous solutions), 
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72.6% (61/84; 95% CI: 61.8-81.8) animals were diagnosed to be infected with any trypanosome 
species. Compared to the gold standard, the sensitivities and negative predictive values of the 
examined preparations were determined as shown in Table 3.9.  
3.9: Sensitivity and NPV of the examined preparations compared to the gold standard for 
identifying any trypanosome species (n=84) 







Whole blood onFTA®cards 
 




Buffy coat on FTA®cards 
 




DNA on FTA®cards* 
 












*DNA samples applied on FTA®cards were only 49 samples 
Table 3.9 shows the sensitivities and negative predictive values of different sample preparations in 
diagnosing any trypanosome using ITS-PCR. The results show that the sensitivity of trypanosome 
genomic material amplification from DNA homogenous solution extracted from whole blood (GFX) 
was 17.7 times higher than the amplification of the same whole blood extracted DNA from FTA®card 
matrix, which was statistically significant (χ1
2=35.9, p<0.001). Also, the amplification sensitivity of 
genomic materials in DNA solution extracted from buffy coat preparation (Q) was 12.4 times higher 
than amplification from buffy coat on FTA®cards which was significant (χ1
2=35.7, p<0.001). 
Moreover, the sensitivity of detecting trypanosomes from DNA solutions extracted from whole blood 
(GFX) was 1.4 times higher than amplifying the DNA from buffy coat extract (Q), which was 
statistically significant (χ1
2=6.1, p=0.01). The sensitivity of amplifying any trypanosome genomic 
material from DNA extract applied on FTA®cards was 2.6 times higher than from whole blood and 
buffy coat applied on FTA®cards, this was not statistically significant (p=0.4).  
The results in Table 3.10 summarise the Kappa statistic that gives a measurement of the degree of 
agreement between the studied materials compared to the gold standard for the amplification of any 





Table 3.10: Kappa value for testing the agreement between detecting trypanosome DNA in 
different sample preparations 
Material Kappa value Interpretation 
 
Whole blood on FTA®cards 
 
0.03 Poor agreement 
Buffy coat on FTA®cards 
 
0.03 Poor agreement 
DNA on FTA®cards 
 
0.1 Poor agreement 
DNA extract 
(GFX) 
0.8 Very good agreement 
DNA extract 
(Qiagen) 
0.5 Moderate agreement 
  
The results in Table 3.10 show that there was a very good agreement between detecting trypanosome 
genomic material in DNA extract from whole blood compared to the gold standard. Poor agreement 
was detected when the same extract was applied on FTA®cards compared to the gold standard. A 
moderate agreement in amplifying trypanosome ITS target was also detected between DNA extract 
from buffy coat and gold standard. However, poor agreement was observed in detecting any 
trypanosome DNA from whole blood and buffy coat applied to FTA®cards compared to the gold 
standard.  
3.5.4.2 Diagnosis of pathogenic trypanosome species 
Excluding the non-pathogenic trypanosome species T. theileri would give more precise evaluation of 
the suitability of different material preparations for the diagnosis of the three important pathogenic 
African trypanosomes. This approach omitted 38 animals previously identified as infected with T. 
theileri. In this case, the gold standard (defined as positive PCR result from amplifying pathogenic 
trypanosome DNA from FTA®cards and/or positive PCR result from amplifying pathogenic 
trypanosome DNA in homogenous solutions), detected 27.4% (23/84; 95% CI: 18.2-38.2) animals 
infected with pathogenic trypanosomes. Compared to the gold standard, the sensitivities and negative 






Table 3.11: Sensitivity and NPV of the examined preparations compared to the gold standard 


















0 0 61 23 NA NA 
Buffy coat on FTA®cards 
 




DNA on FTA®cards** 
 


















*Sensitivity was not calculated due to the inability of the PCR to amplifiy any DNA from this material ** DNA samples 
applied on FTA®cards were only 49 samples 
Table 3.11 shows the sensitivities and negative predictive values of different sample preparations in 
diagnosing pathogenic trypanosomes using ITS-PCR. The results show that the sensitivity of 
amplifying pathogenic trypanosome genomic material from whole blood DNA extract (GFX) was 
78.3% compared to the gold standard, however, the same DNA extract applied on FTA®cards failed to 
be amplified using ITS-PCR.The sensitivity of amplifying pathogenic trypanosomes from whole 
blood extract (GFX) was 1.6 times higher than amplification from buffy coat extract (Q), which was 
statistically insignificant (χ1
2=1.5, p=0.2). Buffy coat DNA extract (Q) was 11 times more sensitive in 
detecting pathogenic trypanosomes than from buffy coat applied on FTA®cards which was statistically 
significant (χ1
2=7.3, p=0.01). Comparing the materials applied on FTA®cards in amplifying 
pathogenic trypanosome DNA, whole blood extract (GFX) on FTA®cards was 4.2 times higher than 
from buffy coat applied on FTA®cards, which was statistically insignificant (p=0.06). However, 
screening five discs from whole blood on FTA®cards failed to amplify any of the pathogenic 
trypanosome DNA.  
The results in Table 3.12 summarise the Kappa statistic that gives a measurement of the degree of 
agreement between each of the studied materials and the gold standard for the amplification of 
pathogenic trypanosome DNA.  
Table 3.12: Kappa value for testing the agreement 
Material Kappa value Interpretation 
Whole blood on FTA®cards 
 
NA NA 
Buffy coat on FTA®cards 
 
0.1 Poor agreement 
DNA on FTA®cards 
 
0.2 Poor agreement 
DNA extract 
(GFX) 
0.8 Very good agreement 
DNA extract 
(Qiagen) 
0.6 Very good agreement 
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The results in Table 3.12 show that there was a very good agreement between detecting trypanosome 
genomic material in DNA extract from whole blood compared to the gold standard. Poor agreement 
was detected when the same extract was applied on FTA®cards; compared to the gold standard. A 
moderate agreement in amplifying trypanosome ITS target was also detected between DNA extract 
from buffy coat and gold standard. Moreover, poor agreement was noticed in detecting the pathogenic 
trypanosome DNA from buffy coat samples applied on FTA®cards compared to the gold standard.         
3.5.5 Proportion and species of trypanosomes detected by ITS-
PCR in the examined materials   
The proportion and species of trypanosomes identified using PCR amplification of DNA from 
different materials are summarised in Table 3. 
Table 3.13: Proportion and species of trypanosomes detected in different examined materials 
Parasitic events* 
Examined 
Materials T. brucei s.l. 
T. 
congolense 















 (0/84; 0-3.5) 
3.6% 















 (2/84; 0.3-8.3) 
0 
 (0/84; 0-3.5) 
0 











 (0/49; 0-5.9) 
0 
 (0/49; 0-5.9) 
0 
























































 (1/84; 0.03-6.5) 
*Includes parasite species existing in single and mixed infections **Gold standard is defined as animals diagnosed 
positive using ITS-PCR on at least one of the sample preparations used   
The results in Table 3.13 show that T. congolense genomic material was not amplified from materials 
applied on FTA®cards. However, this species was diagnosed only in the DNA extract preparations. T. 
brucei s.l. was significantly detected in DNA extract solutions rather than in FTA®card preparations 
(p=0.03). T. vivax was only detected in FTA®card containing DNA extract and this was insignificantly 
different from diagnosing this species in the same extract when tested using only 1 µl for PCR.   
Mixed infections were only detected in the DNA extract. A total of eight animals were found to 
harbour a mixed infection, with T. theileri included in seven of them. Screening of five discs from 
whole blood and buffy coat applied on FTA®cards failed to detect any type of mixed infection. 
Therefore, 30 discs from material applied on FTA®cards of animals infected with mixed infection 
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were screened further. There was not enough material to screen 30 discs more from DNA extract 
applied on FTA®cards. Table 3.14 shows the results from screening 30 discs contained whole blood 
and buffy coat compared to PCR results using only 1 µl DNA extract from whole blood and buffy 
coat from animals with mixed infections.  
Table 3.14: Further screening of animals with mixed infection 
Sample 
number 
1 µl DNA extract from 
whole blood  
(GFX) 
30 discs from whole 
Blood on FTA card 
(positive discs) 
1 µl DNA extract 
from buffy coat  
(Q) 
30 discs from buffy coat 
on FTA card 
(positive discs) 
1 T. brucei s.l./ T. theileri 0 
T. brucei s.l./ T. 
theileri 
0 
2 T. theileri/ T. vivax 0 0 (2/30) T. theileri 
3 T. theileri/ T. vivax 0 T. theileri 0 
4 T. vivax (7/30) T. theileri T. theileri/ T. vivax (8/30) T. theileri 
5 T. brucei s.l. 0 




T. brucei s.l./ 
T.congolense 
0 T. brucei s.l 0 
7 T. brucei s.l./ T. theileri 0 
T. brucei s.l./ T. 
theileri 
0 
8 T. theileri 0 T. brucei s.l 0 
 
The results in Table 3.14 show that mixed infections with different trypanosome species were only 
diagnosed in extracted DNA solutions either from whole blood or buffy coat. In spite of examining 30 
punches from both whole blood and buffy coat applied on FTA®cards, mixed infection could not be 
detected.  
3.6 Discussion 
3.6.1 Evaluation of PCR and microscopy in trypanosomes 
diagnosis 
Diagnosis of trypanosomiasis using molecular methods has been shown to be highly sensitive and 
more specific than the more traditional microscopic techniques (Desquesnes, 1997; Masake et al., 
1997; Masake et al., 2002). Despite this fact, the application of the molecular techniques in the disease 
control and research programmes in the field has not been widely used (Clausen et al., 1998; Masake 
et al., 1997; Mugittu et al., 2001; Solano et al., 1999). This is due to the costs, the need of specialised 
equipment and the high time costs involved in performing molecular techniques.  
In the present study, a total of 84 cattle were examined for any trypanosome species by microscopy 
and PCR amplification on different sample preparations from each animal. The results showed that 
microscopy was able to detect trypanosome infections in 13 (15.5%) animals while PCR detected 61 
(72.6%). PCR was 4.7 times more sensitive compared to microscopy when compared to one another, 
the agreement between these two diagnostic approaches was poor (Kappa value=0.1).  
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3.6.1.1 T. theileri species 
T. theileri is a cosmopolitan parasite of cattle which has been reported from cattle in every country 
they inhabit (Farrar and Klei, 1990; Herbert, 1964; Matthews et al., 1979; Rodrigues et al., 2003; 
Schlafer, 1979; Verloo et al., 2000). This parasite is the species of the subgenus Megatrypanum that is 
produced in the hindgut of the vector then transmitted to the host through faecal contamination 
(Hoare, 1972; Levine et al., 1980). The most important vectors for transmitting this parasite are 
Tabanids (Dirie et al., 1990; Marquardt et al., 2000). In a study conducted by Bose and Heister 
(1993), 39% of the collected Tabanid flies were found to be carrying T. theileri. Moreover, ticks were 
found to have a high vectorial capacity for T. theileri suggesting the ability of ticks to act as a vector 
for the parasite (Latif et al., 2004). Although considered non pathogenic, other cases of clinical illness 
suggested that T. theileri may be considered potentially pathogenic, showing a correlation of this 
species with lymphocytosis and suggesting an activation of its virulence in the presence of some 
intercurrent infections, stress, gestation and poor nutritional status (Doherty et al., 1993; Hussain et 
al., 1985; Rodrigues et al., 2003; Seifi, 1995). 
Although the large size of the parasite aids in distinguishing from other trypanosome species present 
in the same microscopic field, it was not detected by microscopy in this study. This was attributed to 
the low parasitaemia caused by T. theileri (Dirie et al., 1990) making the detection of the parasite by 
microscopy difficult due to the lower number of parasites than the microscopy threshold. Similar 
results were obtained by Goossens et al. (2006) who diagnosed 42.4% of the examined cattle to be 
infected with T. theileri species using PCR, while using microscopy, 3.1% of the examined cattle were 
positive for T. theileri. The high prevalence of T. thieleri in the studied area indicated the presence of 
other blood sucking arthropods, mainly Tabanids (Dirie et al., 1990; Marquardt et al., 2000; 
Rodrigues et al., 2003), that may act also as a vector for other trypanosomes such as T. vivax  by 
mechanical transmission (Desquesnes and Dia, 2003; Desquesnes and Dia, 2004). Similar findings 
from Tororo district were reported by Cox (2007) who analysed 35 blood samples applied on 
FTA®cards for the prevalence of different trypanosome species using ITS-PCR. The results revealed 
that T. theileri was the predominant species (25.7%) and it was involved in all mixed infections 
reported. 
3.6.1.2 Overall pathogenic trypanosomes 
Analysing the same data after excluding the non-pathogenic T. theileri indicated that ITS-PCR was 
1.8 times more sensitive than microscopy in diagnosing pathogenic trypanosomes.  
Microscopy missed 17 cases found to be positive for pathogenic trypanosomes by PCR amplification 
(Table 3.7) indicating that the use of microscopy in diagnosing animal trypanosomiasis does not give 
the actual disease situation, leading to under estimation of the herd prevalence. These findings are in 
agreement with those reported by Clausen et al. (1998) who evaluated the sensitivity and specificity of 
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PCR assay compared with microscopy in detecting trypanosomes in infected cattle, Uganda. The 
results revealed that the detection rate of PCR (34.8%) was three times higher as compared to 
microscopy. In another study conducted in Tororo and Busia districts where the current study was also 
done, McOdimba (2006) reported that PCR was 6.4 times more sensitive than microscopy in 
identifying different pathogenic trypanosomes in the examined cattle. In Kenya, Ng’ayo et al. (2005) 
reported that PCR was 17.8 times more sensitive in detecing trypanosmes from small ruminants than 
microscopy. de Almeida et al. (1997) and Solano et al. (1999) reported that PCR was two times more 
sensitivite than microscopy in diagnosing trypanosome infected animals. 
The higher sensitivity of PCR could be contributed to the fact that amplification of DNA by PCR 
permits the amplification of parasite levels far below that detectable by microscopic inspection 
(Masake et al., 1997; Moser et al., 1989a). When less than 25,000 parasites/ml were present in blood 
samples, the parasite is not detectable by microscopic diagnosis (Herbert and Lumsden, 1976). The 
higher sensitivity of PCR over microscopy permits the diagnosis of infection at stages before the 
parasitemia was observed using microscopy. Clausen et al. (1999) supported the high sensitivity of 
PCR by the findings that specific PCR products could be amplified from blood samples of 
experimentally infected animals collected on day one post infection; whereas trypanosomes were 
detected by microscopy four days post infection. In naturally infected animals, PCR identified 50% 
(Duvallet et al., 1999) and 43.5% (Mugittu et al., 2001) of microscopically negative animals to be 
infected. The obtained results and the published findings concluded that despite their simple 
application, parasitological techniques provide inaccurate and inadequate data, which shows the 
pitfalls of relying on these techniques for the control and treatment decision (Picozzi et al., 2002).     
In the present work, one animal was found to be positive by microscopy for T. vivax, while, by testing 
different sample preparations using ITS-PCR, the results were negative for any species. This false 
negative result may be due to presence of PCR inhibitors in the blood sample or the contamination of 
the sample with exogenous DNA or DNAases that provoke the destruction of DNA (Desquesnes, 
1997; Desquesnes and Davila, 2002; Solano et al., 2002). Other possible explanations of this result are 
that the primers used were not able to amplify the DNA from certain species or the sample was not 
prepared well leading to loss of the DNA (Masake et al., 1997; Solano et al., 1999). 
3.6.1.3 Individual pathogenic species  
The overall prevalence of different trypanosome species was determined by microscopy and PCR 
amplification in samples from 84 animals. The results indicated that the overall prevalence of T. 
brucei s.l., T. congolense, T. vivax and T. theileri in the 84 cattle examined by PCR was 13.1%, 7.1%, 
8.3% and 53.6%, respectively. While the prevalence of T. brucei s.l., T. congolense and T. vivax in the 
examined cattle when determined by microscopy was 2.4%, 1.2% and 13.1%, respectively. 
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The overall prevalence of T. brucei s.l. in cattle examined by PCR and microscopy was 8.3% and 
1.2%, respectively, with PCR seven times more sensitive than microscopy. This is in agreement with 
several studies that compared the use of microscopy and PCR amplification in detecting T. brucei s.l. 
Clausen et al. (1999) revealed that the prevalence of T. brucei s.l. in the examined cattle by 
microscopy and PCR was 5.3% and 9.9%, respectively.  
The prevalence of T. vivax in cattle in the present work as determined by microscopy was 13.1% 
while by PCR was 8.3%. Noticing the type of species identified by PCR in the six samples positive 
for T. vivax using microscopy and missed by PCR, it was found that PCR amplified T. theileri in five 
samples and only one sample was identified as T. brucei s.l. The possible explanation of this condition 
is these six animals might have mixed infection of T. brucei s.l./T. theileri, and microscopy 
misclassified T. brucei s.l. as T. vivax (Delafosse et al., 2006) and was unable to identifiy T. theileri 
due to low parasitemia.  
Concerning T. congolense, the overall prevalence as determined by microscopy and PCR was 1.2% 
and 7.1%, respectively, with PCR seven times more sensitive. The results obtained from the same 
study area by McOdimba (2006) showed ten times more sensitivity of PCR in diagnosing T. 
congolense. This difference in the results might be due to different factors including, different primers 
used by the author targeting specific repetitive sequence for T. congolense Savannah with a higher 
copy number (5400), the use of buffy coat samples prepared from spinning down 10 ml blood and 
screening of eight FTA ®card discs from each sample. Another explanation could be the less 
sensitivity of the primers used in amplification of T. vivax DNA.  
The overall prevalence of pathogenic trypanosomes in the current study was found to be 28.6% as 
determined by PCR. This finding was lower than that obtained by McOdimba (2006) who found that 
the prevalence of trypanosomes in the same districts when using PCR amplification was 44.3%. This 
difference might be attributed to that the author used primers specific for T. congolense, T. brucei s.l. 
and T. vivax that are more sensitive and specific for the aforementioned species due to amplification 
of higher copy number targets (Chapter V) and the screening of hogher volume of the sample.  
Mixed infections were mainly diagnosed by PCR (8.3%) rather than microscopy (1.2%), indicating 
that PCR was 7.9 times more sensitive than microscopy in detecting mixed infections (χ2=5.75 and 
p<0.03). This finding is due to the lower sensitivity of microscopy to differentiate between different 
species in mixed infections (Majiwa et al., 1994; Moser et al., 1989a) or mis-diagnosis by 
microscopy. The type of the identified mixed infections using PCR was 1.2% T. brucei s.l./T. 
congolense, 3.4% T. brucei s.l./T. theileri and 3.4% T. vivax/T. theileri. Microscopy identified only 
one mixed infection of T. brucei s.l./T. vivax combination; however, T. brucei s.l. in this animal was 
not identified using PCR. This could be due to the low sensitivity and specificity of ITS-PCR in 
amplifying T. brucei s.l. DNA (fully discussed in Chapter V).  Solano et al. (1999) reported similar 
 91 
findings of PCR diagnosis of four mixed infections which couldn’t be detected by parasitological 
examination.  
These results are in agreement with other results obtained by different authors in different studies to 
detect trypanosome species (Clausen et al., 1998; Kaare et al., 2006; Mugittu et al., 2001; Njiru et al., 
2005; Waiswa et al., 2003). In a first trial of using PCR to detect cattle infected with trypanosomes in 
Zambia, Katakura et al. (1997) reported that by examining 100 blood samples applied on filter papers 
using specific primers for T. brucei s.l. and T. congolense Savannah, 29 animals were found to have 
mixed infections with both species. While, by examining thin smears from the same samples, two 
mixed infections with these two species were observed. These findings concluded that PCR technique 
is a sensitive diagnostic tool not only for trypanosome identification but also for the detection of 
mixed trypanosome infections. 
3.6.2 Suitability of various sample preparations for the accurate 
diagnosis of trypanosome infected animals 
In order to determine the suitable sample preparation for the accurate diagnosis of trypanosome 
genomic material by PCR amplification, the sensitivities of detecting trypanosome DNA in 
FTA®cards and DNA purified solutions were studied. The different sample preparations included 
whole blood, buffy coat and DNA applied on FTA®cards and extracted DNA solutions from whole 
blood and buffy coat. The detection of trypanosomes in the aforementioned materials was compared 
to a gold standard which was defined as positive PCR result from amplifying trypanosome DNA from 
FTA®cards and/or positive PCR result from amplifying trypanosome DNA in homogenous solutions. 
The specially designed surface of an FTA®card allows the lysis of the cells upon application; 
however, there is no homogenous distribution of the entrapped DNA. Assuming that 100 µl sample 
contains only one trypanosome cell, positive PCR result requires the presence of the target DNA in 
the examined disc. Screening one disc is equivalent to 1.34 µl from the sample (Becker et al., 2004), 
examining several discs represents an increase in the volume of the original sample screened. In the 
current study, 100 µl of blood was applied on FTA®cards and five discs were screened and they were 
equivalent to screening 6.7 µl of blood sample.  
Buffy coat was obtained by spinning down 4 ml whole blood, and then 100 µl of the buffy coat was 
applied to FTA®cards. Assuming that the buffy coat is representative of the original blood sample, 1 
µl buffy coat is equivalent to 40 µl blood. Examining five discs from the buffy coat applied on 
FTA®card is equivalent to examining 6.7 µl of buffy coat which in turn is equivalent to screening 268 
µl from the original blood sample.  
Extracting the DNA in solution ensures the homogenous distribution of the genomic material. DNA 
extraction from 300 µl whole blood was performed using GFX extraction kits. Assuming that the 
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blood sample to be subjected to DNA extraction contained one trypanosome, after sample lysis, the 
resulting solution becomes “contaminated” by the parasitic DNA with 200 copies per genome of the 
target. This contaimination is such that you would expect every 1 µl of DNA examined there after by 
PCR to be positive. Application of 100 µl of the extracted DNA solution on FTA®card should give the 
same result when screening only one disc because it should present a homogenous surface 
“contaminated” by the DNA of the single trypanosome. However, this was not found to be the case, 
although one disc from the same whole blood DNA extract (GFX) applied on FTA®cards should have 
contained 2.7 copies of the target, screening five discs (containing 13.4 copies of the target if one 
trypanosome cell was contained in the sample) failed to amplify the trypanosome DNA. This 
indicated that it was not easy to release the entrapped DNA from the FTA matrix; this could be due to 
the long time storage (four years) of the samples on FTA®cards (Becker et al., 2004). Although 
detecting trypanosome DNA from homogenous extract (GFX) on FTA®cards was not as expected, but 
the senisitivty was 2.5 times more compared to the amplification of trypanosomes DNA from whole 
blood and buffy coat samples applied on FTA®cards, however this was not significant.  
Based on the same assumption used to calculate the level of content of blood with parasitic material, 
let us imagine that we have 1 ml of blood contains 3.33 parasites (one parasite per 300 µl). A further 
assumption is that these parasites are contained with the buffy coat following centrifugation, if this 
buffy coat is then extracted and lysed it will be “contaminated” by these parasites at a factor of 3x 
greater than the whole blood DNA preparation. Interestingly, with analysing the buffy coat DNA 
extract we found this not to be the case.  
In the case of extracting DNA from buffy coat, 1 ml of blood sample was spun down to collect 100 µl 
of buffy coat layer, so 1 µl of buffy coat is equivalent to 10 µl whole blood. Assuming that one 
trypanosome cell was included in the sample, after lysing the sample using the lysis buffer in the 
Qiagen extraction kits, each µl  of the lysed sample contained two copies of the ITS target. After 
extraction, DNA was eluted in 200 µl eluting buffer, meaning that screening 1 µl from the extract 
should have been ampilified as it contained one copy of the target. According to the aforementioned 
hypothesis, it was expected to obtain the same positive results from the samples of DNA extract 
preparations either on FTA®cards or in homogenous DNA extract. 
3.6.2.1   Diagnosis of any trypanosome species 
The results in Table 3.9 indicated that the sensitivity of PCR to amplify any trypanosome DNA from 1 
µl of DNA homogenous solution extracted from whole blood was significantly higher than amplifying 
1 µl of DNA solution extracted from buffy coat (Q) by a factor of 1.4. This was expected because 
examining 1 µl from whole blood DNA extract should contain twice the copy number of the target 
contained in the same volume of buffy coat DNA extract.  
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These results are in disagreement with those obtained by Alhassan et al. (2007) who compared 
different sample preparations for the diagnosis of Theileria equi using PCR. The samples compared 
were blood applied on FTA®cards and extracted DNA using Qiagen kits and phenole extraction using 
different parasite concentrations from 10-10-5. The results revealed minimal variation in the limit of 
detection between the used sample preparation methods. The authors concluded that Theileria equi 
can be detected directly from whole blood samples using PCR amplification from single FTA®card 
discs. This could be attributed to the use of more FTA discs (the authors mentioned only the use of 
multiple 3 mm) which increased the probability of obtaining the target of interest in the screened 
discs. Another explanation would be the use of fresh samples applied on FTA®cards which in turn 
made it easier to wash out the blood impurities from the examined discs and release the DNA from the 
matrix during the PCR cycles. However, in the current study; samples were preserved in FTA®cards 
four years prior to screening which made it difficult to remove the impurities from the sample. This 
conclusion was supported by Becker et al. (2004) who reported that long term storage (more than nine 
months) could prevent the complete removal of blood from the discs by washing. Nevertheless, 
washing the discs for longer time may lead to the removal of the DNA from the card matrix or 
inhibition of the PCR reaction       
By calculating the Kappa values for the degree of agreement between the detection of trypanosomes 
in different sample preparations and the gold standard, it was found that there was a very good 
agreement between the detection of the trypanosome DNA using whole blood DNA extract (Kappa 
value= 0.8) when compared with the gold standard. There was less agreement between the gold 
standard and detecting the trypanosomes in buffy coat DNA extract (Kappa value=0.5). However, no 
significant agreement was found between the gold standard and the ampilification of trypanosome 
DNA from different materials applied on FTA®cards (Table 3.10). There was no significant difference 
between the amplification of the trypanosome genomic material from FTA discs contained blood and 
buffy coat, although the equivalent examined volume of screened blood was 6.7 µl and 268 µl from 
whole blood and buffy coat preparations, respectively. This is not in agreement with the findings 
previously reported by Woo (1971), Murray (1977) and Picozzi et al. (2002) who suggested that the 
detection of trypanosomes in samples prepared from buffy coat was significantly higher than whole 
blood due to the concentration of trypanosome cells in the buffy coat layer. 
3.6.2.2 Diagnosis of pathogenic trypanosome species 
Excluding the non-pathogenic T. theileri from the analysis, the results show that a highly significant 
agreement between both DNA extract from blood (GFX) and buffy coat (Q) was observed when 
compared to the gold standard. This was expected due to the assumed existence of at least one copy of 
the target sequence when using 1 µl from the homogenous solution. Application of DNA extracted 
from whole blood (GFX) on FTA®cards and examining 5 discs resulted in 18.2% sensitivity in 
amplifying the target. However, examining 1 µl from the same extract resulted directly in 4.3 times 
more sensitivity, although this was not significant.   
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3.6.3 Proportion and species of trypanosomes detected by ITS-
PCR in the examined materials   
Among the 84 animals examined, eight were found to harbour mixed infection by PCR of DNA 
extract. However, application of five separate PCR reactions on samples applied on FTA®cards failed 
to detect such mixed infections. Therefore, blood and buffy coat applied on FTA®cards of the animals 
with mixed infection were further screened by increasing the number of examined discs from each 
material to 30. The volume of blood equivalent to screening 30 discs from whole blood applied on 
FTA®card was 40.2 µl, whereas 30 discs from buffy coat samples on FTA®card were equivalent to 
1608 µl of the original blood sample. It was expected to detect more positive discs using PCR; 
however, this was not the case. The results of the 30 separate discs from both blood and buffy coat on 
FTA®card discs revealed that the reactions failed to detect the mixed infection.  
These findings could be due to the un-even distribution of the DNA on the FTA®card matrix due to 
the localised immobilization of the DNA when come in contact with the matrix after cell lysis. 
However, the screening of the 30 discs should have picked the DNA due to increased volume of 
examined sample, this supports the argument that the DNA release from the discs seemed to be 
difficult. Moreover, the long storage of the samples used in the current study might be another factor 
in the difficult release of the entrapped DNA from the FTA matrix (Becker et al., 2004). Cox (2007) 
screened between 92-114 discs (~123.3 µl – 152.8 µl) containing whole blood and 85.7% of the 
samples were positive for trypanosomes. Mixed infection was detected in 60% of the samples, with T. 
theileri included in all types of the mixed infections. This disagreement with the current results could 
be due to the higher volume of blood sample examined and the ability to release DNA from the matrix 
due to screening the samples shortly after collection. The low prevalence of mixed infections 
compared with single infections with the predominance of T. theileri in the current study, could be due 
to the reduced ability of other trypanosome species to be established in the presence of T. theileri 
giving a probability that there may be competition occurring between T. theileri and other 
trypanosomes in the host (Cox, 2007). Another explanation to the low prevalence of mixed infection 
is the presence of defence mechanism either within the vector or vertebrate host. 
In conclusion, the work presented aimed to evaluate FTA®cards for sample collection to be diagnosed 
for trypanosome using PCR. The main drawback encountered with FTA®card matrix is the uneven 
localised distribution of the DNA when in contact with the matrix after cell lysis. This requires the 
presence of the DNA in the examined disc to be amplified and diagnosed with PCR. However, lysing 
the cells to release the genomic material and extracting the DNA in homogenous solution ensures the 
presence of the target in as little as 1 µl of the homogenous extract. The main obstacles of the DNA 
extraction approach are time consumption, requirement of certain equipments and the highly 
economic cost (Desquesnes and Tresse, 1996; Devost and Choy, 2000). In order to overcome the 
 95 
drawbacks of DNA extraction and to obtain a homogenous solution of DNA using FTA®cards, the 






















4 Chapter four 
Improvement of blood sample preparation from FTA®cards 























The results obtained in Chapter III, showed that the detection of trypanosome DNA from whole blood 
and buffy coat extracts was significantly more sensitive than from whole blood or buffy coat applied 
directly on FTA®cards (χ2=56.9, p<0.001). This can be interpreted as either the inability to access 
parasitic DNA on the card matrix or the uneven distribution of the genomic material across the surface 
of the card.  
In order to improve the accuracy of sample screening, trials were undertaken to modify the original 
protocol for the preparation of blood prior to application onto the FTA®cards by the introduction of a 
lysis step. Cell lysis can be caused by excessive osmosis or movement of water towards the inside of a 
cell. Eukaryotic cell membranes can not withstand the osmotic pressure of the water inside, leading to 
explosion of the cell and release of its contents including DNA (Christensen and Hoffmann, 1992; 
Wang et al., 2008). Lysis promotes the release of the DNA into a homogenous solution consisting of 
genetic material from both the host as well as any infectious agent. The probability of detecting the 
parasitic DNA in the examined material is therefore increased with a more even distribution of the 
parasitic DNA over the surface of the FTA matrix. Lysis, if successful, would therefore avoid time 
consuming, laborious and expensive DNA extraction in the field. 
Different studies have been conducted to compare between different methods to extract DNA using 
different commercial DNA extraction kits and the use of Chelex®100 to elute DNA from the same 
samples. Chelex®100 is a chelating resin that has a high affinity for polyvalent metal ions, moreover, 
the alkalinity (pH 10-11) and the exposure to temperature result in the disruption of the cell membrane 
and denaturation of DNA into its component single strands facilitating PCR amplification (Sweet et 
al., 1996; Walsh et al., 1991).  
For example, in the field of forensic medicine, a study to compare between five different methods to 
extract DNA from decomposed tissues including phenol-chloroform extraction, silica based, 
InstaGene Matrix™ (Bio Test), glass fibre filter and the Chelex®100 based method, was conducted by 
Hoff-Olsen et al. (1999). The aim of the study was to compare the time required to perform the 
extraction, the cost of the method and the quality of the electrophoretic product by each method. The 
Chelex®100 based extraction was proven to be the most rapid and least expensive method (less than 
0.01$ per extraction), but failed to produce electrophoretic product especially from degraded tissue 
samples. Another evaluation of DNA extraction using Chelex®100 was done by performing a 
comparison of extracting DNA from hair using Chelex®100 compared to QIAamp® Mini Kit method 
and ISOHAIR® method (Suenaga and Nakamura, 2005). The authors recommended the use of 
Chelex®100 because of its simplicity and low cost when compared with the other methods used. 
Moreover, PCR of DNA extracted using Chelex®100 was shown to be less affected by inhibitors and 
at the same time gave a reasonable quantity of extracted DNA (120-140 ng). Also, an increase in the 
signal strength from PCR amplification was noticed using Chelex®100 (Singer-Sam et al., 1989). The 
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benefits from using Chelex®100 to extract DNA from blood has been shown to be six-fold increase in 
extraction efficiency, the use of non-organic solvents and the expenditure of less analyst time, effort 
and cost (Jung et al., 1991). This is in contrary to the use of conventional methods of DNA extraction 
that usually require large volume of blood, the use of health hazard organic solvents and the time and 
cost consuming (Loparev et al., 1991). 
Chelex®100 has been used to extract DNA from different samples that are important from the forensic 
point of view, including, blood (Jung et al., 1991), decomposed tissues (Hoff-Olsen et al., 1999), hair 
(Suenaga and Nakamura, 2005), waxed tissues (Sepp et al., 1994), saliva (Sweet et al., 1996), 
incinerated teeth (Tsuchimochi et al., 2002), semen (Crouse et al., 1993) and vaginal swabs (Iwasa et 
al., 2003). Moreover, it has been documented that Chelex®100 has been used to extract DNA in fields 
other than forensic medicine such as, plant diseases. Chunwongse et al. (1993) extracted DNA from 
half-seeds using Chelex®100, the produced amplicon was comparable to those obtained using 
proteinase K treatment but with less time and cost.  
In the virology field, Chelex®100 was used to extract human immunodeficiency virus (HIV) from 
blood samples in a study conducted by Vignoli et al. (1995). The increase in the yield of PCR 
products was attributed to many factors, firstly, the protective effect of Chelex®100 against DNA 
degradation. Secondly, the less chance of sample contamination and finally the removal of most PCR 
inhibitors through chelation with the resin. Moreover, the authors argued that the eluate extracted by 
Chelex®100 can be stored at -20ºC and used for PCR several months later (Vignoli et al., 1995).  
In parasites isolation and identification, Chelex®100 was used to extract the genomic material of 
Theileria parva (Geysen et al., 1999; Polski et al., 1998) and Plasmodium falciparum (Wooden et al., 
1993) from blood samples. Concerning trypanosome DNA extraction from different samples, 
Chelex®100 was used to elute trypanosome genomic material from blood (Boid et al., 1999; de 
Almeida et al., 1997; de Almeida et al., 1998b; Jamonneau et al., 2004; Katakura et al., 1997; Solano 
et al., 2002), buffy coat (de Almeida et al., 1998a; Solano et al., 2002; Solano et al., 1999) and CSF 
(Truc et al., 1999)  to follow up the treatment programme and to determine the stage of the disease 
using PCR. 
Various studies have proven that prophyrin compounds that are present in the heme component of the 
red blood cells are one of the major PCR inhibitory components of blood. These compounds have 
been shown to inhibit the activity of the thermo-stable DNA polymerases used in the PCR reaction 
(Akane et al., 1994; Cox, 2007; de Franchis et al., 1988; Loparev et al., 1991; Wooden et al., 1993). 
The higher suitability of hot eluates was attributed to the removal of the PCR inhibitors and release of 
the bound DNA to the filter paper matrix into the eluate by boiling (Boid et al., 1999). If just water is 
used, the elaute will not remain stable due to the presence of inhibitors and also due to the easiness of 
DNA degeneration. However, DNA extraction from blood using Chelex®100 is less likely to have 
PCR inhibitors because Chelex®100 helps in the removal of such inhibitors by binding to the 
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Chelex®100 bead matrix itself (Walsh et al., 1991). From the previous studies, it is clear that the use 
of Chelex®100 is effective in extracting highly pure template DNA from blood samples that are 
notorious for the carryover of PCR inhibitors (Polski et al., 1998). Because it seems to overcome the 
problems associated with inhibitory effects of the blood components such as heme, lactoferrin, IgG 
and non-target DNA (Cox, 2007; de Almeida et al., 1997). Moreover, Chelex®100 protects DNA from 
the effect of high temperature that causes degradation of DNA by chelating metal ions which might 
act as catalysts in the breakdown of DNA at high temperature in low ionic strength solutions (Singer-
Sam et al., 1989).  
In contrast to the previous studies, Becker et al. (2004) reported that the presence of PCR inhibitors 
cannot be completely ruled out after Chelex®100 extraction. The authors observed low reaction 
efficiency values when Chelex®100 was used for eluting DNA from blood samples applied on 
FTA®cards for quantifying trypanosomes DNA using quantitative PCR. They argued that the low 
efficiency values indicated that Chelex®100 extraction does not remove all inhibitory substances from 
blood samples, however, the template DNA obtained by this method leads to quantitative results. 
Another study was conducted by Reithinger et al. (2000) to detect leishmania species in dog blood 
using PCR in Chelex®100 extracted samples. The authors reported that none of the Chelex®100 
extracted samples amplified the target DNA. They attributed this failure to the presence of PCR 
inhibitors that were not removed using Chelex®100. 
4.2 Objectives 
The aim of this study is to improve blood sample preparation from FTA®cards for trypanosome 
diagnosis. A very sensitive PCR protocol directed against a repetitive sequence existing in the genome 
at a  copy number of more than 10,000 (Moser et al., 1989a; Sloof et al., 1983a) was chosen. This aim 
was achieved by: 
1- Application of experimental lysis trials using serial dilutions of T. brucei s.l. to end with 
concentration of less than one parasite/100 µl applied on FTA®cards thereby releasing the 
trypanosome genomic material in a homogenous solution to increase the probability of 
detecting trypanosome DNA on FTA®cards. 
2- The field application of the lysis approach was carried out on two scales; a preliminary small 
scale lysis trial comparing the lysed samples with the conventional whole blood samples 
applied on FTA®cards, and the large scale lysis trial was applied on a larger number of 
samples and compared to elution of DNA using Chelex®100 from the whole blood samples 
collected on FTA®cards and in situ DNA extraction. 
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4.3 Material and methods 
4.3.1 Experimental lysis of blood samples  
4.3.1.1 Preparation of the procyclic insect forms  
Procyclic trypanosomes (insect form trypanosomes) were obtained by infecting Glossina morsitans 
morsitans with bloodstream form trypanosomes (isolate Buteba 135 originally isolated from a cow in 
Buteba village, Uganda in 1990  (Dale et al., 1995)) and dissecting mid-guts from tsetse 10 days post-
infection (Maudlin, 1996). Before dissection, tsetse flies were sterilised with 5% sodium hypochlorite 
(VWR, UK) followed by rinsing in sterile saline. Trypanosome infected mid-guts were then placed in 
a 24 well plate (SLS, UK) in 1 ml Cunningham’s medium (Invitrogen, UK) containing 20% foetal calf 
serum (Invitrogen, UK) and 120 µg/ml gentamicin (Sigma, UK). Cunningham’s media was made to 
the recipe of Cunningham (1977) by Invitrogen (UK). 
Once the procyclic culture was established, it was transferred to 25 cm3 culture flask (SLS, UK) and 
diluted every other day 1:10 in fresh Cunningham’s medium containing 20% foetal calf serum and 20 
µg/ml gentamicin. One ml of procyclics was centrifuged at 4000 rpm for three minutes, the 
supernatant was discarded and the pellet remaining was re-suspended again in a fresh Cunningham’s 
media. The dilutions were examined under the microscope (magnification=x400) and the dilution that 
had one parasite per 20 microscopic fields was equivalent to 2.5x105 parasites/ml (Herbert and 
Lumsden, 1976). Serial dilutions (from 2.5x105- 2.5 parasites/ml) were then made in Cunningham’s 
media to obtain less than one parasite/100 µl for application on FTA®cards.. For controls, 100 µl from 
each dilution was taken out and applied to FTA®cards (Table 4.1).  
Table 4.1: Number of parasites and the equivalence in the examined discs (controls) 
Number per ml Number per 100 µl Number per one disc Chance of isolating a 
parasite in one disc 
2.5x105 2.5x104 335 100% 
2.5x104 2.5x103 33.5 100% 
2.5x103 2.5x102 3.35 100% 
2.5x102 25 Less than one (0.335) 33% 
2.5x101 2.5 Less than one (0.0335) 3% 
2.5 0.25 Less than one (0.00335) 0.3% 
 
4.3.1.2 Preparation of the infected blood dilutions 
TO (BKl:BLW) mice (B and K Ltd, UK) were immunosuppressed by intra-peritoneal injection of 
80 mg/kg cyclophosphamide (Pharmica and Upjohn Ltd) and infected from a thawed T. b. brucei 
stabilate (Buteba 135) 24 hours later by intra-peritoneal injection (Welburn and Maudlin, 1987). 
Regular checks were made by microscopical examination of blood. When the parasitaemia reached 
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between 108 and 109 parasites/ml; the blood from the mice was collected by cardiac puncture under 
terminal anaesthesia. 
Dilutions of the infected blood using non infected mouse blood were examined under the microscope 
(magnification= x400) in order to estimate the concentration of parasites per ml. The dilution that had 
one parasite per 20 microscopic fields was equivalent to 2.5x105 parasites/ml (Herbert and Lumsden, 
1976). Serial dilutions (from 2.5x105- 2.5 parasites/ml) were then made to obtain less than one 
parasite/100 µl for application on FTA®cards. This aimed to determine the sensitivity of the lysis 
approach in releasing sufficient DNA from less than one trypanosome cell into a homogenous solution 
before application onto the FTA matrix. Before the addition of the lysis agent to the prepared 
dilutions, 100 µl of each dilution was applied on FTA®cards as a control (Table 4.1).  
4.3.1.3 Preparation of the lysis agents 
The lysis agents used were H2O, 1% (w/v) SDS (Sodium Dodecyl Sulfate, Sigma) in distilled water 
and hypotonic PBS (Phosphate Buffer Saline tablets, Sigma). PBS was prepared by dissolving one 
tablet in 200 ml water to obtain: 0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M 
sodium chloride with pH 7.4.   
4.3.1.4 Lysis trials 
4.3.1.4.1 First experimental lysis trial 
The first trial was performed using procyclic forms to investigate the efficiency of lysing the cells 
using different lysing agents. Serial dilutions from procyclic forms starting from a concentration of 
2.5x105 were made in Cunningham’s media as a diluent. After preparing the serial dilutions, to micro-
centrifuge tubes, 50 µl of each diluent containing procyclic forms and 50 µl of each lysis agent (H2O, 
PBS and 1% SDS) were added. The tubes were incubated at room temperature for three hours and 
then 100 µl was applied on FTA®cards and left for one hour to dry (Table, 4.2). The controls used in 
this trial were 100 µl taken from each serial dilution before adding the lysis agents and applied on 
FTA®cards (Table 4.1). 
Table 4.2: Number of parasites per ml and the equivalence in the examined discs after lysis 
Number per ml Number per 50 µl Number of parasites applied 
to FTA®cards*   
Estimated copy number of 
the target in one disc 
2.5x105 1.25x104 1.25x104 1.68x106 
2.5x104 1.25x103 1.25x103 1.68x105 
2.5x103 1.25x102 1.25x102 1.68x104 
2.5x102 12.5 12.5 1.68x103 
2.5x101 1.25 1.25 1.68x102 
2.5 Less than one (0.125) Less than one (0.125) 16.8 
*This indicates the number of parasites from which DNA content was released into the homogenous solution after lysis 
Table 4.2 shows the number of parasites/ml in each dilution and the number of parasites after lysis 
from which DNA was released into solution. Relating the DNA released from the parasite number in 
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each dilution to the copy number of the PCR target, the table shows the copy number of the target in 
each examined disc. For instance, after lysing the sample containing 2.5x103 parasites/ml; 100 µl from 
the lysed sample contained DNA from 1.25x102 released in homogenous solution. Each examined 
disc is equivalent to 1.34 µl, therefore one disc would contain DNA from 1.7 (~2) parasites and the 
copy number of the target in this disc was 1.68x104 copies which in theory should be enough for 
amplification. 
4.3.1.4.2 Second experimental lysis trial 
The second lysis trial was carried out using procyclic forms diluted in Cunningham’s media (the same 
protocol as the first trial) with the addition of cow’s DNA (natural host DNA) to match the natural 
conditions where both the parasitic and host DNA co-exist in the sample. It was assumed that 50 µl of 
bovine blood would contain 1.6 µg DNA (Qiagen extraction kits, 2007). The DNA was extracted from 
blood using DNeasy®Tissue Extraction kits (Qiagen) (100 µl of anticoagulated blood was added in 1.5 
ml tube containing 20 µl proteinase K, the volume was then adjusted to 220 µl using PBS and the 
extraction procedure was then completed as previously detailed in Chapter III, section 3.4.3.2). After 
lysis took place, 5 µl of extracted DNA was added to each tube (each 1 µl of extraction buffer contains 
0.2-0.4 µg DNA). The control used in this trial was 100 µl taken from each serial dilution containing 
host DNA before adding the lysis agents and applied on FTA®cards (Table 4.1). 
4.3.1.4.3 Third experimental lysis trial 
In this trial, lysis of bloodform trypanosomes from vertebrate host was investigated. Trypanosome 
cells were collected from an experimentally infected mouse. Serial dilutions were made from a 
starting concentration of 2.5x105 using uninfected mouse blood as the diluent. After preparing the 
serial dilutions, in micro-centrifuge tubes, 50 µl of each diluent containing infected blood forms and 
50 µl of each lysis agent (H2O, PBS and 1% SDS) were added. The tubes were incubated at room 
temperature for three hours (to match the conditions in the field and to give a chance for lysis to 
occur). Afterwards, 100 µl was applied on FTA®cards and left for one hour to dry (Table, 4.2). The 
controls used in this trial were 100 µl taken from each serial dilution before addition of the lysis 
agents and applied on FTA®cards. 
4.3.1.5 TBR-PCR 
TBR-PCR is a species-specific reaction that amplifies 173 bp product from a repetitive satellite 
sequence of 177 bp size (Moser et al., 1989a). The copy number of the satellite sequence was reported 
to be 10,000 copies/genome (Sloof et al., 1983); which lead to the appearance of a double band at 346 
bp due to the repetitiveness of the sequence (Figure 4.1). The primers sequence used were TBR1: 5’-
CGA ATG AAT ATT AAA CAA TGC GCA GT-3’ and TBR2: 5’-AGA ACC ATT TAT TAG CTT 
TGT TGC-3’ (Moser et al., 1989a). 
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The reaction volume used was 25 µl and contained NH4 Buffer (Bioline, London, UK) that is formed 
of 16.0 mM (NH4)2SO4, 67 mM Tris-HCl (pH8.8 at 25ºC) and 0.01% Tween 20. Moreover, 0.4 µM of 
each primer, 1.5 mM Mg2+, 200 µM of each of the four-deoxynucleoside triphosphates (dNTP) and 
one Unit of BIOTAQ RED DNA Polymersase (Bioline) were added. One positive control (genomic 
DNA) and one negative control were run with each PCR.  
The reaction conditions were as follows: 1 cycle of 95ºC for seven minutes followed by 30 cycles of 
94ºC for one minute, 55 ºC for one minute and 72 ºC for 30 seconds. The reaction was carried out in a 
DNA Engine DYADTM Peltier Thermal Cycler. Figure 4.1 shows a gel picture of TBR-PCR positive 
results.  
 
Figure 4.1: Example of TBR-PCR results in 1% agarose showing the product at 173 bp and the 
double band that results from the repetitiveness of the target at 346 bp (L: 100 bp ladder, P: 
positive control, N: negative control) 
4.3.2 In field application of lysis 
In field application of the blood lysis approach was carried out over two stages; the first was a 
preliminary lysis study (June, 2006) in which a total of 80 blood samples were collected from cattle in 
Uganda. The second in field application was done using a larger sample set (300) and these were 
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collected in Uganda, October, 2006. Figure 4.2 shows a map of Uganda with the sampling sites in 
both the preliminary and large in field lysis application. 
 
Figure 4.2: Uganda map showing the in field lysis sampling sites 
4.3.2.1 Preliminary in field lysis application 
4.3.2.1.1 Study area 
Samples were collected during a survey in Uganda to estimate the prevalence of trypanosomes in a 
newly affected area with T. b. rhodesiense, before the initiation of a mass treatment campaign to stop 
the further spread of the parasite (Stamp Out Sleeping sickness campaign, Chapter VI). One site 
(Olemai village, Lwala parish, Kabermaido district) was randomly chosen by the SOS group to apply 
the lyses protocol on blood samples collected from the 80 cattle assembled in the chosen site. Figure 
4.2 shows the selected site (Olemai village), Eastern Uganda.  
4.3.2.1.2 Sample collection 
Collection of whole blood samples  
After lancing the animal ear vein (Figure, 4.3), blood was collected into two heparinised capillary 
tubes of 50 µl capacity, each. After collection of whole blood samples, they were applied on 
FTA®cards. While pipetting the sample, the capillary tube tip was held slightly above the surface of 
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the FTA matrix and the blood was dispensed in a concentric circle pattern within the printed card 
circle (Figure, 4.4). The card was then allowed to air dry for about one hour at room temperature then 
sealed in envelopes containing desiccant to be transferred for analysis. 
Figure 4.3: Bleeding of the ear vein for sample 
collection 
Figure 4.4: Blood samples applied on 
FTA®cards 
 
Collection of lysed blood samples 
One heparinised capillary tube of blood (50 µl) was collected from the ear vein of the animal. The 
content of the capillary tube was allowed to flow into an Eppendorf tube containing 50 µl of distilled 
water. The tubes were sealed and lysis was allowed to take place during three hours incubation at 
ambient temperature. After that, 100 µl of the lysed solution was removed and applied on FTA®cards 
and then the cards were allowed to dry before storage. 
4.3.2.1.3 Sample processing  
Preparation of the samples from FTA
®
cards 
In this study, 10 discs from both whole blood and lysed blood applied on FTA®cards were examined 
by separate PCR (each disc examined with a separate PCR). The protocol for washing and preparing 
the discs for PCR were fully described in Chapter III (section 3.4.4). 
TBR-PCR 
The primer sequences, reaction conditions and product size are fully described in section 4.3.1.5 in 
this chapter. 
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4.3.2.2 Large scale field lysis application 
4.3.2.2.1 Study area 
In this study, 300 animals were sampled from three villages during baseline sampling of the Stamp 
Out Sleeping sickness campaign (Chapter VI) in Apac and Lira districts, Uganda (Figure, 4.2). Agwea 
village (Apac district) is not shown in the map due to inability to obtain the longitude and latitude data 
to include the village in the map. The choice of 300 samples was based on the availability of DNA 
extraction kits enough for only this number of samples. The sites of sample selection were selected 
according to the availability of at least 100 cattle in the visited sites; from each site 100 cattle were 
sampled.  
4.3.2.2.2 Sample collection 
Three sample preparations were collected (whole blood, lysed blood and DNA extract) to compare 
between the detection of trypanosomes using PCR in those preparations. 
Collection of whole and lysed blood samples  
Collection of the whole and lysed blood samples on FTA®cards was done as previously mentioned 
during the preliminary in field application (section 4.3.2.1.3).  
In situ DNA extraction 
For in situ DNA extraction, blood was collected into capillary tube containing EDTA to prevent 
coagulation of the blood. The tube was inserted into a collection tube for storage of the blood 
(MiniCollect, greiner bio-one) until the extraction protocol was processed. 
4.3.2.2.3 Sample processing 
Whole and lysed blood samples collected on FTA
®
cards 
Ten discs from both whole blood and lysed blood applied on FTA®cards were examined by separate 
PCR (each disc examined with a separate PCR). The protocol for washing and preparing the discs for 
PCR were fully described in Chapter III (section 3.4.4). 
Another 10 discs from each sample collected on FTA®cards (whole blood and lysed blood) were cut 
and placed into one micro-centrifuge tube. After washing and drying the discs (Chapter III, section 
3.4.4), DNA was eluted by boiling the discs for 30 minutes at 90ºC in 60 µl of 5% (w/v) aqueous 
suspension of Chelex 100® resin (sodium form, 50-100 dry mesh, Sigma) (Becker et al., 2004). For 
PCR, 5 µl of the eluate was added to 20 µl of the PCR master mix. 
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In situ DNA extraction 
In situ DNA extraction was done using ChargeSwitch® gDNA kit. The principle of this extraction 
method is the use of magnetic beads. At low pH, the magnetic beads have a positive charge that binds 
the negatively charged nucleic acid backbone of DNA. Proteins and other contaminants do not bind 
and are removed by washing. For the elution of the bound DNA, the charge of the magnetic beads was 
neutralised by raising the pH to 8.5 using a low salt elution buffer. The purified DNA was released 
into the elution buffer; the yield from 50 µl of blood was up to 2 µg. For PCR, 1 µl from the extract 
was used as the template for the TBR-PCR reaction. 
Procedure 
DNA binding 
To extract DNA from 50 µl whole blood in EDTA, 1ml lysis buffer (L10) and 20 µl of the magnetic 
beads were added to the sample. The sample was mixed by pipetting up and down gently five times. 
The tubes were incubated at room temperature for one minute before being placed on MagnaRackTM 
until the beads had formed a tight pellet. The supernatant was then discarded without removing the 
tubes from the magnet. 
Proteinase K digestion 
For each sample, 100 µl purification buffer (N5), 1ml lysis buffer (L11) and 5µl proteinase K were 
added after the tubes were removed from the MagnaRackTM. The samples were mixed and incubated 
at room temperature for 5 minutes. After the tubes being placed in the rack for one minute, the 
supernatant was removed carefully from the tubes and discarded. 
Washing of DNA 
One ml wash buffer (W12) was added to the tubes after removing them from the MagnaRackTM. The 
samples were mixed and placed in the rack for one minute; the supernatant was removed carefully 
from the tubes and discarded. This washing step was then repeated once more. 
Eluting DNA 
After removing the tubes from the rack, 100 µl Elution buffer (E5) was added. The samples were 
mixed by pipetting up and down 15-30 times. The tubes were incubated at room temperature for 10 
minutes, and then placed on the rack for 2 minutes until the magnetic beads formed a tight pellet. 
Without removing the tubes from the MagnaRackTM, the supernatant containing the DNA was 
transferred to a sterile tube.  
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4.3.2.3 Statistics 
Sensitivity, negative predictive value and Kappa value were calculated as previously described in 
Chapter III (section, 3.4.8). 
4.4 Results 
4.4.1 Experimental lysis of blood samples 
Lysis trials were made in three approaches using procyclics and bloodforms of trypanosomes. The 
first and second trials were performed using procyclics with the absence and presence of the host 
DNA, while the third trial was conducted in a vertebrate host to create a natural condition to asses the 
approach.  
4.4.1.1 First experimental lysis trial 
Procyclics were used to investigate the possibility of lysing the cells to obtain a more homogenous 
distribution of the trypanosome genomic material on the card matrix using different lysing agents. 
Five discs from each control (serial dilution of procyclics using Cunningham’s media applied on 
FTA®cards) were examined using TBR-PCR on each disc. The same number of discs containing serial 
dilution of procyclic forms after lysis with the different lysis agents (H2O, PBS and 1% SDS) were 
also examined by separate TBR-PCR reaction on each disc. Table 4.3 shows the number of discs 
reacting positive using TBR-PCR in the controls and the lysed procyclic forms.     
Table 4.3: PCR results for the first experimental lysis trial (n=5 discs) 
 
The results in Table 4.3 show that with the higher procyclic concentrations in the controls (2.5x105-
2.5x102), all the examined discs were positive for T. brucei s.l. However, at lower concentrations (25 
and 2.5 parasites/ml) none of the examined discs contained the trypanosome DNA.  




2.5x105 2.5x104 2.5x103 2.5x102 25 2.5 
Control (no lysis) 
 















5 5 5 5 5 
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Although the lysed samples were half the concentration of the controls after the addition of the lysing 
agent, TBR-PCR was able to amplifiy the DNA from all the concentrations.   
In this trial, no natural host DNA was present; these conditions therefore do not reflect the natural 
conditions where the host DNA would also been present. In order to match the natural conditions, 
another trial by using procyclics was carried out with the addition of natural host DNA (cow). 
4.4.1.2 Second experimental lysis trial 
In natural conditions, host DNA exists with the parasitic genomic material in the same sample. In 
order to match the natural conditions, this trial was made by adding extracted host DNA to find out if 
there was an effect of the host DNA on the detection of the parasitic genomic material using PCR 
amplification. The same protocol was used as described for the first trial with the addition of extracted 
host DNA (bovine) to the controls and to the lysed samples after the lysis step took place. Five discs 
from each control (serial dilutions applied on FTA®cards) were examined using TBR-PCR on each 
disc. The same number of discs containing serial dilution of procyclic forms after lysis with the 
different lysis agents (H2O, PBS and 1% SDS) were also examined by separate TBR-PCR reaction on 
each disc. Table 4.4 shows the number of discs reacting positive using TBR-PCR in the controls and 
the lysed procyclic forms.     
Table 4.4: PCR results for the second experimental lysis trial (n=5 discs) 
 
The results in Table 4.4 show that with the controls, TBR-PCR detected trypanosome DNA in the four 
high parasite concentrations. However, at the two low concentrations, none of the discs was positive 
by PCR. After application of cell lysis with different lysis agents (H2O, PBS and 1% SDS), the PCR 
reaction detected the trypanosome DNA in all concentrations including the lower ones except for cells 
lysed using 1% SDS (2.5 parasites/ml). These results suggest the masking of the parasitic DNA with 
the host genomic material. This assumption was further investigated by lysing bloodforms using a 
vertebrate host to match natural field conditions. 
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4.4.1.3 Third experimental lysis trial 
In this trial, an experimental infection of a vertebrate host (mice) was conducted to apply the lysis 
approach on bloodform cells to investigate the existence of a masking effect of the parasitic DNA with 
the host genomic material. Five discs from each control (serial dilution of bloodforms in mouse blood 
applied on FTA®cards) were examined using TBR-PCR on each disc. The same number of discs 
containing serial dilution of bloodforms after lysis with the different lysis agents (H2O, PBS and 1% 
SDS) were also examined by separate TBR-PCR reaction on each disc. Table 4.5 shows the number of 
discs reacting positive using TBR-PCR in the controls and the lysed bloodforms.     
Table 4.5: Positive discs with TBR-PCR from the first experimental lysis trial (n=5 discs) 
 
This trial was performed to apply the lysis protocol in natural infection conditions using bloodforms 
from a vertebrate host. The results show that T. brucei s.l. DNA was amplified in the higher parasite 
concentrations before lysing the cells; while none of the lower concentrations were found to be 
positive. After lysing the cells, trypanosome DNA was detected in all the concentration range except 
in case of using PBS hypotonic solution for lysis.  
4.4.2 In field application of lysis 
4.4.2.1 Preliminary in field lysis application 
4.4.2.1.1 Overall results of TBR-PCR from all examined discs 
A total of 80 cattle samples were collected, 10 discs from whole blood and another 10 discs from 
lysed blood were examined using TBR-PCR separately on each disc. The sample was considered 
positive when at least one disc reacted positive in the reaction, the results of TBR-PCR are 
summarised in Table 4.6. 
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Table 4.6: TBR-PCR results for 80 samples from whole and lysed blood 
 Whole blood positive Whole blood negative Total 
Lysed blood positive 1 15 16 
Lysed blood negative 0 64 64 
Total 1 79 80 
 
The results in Table 4.6 show the overall PCR results from examining 10 discs containing whole 
blood and 10 discs containing lysed blood for the presence of T. brucei s.l. infections. It was observed 
that 16 animals were infected with trypanosomes when the lysis approach was used prior to 
application on FTA®cards. Only one animal was found to be infected with T. brucei s.l. by examining 
the un-lysed whole blood discs. The sensitivity of diagnosing the samples for T. brucei s.l. infection in 
whole blood discs was 6.3% compared to the amplification of the genomic material from lysed blood 
samples. The negative predictive value was 81% compared to lysed blood samples. The Kappa value 
for the agreement between identifying T. brucei s.l. using TBR-PCR in whole and lysed blood 
samples was calculated to be 0.1.  
4.4.2.1.2 Proportion of positive discs from lysed blood samples 
A total of 16 samples were found positive by application of TBR-PCR on 10 discs from lysed blood 
samples and another 10 discs from whole blood samples. The gold standard (defined as a positive 
PCR result from amplifying trypanosome DNA from whole blood and/or lysed blood applied on 
FTA®cards) was used to estimate the sensitivity of examining an increasing number of discs from 
lysed blood samples applied on FTA®cards. Table 4.7 shows the cumulative number of discs 
examined using TBR-PCR with their sensitivity, negative predictive value (NPV) and Kappa value 
compared to the gold standard.  
Table 4.7: Sensitivity of cumulative number of examined discs from lysed blood samples 
compared to gold standard 
Examined 
discs 








































































0.4 0.4 0.6 0.6 0.7 0.7 0.7 0.7 1 1 
Gold standard diagnosed 16 samples to be positive using TBR-PCR reaction 
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The results in Table 4.7 show that with increasing the number of examined discs containing lysed 
blood, the sensitivity of amplifying T. brucei s.l. genomic material increased until reaching 100%. 
Examining one to two discs from lysed blood resulted in fair agreement compared to the gold 
standard, while increasing the number of examined discs to 3-8 resulted in moderate (0.6) and good 
(0.7) agreement until reaching very good agreement by examining 9-10 discs. 
Looking at the number of positive discs from each sample containing whole and lysed blood, Table 
4.8 shows the number of positive discs out of the 10 discs examined from each sample.  
Table 4.8: Number of positive discs using TBR-PCR from the 16 positive samples (whole and 
lysed blood) 
Sample number Whole blood discs Lysed blood discs 
1 0/10 2/10 
2 0/10 2/10 
3 0/10 2/10 
4 0/10 2/10 
5 0/10 2/10 
6 0/10 4/10 
7 0/10 4/10 
8 0/10 6/10 
9 0/10 6/10 
10 0/10 6/10 
11 0/10 6/10 
12 0/10 10/10 
13 0/10 10/10 
14 0/10 10/10 
15 0/10 10/10 
16 2/10 10/10 
Total 2/160 92/160 
 
The aforementioned results indicated that out of 160 discs examined from the entire whole blood 
samples, only two were positive for T. brucei s.l. DNA (1.3%). However, out of 160 discs containing 
lysed blood, 92 (57.5%) discs were positive for T. brucei s.l. The proportion of positive discs 
containing lysed blood was significantly higher than those contained whole blood (χ1
2=122.01, 
p<0.001).    
4.4.2.2 Large scale field lysis application 
The results from the preliminary in field lysis application were promising regarding the improvement 
for identification of trypanosome DNA from FTA®card based sampling using PCR. For further 
evaluation of the lysis approach, another in field study was conducted on a larger scale by sampling a 
higher number of animals and comparing different sample preparations.    
Three different sample preparations were collected from 300 animals. These preparations included, 
whole blood applied on FTA®cards, lysed blood on FTA®cards and in field purification of DNA from 
blood using extraction kits. The results from the preliminary in field lysis study indicated the 
improvement of identifying animals infected with T. brucei s.l. using TBR-PCR on lysed blood 
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samples by increasing the number of examined FTA discs to 9-10 discs. However, using a single PCR 
reaction for each disc was very expensive and time consuming. Therefore, in the large in field lysis 
study, ten discs from each FTA®card applied sample were examined using one PCR reaction. This 
was achieved by eluting the genomic material from 10 discs by heating at 90ºC using Chelex®100 
resin. Moreover, another 10 discs were examined from each sample preparation using separate PCR 
reaction on each disc. 
4.4.2.2.1 Sensitivity of cumulative number of examined discs containing 
whole and lysed blood  
Ten discs containing whole blood samples and another 10 discs containing lysed blood samples were 
examined using a separate TBR-PCR reaction, the sensitivity of increasing the number of examined 
discs was calculated compared to the gold standard (defined as PCR positive results from amplifying 
trypanosome DNA from samples applied to FTA®cards and/or positive PCR results from amplifying 
trypanosome genomic material in DNA extract). Table 4.9 summarises the sensitivity of increased 
number of examined discs containing whole and lysed blood compared to the gold standard. The 
negative predictive value and Kappa value are also shown. 
Table 4.9: Sensitivity of cumulative number of examined discs from whole and lysed blood 
samples compared to gold standard 
Whole blood samples 
Examined 
discs 










































































0.08 0.08 0.08 0.08 0.08 0.1 0.2 0.3 0.4 0.4 









































































0.1 0.1 0.2 0.2 0.2 0.3 0.4 0.5 0.6 0.8 
Gold standard identified 101 samples to be positive using TBR-PCR reaction 
A total of 101 animals were diagnosed as infected with T. brucei s.l. by examining different sample 
preparations including whole blood on FTA®cards, lysed blood on FTA®cards and DNA extract from 
whole blood (33.7%, 95% CI: 28.3-39.3). The results in Table 4.9 show the increase in the sensitivity 
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of amplifying trypanosome genomic material by increasing the number of examined discs containing 
whole and lysed blood. Examining one to seven discs containing whole blood resulted in poor 
agreement compared to the gold standard, while fair agreement was observed when examining eight 
to ten discs using separate PCR reactions on each disc containing whole blood. 
The results in Table 4.9 show also the increase in the sensitivity of amplifying trypanosome genomic 
material by increasing the number of examined discs containing lysed blood samples. Examining one 
to five discs resulted in poor agreement compared to the gold standard, while fair agreement was 
observed when testing six to seven discs and moderate agreement was found by examining eight to 
nine discs, and good agreement was noticed by examining ten discs using separate PCR reactions on 
each disc. 
4.4.2.2.2 Sensitivity of different sample preparations compared to the gold 
standard 
The different sample preparations collected from the 300 animals included whole blood on 
FTA®cards, lysed blood on FTA®cards and DNA extract from whole blood were compared to a gold 
standard (defined as PCR positive results from amplifying trypanosome DNA from samples applied to 
FTA®cards and/or positive PCR results from amplifying trypanosome genomic material in DNA 
extract) to determine the sensitivity of each preparation in identifying T. brucei s.l. DNA using TBR-
PCR. The gold standard was able to identify 101 animlas to be infected with T. brucei s.l. by PCR any 
of the used preparations.   
Table 4.10: Sensitivity of the used sample preparations compared to the gold standard for 
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Table 4.10 shows the sensitivities, negative predictive value and Kappa value of different sample 
preparations in amplifying T. brucei s.l. genomic material using TBR-PCR. The results show that the 
sensitivity of a single PCR reaction using 5 µl of DNA eluted from 10 discs with Chelex®100 solution 
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was 1.6 times higher than the amplification of the DNA from 10 separate discs of the same sample, 
which was statistically significant (χ1
2=7.3, p=0.007).  
Lysed blood samples were also screened for T. brucei s.l. genomic material using TBR-PCR on eluate 
from 10 discs and from another 10 discs screened separately. The sensitivity of detecting T. brucei s.l. 
DNA from lysed blood eluate was the same as screening 10 separate discs from the same sample.  
Comparing the sensitivity of examining eluates either from whole, lysed blood or in situ DNA extract, 
it was found that PCR on 5 µl lysed blood eluate was 1.3 times higher than PCR on  5 µl whole blood 
eluate, however this difference was statistically insignificant (χ1
2=1.7, p=0.2). Moreover, the 
sensitivity of PCR on 5 µl lysed blood eluate from 10 discs using Chelex®100 was 1.1 higher than 
PCR on 1 µl from whole blood DNA extract. Therefore, these single PCR reactions on eluate released 
from material stored on FTA®cards are comparable to DNA prepared directly under field conditions at 
the point of collection.  
The results in the table show also the Kappa value for the degree of agreement between the 
amplification of T. brucei s.l. genomic material in different preparations compared to the gold 
standard. There was fair agreement between the detection of the DNA in whole blood samples using 
separate 10 discs for the PCR and the gold standard. Moderate agreement was noticed when 
amplifying the parasite genomic material from eluates of whole blood discs. However, very good 
agreement was found between the use of lysed blood eluate, 10 separate discs contained lysed blood 
and the gold standard. Good agreement was also observed in the amplification of the trypanosome 
genomic material using DNA extract compared to the gold standard.  
4.5 Discussion 
4.5.1 Experimental lysis of blood samples 
Previous work had demonstrated that when infected blood is applied to the surface of the FTA®card, 
parasitic material is localised at the point of contact (Cox, 2007). Therefore, at low parasitaemia much 
of the FTA®card surface must be screened in order to confirm the infective status of the animal. 
The aim of this chapter was to demonstrate that by lysing blood, it is possible to create a more 
homogenous solution of DNA consisting of the genetic material from both the host as well as any 
infectious agent prior to application on FTA®cards. 
Application of the lysis agents (H2O, PBS and 1% SDS) to procyclic cultures improved the detection 
of the trypanosome DNA. This improvement was attributed to the rupture of the procyclic cells due to 
osmotic pressure resulting from addition of the lysis agents leading to release of the genomic material 
into the solution. This release of the DNA resulted in a more homogenous distribution of the 
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trypanosome DNA across the surface of the FTA®card, increasing the chances of detecting the 
trypanosome genomic material by PCR.   
Three experimental lysis trials were performed using procyclic and bloodforms of T. brucei s.l. in 
order to improve the downstream sensitivity of PCR screening of samples stored on FTA®cards. The 
first trial was conducted using procyclic forms in Cunningham’s media with concentrations ranging 
from 2.5x105 to 2.5 parasites/ml. Samples prior to lysis were examined using a PCR that specifically 
targets a multi-copy region within the genome of T. brucei s.l.; the results indicated that at high 
concentrations (2.5x105- 2.5x102 parasites/ml) there were sufficient trypanosomes on the card matrix 
to be amplified with the PCR reaction. However, at lower concentrations (25-2.5 parasites/ml) the 
chance of isolating a parasite in each of the examined disc was lower (3% and 0.3%, respectively), 
therefore, it was unsurprising that none of the examined discs from these low concentrations contained 
the trypanosomes.  
The choice of a PCR that targets a high copy number sequence also improved the detection of the 
DNA from as low as one parasite per ml. For instance, at the concentration containing 25 parasites/ml; 
50 µl from this concentration would contain one parasite. Lysing the cell using 50 µl of lysis agent 
resulted in the release of the genomic material from the parasitic cell into the solution. The copy 
number of the target in one trypanosome cell is 10,000 copies; therefore, this copy number of the 
target exists in 100 µl lysed sample applied on FTA®card. One disc from FTA®card is equivalent to 
1.34 µl, so examining one disc from such solution after application on FTA®cards resulted in the 
amplification of the parasite DNA because it was assumed that one disc would contain 134 copies of 
the target. This assumption clarifies the detection of the trypanosome DNA at low concentrations after 
lysing the cells.  
Lysis was also successful in the second trial, however, the number of discs reacting positive by PCR 
was lower compared to the first trial. This could be attributed to masking of the parasite DNA by the 
presence of host DNA. The DNA content in the 50 µl volume of the host blood sample was reported 
to be 1.6 µg (Qiagen extraction kits, 2007), so this amount was added to match the natural conditions 
where both the parasitic and host DNA co-exist in the sample. The lysis experiment was repeated 
using bloodforms from a mouse blood. This trial further indicated that lysing the cells prior to their 
application onto FTA®cards, especially at the low parasite concentration improved the trypanosome 
diagnosis by PCR. However, the number of the discs reacting positive by PCR was again less 
compared to the first trial which again suggests the masking of the parasite genomic material with the 
host DNA.  
These results are in agreement with those obtained by Moser et al. (1989a) who stated that the 
presence of up to 1 µg of mouse or human DNA with the trypanosome DNA in the PCR reaction did 
not affect the sensitivity of parasite DNA detection. In the current study, the concentration of the host 
DNA was 60% higher than the acceptable concentration reported by Moser et al. (1989a).  
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The presence of human DNA is an important factor that interferes with the reaction yield of the PCR; 
this was described by Contamin et al. (1995) who noticed a decrease of the PCR sensitivity in 
identifying malaria parasites in human blood by 10 fold due to the presence of human DNA. Cogswell 
et al. (1996) reported that a diagnostic PCR can be inhibited if the amount of host DNA exceeds a 
certain threshold. In their system, this value was calculated to be > 0.5 µg of host DNA. The possible 
explanation for this masking effect is that the host DNA is able to competitively inhibit primer-
template hybridization when the host DNA is present at high concentration due to the short sequence 
of primers which allows identities to be found with some of the host DNA sequences (Cogswell et al., 
1996).   
Regarding the lysing agents used, water was chosen for the in field application due to the availability, 
low cost and unnecessary pre-use preparations.  
4.5.2 In field application of lysis 
The experimental lysis trials clarified the possibility of increasing the chance of trypanosome DNA 
identification using PCR by pre-treating the blood releasing the genomic material in a more 
homogenous solution prior to application to FTA®cards. The lysis trial was then applied under field 
conditions to help evaluating this approach as a tool for field application. 
4.5.2.1 Preliminary field lysis trial  
The preliminary field lysis trial was a pilot study to obtain initial information about the logistics of 
lysis in the field; therefore, opportunistic samples were collected from 80 cattle at Lwala parish, 
Olemai village in Kabermaido district, Eastern Uganda, in July, 2006.  
Whole and lysed blood samples were collected from 80 cattle and 10 separate discs from each 
preparation were examined by PCR directed against T. brucei s.l., this is the same PCR protocol that 
was used in the experimental trials. The overall PCR results showed that examining lysed blood 
samples indicated 20% of the animals were infected with T. brucei s.l., while examining whole blood 
samples identified only 1.3% to be infected. To discuss these findings, let us assume that the 100 µl 
whole blood sample collected from the animal contained two parasites; application of this amount on 
FTA®card matrix would entrap these parasite cells in a certain location on the matrix, for the animal to 
be diagnosed positive, the examined disc should contain a parasite cell. However, assuming that 50 µl 
of the whole blood collected from the animal contained one parasite, after adding the lysis agent the 
cell ruptured and the genomic material released into the solution. After application of the lysis 
solution to FTA®cards, examining just one disc should contain sufficient parasitic material to produce 
a positive PCR.  
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Increasing the number of discs examined improved the detection further due to increasing the chance 
of selecting a region of the card where parasitic material was stored. This was clearly noticed from 
comparing the sensitivity of cumulative number of examined discs to the gold standard (defined as a 
positive PCR result from amplifying trypanosome DNA from whole blood and/or lysed blood applied 
on FTA®cards).  
 
Figure 4.5: Cumulative number of examined discs containing lysed blood (the level of Kappa 
agreement is shown between brackets according to Altman (1991))  
Figure 4.5 shows that increasing the number of the examined discs containing lysed blood samples to 
10 discs resulted in 100% sensitivity compared with the gold standard. The steep increase in the 
sensitivity would suggest that although the distribution is improved by pre-lysis, it should not be 
assumed to be a homogenous distribution; by increasing the number of screened discs it is possible to 
improve the detection of trypanosome DNA.  
Looking closely at the results of the examined discs from the 16 positive animals, examining 10 discs 
from whole and lysed blood samples resulted in a significantly higher proportion of lysed blood discs 
identified positive for the trypanosome target compared to whole blood examined discs. The results 
from the pilot study confirmed that the lysis step did indeed improve the sensitivity of trypanosome 
DNA detection from infected cattle blood. However, this level of sensitivity required the examination 
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of nine to ten discs using a separate PCR reaction on each disc which is time consuming and 
expensive. Therefore, a larger field lysis study was conducted for further evaluation of the approach.   
4.5.2.2 Large scale field lysis trial  
For further evaluation of the lysis approach, a large scale field study was conducted using a larger 
sample number (n=300) and three types of sample preparations. The sample preparations used in this 
study were whole blood on FTA®cards, lysed blood on FTA®cards and in situ DNA extraction. 
Starting with examining 10 separate discs from FTA®card applied samples, the sensitivity of detecting 
positive discs containing whole blood was constant at 5.9% using one to five discs, while the 
sensitivity was increased using more discs until reaching 35.6% after examining 10 discs using PCR 
(Figure 4.6). This was due to increasing the chance of obtaining the parasite genomic material in the 
examined disc. However, using discs containing lysed blood samples, the sensitivity of detecting 
positive discs using PCR increased from 12.9% using one to two discs to 73.3% using 10 discs. 
Comparing the sensitivity of examining one disc containing whole blood and lysed blood (5.9% and 
12.9%, respectively), it was noticed that the lysis step doubled the sensitivity of the screening 
protocol; also this was the case in comparing the sensitivity of examining 10 discs from the two 
preparations using separate PCR reactions (35.6% and 73.3%, respectively).  
 
Figure 4.6: Cumulative number of examined discs containing whole and lysed blood 
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The improvement of detecting trypanosome target sequence was clear using the lysed blood samples; 
however, it required the screening of at least 10 separate discs to achieve a sufficient sensitivity. The 
prevalence obtained from a single disc may be completely representative of the population if infection 
intensities are generally very high, or may completely underestimate the population prevalence if the 
infection intensities are generally very low in the population (Cox, 2007). Therefore, in order to 
decrease the probability of false negative results from using a single disc, examining more discs would 
give more accurate estimation of the disease prevalence.  
Although the higher sensitivity of examining more discs, the use of 10 discs from whole blood or 
lysed blood samples with a separate PCR reaction on each disc was considered time consuming and 
expensive. Moreover, the use of 10 discs for detecting each trypanosome species would quickly use 
all the archived material on the card matrix. Therefore, to improve the detection of trypanosomes 
using only 10 discs with one PCR reaction for each species, another 10 discs from whole and lysed 
blood preparations were examined using one PCR reaction.  This was achieved by eluting DNA from 
FTA®cards containing whole blood and lysed blood using 5% Chelex®100 resin aqueous suspension 
(Becker et al., 2004).  
Genomic material in the 10 discs of whole and lysed blood was eluted in 60 µl Chelex®100 
suspension solution, 5 µl eluate was subjected to PCR amplification using TBR-PCR. This volume of 
the eluate would be sufficient for about 12 PCR reactions. The results showed that the sensitivity of 
identifying trypanosome DNA from whole blood and lysed blood eluate was 56.4% and 73.3%, 
respectively, compared to the gold standard (Figure 4.6). 
The sensitivity of lysed blood eluate in detecting trypanosome DNA was insignificantly higher than 
the eluate obtained from the whole blood samples (χ1
2=2.8, p=0.1). Although the difference was 
insignificant, the increased proportion of animals diagnosed to be infected with T. brucei s.l. using 
lysed blood preparations supported the conclusion obtained from the initial field lysis analysis and the 
experimental lysis trials that lysing trypanosome cells increased the probability of the target detection. 
Therefore, the improved distribution of the genomic material on the FTA®card matrix gives a greater 
possibility of detecting trypanosomes than in whole blood applied directly on FTA®cards.  
In situ DNA extraction from 50 µl blood sample was compared to the gold standard for the sensitivity 
of detecting the parasite DNA when a single µl was examined by PCR. Assuming that the collected 
volume of blood contain a single trypanosome cell, after sample lysis, the resulting solution becomes 
“contaminated” by the parasite DNA with 10,000 copies per genome of the target. This contamination 
is such that you would expect every 1 µl of DNA extract examined thereafter by PCR to be positive, 
because it would, theoretically, contain 200 copies of the target sequence. However, the sensitivity of 
detecting the parasite target sequence in the DNA extract was insignificantly lower than that obtained 
using eluate from lysed blood discs (χ1
2=0.2, p=0.6).       
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DNA extraction from different samples including blood, CSF, tissues and cultures is an important step 
for conducting PCR for the diagnosis and research purposes. Extraction of DNA using different kits 
has been proven to recover high molecular weight DNA but this process is time consuming and 
expensive. Moreover, these methods require several steps and may include the transfer of DNA 
extracts to additional containers and columns increasing the chance for cross-transfer of samples or 
the introduction of contaminants (Walsh et al., 1991). ChargeSwitch® gDNA kit used in this study to 
extract DNA from blood did not require the use of any electrical equipment because it depends on the 
use of magnetic beads, however, it was time consuming and expensive. For extracting DNA from one 
sample using ChargeSwitch® gDNA kit, the cost was £4.20 compared to £2.70 and £3.20 using whole 
blood and lysed blood on FTA®cards, respectively.   
Research has focused on the development of alternative extraction protocols that overcome the 
drawbacks of the conventional methods, but at the same time producing efficient DNA yield in both 
the quantity and quality to be easily amplified using PCR (Polski et al., 1998). DNA elution from 
blood applied on FTA®cards or filter papers using 5% aqueous Chelex®100 solutions appear to be 
more convenient and cheaper than DNA extraction using extraction kits (Becker et al., 2004). This is 
because the use of Chelex®100 has decreased the number of steps in sample preparation for DNA 
extraction, thus decreasing the possibility of cross transfer and contamination of samples (Walsh et 
al., 1991).  
In conclusion, successful molecular diagnosis requires the availability of genomic material of an 
appropriate quality and concentration to be present within the sample under examination. The 
insignificant difference between using DNA eluted from whole blood, lysed blood discs and DNA 
extracted using kits suggests to use any of the aforementioned preparations for obtaining trypanosome 
genomic materials. The choice will be based on economic and time factors, in field DNA extraction 
using kits will be excluded due to the expensive kits and time consumed for extracting DNA. 
FTA®card technology is an important archiving matrix for DNA, pre-application lysis of infected 
blood products can help create a more homogenous distribution. It is possible to elute DNA from 
FTA®cards; this approach overcomes the uneven distribution of materials across the matrix. The pre-
lysis step further improves the detection of trypanosomes in this eluted preparation to an acceptable 
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Diagnosis of human and animal African trypanosomiasis has been the subject of extensive research 
since the discovery of the disease by Bruce in 1903. The most important reason for trypanosome 
diagnosis is for the appropriate application of effective control measures and management of the 
disease (Eisler et al., 2004; Molyneux, 1975). The routine diagnosis of trypanosomiasis using 
parasitological approaches has been reported to have poor sensitivity under field conditions due to low 
peripheral parasitemia in infected animals (Masake et al., 2002; Picozzi et al., 2002).  
The drawbacks of microscopy led scientists to turn their attention towards the detection of antibodies 
against the infectious agent as an alternative means of diagnosing infection. Serological tests such as 
complement fixation test (CFT), indirect fluorescent antibody test (IFAT), card agglutination test 
(CATT) and enzyme linked immunosorbant assay (ELISA) have been used for the diagnosis of 
trypanosomes (Luckins, 1977). However, these methods are unable to differentiate between existing 
and previous exposure to infection (Bengaly et al., 1995). This has led the attention to be directed 
towards the identification of the infectious agent DNA for diagnosis using the polymerase chain 
reaction (PCR). 
In recent years, PCR has been developed and widely used for the detection of trypanosomes (Gonzales 
et al., 2003; Moser et al., 1989a). PCR has proven to be highly sensitive and specific for trypanosome 
detection (Becker et al., 2004). The use of PCR in detecting trypanosome DNA seems to be the most 
reliable and accurate technique to assess the efficacy of trypanosomiasis treatment by the specific 
identification of natural animal infections with most trypanosome species and sub-species (Njiokou et 
al., 2004; Truc et al., 1999).  
Different types of PCR are in use for the diagnosis of trypanosomes, including conventional, 
multiplex and nested reactions. Conventional PCR reactions mainly depend on the use of primer sets 
targeting a specific DNA sequence. In multiplex reactions, more than one primer set can be used 
which allows more than one DNA sequence to be targeted. Finally, nested PCR depends on the run of 
two separate reactions where the amplification product from the first reaction is used as a template for 
the second reaction. 
The diagnosis of the most important pathogenic trypanosome species (T. brucei s.l., T. congolense and 
T. vivax) has been achieved using PCRs designed for species-specific targets. The most favourable 
target for identifying T. brucei s.l. is the satellite repetitive 177 bp sequence described by Sloof et al. 
(1983a,b) due to the high copy number in the parasite genome (10,000).  The sensitivity of the primers 
designed to target the sequence is detailed in Chapter II (section 2.2.5.2.1).  
The Savannah type of T. congolense  is highly pathogenic and is the most widespread, in terms of both 
geographical and host range (Bengaly et al., 1995; Gibson et al., 1988; Young and Godfrey, 1983). 
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The specific primers designed for this species targeting a satellite sequence of 316 bp were designed 
by Moser et al. (1989a) and the sensitivity of the primers are detailed in Chapter II (section 2.2.5.2.1). 
Universal primers targeting a fragment of the gene encoding T. vivax specific antigen were described 
by Masake et al. (1994). The antigen is recognised by a monoclonal antibody (Tv27) in an Ag-ELISA, 
the cloned gene was found to be tandemly repeated with a monomeric unit length of 900 bp in the 
genome of all T. vivax isolates from diverse geographic locations in Africa and South America 
(Chapter II, section 2.2.5.2.1). 
A high copy number combined with inter-species length variation makes the internal transcribed 
spacers (ITS), located within the ribosomal RNA genes, a useful marker for species differentiation in 
trypanosomes and other species (Cox et al., 2005; Desquesnes et al., 2001; McLaughlin et al., 1996; 
Njiru et al., 2004). The development of different PCR reactions based on the amplification of the ITS 
region is fully discussed in Chapter II (section 2.2.5.2.2). Cox et al. (2005) developed a simple nested 
PCR method which detects the inter-species length variation of the ITS region of ribosomal genes, 
thereby producing a unique size of PCR product for each species of trypanosomes.  
5.2 Objectives  
The aim of the work presented in this chapter is to evaluate the different PCR reactions currently in 
use for the diagnosis of the most important pathogenic trypanosomes. The PCR reactions evaluated in 
this study include species-specific PCR reactions that amplify T. brucei s.l., T. congolense Savannah 
and T. vivax, compared to the pan-trypanosome nested reaction that amplifies the ITS locus in the 
rRNA gene (Cox et al., 2005).   
5.3 Material and methods 
5.3.1 Collected samples 
The blood samples used in the current study were collected in Uganda and Zambia from cattle, 
wildlife, sheep and dogs. Table 5.1 summarises the origin of the samples used. The blood samples 
spotted directly onto FTA®cards were analysed for the presence of trypanosome infection with a 





Table 5.1: Description of the samples used in the current study 
Area of collection Host Number of samples Date of collection Comments 
 
Uganda Cattle 600 October, 2006 Samples collected 
during baseline 
sampling of Stamp 
Out Sleeping sickness 
campaign 
Wildlife 276 July, 2005 Kindly provided by 
Neil Anderson 
Sheep 58 October, 2005 
Zambia 
Dogs 35 October, 2005 
Kindly provided by 
Joseph Matemba 
Total  969   
 
5.3.2 Samples processing 
Samples applied onto FTA®cards were processed by eluting DNA from 10 discs (0.2 mm) using 
Chelex®100 as previously described in Chapter IV (section, 4.3.2.2.3). The same eluate was used for 
all the PCR reactions on each sample to make these reactions comparable.   
5.3.3 PCR 
The primer sequences, reaction conditions and the size of the amplified products of ITS-PCR and 
TBR-PCR are detailed in chapters III and IV, respectively. The primer sequence, reaction conditions 
and size of the amplified products using PLC-PCR, TCS-PCR, TCK-PCR, TCF-PCR, universal TV-























657: 5’- CGC TTT GTT 
GAG GAG CTG CAA 
GCA-3’ 
PLC-PCR T. brucei  s.l. 324 bp  
658: 5’- TGC CAC CGC 
AAA GTC GTT ATT 
TCG-3’ 
40 94ºC for 30 sec, 
63ºC for 90 sec, 
72ºC for 70 sec. 
(Picozzi et 
al., 2008) 
TCS1: 5’-CGA GAA 






TCS2: 5’-GGA CAA 
ACA AAT CCC GGGCA 
CA-3’ 
35 94ºC for 1 min, 
55ºC for 2 min, 
72ºC for 2 min. 
(Moser et 
al., 1989a) 
TCK1: 5’- GTG CCC 






TCK2: 5’- ACT CAA 
AAT CGT GCA CCT CG-
3’ 
35 94ºC for 1 min, 
55ºC for 2 min, 
72ºC for 2 min. 
(Masiga et 
al., 1992) 
TCF: 5’- GGA CAC GCC 





TCF2: 5’- GTT CTC GCA 
CCA AAT CCA AC-3’ 
35 94ºC for 1 min, 
55ºC for 2 min, 
72ºC for 2 min. 
(Masiga et 
al., 1992) 
ILO1264: 5’-CAG CTC 
GGC GAA GGC CAC 
TTC GCT GGG GTG-3’ 
Universal 
TV-PCR 
T. vivax 400 bp 
ILO1265: 5’-TCG CTA 
CCA CAG TCG CAA 
TCG TCG TCT CAA GG-
3’ 
35 94ºC for 1 min, 
55ºC for 2 min, 
72ºC for 2 min. 
(Masake et 
al., 1997) 
TVW1: 5’-GTG CTC 





T. vivax 175 bp 
TVW2: 5’-CAT ATG 
GTC TGG GAG CGG 
GT-3’ 
35 94ºC for 45 sec, 
60ºC for 1 min, 




Generally, the reaction volume used was 25 µl containing NH4 Buffer (Bioline, London, UK) that is 
formed of 16.0 mM (NH4)2SO4, 67 mM Tris-HCl (pH 8.8 at 25ºC) and 0.01% Tween 20. Moreover, 1 
µM of each primer, 1.5 mM MgCl2, 200 µM of each of the four-deoxynucleoside triphosphates 
(dNTP) and one Unit of BIOTAQ RED DNA Polymersase (Bioline) were added.  
PLC-PCR reaction mix routinely contained 1.5 U Hot Star Taq, 1.25 µl of Rediload dye (Invitrogen) 
with a final concentration of 3 mM MgCl2 and 0.2 µM of each primer.  
After preparing the master mix, 5 µl of the eluate was added to 20 µl of the PCR master mix. The 
reaction conditions for the individual PCR are summarised in Table 5.2, an initial denaturation step at 
94ºC for 3 minutes was used together with a final elongation step at 72ºC for five minutes except for 
PLC-PCR this step was for 10 minutes. Also, for PLC-PCR the initial denaturation was at 95ºC for 15 
minutes to activate Hot Start Taq polymerase. The reactions took place in a DNA Engine DYADTM 
Peltier Thermal Cycler. Visualization of the amplified bands was detailed in Chapter three (section 
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3.4.7.3) with an example of ITS-PCR and TBR-PCR gel results. Figure 5.1 shows an example of the 
universal TV-PCR, TCS-PCR and PLC-PCR gel results. 
 
Figure 5.1: Example of the universal TV-PCR, TCS-PCR and PLC-PCR gel results (size of the 
amplified product in each reaction is shown in the image, L: Ladder)  
5.3.4 Cloning protocol 
The amplified products from ITS-PCR reaction used in this study were cloned and sequenced to 
further evaluate the specificity of the PCR reaction. 
5.3.4.1 Gel extraction 
Gel extraction of the desired fragment was carried out with MinElute gel extraction kits (Qiagen), 
using spin-columns designed to give high end concentrations of purified DNA fragments. The main 
principle of these kits is the adsorption of DNA to the silica-gel membrane in the presence of a high 
chaotropic salt concentration, contaminants pass through the column with washing of impurities and 
elution of the pure DNA with Tris buffer. The silica-gel membrane is designed to adsorb up to 5 µg 
DNA allowing the purification of concentrated DNA fragments in high yields, in as little as 9 µl 
eluate. The adsorption of DNA to silica depends on pH with 80% recovery of DNA when the loading 
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mixture pH is ≤7.5. QG buffer is a binding and solubilisation buffer which solubilises the agarose gel 
slice and provides the appropriate conditions for binding of DNA to the silica membrane. The pH 
indicator in QG buffer appears yellow at pH ≤7.5, but in cases of pH> 7.5 which occurs due to 
running the gel in repeatedly used electrophoresis buffer or incorrectly prepared buffer, the binding 
mixture turns orange or violet leading to inefficient binding of the DNA to the silica-gel membrane. In 
this case, the pH can be corrected by adding a small volume of 3 M sodium acetate (pH 5). The 
indicator dye does not interfere with DNA binding and is removed during the cleanup procedure.  
During the DNA adsorption step, unwanted primers and impurities (salts, enzymes, unincorporated 
nucleotides, agarose, dyes, ethidium bromide, DMSO, oils and detergents) do not bind to the silica 
membrane but flow through the column. Salts are washed away with the ethanol-containing buffer PE 
which is removed by an additional centrifugation step to avoid its interference with subsequent 
enzymatic reactions.  
Elution efficiency is strongly dependent on the salt concentration and pH of the elution buffer, 
contrary to adsorption; elution is most efficient under basic conditions (pH 7-8.5) and low salt 
concentrations. Elution with TE is possible but not recommended because EDTA may inhibit 
subsequent enzymatic reactions. Also, elution in water is possible, but DNA should be stored at -20ºC 
since DNA may degrade in the absence of a buffering agent. 
The desired DNA fragment was excised from the agarose gel with a clean, sharp scalpel, and weighed 
in a colourless tube (the maximum amount of gel slice per spin column is 400 mg). Buffer QG was 
added as 3 volumes to one volume of the gel (<2%), but for gels >2%, 6 volumes of the buffer were 
added.  
The tubes containing the gel slice and QG buffer were incubated in a water bath at 50ºC for 10 
minutes or until the gel slices were completely dissolved. Isopropanol was added as one gel volume 
and the tubes were mixed by inversion several times. To bind the DNA, the samples were applied to 
the MinElute spin column and centrifuged for one minute at 13,000 rpm. The flow through was 
discarded and 500 µl of buffer QG was added to the spin column and centrifuged for one minute at 
13,000 rpm. To wash away the impurities, 750 µl of buffer PE was added to the column and left to 
stand at room temperature for five minutes before centrifugation at 13,000 rpm for one minute. After 
discarding the flow through, the tubes were additionally centrifuged for one minute at 13,000 rpm to 
remove the residual ethanol. For eluting DNA, the spin column was replaced into a clean 1.5 ml 
micro-centrifuge tube and 10 µl of buffer EB was added to the centre of the membrane and the tubes 




Qiagen PCR Cloning kits are considered a highly efficient technology for cloning of PCR products 
using Taq and other non-proofreading DNA polymerases. The supplied vector in the kits, pDrive 
Cloning vector (Figure 5.2), is provided in a linear form with a Uracil overhang (U) at each end to 
hybridise with high specificity to PCR products generated using Taq and other non-proofreading 
polymerases with a single Adenosine overhang (A) at each end. For efficient addition of an A 
overhang during the PCR amplification, a final extension step at 72ºC for 10 minutes is strongly 
recommended. The Ligation master mix provides optimal buffer conditions for the hybridisation of 
the pDrive vector and the PCR products.  
The pDrive cloning vector is supplied in a linear form, and allows ampicillin and kanamycin selection 
as well as blue/white colony screening. The vector contains several unique restriction endonuclease 
recognition sites around the cloning site allowing easy restriction analysis of recombinant plasmids.  
 






After thawing 2x Ligation master mix and pDriver cloning vector, DNA was placed on ice and the 
ligation reaction mixture was prepared as follows in the same order (Ligation master mix was added 
last): 
PCR product                                      4 µl 
pDrive cloning vector                         1 µl 
Ligation master mix                            5 µl 
Total                                                  10 µl 
The ligation reaction mixture was briefly mixed by pipetting up and down few minutes then the mix 
was incubated at 4ºC for two hours. 
5.3.4.4 Preparation of Agar plates 
Luria Bertani (LB) Broth was prepared by dissolving 10 g tryptone, 5 g yeast extract, 10 g sodium 
chloride and 15 g agar in 950 ml of de-ionised water. The pH of the solution was adjusted to seven 
and water was added to make up the volume to 1000 ml. The solution was then autoclaved for 20 
minutes at 15 lbs pressure. The autoclaved solution was cooled to 55ºC and one ml of 50 mg/ml 
ampicillin suspension was added and poured into sterile Petri dish. After the plates had set, 20 µl of 
X-Gal (50 mg/ml 5-bromo-4-chloro-3-indolyl β-D-galactopyransoide) and 100 µl IPTG (100 mM 
isopropyl β-D-thiogalactopyranoside) were added to the surface of each plate and evenly distributed 
using a spreader, the plates were then left to absorb these solutions at 37 ºC for 30 minutes. Cells 
transformed by pDrive cloning vector which do not contain a PCR product will form blue colonies 
when grown in the presence of X-Gal/IPTG, while, cells transformed by pDrive cloning vector which 
contain PCR product will form white colonies.       
The plates were then inverted and stored at 4ºC till further use. It is recommended to use freshly 
poured plates (< one week old) for screening plates because long term storage of plates can result in 
decreased antibiotic activity. 
5.3.4.5 Transformation 
Qiagen EZ competent cells were thawed on ice, while, SOC medium [tryptone (pancreatic digest of 
casein) 2% (w/v), yeast extract 0.5% (w/v), NaCl 8.6 mM, KCl 2.5 mM, MgSO4 20 mM and glucose 
20 mM] was thawed and allowed to warm to room temperature before being used. 2 µl of the Ligation 
reaction mixture was added to each tube of competent cells and mixed by gently flicking the tubes. 
The cells were incubated on ice for five minutes, then, the tubes were heated in a water bath at 42ºC 
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for 30 seconds and again incubated on ice for two minutes. SOC medium (250 µl) was then added to 
each tube and half of each mixture was plated on an agar plate. The plates were incubated at room 
temperature until the transformation mixture was completely absorbed, then they were inverted and 
incubated at 37ºC overnight. The next day, the plates were further incubated at 4ºC for three hours to 
facilitate blue/white screening. 
After blue/white screening, six white colonies from each agar plate were chosen and suspended in 100 
µl of LB broth containing ampicillin (100 mg/ml). The tubes were incubated at 37ºC for three hours; 
the presence of the DNA insert was then confirmed by PCR amplification. The bacterial colonies 
positive with PCR amplification were re-suspended in 3 ml of LB broth containing ampicillin 
suspension and incubated at 37ºC overnight. 
5.3.4.6 Preparation and storage of bacterial culture stock 
After incubating the bacterial culture in LB broth, some part of the bacterial culture was mixed with 
Glycerol (1:2) and was stored at -80ºC for future use. The plasmid DNA was extracted from the rest of 
the culture by using the Qiagen Miniprep kit. 
5.3.4.7 Plasmid DNA purification 
The QIAprep miniprep procedure is based on alkaline lysis of bacterial cells followed by adsorption 
of DNA onto silica membrane in the presence of high salt buffer and elution in low salt buffer. 
Bacterial cells suspended in LB broth (3 ml) were pelleted by centrifugation at 3000 rpm for 10 
minutes followed by re-suspension of the bacterial pellet in 250 µl buffer P1 and transferred to 1.5 ml 
micro-centrifuge tube. 250 µl of buffer P2 was also added to the tube and mixed thoroughly by 
inverting the tube several times immediately, 350 µl of buffer N3 was added and mixed thoroughly by 
inverting the tube several times to avoid localised precipitation until the solution became cloudy. The 
solution was then centrifuged at 13,000 rpm for 10 minutes and the supernatant was pipetted to the 
QIAprep spin column and centrifuged for 60 seconds at 13,000 rpm. The flow-through was discarded 
and the spin column was washed by adding 500 µl of buffer PB followed by centrifugation at 13,000 
rpm for 60 seconds and the flow-through was discarded. The spin column was washed using 750 µl 
buffer PE by centrifugation at 13,000 rpm for 60 seconds. The flow-through was discarded before 
centrifugation for an additional minute to remove residual wash buffer. The QIAprep column was 
placed in a clean 1.5 ml micro-centrifuge tube. DNA was eluted by adding 50 µl of buffer EB (10 mM 
Tris-Cl, pH 8.5) at the centre of the spin column; this was left to stand for one minute then centrifuged 
at 13,000 rpm for another minute. Eluted plasmid DNA was stored at -20ºC until it was sent for 
sequencing.  
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5.3.5 Sequence analysis 
Clones were sequenced by GATC biotechnology, Germany. Sequences were analysed using 
DNASTAR software and the BLAST search on the National Centre of Biotechnology Information 
(NCBI) website (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?). 
5.3.6 Statistical analysis 
Sensitivity, negative predictive value and Kappa value were calculated as previously described in 
Chapter III (section, 3.4.8). 
5.4 Results 
The aim of the current study was to evaluate different PCR reactions for the detection of trypanosome 
DNA in blood samples applied on FTA®cards. Eluate from 10 discs was used to run all PCR reactions 
for each sample, accordingly the results are comparable. Species-specific PCR reactions used in this 
study were TBR-PCR, TCS-PCR, TCF-PCR, TCK-PCR and TV-PCR reactions for the diagnosis of T. 
brucei s.l., T. congolense Savannah, T. congolense Forest, T. congolense Kilifi and T. vivax, 
respectively.  
5.4.1 Comparing ITS-PCR with species-specific PCR reactions  
A total of 969 blood samples collected from different animal species on FTA®cards were examined 
using ITS-PCR and species-specific PCR, the parasitic events identified are summarised in Table 5.3.  
Table 5.3: Number of animals infected with trypanosomes diagnosed by different PCR reactions 
 T. brucei s.l. T. congolense* T. vivax Total 
ITS-PCR 2 21 24 47 
Species-specific PCR 77 79 41 197 
*ITS-PCR results with amplicon size more than 1400 bp were classified as T. congolense due to the difficulty in 
classifying the sizes of the three sub species 
The results in Table 5.3 show the number of infected animals with different trypanosome species 
using ITS and species-specific PCR. Overall, ITS-PCR detected 47 parasitic events, while species-
specific PCR reactions identified 197 parasitic events, the difference was statistically significant 
(χ1
2=105.5, p<0.001).  
T. brucei s.l. species 
Looking at the sensitivity of the different PCR reactions in the diagnosis of each trypanosome species, 
specific PCR for T. brucei s.l. identified 77 parasitic events. ITS-PCR confirmed only two animals to 
be infected with T. brucei s.l., the sensitivity of ITS-PCR and species-specific PCR was compared to a 
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gold standard which in this case was defined as a positive result of ITS-PCR and/or TBR-PCR in 
amplifying T. brucei s.l. DNA. The sensitivity of TBR-PCR was found to be 100% in amplifying T. 
brucei s.l. DNA compared to the gold standard with a very good agreement (Kappa value=1). 
However, ITS-PCR sensitivity was only 2.6% (95% CI: 0-6.2) with NPV of 92.2% (95% CI: 90.6-
93.9) and poor agreement compared to the gold standard (Kappa value=0.04). Overall, TBR-PCR 
significantly identified more T. brucei s.l. infections than ITS-PCR (χ1
2=74.2, p<0.001). 
To investigate if this difference in the sensitivity was attributed to the difference in the copy number 
of the target, another PCR reaction specific for T. brucei s.l. targeting a single copy gene (PLC-PCR) 
was used using the same eluted DNA prepared. PLC-PCR identified 49 animals to be infected with T. 
brucei s.l. of which only two were confirmed with ITS-PCR. The results of the PLC-PCR show that 
the sensitivity of the reaction was 63.6% (95% CI: 52.9-74.4), NPV was 97% (95% CI: 95.8-98.1) and 
there was good agreement compared to the gold standard (Kappa value=0.8). Although targeting a 
single copy gene, PLC-PCR was able to significantly detect ~25 times more T. brucei s.l. infections 
than ITS-PCR (χ1
2=44.5, p<0.001).   
T. congolense species      
Three sub species of T. congolense are recognised and can be detected using three different PCR 
reactions, each one specific for a different sub-species. These three sub-species are T. congolense 
Savannah, T. congolense Kilifi and T. congolense Forest, the respective specific PCR reactions for the 
diagnosis of these sub species are TCS, TCK and TCF.  
The results in Table 5.3 show that specific PCR targeting T. congolense Savannah DNA diagnosed 79 
animals to be infected. However, ITS-PCR identified only 21 animals to be infected with T. 
congolense species, the difference was statistically significant (χ1
2=35.5, p<0.001). Only three animals 
were confirmed infected with T. congolense Savannah using both ITS-PCR and TCS-PCR reactions. 
Specific PCR for Kilifi and Forest types were negative in all the examined samples.     
Using the gold standard defined as a positive result of ITS-PCR and/or species-specific PCR reactions 
for T. congolense, 97 animals were diagnosed to be infected with T. congolense species. Compared to 
the gold standard, the sensitivity of the specific PCR for T. congolense Savannah was 81.4% (95% CI: 
73.7-89.2), NPV was 98% (95% CI: 97.1-98.9) and there was a very good agreement between the two 
reactions in identifying T. congolense (Kappa value=0.9). However, the sensitivity of ITS-PCR to 
identify T. congolense Savannah was 21.6% (95% CI: 13.5-29.8), NPV was 92% (95% CI: 90.3-93.7) 
and there was fair agreement when compared to the gold standard (Kappa value=0.3).  
T. vivax species 
T. vivax was identified in 41 animals using specific PCR reaction with the universal primers targeting 
the gene encoding T. vivax specific antigen, while ITS-PCR identified 24 animals, of which 10 were 
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confirmed by both tests, the difference between the two reactions was statistically significant (χ1
2=4.6, 
p=0.03).  
Interestingly, ITS-PCR identified 14 animals to be infected with T. vivax while they were not 
confirmed with the universal primers. Therefore, another set of primers targeting a highly repetitive 
G+C rich (64%) satellite DNA of 180 bp in size were used to investigate this disagreement between 
the universal TV-PCR and the ITS-PCR. However, the PCR reaction targeting the satellite sequence 
of T. vivax species was not able to identify any T. vivax isolate in the samples examined. 
The gold standard for T. vivax identification was defined as any positive PCR result with ITS-PCR 
and/or TV-PCR for T. vivax species. The gold standard identified 55 animals to be infected with T. 
vivax species. The sensitivity of the universal TV-PCR compared to the gold standard was found to be 
74.5% (95% CI: 63-86.1) with NPV of 98.5% (95% CI: 97.7-99.3) and a very good agreement (Kappa 
value=0.8). However, ITS-PCR sensitivity was only 43.6% (95% CI: 30.5-56.7) with 96.7% (95% CI: 
95.6-97.9) NPV and good agreement compared to the gold standard (Kappa value=0.6) in the 
diagnosis of T. vivax species. 
Other species 
In addition to the aforementioned pathogenic trypanosome species, ITS-PCR was able to identify the 
non-pathogenic T. theileri species. The reaction diagnosed 46 animals to be infected with T. theileri. 
A species-specific PCR reaction that targets T. theileri satellite sequence of 500 bp size was developed 
by Rodrigues et al. (2003). This reaction was used in the current study but failed to amplify T. theileri 
DNA in the examined samples. Moreover, T. simiae was diagnosed by ITS-PCR in five animals, the 
species-specific reaction failed to amplify the examined samples. The lack of positive controls for T. 
theileri and T. simiae hindered the optimisation of these two reactions.  
5.4.2 Breaking down the results according to sampling sites and 
animal species 
Different animal species were used in the current study from Uganda and Zambia for the evaluation of 
ITS-PCR and species-specific PCR reactions. Further breakdown of the results was done according to 
the location of sample collection and the animal species.  
5.4.2.1 Samples collected from Uganda 
A total of 600 samples were collected from cattle in Uganda, DNA was eluted from 10 discs and the 
eluate was used for PCR reactions. Table 5.4 shows the results of ITS-PCR versus species-specific 
PCR reactions in cattle blood samples collected in Uganda. 
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Table 5.4: Number of cattle infected with trypanosomes diagnosed by different PCR reactions 
 T. brucei s.l. T. congolense T. vivax Total 
ITS-PCR 1 13 17 31 
Species-specific PCR 63 0 34 97 
 
The results in Table 5.4 show that ITS-PCR identified 31 parasitic events, while species-specific PCR 
reactions identified 97 parasitic events, the difference was statistically significant (χ1
2=38.1, p<0.001). 
Looking at the individual species, ITS-PCR identified only one animal infected with T. brucei s.l. 
while, 63 animals were diagnosed with TBR-PCR, the difference between the two tests were 
statistically different (χ1
2=63.4, p<0.001). The animal that was diagnosed infected with ITS-PCR was 
also confirmed to harbour T. brucei s.l. by TBR-PCR.  
T. congolense was diagnosed using ITS-PCR in 13 animals, however, the species-specific PCR of the 
three T. congolense sub-species failed to amplify any of the samples. 
T. vivax was identified in 17 animals using ITS-PCR, of which eight were confirmed using the 
universal primers for T. vivax species. TV-PCR identified 34 T. vivax infections in the examined cattle 
with a statistical significant difference between the two reactions (χ1
2=5.9, p=0.02). Compared to a 
gold standard defined as any positive PCR result with ITS-PCR and/or TV-PCR for T. vivax species 
that identified 43 animals infected with T. vivax, the sensitivity of TV-PCR was 79.1% (95% CI: 66.9-
91.2) with NPV 98.4% (95% CI: 97.4-99.4) and a very good agreement (Kappa value=0.9). However, 
ITS-PCR sensitivity was 39.5% (95% CI: 24.9-54.1) with NPV 95.5% (93.9-97.2) and a moderate 
agreement compared to the gold standard (Kappa value=0.5).   
Finally, the non-pathogenic T. theileri species was identified in 46 cattle using ITS-PCR. 
5.4.2.2 Samples collected from Zambia 
A total of 369 samples collected from different animal species in Zambia in 2005 were kindly 
provided by Neil Anderson and Joseph Matemba. These samples were re-analysed using ITS-PCR and 
species-specific PCR reactions for trypanosome diagnosis using the same eluate from 10 discs. Table 






Table 5.5: Number of animals sampled in Zambia infected with trypanosomes 
Host PCR T. brucei s.l. T. congolense T. vivax Total 
ITS-PCR 1 7 7 15 Wildlife 
Species-specific PCR 3 47 4 54 
ITS-PCR 0 0 0 0 Sheep 
Species-specific PCR 0 22 3 25 
ITS-PCR 0 1 0 1 Dogs 
Species-specific PCR 11 10 0 21 
ITS-PCR 1 8 7 16 Total 
Species-specific PCR 14 79 7 100 
 
Compiled animal species 
Parasitic events were identified in 16 animals using ITS-PCR, while 100 animals were diagnosed to be 
infected with trypanosomes using species-specific PCR reactions, the difference was statistically 
significant (χ1
2=72.2, p<0.001).    
ITS-PCR identified only one animal to be infected with T. brucei s.l. compared to 14 animals 
diagnosed with TBR-PCR, the difference was statistically significant (χ1
2=11.5, p=0.001). The animal 
identified using ITS-PCR was also confirmed using TBR-PCR to have T. brucei s.l. infection. 
T. congolense was identified in eight animals using ITS-PCR, of which three were confirmed to be T. 
congolense Savannah using TCS-PCR reaction. However, TCS-PCR identified 79 animals infected 
with T. congolense Savannah, the difference between the two reactions was statistically significant 
(χ1
2=63.4, p<0.001). Using the gold standard defined as a positive result of ITS-PCR and/or species-
specific PCR reactions for T. congolense, 84 animals were diagnosed to be infected with T. 
congolense species. Compared to the gold standard, the sensitivity of the specific PCR for T. 
congolense Savannah was 94.1% (95% CI: 89-99.1), NPV was 98.3% (95% CI: 96.8-99.8) and there 
was a very good agreement between the specific PCR reactions in identifying T. congolense and the 
gold standard (Kappa value=1). However, the sensitivity of ITS-PCR to identify T. congolense 
Savannah was 9.5% (95% CI: 3.2-15.8), NPV was 78.9% (95% CI: 74.7-83.2) and there was poor 
agreement when compared to the gold standard (Kappa value=0.1).  
A gold standard defined as a positive result of ITS-PCR and/or species-specific PCR for T. vivax 
identified 12 animals infected with this species. ITS-PCR diagnosed seven T. vivax infected animals 
with only two confirmed positive using TV-PCR, also TV-PCR identified seven T. vivax animals with 
no statistical significant difference. The sensitivity of the ITS-PCR and universal TV-PCR compared 
to the gold standard was found to be 58.3% (95% CI: 30.4-86.2) with NPV of 98.6% (95% CI: 97.4-
99.8) and good agreement (Kappa value=0.7), each.  
T. theileri was not diagnosed in any of the samples collected from Zambia, while five animals were 
found infected with T. simiae using ITS-PCR. 
 137 
Wildlife 
Further breaking down of the results according to the species of the examined animals, Table 5.5 
shows the number of wildlife infected with different trypanosomes using ITS-PCR and species-
specific reactions. The results show that 15 parasitic events were detected in wildlife using ITS-PCR, 
while 54 were diagnosed with species-specific reactions, the difference was significant (χ1
2=25.2, 
p<0.001).   
Only one animal was found infected with T. brucei s.l. using ITS-PCR and it was also confirmed with 
the species-specific reaction, while three were diagnosed using TBR-PCR, the difference was 
statistically insignificant (p=0.6).  
T. congolense was detected in seven animals using ITS-PCR, of which two were confirmed with the 
species-specific reaction of T. congolense Savannah. However, TCS-PCR diagnosed 47 animals to be 
infected with the species, the difference between the two reactions was statistically significant 
(χ1
2=32.8, p<0.001). Using the gold standard defined as a positive result of ITS-PCR and/or species-
specific PCR reactions for T. congolense, 52 animals were diagnosed to be infected with T. 
congolense species. Compared to the gold standard, the sensitivity of the specific PCR for T. 
congolense Savannah was 90.4% (95% CI: 82.4-98.4), NPV was 97.8% (95% CI: 95.9-99.7) and there 
was a very good agreement between the two reactions in identifying T. congolense (Kappa value=0.9). 
However, the sensitivity of ITS-PCR to identify T. congolense Savannah was 13.5% (95% CI: 4.2-
22.7), NPV was 83.3% (95% CI: 78.8-87.7) and there was poor agreement when compared to the gold 
standard (Kappa value=0.2).  
Regarding T. vivax, ITS-PCR diagnosed seven animals infected with the species and two of them were 
confirmed using the universal primers for T. vivax. Only four animals were found infected with T. 
vivax using the species-specific T. vivax PCR, the difference between the two reactions was 
statistically insignificant (χ1
2=0.8, p=0.4). Compared to a gold standard defined as any positive PCR 
result with ITS-PCR and/or TV-PCR for T. vivax species that identified nine animals infected with T. 
vivax, the sensitivity of TV-PCR was 44.4% (95% CI: 12-76.9) with NPV 98.2% (95% CI: 96.6-99.8) 
and a good agreement (Kappa value=0.6). However, ITS-PCR sensitivity was 77.8% (95% CI: 50.6-
100) with NPV 99.3% (95% CI: 98.2-100) and a very good agreement compared to the gold standard 
(Kappa value=0.9).     
T. simiae was identified using ITS-PCR in five animals. However, none of the examined animals were 




Sheep and Dogs 
In sheep, ITS-PCR failed to identify any trypanosome infections, however, species-specific PCR 
diagnosed 25 parasitic events. T. congolense Savannah was detected in 22 animals while T. vivax was 
diagnosed in three animals. 
A total of 21 dogs were found infected using the species-specific PCR, of which 11 were infected with 
T. brucei s.l. and 11 with T. congolense Savannah. However, ITS-PCR detected only one animal 
infected with T. congolense Savannah, this animal was also confirmed using the species-specific TCS-
PCR.  
5.4.3 Sequence analysis 
The results from comparing the sensitivity of ITS-PCR amplification with other species-specific PCR 
reactions highlighted the need of further investigation into the specificity of the ITS-PCR reaction. 
Amplicons produced by this reaction were cloned in pDrive cloning vector (Qiagen) and sequenced 
(GATC). The sequences were analysed using DNASTAR software; the sequences were compared 
with reference sequences available on the NCBI database. 
5.4.3.1 T. brucei s.l. sequencing 
Two animal samples were identified by ITS-PCR to have T. brucei s.l. infections, one from a cow 
sampled in Uganda while the other was from an Impala sampled in Zambia. Also, bands obtained 
from ITS-PCR carried out on T. brucei s.l. isolate (BUT 135) were cloned and sequenced. BLAST 
searches were used to compare the T. brucei s.l. sequences obtained to reference sequences in the 










Table 5.6: BLAST search results of T. brucei s.l. sequences 





















98% Tb1 Cattle 
(Uganda) 
 
100% 1210 bp 1216 bp 










98% Tb2 Wildlife 
(Zambia) 
100% 1216 bp 1216 bp 










98% Tb3 BUT 135 100% 1219 bp 1219 bp 






The results in Table 5.6 show that T. brucei s.l. sequences from cattle, wildlife and BUT 135 were 
similar with 98% identity to the reference sequence of T. brucei s.l. ribosomal RNA sequence 
available in NCBI (Accession no. AF306776.1) and T. evansi 18S ribosomal RNA gene (D89527.1). 
Moreover, comparing the cattle and wildlife sequences revealed 98.4% identity of each other, while 
comparing BUT 135 to cattle and wildlife sequences revealed 97.9% and 97.6% identity, respectively. 
The expected band size of T. brucei s.l. from NCBI is 1207-1224 bp; the band size for T. brucei s.l. 
that was published by Cox et al. (2005) was 1215 bp but in the current study amplicon sizes of 1210 
bp, 1216 bp and 1219 bp were obtained from cattle, wildlife and BUT 135 strain, respectively, which 
covers 1216 bp, 1216 bp and 1219 bp of the reference sequence, respectively.  
5.4.3.2 T. congolense sequencing 
Twenty one samples were identified to have T. congolense infection, 13 from cattle sampled in 
Uganda, seven wildlife samples and one dog sample from Zambia. The cattle samples were not 
identified with TCS-PCR, TCF-PCR and TCK-PCR, while three of the Zambia samples were 
confirmed with TCS-PCR. Six bands amplified from the Uganda samples and three bands amplified 
from the Zambia samples were successfully cloned and sequenced including one confirmed with TCS-
PCR. Moreover, the amplified band from the T. congolense Savannah isolate Sikudo 124 which was 
isolated from a cow in Sikudo, Tororo district, Uganda, 1990 was cloned and sequenced. BLAST 
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searches were used to compare the T. congolense sequences obtained to reference sequences in the 
NCBI database. The closest matches for each sequence are summarised in Table 5.7. 
Table 5.7: BLAST search results of T. congolense sequences  















1132 bp 99%  1510 bp T. congolense Forest 
(U22319.1) 
93% Tc1* Cattle- Uganda 




1446 bp 100% 1513 bp T. congolense  
Forest (U22319.1) 
92% Tc2 Cattle- Uganda 




1453 bp 100% 1513 bp T. congolense Forest 
(U22319.1) 
93% Tc3 Cattle- Uganda 




1332 bp 100% 1513 bp T. congolense Forest 
(U22319.1) 
94% Tc4* Cattle- Uganda 




1461 bp 100% 1513 bp T. congolense Forest 
(U22319.1) 
93% Tc5 Cattle- Uganda 




1452 bp 100% 1513 bp T. congolense Forest 
(U22319.1) 
92% Tc6 Cattle- Uganda 




























1393 bp 76% 1413 bp T. congolense Forest 
(U22319.1) 
93% Tc10 Sikudo 124 




   *No overlap of the forward and reverse sequences   **Sample confirmed with TCS-PCR 
The results in Table 5.7 show that all the sequenced amplicons from Uganda and Zambia are 91-94% 
similarity with T. congolense Forest (IL3900) isolate (U22319.1) and 77-91% similarity with T. 
congolense Savannah (IL1180) isolate (U22315.1). One sample that was confirmed as T. congolense 
Savannah with TCS-PCR showed 78% similarity to T. congolense Forest reference sequence and 95% 
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similarity to T. congolense Savannah reference sequence. Two sequences were 98-100% similar to T. 
brucei s.l. chromosome 2 reference sequence (AC012647.18), the two sequences were from wildlife 
and dog isolated in Zambia, the sequenced fragments were 210 and 496 bp in length, respectively. 
There is a variation in the size of the amplicons between different samples although all the sequences 
start and end with the ITS primer sequence. The band sizes of T. congolense Savannah and T. 
congolense Forest reported by Cox et al. (2005) are 1408 bp and 1501 bp, respectively. 
5.4.3.3 T. vivax sequencing 
ITS-PCR identified 24 animals infected with T. vivax species, of which 10 were confirmed with the T. 
vivax specific reaction. From Uganda, ITS-PCR identified 17 animals infected with T. vivax, of which 
eight were confirmed with the species-specific reaction. In Zambia, ITS-PCR identified seven wildlife 
samples infected with T. vivax, of which two were confirmed with TV-PCR. For sequencing, from the 
cattle samples collected in Uganda, eight samples identified with ITS-PCR were successfully cloned 
and sequenced of which one was confirmed with both ITS-PCR and TV-PCR. From the Zambia 
samples, four animals identified with ITS-PCR were successfully cloned and sequenced of which one 
was confirmed with TV-PCR. The BLAST search results of T. vivax sequences are summarised in 
Table 5.8. 
Table 5.8: BLAST search results of T. vivax sequences 
Sample ID Origin of the 
sample 





to reference*  
Tv1 Cattle-Uganda 568 bp 
 
100% 612 bp 87% 
Tv2 Cattle-Uganda 570 bp 
 
99% 612 bp 84% 
Tv3 Cattle-Uganda 574 bp 
 
98% 612 bp 86% 
Tv4 Cattle-Uganda 573 bp 
 
95% 612 bp 87% 
Tv5 Cattle-Uganda 528 bp 
 
100% 612 bp 86% 
Tv6 Cattle-Uganda 554 bp 
 
100% 612 bp 86% 
Tv7 Cattle-Uganda 
 
572 bp 100% 612 bp 85% 
Tv8** Cattle-Uganda 
 
596 bp 100% 612 bp 94% 
Tv9 Wildlife-Zambia 550 bp 100% 612 bp 86% 
 
Tv10 Wildlife-Zambia 567 bp 96% 612 bp 85% 
 
Tv11 Wildlife-Zambia 578 bp 95% 612 bp 83% 
 
Tv12** Wildlife-Zambia 587 bp 100% 612 bp 93% 
 
*All the sequences were closely matched to T. vivax 18S, 5.8S, 28S and rRNA complete sequence (U22316.1) **Sample 
was confirmed with TV-PCR 
The results in Table 5.8 show that the sequenced amplicons from Uganda and Zambia are 83-87% 
similarity with T. vivax 18S, 5.8S, 28S and rRNA complete sequence (U22316.1), except the two 
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samples confirmed with TV-PCR were 93% and 94% similar to the reference sequence. The 
sequenced amplicon sizes were shorter than the 620 bp T. vivax band obtained by Cox et al. (2005), 
but they cover 612 bp expected sequence in the reference sequence. 
5.4.3.4 T. theileri sequencing 
T. theileri was identified in 46 animals sampled in Uganda; seven were successfully cloned and 
sequenced to validate the specificity of ITS-PCR reaction in the diagnosis of different trypanosome 
species. BLAST searches were used to compare the T. theileri sequences obtained to reference 
sequences in the NCBI database. The closest matches for each sequence are summarised in Table 5.9.  
Table 5.9: BLAST search results of T. theileri sequences 
Sample ID Sequence length Query coverage Length of covered 
reference sequence 
Percent identity to 
reference*  
Tt1 964 bp 100% 991 bp 94% 
Tt2 963 bp 100% 991 bp 95% 
Tt3 949 bp 100% 991 bp 92% 
Tt4 957 bp 100% 991 bp 89% 
Tt5 952 bp 100% 991 bp 91% 
Tt6 951 bp 100% 991 bp 91% 
Tt7 934 bp 100% 991 bp 92% 
*All samples are closely matched to T. theileri gene for 18S rRNA, 5.8S rRNA, 28S rRNA, partial and complete sequence 
(AB007814.1) 
The results in Table 5.9 show that all the sequenced amplicons from Uganda are 89-95% similarity to 
the T. theileri gene for 18S rRNA, 5.8S rRNA, 28S rRNA, partial and complete sequence 
(AB007814.1). The amplicon sizes were shorter than the 998 bp T. theileri band obtained by Cox et 
al. (2005), but the sequence covers 991 bp of the reference sequence on NCBI database. 
5.5 Discussion 
The aim of this work was to evaluate the pan-trypanosome ITS-PCR for the diagnosis of different 
trypanosome species compared to the species-specific PCR reactions. A total of 969 blood samples 
collected from different animal species in Uganda and Zambia were subjected to ITS-PCR and 
species-specific PCR reactions for the identification of different trypanosomes. Four species were 
identified with ITS-PCR including the three major pathogenic species; T. brucei s.l., T. vivax and T. 
congolense; and the non-pathogenic T. theileri species.  
5.5.1 Comparing ITS-PCR with species-specific PCR reactions 
ITS-PCR identified 47 pathogenic parasitic events compared to 197 diagnosed by the species-specific 
reactions, the difference was statistically significant.  
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T. brucei s.l. species 
In the current study, ITS-PCR identified only two samples to have T. brucei s.l. infection; while the 
species-specific reaction diagnosed 77 parasitic events. The sensitivity of TBR-PCR was 100% 
compared to the gold standard that was defined as a positive result of ITS-PCR and/or TBR-PCR in 
amplifying T. brucei s.l. DNA. The low sensitivity of ITS-PCR in the diagnosis of T. brucei s.l. was 
reported by Auty (2009) who compared ITS-PCR and TBR-PCR for the diagnosis of T. brucei s.l. 
from blood samples collected from Tanzania on FTA®cards using DNA eluate. The sensitivity of ITS-
PCR compared to TBR-PCR was 7% and the author attributed this finding to the low parasitemia of T. 
brucei s.l. in wildlife and the lower copy number of ITS target (100-200) in detecting T. brucei s.l 
when compared to the target amplified with the species-specific primers (10,000 copies). 
This difference between the sensitivity of ITS-PCR and the species-specific PCR reactions might be 
related to the frequency of the target on the parasite genome. The copy number of ITS target in the 
genome is 100-200 compared to 10,000 and 5400 copies of satellite sequence specific for T. brucei s.l. 
and T. congolense Savannah, while T. vivax gene target was reported to be tandemly highly repeated. 
To investigate if the target copy number is a factor that determines the sensitivity of ITS-PCR in the 
diagnosis of trypanosomes; a PCR targeting the PLC single copy gene specific for T. brucei s.l. was 
compared to ITS-PCR. The results revealed that PLC-PCR was able to detect ~25 times more T. 
brucei s.l. infections than ITS-PCR.  This suggests that it is not simply an issue of copy number. 
In another study, ITS-PCR identified two T. brucei s.l. infected wildlife sampled in Zambia compared 
to 22 positive samples diagnosed by TBR-PCR (Anderson, 2009). In contrast, Njiru et al. (2005) 
reported that ITS-PCR using other primer sets were comparable to the species-specific reactions 
where ITS primers detected 84.9% of the samples positive using species-specific primers. The higher 
sensitivity of ITS primers compared with species-specific primers could be attributed to the sample 
processing method, because Njiru et al. (2005) used extracted DNA from blood samples with Qiagen 
extraction kits and 2 µl of the extract was used as a template in the PCR reaction. Also, Cox et al. 
(2005) evaluated ITS-PCR using the same primers used in the current study; they reported that ITS-
PCR identified 40 samples positive for T. brucei s.l. while TBR-PCR identified 37 samples. These 
samples were collected on FTA®cards from cattle in Uganda; however, the PCR was conducted on the 
discs directly. There is no explanation of the discrepancy between the results of Cox et al. (2005) and 
the current study regarding the sensitivity of ITS-PCR in the detection of T. brucei s.l. DNA. There is 
no reported data from Cox et al. (2005) study regarding the number of discs examined and the age of 
the samples that could have been a factor to explain such differences.     
T. congolense species 
It was difficult to differentiate between the three sub-species of T. congolense during the visualisation 
of the amplified targets using the UV transilluminator, even after prolonged separation time of the 
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bands by electrophoresis. This is attributed to that the band sizes of the amplified products of the three 
types are close to each other (1513 bp, 1422 bp and 1413 bp for T. congolense Forest, T. congolense 
Kilifi and T. congolense Savannah, respectively). For this reason, any product with a band size above 
1400 bp was classified as T. congolense species in the current study. The PCR reactions specific for T. 
congolense Forest and T. congolense Kilifi were negative for all the examined samples.  
A total of 79 animals were diagnosed infected using TCS-PCR, while only 21 were categorised as T. 
congolense species using ITS-PCR. The sensitivity of ITS-PCR and TCS-PCR compared to a gold 
standard which in this case defined as any positive PCR result with ITS-PCR and/or TCS-PCR for T. 
congolense species was 81.4% and 21.6%, respectively. Only three samples positive for T. congolense 
with ITS-PCR were confirmed with the species-specific PCR for T. congolense Savannah. The 
inability of TCS-PCR to confirm 18 samples diagnosed with ITS-PCR were surprising because it is 
assumed that TCS-PCR would identify more T. congolense Savannah species due to the higher copy 
number of the target in the trypanosome genome (5400 copies). The possibility of these samples to be 
related to T. congolense Forest or T. congolense Kilifi was excluded due to the negative TCF-PCR and 
TCK-PCR results. In order to clarify the identity of those species diagnosed as T. congolense by ITS-
PCR, cloning and sequencing was done and the results of the sequencing is discussed later in this 
chapter (section 5.5.3). 
Cox et al. (2005) compared ITS-PCR with species-specific reactions on cattle blood samples collected 
on FTA®cards from Uganda. ITS-PCR identified six samples as T. congolense while only one sample 
was diagnosed using specific reactions for T. congolense Savannah. These findings do not coincide 
with the current study and there is not enough information to discuss the possible reason for this 
discrepancy. 
 T. vivax species 
In the current study, universal primers targeting the gene encoding T. vivax specific antigen were used 
for the diagnosis of T. vivax species. The universal primer set diagnosed 41 T. vivax infections while 
ITS-PCR identified 24 positive samples. The sensitivity of the universal TV-PCR and ITS-PCR  were 
74.5% and 43.6%, respectively, compared to the gold standard that was defined as any positive PCR 
result with ITS-PCR and/or TV-PCR for T. vivax species. The higher sensitivity of TV-PCR could be 
related to the copy number of target which is reported to be tandomly in the trypanosome genome. 
Fourteen samples were identified as T. vivax with ITS-PCR but they were negative using the universal 
T. vivax primers. Therefore, another set of primers targeting a satellite DNA sequence were used and 
none of the samples were positive with these primers. This was not unexpected because the primers 
targeting the satellite sequence are not present in some T. vivax isolates (Masake et al., 1997). Cox et 
al. (2005) identified nine T. vivax infections in cattle blood samples using the primer set amplifying 
the satellite sequence, while ITS-PCR identified six T. vivax infections.  
 145 
Fourteen samples were diagnosed positive for T. vivax by ITS-PCR while they were not confirmed 
with TV-PCR; therefore cloning and sequencing of PCR products was done to clarify the identity of 
these samples. The discussion of the sequencing results are detailed later in this chapter (section 
5.5.3).  
5.5.2 Sequence analysis 
The specificity of ITS-PCR was evaluated by cloning and sequencing a number of the amplified 
products of the second round representing the different trypanosome species. 
5.5.2.1 T. brucei s.l. sequencing 
T. brucei s.l. was only identified in two samples, one from a cow in Uganda and the other from an 
Impala in Zambia. The amplified products from these two samples and from T. b. brucei procyclic 
form (BUT 135) were cloned and sequenced; the sequences were compared to the reference sequences 
in the NCBI database. The three amplicons were 98% identical to T. brucei NW2 18S rRNA gene 
(AF306776.1). According to information available in PubMED the reference strain was isolated in 
1992 from a human in Uganda and was classified as T. b. gambiense. Identity of the sequenced 
amplicons with other reference T. brucei s.l. ranged from 95-97%. The other reference sequences 
available included T. b. gambiense isolated from a human in Cote d’Ivoir and Sudan, also T. b. brucei 
isolated from a pig in Nigeria, a fly in Cote d’Ivoir and a lion in Tanzania. Moreover, the sequences in 
the current study were 96-98% identical to different T. evansi isolates from different host species 
(cattle, buffalo and deer) isolated from Thailand and Taiwan. This indicates low variation in T. brucei 
s.l. and T. evansi species in different areas and hosts. This conclusion was supported by Cortez et al. 
(2006) who reported more conserved ITS sequences within T. b. brucei isolates, although 2.8% and 
1.2% polymorphism in ITS1 and ITS2 sequences, respectively, exists. Also, these results indicate that 
ITS-PCR is specific for Trpanozoon species despite the lower sensitivity of this reaction in amplifying 
Trypanozoon DNA. The similarity between T. brucei s.l. and T. evansi reference sequences was 
98.9%.  
Similar results were obtained by Auty (2009) who sequenced T. brucei s.l. products identified in 
hyaena and zebra from Tanzania; the sequences were >97% identity with the reference sequences. The 
band sizes obtained in the current study were 1210 bp, 1216 bp, 1219 bp in the cattle, Impala and 
BUT 135 isolates, respectively. The obtained amplicon sizes are within the expected band size from 
NCBI database (1207~1224 bp), while they were longer than the band size of 1215 bp obtained by 
Cox et al. (2005). Auty (2009) obtained 1220 bp and 1207 bp from the hyaena and zebra isolates, 
respectively. These variations could be a result from sequencing or cloning errors which might result 
in adding or missing of some bases. 
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5.5.2.2 T. congolense sequencing 
ITS-PCR identified 13 cattle samples collected in Uganda and eight samples collected from Zambia to 
have T. congolense infections; it was difficult to differentiate between the three T. congolense types 
by visualisation of the bands after gel electrophoresis. Therefore, bands of sizes more than 1400 bp 
were classified as T. congolense species. The species-specific PCR for the three T. congolense types 
were unable to identify any of the T. congolense species diagnosed from cattle by ITS-PCR, while 
three isolates from Zambia were confirmed with TCS-PCR. To clarify the identity of these isolates, 
six amplified products from cattle samples and three from Zambia collected samples were 
successfully cloned and sequenced. Moreover, the amplicon obtained from the ITS-PCR of Sikudo 
124 isolate procyclic form was also cloned and sequenced.  
The BLAST search of the T. congolense isolates from cattle in Uganda resulted in 92-94% identity 
with T. congolense Forest (IL3900, U22319.1) that was isolated from a dog in Burkina Faso, and 77-
87% identity with T. congolense Savannah (IL1180, U22315.1) that was isolated from Tanzania. The 
similarity of T. congolense Forest reference sequence (IL3900, U22319.1) and T. congolense 
Savannah reference sequence (IL1180, U22315.1) is 73.5% and the alignment of the two sequences is 
illustrated in Figure 5.3. 
T.c.forest.ref        GGAAGCAAAAGTCGTAACAAGGTAGCTGTAGGTGAACCTGCAGCTGGCTCATTTTCCGAT 60 
T.c.savannah.ref      GGAAGCAAAAGTCGTAACAAGGTAGCTGTAGGTGAACCTGCAGCTGGCTCATTTTCCGAT 60 
                      ************************************************************ 
 
T.c.forest.ref        GATAAAAAA-GTATACATACATATGTGTAC-GTGTA-GTGTAGGTGTGTGCTATCGAAGG 
117 
T.c.savannah.ref      GATAATATATATATACATATGCGTGTATATTATACGCATGTGGGTGTTTGTTGTGAGAGG 
120 
                      ***** * *  ********    *** **   *     *** ***** ** * *   *** 
 
T.c.forest.ref        TTGTTGTTGT---GTGCTTGTGTGC---------CCCTCGCTCATGCG---CATCCCCAT 
162 
T.c.savannah.ref      TTGTTGTTGTTGTGTGCTCGTGTGCGTACGGTGCCCCTCGTTCGTGCGAATTATTCCCAT 
180 
                      **********   ***** ******         ****** ** ****    ** ***** 
 
T.c.forest.ref        CC-CGCACGCCCCAGTGTTTTGTGTGCTGTGCGATGCGGTGTGTGTTGGGTCGCGCATTG 
221 
T.c.savannah.ref      CCGCATCCGCCCCGGTGTGGTGTGCGGTGTGTGTTGGGG--------GAGCCGCACGTGG 
232 
                      ** *   ****** ****  **** * **** * ** **        * * *** * * * 
 
T.c.forest.ref        TCGG-CGCTGT-GATGTGCCGGCCACGAACCTTGAAAACCTTGAAGCACGTCTCGCGAAA 
279 
T.c.savannah.ref      TGGGGTGCTGCCGTTGTACCGGCCGC---------AATCTCTAAAACGCGCCTCGGAGCA 
283 
                      * **  ****  * *** ****** *         ** *  * ** * ** ****    * 
 
T.c.forest.ref        CACACGTGTCCAAGCACGCGTCTCC-ATGTCGCTGTCTCTCTCTTGTGTTGCGAAGATGC 
338 
T.c.savannah.ref      CGCACGTGTCCAAACACGCGTCCCCCATGTCGCTCTCTTTCTCTTGTGTTGCGAGGGTGC 
343 
                      * *********** ******** ** ******** *** *************** * *** 
 
T.c.forest.ref        TTACTGTCGTGTTTGCTCCGCCAGGCGGCGCGGCCGTGACGTATGTGTCCGCAAAGACAA 
398 
T.c.savannah.ref      TTACGGTTGTGTGCGCGCC--------------CCGCAAGG---------GCAAGGAAGA 
380 
                      **** ** ****  ** **              ***  * *         **** **  * 
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T.c.forest.ref        AAGAAG-GGTGTGGAGGAGACGGCGTGTTCTTATGCCGCCTGACGCTTTTTGTGTGCGCA 
457 
T.c.savannah.ref      AGGAGGTGGTGTGGAGGAGACGACGTGTTCTTATGCCGCCCGACGCTTATTGTGTGCGCA 
440 
                      * ** * *************** ***************** ******* *********** 
 
T.c.forest.ref        CCGGCTCGGCTCACTTTTTCCTCCCTCTCCTCTTTTCCTCCTCTTCTTTTCCCCGCCTTC 
517 
T.c.savannah.ref      CTGGCTCGCTT---TTCTCCCTCTTCTTCTCCTCCTCGTCCTCATCTTTTCCAAGCCTTC 
497 
                      * ******  *   ** * ****    **  **  ** ***** ********  ****** 
 
T.c.forest.ref        CCACGTGTGTTGGGAGAGGACAGAGGGCAAGAAGGCGTGGTGTATTTGGAGGAAT---GT 
574 
T.c.savannah.ref      CCACGTGTGTTGGGAGAGT-----GGAAGAGGAAGTGTG-TGTGTTTGGAGGAAGAAGGT 
551 
                      ******************      **   ** * * *** *** **********    ** 
 
T.c.forest.ref        GCGGGGTGAAA----TGGTGAAAGCGTGCGTGCGTGCGCAGGCGT--TGGTCACGGCTCT 
628 
T.c.savannah.ref      GCAGTGGGAGAAATATGGTGAGTGCTTGTGTGTGTACGCAGGTGTGTTGGTCACGGCTCT 
611 
                      ** * * ** *    ******  ** ** *** ** ****** **  ************* 
 
T.c.forest.ref        CACAACGTGTCGCGATGGATGACTTGGCTTCCTATTTCGTTGAAGAACGCAGCAAAGTGC 
688 
T.c.savannah.ref      CACAACGTGTCGCGATGGATGACTTGGCTTCCTATTTCGTTGAAGAACGCAGCAAAGTGC 
671 
                      ************************************************************ 
 
T.c.forest.ref        GATAAGTGGTATCAATTGCAGAATCATCACATTGCCCAATCTTTGAGCGCAAACGGCGCA 
748 
T.c.savannah.ref      GATAAGTGGTATCAATTGCAGAATCATCACATTGCCCAATCTTTGAACGCAAACGGCGCA 
731 
                      ********************************************** ************* 
 
T.c.forest.ref        TGGGAGAAGCTCTTCCGAGCCATCCCCGTGCATGCCACATTCTCAGTGTCGACCAACATA 
808 
T.c.savannah.ref      TGGGAGAAGCTCTTCCGAGTCATCCCCGTGCATGCCACATTCTCAGTGTCGACCAACAAA 
791 
                      ******************* ************************************** * 
 
T.c.forest.ref        AGAACAACAACAGTGCCCTCTTCCCTCTGTTTCTCTCTCTGGTGATGGGCAGGGTGTGGG 
868 
T.c.savannah.ref      AAAACAACAGCAG--CCCTCTTCT---TCTCCCTGTCTCTGATGACGAGCATGGTGTGTG 
846 
                      * ******* ***  ********    * *  ** ****** *** * *** ****** * 
 
T.c.forest.ref        GTGTGTGCTGTGTATATGTTGTTGTCGTGGCGTGTGTGAAAGTGGTGTGGTGGGGCGACG 
928 
T.c.savannah.ref      GTATGTG-TGTGC-TGTAT-GTTCTCGTGACGTGCTTGAAAATGGGGCGG---------G 
894 
                      ** **** ****  * * * *** ***** ****  ***** *** * **         * 
 
T.c.forest.ref        CGCATGTGCGCATCGTTGTTACGTACGTACATTTACGCACACACACGTGTGCTGCGTGTG 
988 
T.c.savannah.ref      CGCGTGTATGTACCGTCGTC---------------------------------------- 
914 
                      *** ***  * * *** **                                          
 
T.c.forest.ref        TATGTGTTTGTTGTCCCCATTATTATTTTTCATGCCGTCAGGAAGGAGAGAGTCCGGTGT 
1048 
T.c.savannah.ref      --------------CCCTATTAATATT--TCATGCCGTCAGGAGGGAGAGAGTCCGGTGT 
958 
                                    *** **** ****  ************** **************** 
 
T.c.forest.ref        GTGCATAGTGGTGTTGTTGCG-TGCGTGTGAAGGGTTGTGTTTGTGTTCTATATGAGTGT 
1107 
T.c.savannah.ref      GTGTATTGTGGTGTTGTTACGACGTGTGAGAAGGGTTGTATGTGGTATGTGTGTGGAGGT 
1018 
                      *** ** *********** **  * *** ********** * **   * * * **   ** 
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T.c.forest.ref        GTGGCATGTGTGA-GTGGTGTCTGTGCAAGAAGGTGTGGTGTCCTTGTGGGCGTGCTTTT 
1166 
T.c.savannah.ref      GTGGAGTCTGTGGCACGGGGGCTGTG--------TGTGGTGTCTTTGTGGGCG-GCGTGC 
1069 
                      ****  * ****    ** * *****        ********* ********* ** *   
 
T.c.forest.ref        GCATGTTGTTTGTTCCCGCTTGAGAC--GGCCCCGCTTTTCTCCCCTCACTTTCTCTCCC 
1224 
T.c.savannah.ref      TCTTGC-ATTTGTTCCC-CTTGAGACACGACCCCTCTCTCGTCTCCTT-CTTTCCCTCTC 
1126 
                       * **   ********* ********  * **** ** *  ** ***  ***** *** * 
 
T.c.forest.ref        CGTGCTGCCATCACTACACTTCCTTTCGGCCATA--GCAGTAGAAC---ACCCTTGCCTC 
1279 
T.c.savannah.ref      CGCGTCATCATCGC--CGCTTCCTTTCACCCGTGTCGCAGTAGAACGCCACCTTTACCTC 
1184 
                      ** *    **** *  * *********  ** *   **********   *** ** **** 
 
T.c.forest.ref        CCCCGGTGTGTTTACCTCGAAGCCATTTGAGCTAAAGAGACAAAGTGGGGA-ATGATCTT 
1338 
T.c.savannah.ref      CTCCGGTGT--TTACCTCGAAGCTATTTGAGCTAAAGAGACAAAGTGGGGATGTTGCTTG 
1242 
                      * *******  ************ ***************************  *    *  
 
T.c.forest.ref        GGAGAGAGGCTCTTGTCTTCTCTCACCTCCACATAACTGTTGTGCTTTGTGCATCCCGT- 
1397 
T.c.savannah.ref      GGAGGGAGGCTTTCTTCCTTCCTCAGCAGTCCTCACCC----CGCATTGCGGGACGGGTG 
1298 
                      **** ****** *  ** *  **** *    *  * *      ** *** *   *  **  
 
T.c.forest.ref        CACGCGATGTACGCACGCTAACCAAAGTTCATATGTATGTACATGTTGACAGACCTGAGT 
1457 
T.c.savannah.ref      TGTGCG-TGAGCGCACATCTGCAAGAATTTATATATGTATACATGTTGACAGACCTGAGT 
1357 
                         *** **  *****     * * * ** **** * * ********************* 
 
T.c.forest.ref        GTGGCAGGACCACCCGCTAAACTTAAGCATATTACTCAGCGGAGGAAAAGAAAACAA 1514 
T.c.savannah.ref      GTGGCAGGACCACCCGCTAAACTTAAGCATATTACTCAGCGGAGGAAAAGAAAACAA 1414 
                      *********************************************************  
 
Figure 5.3: Alignment of T. congolense Forest (IL3900, U22319.1) and T. congolense Savannah 
(IL1180, U22315.1) reference sequences (forward and reverse primers are red in color, *shows 
the similarity between the two sequences) 
The samples that were not confirmed with TCS-PCR or TCF-PCR were 91-94% similarity to T. 
congolense Forest, while showing 77-91% similarity to T. congolense Savannah. This resulted in 
inability to accurately classify these samples especially with 73.5% similarity of T. congolense Forest 
and T. congolense Savannah reference sequences. Therefore, these samples were classified as T. 
congolense species. 
Looking at sequence of the sample that was confirmed with TCS-PCR and the T. congolense 
Savannah isolate (Sikudo), both were 95% similar to T. congolense Savannah IL1180, while 78% and 
93% identical to T. congolense Forest IL3900, respectively. Despite these samples were identified as 
T. congolense Savannah but the close similarity to T. congolense Forest made it difficult to classify to 
the sub-species level using ITS-PCR. Auty (2009) diagnosed T. congolense species from wildlife in 
Tanzania and by sequencing; the sample was 92% similar to T. congolense Savannah isolate (IL1180).    
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The difficulty to differentiate T. congolense Savannah and T. congolense Forest using the ITS target 
was reported using different primer sets targeting the ITS region. Kin primers designed by 
Desquences (1997) showed only 30 bp difference between the two sub-species, while only 3 bp 
differences was reported using the primers designed by Geysen et al. (2003). Also, ITS-CF and ITS-
BR primers do not differentiate between T. congolense Savannah and T. congolense Forest with 700 
bp product, each (Njiru et al., 2005). Moreover, ITS1 primers designed by Adams et al. (2006) do not 
differentiate between the two sub-species with 640 bp amplicon, for each.  
The inability of the species-specific PCR reactions to identify the T. congolense species diagnosed 
with ITS-PCR could be explained by the existence of a new T. congolense sub-species which is 
similar to T. congolense Savannah and T. congolense Forest in ITS target, while there is no specific 
reaction to identify such isolate. Moreover, variation within T. congolense Savannah isolates was 
confirmed by Cortez et al. (2006) who reported a high polymorphism of ITS sequences (9.7% for 
ITS1 and 8.6% for ITS2) within T. congolense Savannah. Moreover, isoenzyme analysis by 
Gashumba et al. (1998) showed that T. congolense from Uganda was separated from other T. 
congolense isolates suggesting that further analysis of T. congolense isolates may be required. 
In conclusion, it was decided to classify any of the isolates with band size more than 1400 bp as T. 
congolense species regardless to the sub-species classification. In the other chapters in the current 
study it was decided to use TCS-PCR for the diagnosis of T. congolense Savannah because the 
sensitivity of this reaction was 81.4%, while ITS-PCR sensitivity was 21.6% in identifying T. 
congolense species. 
5.5.2.3 T. vivax sequencing 
Eight isolates identified with ITS-PCR as T. vivax sampled from cattle in Uganda of which only one 
was confirmed with TV-PCR and four isolates from wildlife in Zambia diagnosed as T. vivax with 
ITS-PCR of which one was confirmed with TV-PCR were successfully cloned and sequenced to 
clarify the identity of the samples. All the sequenced samples identified only with ITS-PCR showed 
83-87% identity with T. vivax ILDat1.2 (U22316.1) reference sequence with 100% coverage of the 
sequence starting and ending from the designed primers, the origin of such isolate is Nigeria (West 
Africa). Also, the sequences showed 87% identity with different T. vivax isolates from Brazil but with 
only 69% sequence coverage. Moreover, the sequences in the current study were 88% similar to an 
isolate from a cow in Kenya (IL3905) with 56% coverage of the sequence due to the availability of 
only partial sequence of the ITS1 region on the NCBI database.The two isolates that were confirmed 
with TV-PCR showed 93% and 94% similarity to the reference sequence of the isolate from Nigeria 
while 88% similarity to the East African isolate from Kenya.  The existence of similarity between the 
isolates in the current study and the African isolates (East and West African isolates) was expected, 
this was supported by Gardiners (1989) who reported that T. vivax  from Central Africa (Uganda and 
Congo) shared molecular features with both the East and West African isolates.  
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Phylogenetic analysis indicated that T. vivax from West Africa and South America are very similar, 
while the isolates from East Africa are more diverse (Cortez et al., 2006). This variation in T. vivax 
sequence is expected due to the reported genetic variants of T. vivax that exists in East Africa that 
could be attributed to multiple route of transmission because T. vivax could be transmitted cyclically 
and mechanically by biting insects, compared to consistent sequences in West Africa and South 
America where only mechanical transmission occurs (Rodrigues et al., 2008). These findings were 
supported by Njiru et al. (2005) who reported the existence of genetic variants for T. vivax in Kenya, 
also Masake et al. (1997) and Malele et al. (2003) reported T. vivax genetic variants in the field. 
Evidence of size variation in ITS sequences within species were reported, for example, the length of 
ITS1, 5.8S and ITS2 regions in T. vivax from South America and West Africa was 490 bp, while T. 
vivax from East Africa were longer varying between 525 bp and 534 bp and also varied between gene 
copies of the same isolate (Cortez et al., 2006). The inability of the T. vivax specific primers in the 
current study to confirm some of the isolates identified with ITS-PCR could be attributed to the 
existence of genetic variants of T. vivax.   
Similar results were obtained by Auty (2009) who showed 81% similarity of T. vivax isolated from a 
giraffe in Tanzania with the reference T. vivax sequence ILDat1.2 (U22316.1), while 97% and 89% 
similarity of another two isolates from Buffalo and waterbuck, respectively, to IL3905 isolate from 
Kenya. The authors referred to the isolates as T. vivax-like because they shared only 80-90% identity 
with any T. vivax reference sequence.  
Gonzales et al. (2006) reported that the sensitivity of the ITS primers in the diagnosis of T. vivax was 
the lowest despite using different sample preparations compared to species-specific primers. They 
attributed the lower sensitivity of these primers to the partial homology of the ITS1 sequences and 
their limited repetitiveness.   
5.5.2.4 T. theileri sequencing 
A total of 46 cattle were diagnosed to have T. theileri infections, while none of the samples collected 
in Zambia were identified as T. theileri. Seven amplified products were successfully cloned and 
sequenced to validate the specificity of ITS-PCR. The obtained amplicons showed 89-95% similarity 
to the available T. theileri sequence on NCBI website that is isolated from Brazil. The geographic 
difference would explain the divergence between the current isolates and those located in NCBI 
database where there is no available sequences representing the African isolates. The existence of 
divergence between the South American and African isolates could be supported by the inability of 
the species-specific PCR for T. theileri to amplify any of the samples identified with ITS-PCR. 
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5.5.3 Conclusion 
In conclusion, the development of treatment and control strategies to protect livestock and humans 
from trypanosomiasis requires accurate data regarding the disease which in turn depends on accurate 
diagnosis and definitive identification of the causative species (Thumbi et al., 2008). Parasitological 
and serological methods are not reliable due to low sensitivity and specificity, respectively, while 
accurate detection of trypanosomes in both the host and vector heavily depends on PCR. The 
performance of PCR depends on the sample preparation, DNA extraction method and the primers 
used (Gonzales et al., 2006). 
ITS primers are used for the identification of different trypanosomes using a nested reaction, however, 
questions regarding the sensitivity and specificity of the primer set rose during this study. Despite 
being specific to Trypanozoon, ITS primers showed low sensitivity compared to the species-specific 
reaction. This was firstly thought to be attributed to the higher copy number of the specific PCR target 
but this was not the case. ITS-PCR is unable to differentiate between T. congolense sub-species and 
also showed low sensitivity compared to the specific reaction for T. congolense Savannah. However, 
ITS-PCR sensitivity in the diagnosis of T. vivax was found 43.6% compared to 74.5% sensitivity of 
TV-PCR. The issue of ITS-PCR lower sensitivity especially with T. brucei s.l. required the use of the 
specific primers in the current study. The study conducted by Auty (2009) also recommended the use 
of specific-species primers instead of the ITS primers designed by Cox et al. (2005) when studying 
trypanosomes prevalence in wildlife. This was due to the low sensitivity of ITS primers in amplifying 
T. brucei s.l. and the inability to differentiate T. congolense and Trypanozoon sub-species.  
For studying prevalence data, species-specific primers are more suitable in terms of sensitivity, while 
for studying diversity of trypanosome species ITS primers could be used and accompanied by 
sequencing of the obtained products for interpretation of the obtained results (Auty, 2009). However, 
other primers targeting ITS region could be designed to increase the sensitivity of the reaction and to 
differentiate between different T. congolense sub-species because the requirement of a pan-
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Tsetse transmitted trypanosomes affect nearly nine million km2 of sub-Saharan Africa, precluding the 
keeping of livestock in areas of high challenge; leading to disruption in the development of 
sustainable mixed farming over large and potentially productive areas (Hursey, 2001). 
Trypanosomiasis, a disease that tsetse flies transmit has been endemic in south-eastern and north-
western Uganda for two decades (Wendo, 2002) where it is known to be a severe constraint to human 
and animal health. Moreover, it has a great impact on the productivity of animals kept in endemic 
areas, where the disease sometimes rises to epidemic levels (Waiswa and Katunguka-Rwakishaya, 
2004).  
In Uganda, it is estimated that Glossina species infest 106,400 km2 (50% of the entire landmass) 
leading to exposure of more than 40% of cattle to trypanosome infection risk (Magona et al., 2004).  
According to a survey carried out in late 2001, 8% of the cattle in south-eastern Uganda have the 
microscopic blood-borne parasites but many of them do not show symptoms (Wendo, 2002). 
Proper diagnosis of the disease using molecular tools is important for the intervention decisions and to 
follow up the campaign for rational evaluation of the success or failure of such programme. The 
results in chapters IV and V concluded that for the diagnosis of trypanosome species, genomic 
material of an appropriate quality and concentration are required. Elution of trypanosome DNA from 
FTA®cards, containing blood samples examined directly after collection, (10 discs) using Chelex®100 
obtained genomic material of sufficient quality and quantity overcoming the uneven distribution of the 
genomic material on the card matrix. Specific targets are required for accurate diagnosis of 
trypanosomes; the study recommended that using species-specific PCR reactions would give an 
acceptable level of accuracy about the disease prevalence due to higher sensitivity of the specific 
reactions compared to ITS-PCR. 
The spread of T. b. rhodesiense into previously unaffected districts in Uganda, including Kabermaido, 
Lira and Dokolo, Uganda, was reported in August 2004 (Wissmann et al., June, 2007). The main 
cause for such spread was suspected to be the movement of cattle from established animals 
trypanosomiasis and Human African Trypanosomiasis (HAT) endemic areas northwards into the 
newly affected districts (Fevre et al., 2001; Kabasa, 2007). The newly introduced animals bring with 
them  the human infective T. b. rhodesiense as well as the trypanosome species causing animal 
Nagana, to areas previously free of human and animal infective parasites (Kabasa, 2007).  
The World Health Organization (WHO) recommended the block treatment of cattle using trypanocidal 
drugs at a meeting conveyed in 2005. In response, the Stamp Out Sleeping sickness campaign (SOS) 
was initiated in late 2006 in central Uganda by the University of Edinburgh and Makerere University, 
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Uganda, in partnership with CEVA Santé Animale (a French based pharmaceutical veterinary 
laboratory) creating a public private partnership. The campaign was funded by Industri Kapital which 
is a European private equity firm (Kabasa, 2007). 
6.2 Objectives 
The aim of the current chapter is to evaluate and follow up the impact of a treatment programme 
conducted in central Uganda on trypanosome species using DNA eluted from 10 whole blood discs to 
amplify the species-specific targets with PCR reactions.  
6.3 Material and methods 
6.3.1 Stamp Out Sleeping sickness campaign 
The aim of phase I of SOS campaign was the mass treatment of the cattle population in the newly 
epidemic areas with trypanocidal drugs followed by prophylaxis from re-infection through application 
of insecticides by the spraying of cattle (hence using them as live-bait). The treatment of the animal 
reservoirs is more beneficial in terms of prevention of new cases of sleeping sickness arising, as it is 
estimated that cattle-tsetse-human transmission cycle for T. b. rhodesiense is five times more likely to 
occur than human-tsetse-human cycle (Hide, 1999; Hide et al., 1996; WHO, 2006).   
The impact of the mass treatment programme on the cattle reservoir was monitored by repeated cross-
sectional sampling in 23 sentinel villages distributed across the project area. In each village, 80-100 
cattle were monitored at baseline (immediately before mass-treatment in November, 2006), 3 months 
(January, 2007) and 9 months (July, 2007) post-implementation of the mass treatment with blood 
samples being analysed by PCR.  
In July, 2006, a survey was carried out in the study area to obtain an estimation of the prevalence of T. 
brucei s.l. to decide the type of trypanocide to be used in each area. There were insufficient stocks of 
one trypanocide to treat the whole area, therefore, in areas of high transmission, isometamedium 
chloride (ISM, Veridium) was used due to prophylactic period of two to three months provided by 
ISM to decrease re-infection rate. Diminazine-aceturate (DI) was used in areas with low prevalence. 
The trypanocidal drug used to treat cattle from Kabermaido and Dokolo was ISM with a dose 1 mg/kg 
body weight. While DI was used in a dose 7 mg/kg, it has a curative effect without any prophylactic 
effects. All cattle were sprayed with deltamethrin insecticide (Vectocid) using the restricted 
application technique to the tsetse feeding sites (legs and belly) to control the vector aiming to reduce 
the re-infection (Kabasa, 2007). The restricted application of insecticides to the belly and legs with 
two weeks intervals was found to be more cost-effective rather than treating the whole body of the 
animal at monthly intervals. This would cut the cost of insecticides by 40% and improve efficacy by 
27% (Torr et al., 2007). 
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6.3.2 Study area 
The project was conducted in five districts in Uganda, these were, Kabermaido, Dokolo, Lira, 
Amolatar and Apac. In the current work, three districts (Kabermaido, Dokolo and Lira) were chosen 
because they are new foci for sleeping sickness and due to time constraints in analysing the samples 
collected from the five districts. Four villages were randomly selected from each district at three time 
points (baseline, three months and nine months) for analysis during this study. Figure 6.1 shows the 
districts included in the project, Figure 6.2 shows the distribution of the 23 sentinel villages included 
in the project and the 12 villages selected for the current work. 
6.3.2.1 Kabermaido district 
Until 2000, Kabermaido district was part of Soroti district. It borders Soroti in the east, Lira in the 
west, Kamuli in the south and Katakwi in the north-east. The district lies in 1,627.9 km2 at an 
approximate altitude of 1036 m-1127 m above sea level, with rainfall 1000-1500 mm per annum with 
high temperatures. 
6.3.2.2 Lira district 
This district lies in northern Uganda and borders Apac in the west, Kabermaido in the south-east, 
Katakwi in the east and Pader in the north. It lies in 7200.7 km2 at an approximate altitude of 975 m-
1146 m above sea level. The rainfall ranges between 1000-1500 mm with high temperatures.  
6.3.2.3 Dokolo district 
Until July, 2006, Dokolo district was one of the counties of Lira district. It borders Lira in the north, 
Kabermaido in the east and southeast, Amolatar in the south and Apac in the west. The rain fall ranges 




Figure 6.1: SOS project districts, central Uganda 
 
 
Figure 6.2: SOS project districts and the 23 sentinel villages with the selected 12 villages 
highlighted in red 
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6.3.3 Sampling 
For sampling cattle, farmers were asked to present their animals to a central point of treatment. During 
both post-intervention samplings in the studied villages, farmers were asked whether the animal had 
been previously included in the SOS mass treatment programme. This information allowed for 
estimating the coverage of the mass treatment. The samples were collected by SOS team from 
Edinburgh University and Makarare University, Uganda. Table 6.1 shows the number of samples 
collected at each sampling site over the duration of the study. 
Table 6.1: Number of samples at each sampling site selected in the current study over the three 
sampling times 
Sampling sites 
District Sub county Parish Village 
Baseline Three months 
follow up 
Nine  months 
follow up 
Kabermaido Kobulubulu Okille Omer 80 92 100 
Kabermaido Bululu Ochelakur Olep 80 92 76 
Kabermaido Anyara Omid Mwatma 80 100 46 
Kabermaido Otuboi Lwala Olemai 80 62 92 
Dokolo Kangai Abwila Okwar 80 82 100 
Dokolo Dokolo Amwoma Amwoma 100 59 100 
Dokolo Dokolo Angweciba Awinyi ipany 100 76 100 
Dokolo Batta Abienek  Abienek 80 80 100 
Lira Amach Adyaka Abuong B 100 100 100 
Lira Abako Owallo Amuko aola 100 51 53 
Lira Aloi Alal Ogengo 80 71 59 
Lira Amugu Ajonyi Onyakede 80 49 100 
Total      12 1040 914 1026 
 
6.3.4 Geographical data 
The locations of the villages were recorded using a hand-held Global Positioning System (GPS, 
Garmin, Olathe, KS, USA) at the site of sampling. The locations were entered into EXCEL spread 
sheet and saved as a DBF4 file. Geographical data of the districts and other shape files were obtained 
from Land and Surveys Department, Ministry of Land Housing and Urban Development of Uganda.  
GPS data were collected in latitude/longitude format and were converted to the Biomass projection for 
processing of maps (Uganda Forest Department 1996). The parameters of the Biomass projection are 
(Map projection: Transverse Mercator, Spheroid: 1880, Central meridian: 33, Reference latitude: 0, 
Scale factor: 0.9996 and False easting: 500,000). Maps were produced using ArcView 3x Geographic 
Information System (ESRI Systems, Redlands, CA, USA). 
6.3.5 Recording data   
Data including the village name, age/sex/breed and body condition of the animal were recorded. Body 
condition scoring is a measure of the extent to which fat is stored or the muscle mass has declined. 
This can be measured by observing and examining the depth of the sub-lumbar fossa to assess the 
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extent of emaciation (Nicholson and Butterworth, 1986). During sampling, Zebu and Ankole cattle 
were scored for the body condition as follows: Fat (F), Medium (M) or Lean (L). The age of the 
animal was estimated based on teeth eruption; there are three categories as described in Table 6.2.  
Table 6.2: Estimation of the animal age based on teeth eruption 
Age category Teeth eruption Age  
A (young) Milk teeth erupted Less than 18 months 
B One pair of permanent teeth 1.5- 3 years 
C (adults) More than one pair of permanent teeth Over three years 
 
6.3.6 Sample processing 
Samples applied onto FTA®cards were processed by eluting DNA from 10 discs using Chelex®100 as 
previously described in Chapter IV (section, 4.5.2.1.2).  
6.3.7 PCR 
PCR reactions were used to amplify trypanosome DNA from 5 µl of DNA eluted from 10 discs using 
Chelex®100. The PCR reactions used were TBR-PCR for T. brucei s.l., TCS-PCR for T. congolense 
Savannah, TV-PCR for T. vivax and SRA-PCR for T. b. rhodesiense. The primer sets and reaction 
conditions were detailed in Chapter V (section, 5.2.3).  
The primers specific for serum resistant associated gene (SRA) were used in a multiplex reaction with 
the PLC primers for the differentiation of T. b. rhodesiense. The sequence of the SRA primers are: 
651: 5’- GAA GAG CCC GTC AAG AAG GTT TG-3’ and 652: 5’- TTT TGA GCC TTC CAC AAG 
CTT GGG-3’. The reaction conditions are the same as for PLC-PCR (Chapter V, section 5.3.3). The 
amplified product using the SRA primers is 669 bp in size. There are some virulent surface 
glycoproteins (VSG) genes with some sequence identity to the SRA gene, but the SRA gene contains 
an internal deletion when compared with VSG genes (Campillo and Carrington, 2003). The 
aforementioned primers were designed to amplify the SRA gene across the deleted region, ensuring a 
clear size distinction between the SRA amplicon and any VSG amplicon (Picozzi et al., 2008). Figure 




Figure 6.3: Example of multiplex reaction amplifying PLC and SRA genes in T. b. rhodesiense 
positive control (100 bp ladder, PLC amplicon is 324 bp, SRA amplicon is 669 bp and VSG 
amplicon is > 1 kb)  
6.3.8 Statistical analysis 
Trypanosome prevalence was calculated as the proportion of samples in which infection was detected 
by PCR at baseline, three months and nine months follow up, respectively. The 95% confidence 
interval was computed based on the exact binomial distribution and displayed as error bars in the 
respective graphs. The impact of the mass treatment campaign on different trypanosome species at the 
three sampling times across the study area and within districts was investigated using Odds ratios in R 
package and Chi-squared test (degree of freedom were noted as a subscript to the χ2 –statistic). The 
prevalence, 95% CI and χ2 test calculations were computed using Minitab version 15 (Minitab, Inc.). 
Differences were considered to be statistically significant at p<0.05. 
To investigate the impact of the treatment campaign within the villages, Fisher’s exact test was used 
and computed in R package. Differences were considered to be statistically significant at p<0.05. 
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6.4 Results 
6.4.1 Sample description 
A total of 2980 blood samples were collected from cattle in the three districts involved in the SOS 
mass-treatment programme at three time points over the whole study period. At baseline sampling, 
1040 blood samples were collected, while 914 and 1026 were collected during both the three months 
and nine months post-intervention sampling, respectively. For each sample, information regarding 
age, sex, breed and condition score of the examined animal was collected and recorded. Information 
regarding age, sex and breed of some animals were not recorded, so those animals were excluded from 
the study. Table 6.3 summarises the proportion of the sampled animals in each age, sex, breed and 
condition category.  
Table 6.3: Proportion of sampled animals at each age, sex, condition score and breed category at 
district level 
Age Sex Condition Breed District Sampling 
time 
Number 
sampled A B C M F L M F A Z Cross 
Baseline 320 7.5 29.1 63.1 47.5 52.2 4.7 86.9 8.4 20.0 65.0 15.0 
3 month 346 6.6 26.0 67.3 60.4 39.6 1.7 97.4 0.9 13.3 82.9 3.8 
9 month 314 7.0 16.9 75.8 58.0 42.0 3.5 95.9 0.6 17.2 76.8 5.4 
Kabermaido 
Total 980 7.0 24.1 68.7 55.4 44.5 3.3 93.5 3.3 16.7 75.1 8.0 
Baseline 360 12.5 27.2 60.3 55.0 45.0 5.6 92.8 1.7 3.9 89.2 6.4 
3 month 297 7.4 26.3 66.3 62.0 38.0 5.4 92.3 2.4 7.7 87.5 4.7 
9 month 400 12.5 15.8 71.5 53.8 46.0 0.8 99.3 0.0 5.0 92.0 3.0 
Dokolo 
Total 1057 11.1 22.6 66.2 56.5 43.4 3.7 95.1 1.2 5.4 89.8 4.6 
Baseline 360 12.8 20.3 66.9 59.4 40.6 0.3 99.7 0.0 0.0 98.6 1.4 
3 month 271 10.7 22.9 66.4 56.8 43.2 4.1 93.7 2.2 1.8 96.3 1.8 
9 month 312 6.4 15.4 78.2 67.0 33.0 1.9 97.8 0.3 2.9 97.1 0.0 
Lira 
Total 943 10.1 19.4 70.5 61.2 38.8 1.9 97.3 0.7 1.5 97.5 1.1 
Total   2980 9.4 22.1 68.4 57.6 42.3 3.0 95.3 1.7 7.9 87.4 4.6 
* Age categories: A; less than 18 months, B; 1.5-3 years, C; over 3 years- Sex category: M; male, F; female- Condition 
score: L; lean, M; medium, F; fat- Breed category: A; Ankole, Z; Zebu, Cross; Zebu x Ankole or Freisian 
In the three districts, over the three sampling times, the majority of animals were of age over three 
years with a proportion of 68.4%, while the other age categories, less than 18 months and 1.5-3 years, 
were at a proportion of 9.4% and 22.1%, respectively. Most of the cattle sampled in the three districts 
over the sampling time were male animals (57.6%) compared to female animals (42.3%). During the 
three sampling times in the three districts, 95.3% of the sampled animals were of medium category 
condition score, whereas, only 1.7% and 3% were of fat and lean categories, respectively. The 
predominant breed of the examined animals were Zebu breed with 87.4% proportion, while, Ankole 
breed proportion was only 7.9%. The remaining proportion (4.6%) was of cross breeds, either Zebu x 
Ankole or Zebu x Freisian.  
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6.4.2 Baseline results 
6.4.2.1 Overall prevalence of different trypanosome species at baseline 
in the sampled cattle 
A total of 1040 cattle were sampled and examined for trypanosomes using PCR at baseline collection. 
Overall, 26.6% were found to be infected with different trypanosome species including T. brucei s.l., 
T. vivax and T. congolense Savannah with overall prevalences of 20.8%, 5.7% and 0.2%, respectively, 
mixed infection prevalence was 1.7%. The human infective T. b. rhodesiense species was identified in 
1.3% of the examined animals.  
Age of animal 
Overall there was a significant difference between age groups on the prevalence of the overall 
parasitic events (χ2
2=7, p=0.03). The highest prevalence was detected in the adult group (31.1%, 
205/660; 95% CI: 27.5-34.7) followed by the 1.5-3 years age category (25%, 66/264; 95% CI: 19.9-
30.7) and the young age group (20.9%, 24/115; 95% CI: 13.9-29.4). The difference between young 
and 1.5-3 years age groups was not significant (χ1
2=0.8, p=0.4), while the difference between the adult 
and the young group was significant (χ1
2=4.9, p=0.03). The difference between the adult and the 1.5-3 
years age group (χ1
2=3.3, p=0.07) was statistically insignificant. Looking at the prevalence of the 
individual species, there was a significant difference between age groups on the prevalence of T. 
brucei s.l. infection (χ2
2=19.6, p<0.001) and T. vivax infection (χ2
2=8.4, p=0.01). The prevalence of T. 
brucei s.l. infection was significantly higher (χ1
2=5.6, p=0.02) in adults (24.5%, 162/660; 95% CI: 
21.3-28) than in 1.5-3 years age group (17%, 45/264; 95% CI: 12.7-22.1). Also, the prevalence of T. 
brucei s.l. in adults was significantly higher (χ1
2=15.9, p<0.001) compared to the prevalence in young 
calves (7.8%, 9/115; 95% CI: 3.6-14.3). The opposite was observed in T. vivax infections where the 
higher prevalence was in young calves (11.3%, 13/115; 95% CI: 6.2-18.6), followed by the 1.5-3 
years age group (6.1%, 16/264; 95% CI: 3.5-9.7) then the adult group (4.5%, 30/660; 95% CI: 3.1-
6.4). The difference in T. vivax prevalence between the young age group (less than 18 months) and the 
adult age group was significant (χ1
2=8.5, p=0.003), while not significant between 1.5-3 years age 
group and the adult age group (χ1
2=0.9, p=0.3) and between groups A/B (χ1
2=3.1, p=0.08).  
Gender of animals 
No significant difference (χ1
2=0.4, p=0.5) was observed between males and females in the prevalence 
of the overall parasitic events. Overall trypanosome species were found in 29.1% (164/564; 95% CI: 
25.4-33) males and 27.4% (130/475; 95% CI: 23.4-31.6) females. In the case of the individual species, 
no statistical significant difference (χ1
2=0.5, p=0.5) was found between the prevalence of T. brucei s.l. 
infections in male and female animals. The prevalence in males was 19.9% (112/564; 95% CI: 16.7-
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23.4), while in females it was 21.7% (103/475; 95% CI: 18.1-25.7). However, a significant difference 
(χ1
2=5.8, p=0.02) was observed between the prevalence of T. vivax with a higher prevalence in males 
7.3% (41/564; 95% CI: 5.3-9.7) than in females 3.8% (18/475; 95% CI: 2.3-5.9). 
Body condition score of animals 
The overall prevalence of the parasitic events between the animal condition score groups was 
significant (χ2
2=6.4, p=0.04) with the higher prevalence in lean animals (38.9%, 14/36; 95% CI: 23.1-
56.5) followed by medium (28.5%, 277/971; 95% CI: 25.7-31.5) then fat animals (12.1%, 4/33; 95% 
CI: 3.4-28.2). There was no significant difference between the prevalence of the parasitic events in 
lean and medium condition scored animals (χ1
2=1.8, p=0.2), however, the difference between the fat 
animals and the other two categories, lean (χ1
2=6.4, p=0.01) and medium condition scored animals 
(χ1
2=4.3, p=0.04) was significant.  
Concerning the individual species, the prevalence of T. brucei infections was insignificant between 
the three categories (χ2
2=5.4, p=0.07). The higher prevalence was observed in lean animals 27.8% 
(10/36; 95% CI: 14.2-45.2), which was significantly different from the prevalence in fat animals 
(χ1
2=4.2, p=0.04). The prevalence in fat animals was 6.1% (2/33; 95% CI: 0.7-20.2) which was 
slightly different from the prevalence in medium scored animals (21%, 204/971; 95% CI: 18.5-23.7) 
approaching significance (χ1
2=3.5, p=0.06). There was no statistical significant difference between the 
prevalence of T. brucei s.l. infections in lean and medium animals (χ1
2=0.6, p=0.4). The condition 
score effect on the prevalence of T. vivax infections was insignificant when calculated using Fisher’s 
exact test (p=0.6).  
Animal breed 
There was a significant difference in the prevalence of the overall parasitic events between the 
sampled animal breeds (χ2
2=7.3, p=0.03). The highest prevalence was in Zebu cattle 30% (265/884; 
95% CI: 27-33.1) followed by Cross breeds 21.1% (16/76; 95% CI: 12.5-31.9) then Ankole breeds 
17.9% (14/78; 95% CI: 10.2-28.3). The only significant difference in the prevalence of any 
trypanosome species was observed only between Zebu and Ankole breeds (χ1
2=5, p=0.03). By 
investigating the individual species, there was no significant effect of the animal breed on the 
prevalence of T. brucei s.l. infections (χ2
2=4.1, p=0.1). The prevalence of T. brucei s.l. infections was 
higher in Zebu cattle 21.8% (193/884; 95% CI: 19.2-24.7) followed by Ankole 16.7% (13/78; 95% 
CI: 9.2-26.8) and Cross breeds 13.2% (10/76; 95% CI: 6.5-22.9). 
 Looking at the difference between animal breeds infected with T. vivax infections, there was a 
significant effect with p-value=0.04. Ankole breed was not infected with T. vivax infections, however, 
there was insignificant difference (p=0.8) between the prevalence of T. vivax infections in Zebu cattle 
6.1% (54/884; 95% CI: 4.6-7.9) and cross breeds 6.6% (5/76; 95% CI: 2.2-14.7). 
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The prevalences of T. congolense Savannah, T. b. rhodesiense and mixed infections were not 
undertaken in the previous analysis due to low prevalences (0.2%, 1.3% and 1.7%, respectively).  
6.4.2.2 Prevalence of different trypanosome species at district level 
The results in Table 6.4 and Figure 6.4 summarise the prevalence of different trypanosome species at 
district level before the intervention programme.  
Table 6.4: Baseline prevalence of different trypanosome species at district level [% (fraction; 
95% CI)] 
District Trypanosome species 
Kabermaido Dokolo Lira 
Overall 
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Mixed infection** 0.6% 
(2/320;  0.08-2.2) 
1.7% 













* The number of T. b. rhodesiense is included in the number of T. brucei s.l. infections **The number of mixed infection 




Figure 6.4: Baseline prevalence of trypanosome species at district level 
The results in Table 6.4 and Figure 6.4 show the prevalence of trypanosome species identified using 
species-specific PCR at baseline sampling prior starting the intervention programme. A difference was 
observed in the prevalence of trypanosome species in the three districts (χ2
2=14.4, p=0.001). The 
prevalence of the parasitic events in Kabermaido district (20%) was statistically lower than in Dokolo 
(χ1
2=13.7, p<0.001, OR=0.5 (0.3-0.8)) and Lira (χ1
2=8.3, p=0.004, OR=1.7 (1.1-2.6)). However, there 
was no significant difference between the prevalence of the parasitic events in Dokolo and Lira 
districts (χ1
2 = 0.8, p=0.4, OR=0.9 (0.6-1.2)). 
The results also show that T. brucei s.l. was the dominant species at baseline in the three districts 
compared to the other identified species. Overall, there was a significant difference between the 
prevalence of T. brucei s.l., T. b. rhodesiense, T. vivax, T. congolense Savannah and mixed infections 
at baseline (χ4
2=543.1, p<0.001). The prevalence of T. brucei s.l. was significantly different between 
the three districts (χ2
2=12.9, p=0.002). The prevalence in Dokolo (26.9%) was significantly higher 
than the 18.1% prevalence observed in Lira (χ1
2=8.2, p=0.004, OR=0.6 (0.4-0.9)) and16.9% 
prevalence in Kabermaido (χ1
2=12.9, p=0.002, OR=0.6 (0.4-0.8)). No difference was observed 
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between Kabermaido and Lira in the prevalence of T. brucei s.l. infections (χ1
2=0.16, p=0.6, OR=1.1 
(0.6-1.8)).  
The human infective trypanosome (T. b. rhodesiense) had an overall low prevalence (1.3%) at 
baseline. There was a significant difference between the three districts in the baseline prevalence of T. 
b. rhodesiense (p=0.01) with the highest prevalence in Dokolo district (2.8%) which was significantly 
higher than the 0.3% difference in Lira (p=0.01). However, the difference in T. b. rhodesiense 
prevalence was insignificant between Dokolo and Kabermaido (2.8% and 0.9%, respectively) with p-
value of 0.09. 
The overall baseline prevalence of T. vivax was 5.7% which was significantly different between the 
three districts (χ2
2=14.9, p=0.001). Lira district had a significantly higher prevalence (9.4%) than 
Kabermaido district (χ1
2=10.2, p=0.001, OR=3.2 (1.3-8)) which had 3.1% prevalence. Also, the 
difference in prevalence between Lira and Dokolo (9.4% and 4.2%, respectively) was statistically 
significant (χ1
2=7.1, p=0.006, OR=2.4 (1.2-4.9)). However, no statistical significant difference was 
observed in the prevalence of T. vivax infections between Kabermaido and Dokolo (χ1
2=0.51, p=0.5, 
OR=0.7 (0.3-1).  
The other trypanosome species identified at a very low percentage using species-specific PCR was T. 
congolense Savannah. This species had an overall prevalence of 0.2% and was only identified in 
Dokolo district with 0.6% prevalence at baseline sampling.   
Mixed infection was also identified in a low overall prevalence (1.7%) with no significant difference 
in the prevalence between the three districts (χ2
2=14.9, p=0.1). The prevalence was higher in Lira 
district followed by Dokolo and Kabermaido (2.8%, 1.7% and 0.6%, respectively). The type of mixed 
infection identified in the three villages was T. brucei s.l./T. vivax; mixed infections did not include T. 
b. rhodesiense. 
6.4.2.3 The prevalence of different trypanosome species at village level 
The results in Figure 6.5 and 6.6 show the prevalence of T. brucei s.l. and T. vivax infections, 


















































































Figure 6.5: Prevalence of T. brucei s.l. at village level 
The results in Figure 6.5 show the prevalence of T. brucei s.l. at the village level. The highest 
prevalence of T. brucei s.l. infection was in Awinyiipany (39%) and Okwar (32.5%) in Dokolo and 
Ogengo (37.5%) in Lira. However, a low prevalence of 6.3% and 2% were detected in Mwatma in 
















































































Figure 6.6: Prevalence of T. vivax at village level 
The results in Figure 6.6 show the prevalence of T. vivax at the village level. Onyakede and AbuongB 
villages in Lira district had the highest prevalence of T. vivax infections (17.5% and 12%, 
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respectively). T. vivax was not identified in Olep in Kabermaido district and in the other villages 
prevalence ranged from 2%-12%.  
T. congolense Savannah was only detected in Abienek village in Dokolo at baseline. Five villages had 
no mixed infections while other villages had a low prevalence of T. brucei s.l./T. vivax combination 
ranging from 1.3-5%. 
6.4.3 Post intervention follow up results 
6.4.3.1 Impact of intervention at the three sampling time points across 
the study area 
The prevalence of different trypanosome species at baseline was compared with the prevalence in 
treated and non treated animals at three and nine months post-intervention to estimate the impact of 
the treatment programme. Table 6.5 and Figure 6.7 summarise the prevalence of different 
trypanosome species at baseline, three and nine months post-intervention. 
Table 6.5: Prevalence of trypanosome species in animals across the study area [% (fraction; 
95% CI)] 














































































































* The number of T. b. rhodesiense is included in the number of T. brucei s.l. infections **The number of mixed infection 




Figure 6.7: Prevalence of different trypanosome species in treated animals at baseline and post-
intervention 
The results in Table 6.6 and Figure 6.7 show that at baseline, the prevalence of the parasitic events 
was 26.6%, a significant reduction of the parasitic events prevalence was observed three months post-
intervention reaching 7.1% (χ1
2=124.6, p<0.001, OR=0.2 (0.1-0.3)). The prevalence of the parasitic 
events was significantly increased from 7.1% at three months post-intervention to 25.7% at nine 
months post-intervention (χ1
2=107.8, p<0.001, OR=5.1 (3.6-7.2)). There was no significant difference 
between the baseline levels and those found nine months post intervention (χ1
2=0.01, p=0.8, OR=0.9 
(0.8-1.2)). 
The prevalence of T. brucei s.l. infection significantly reduced from 20.8% at baseline to 5.4% three 
months post-intervention (χ1
2=82.3, p<0.001, OR=0.2 (0.15-0.3)). The prevalence significantly 
increased to 15.2% after nine months (χ1
2=36.5, p<0.001, OR=3.1 (2.1-4.7)), however, this increase 
was significantly lower than the baseline prevalence (χ1
2=7.9, p=0.004, OR=0.7 (0.5-0.9)).  
The prevalence of T. vivax infections at baseline (Table 6.6 and Figure 6.7) was 5.7%, which was 
found to be significantly reduced at three months post-intervention to 1.5% (χ1
2=19.9, p<0.001, 
OR=0.3 (0.1-0.5)). Nine months post-intervention, there was a significant increase in the prevalence 
of T. vivax infections to 9.8% compared to three months post intervention (χ1
2=46.8, p<0.001, OR=7.2 
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(3.6-14.4)). This increase was significantly higher compared to baseline prevalence (χ1
2=10.1, 
p=0.001, OR=1.8 (1.2-2.7)). 
The prevalence of T. b. rhodesiense significantly declined from 1.3% at baseline to 0.1% three months 
post-intervention (χ1
2=7.6, p=0.006). Nine months post-intervention, the prevalence increased again to 
1% (p=0.05), however, the prevalence at nine months post-intervention was insignificantly lower than 
that at baseline (p=0.6). 
The same trend was observed on the impact of the treatment programme on T. congolense Savannah 
infections and mixed infection prevalence (Table 6.6 and Figure 6.7). Pre-intervention, the prevalence 
of T. congolense Savannah infections was 0.2% which insignificantly declined to 0.1% three months 
post-intervention (p=1). Nine months post-intervention, animals infected with T. congolense Savannah 
infections were detected with a prevalence of 0.6% which was insignificantly higher than the 
prevalence at baseline and three months post-intervention (p=0.2). 
Mixed infection was identified at baseline with 1.7% prevalence which significantly was cleared three 
months post-intervention (χ1
2=12.9, p<0.001). A significant re-appearance of mixed infection (2.4%) 
was detected nine months post-intervention (χ1
2=17.7, p<0.001). The type of mixed infection detected 
at baseline was only T. brucei s.l./T. vivax, no T. b. rhodeseiense was involved in such mixed 
infection. However, at nine months post intervention 14 out of the detected 15 mixed infections were 
of T. brucei s.l./T. vivax, two of these combinations included T. b. rhodeseinse. Also, T. congolense 
Savannah was included in one case to have mixed infection with T. brucei s.l. 
The prevalence of different trypanosome species at the three sampling time points in animals that had 
not received any intervention are listed in Table 6.5. These animals were used as controls to discuss 
and evaluate the impact of the treatment programme (Discussion section).   
6.4.3.2 Impact of intervention at district level 
The prevalence of different trypanosome species at district level during the treatment programme was 
compared to find out if there was a difference in the prevalence of trypanosome species in the three 
districts chosen for the study. The results of Olemai village were excluded from the follow up results 
due to low proportion of treated animals sampled three and nine months post-intervention (27.4% and 
2.2%, respectively). Table 6.6 shows the prevalence of different trypanosomes in animals that 
received treatment in the three studied districts pre and post-intervention. 
 
 170 
Table 6.6: Prevalence of different trypanosomes in the three districts pre and post-intervention 
[% (fraction; 95% CI)] 
















































































































































































* The number of T. b. rhodesiense is included in the number of T. brucei s.l. infections **The number of mixed infection 
species is included in the relevant column 
6.4.3.2.1 Prevalence of the overall parasitic events 
Table 6.6 and Figure 6.8 show the prevalence of the parasitic events detected using species-specific 
PCR in the three districts all over the time of the study pre and post-intervention.  
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Figure 6.8: Prevalence of the parasitic events at the three studied districts (a= significant 
difference from baseline, b= significant difference from 3 months) 
The results in Table 6.6 and Figure 6.8 show that the prevalence of the parasitic events in the three 
districts was reduced three months post-intervention in each district. In Kabermaido district, the 
prevalence of the parasitic events declined significantly from 20% at baseline to 10.2% three months 
post-intervention (χ1
2=11.1, p=0.001, OR=0.4 (0.2-0.8)). The prevalence significantly increased again 
to 25.8% nine months post-intervention (χ1
2=21.4, p<0.001, OR=3.2 (1.6-6.3)). However, the 
prevalence at nine months was not significantly higher than the baseline prevalence (χ1
2=2.7, p=0.1, 
OR=1.4 (0.8-2.3)). 
The same trend was noticed in Dokolo district where the prevalence of the parasitic events 
significantly reduced from 31.7% at baseline to 7.5% three months post-intervention (χ1
2=54.7, 
p<0.001, OR=0.2 (0.01-0.3)). Nine months post-intervention the prevalence increased significantly to 
24.1% compared to three months post-intervention (χ1
2=32.9, p<0.001, OR=4.6 (2.3-9.01). The 
prevalence at nine months was not significantly higher than the pre-intervention prevalence (χ1
2=2.4, 
p=0.1, OR=0.7 (0.5-1.1)). 
Finally, in Lira district, the prevalence of the parasitic events was reduced significantly from 27.5% at 
baseline to 2.7% three months post-intervention (χ1
2=63.5, p<0.001, OR=0.1 (0.02-0.2)). The 
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prevalence significantly increased again nine months post-intervention to 27.8% (χ1
2=55.9, p<0.001, 
OR=15.2 (5.1-45.1)) which was not significantly lower than the prevalence at baseline (χ1
2=0.01, 
p=0.9, OR=1 (0.6-1.5)). 
At three months post-intervention, there was a significant difference in the prevalence of the parasitic 
events between the three districts (χ2
2=10.3, p=0.006). The 2.7% prevalence in Lira district was 
significantly lower than the 7.5% prevalence in Dokolo (χ1
2=4.5, p0.03, OR=0.3 (0.1-1.01)) and the 
10.2% prevalence in Kabermaido (χ1
2=9.4, p=0.002, OR=0.2 (0.1-0.8)). However, there was 
insignificant difference between Kabermaido and Dokolo in the prevalence of the parasitic events 
(χ1
2=0.8, p=0.4, OR=1.4 (0.7-2.8)).  
Nine months post-intervention, there was no statistical significant difference between the three 
districts in the prevalence of the parasitic events (χ2
2=10.3, p=0.006). The detected prevalence of 
trypanosome species in Kabermaido, Dokolo and Lira was 25.8%, 24.1% and 27.8%, respectively.  
6.4.3.2.2  T. brucei s.l. prevalence 
Figure 6.9 shows the prevalence of infections with T. brucei s.l. at the three studied districts over the 
three sampling periods. 
 
Figure 6.9: Prevalence of T. brucei s.l. at the three studied districts pre and post-intervention (a= 
significant difference from baseline, b= significant difference from 3 months) 
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The results in Table 6.6 and Figure 6.9 show that the prevalence of T. brucei s.l. in Kabermaido was 
significantly reduced from 17% at baseline to 9.4% three months post-intervention (χ1
2=6.2, p=0.01, 
OR=0.5 (0.3-0.9)). Although the prevalence increased again to 14.3% nine months post-intervention, 
this was insignificant compared to three months (χ1
2=2.1, p=0.2, OR=1.5 (0.7-3.4). The prevalence at 
nine months follow up was insignificantly lower than the baseline prevalence (χ1
2=0.4, p=0.5, OR=0.8 
(0.4-1.5)). However, in Dokolo, the prevalence of T. brucei s.l. was significantly reduced from 26.9% 
at baseline to 5.2% three months post-intervention (χ1
2=46.3, p<0.001, OR=0.14 (0.1-0.3)). The 
prevalence significantly increased again to 16.1% nine months post-intervention (χ1
2=14.9, p<0.001, 
OR=3.5 (1.6-7.9)) when compared with the prevalence at three months post-intervention. The 
prevalence after the treatment by nine months was significantly lower than the prevalence at baseline 
(χ1
2=9.6, p=0.002, OR=0.5 (0.3-0.8)). Lira district, the prevalence of T. brucei s.l. was significantly 
reduced from 18.1% at baseline to 0.9% nine months after treatment (χ1
2=37.6, p<0.001, OR=0.04 
(0.01-0.2)). The prevalence significantly increased again to 15% nine months after the treatment 
programme when compared with the prevalence at three months (χ1
2=27.3, p<0.001, OR=19.2 (3.1-
117.2)). However, the prevalence at nine months post intervention was insignificantly lower than the 
prevalence at baseline (χ1
2=0.6, p=0.4, OR=0.8 (0.5-1.4)).  
Three months post-intervention, there was a significant difference in the prevalence of T. brucei s.l. 
infections between the three districts (χ2
2=17.1, p<0.001). The prevalence in Lira (0.9%) was 
significantly lower than the 9.4% prevalence in Kabermaido (χ1
2=15.03, p=0.001, OR=0.1 (0.01-0.5)). 
The prevalence of T. brucei s.l. in Lira was lower than 5.2% prevalence in Dokolo, the difference was 
significant (χ1
2=5.6, p=0.02, OR=0.2 (0.03-1)). However, there was no significant difference in T. 
brucei s.l. prevalence between Kabermaido and Dokolo districts (χ1
2=2.9, p=0.07, OR=1.9 (0.9-4.3)). 
The prevalence of T. brucei s.l. in Kabermaido, Dokolo and Lira districts nine months post-
intervention was 14.3%, 16.1% and 15%, respectively. No statistical significant difference was 
observed in the prevalence of T. brucei s.l. at nine months post-intervention between the three districts 
(χ2
2=0.3, p=0.9).  
6.4.3.2.3 T. b. rhodesiense prevalence 
As shown in Table 6.6, the prevalence of the human infective T. b. rhodesiense in Kabermaido district 
insignificantly decreased from 0.9% at baseline to 0.4% three months post-intervention (p=0.6). At 
nine months follow-up, no T. b. rhodesiense was detected in Kabermaido. However, in Dokolo 
district, the drop in T. b. rhodesiense prevalence was significant from 2.8% at baseline to a complete 
absence at three months follow up (p=0.007). The prevalence significantly increased again to 2.3% 
nine months post-intervention (p=0.03) which is insignificantly higher than the baseline prevalence 
(p=0.8). The animals sampled in Lira district post-intervention were free from the human infective 
parasite T. b. rhodesiense. The fall of T. b. rhodesiense following the intervention from 0.3% baseline 
prevalence was not significant (p=1). 
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6.4.3.2.4 T. vivax prevalence 
Figure 6.10 shows the prevalence of infections with T. vivax at the three districts studied over the 
three sampling periods. 
 
Figure 6.10: Prevalence of T. vivax in the three districts over the study period (a= significant 
difference from baseline, b= significant difference from 3 months) 
The prevalence of T. vivax infections in the three districts pre and post-intervention is shown in Table 
6.6 and Figure 6.10. The prevalence of T. vivax infections in Kabermaido was insignificantly 
decreased from 3.1% pre-intervention to 0.8% three months post-intervention (χ1
2=3, p=0.1, OR=0.2 
(0.04-1.4)). Nine months post-intervention, the prevalence significantly increased again to 9.9% when 
compared to the three months prevalence (χ1
2=19, p<0.001, OR=14.6 (2.1-101)). The nine months 
prevalence of T. vivax infections was also significantly higher than the baseline prevalence (χ1
2=8.8, 
p=0.002, OR=3.4 (1.4-8.8)). In Dokolo, the 4.2% baseline prevalence insignificantly decreased at 
three months post-intervention reaching 2% (χ1
2=1.6, p=0.14, OR=0.5 (0.14-1.5)). The prevalence 
rose significantly nine months post-intervention reaching 7.7% (χ1
2=7.7, p=0.005, OR=4.1 (1.2-
14.2)). The prevalence at nine months post-intervention was insignificantly higher than the prevalence 
at baseline (χ1
2=2.9, p=0.1, OR=1.9 (0.9-4.2)). 
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Finally, the prevalence of T. vivax infections in Lira district was significantly reduced from 9.4% at 
baseline to 1.8% three months post-intervention (χ1
2=11.8, p=0.001, OR=0.2 (0.1-0.6)). Significantly, 
the prevalence increased again nine months post-intervention to 12.8% when compared to the three 
months post-intervention prevalence (χ1
2=17.5, p<0.001, OR=8 (2.1-30.5)). However, the prevalence 
nine months post-intervention was insignificantly higher than the prevalence at baseline (χ1
2=1.2, 
p=0.2, OR=1.4 (0.7-2.7)).  
Three months post-intervention there was insignificant difference in the prevalence of T. vivax 
infections between the three districts (p=0.5). The prevalence of T. vivax infections at three months 
follow up was 0.8%, 2% and 1.8% in Kabermaido, Dokolo and Lira, respectively. Moreover, there 
was no statistical significant difference in the prevalence of T. vivax infections between the three 
districts at nine months follow up (χ1
2=3.3, p=0.2). The respective prevalence of T. vivax infections at 
nine months follow up was 9.9%, 7.7% and 12.8% in Kabermaido, Dokolo and Lira. 
6.4.3.2.5 T. congolense Savannah prevalence  
Dokolo district was the only district where T. congolense Savannah infections were identified pre and 
post-intervention. The prevalence at baseline was 0.6% which insignificantly decreased to 0.4% three 
months post-intervention (p=1). The prevalence at nine months follow up was not changed from 0.4%. 
In Kabermaido district, T. congolense Savannah was only identified at nine months follow-up (1.6%), 
while, none were detected in Lira district over the study period (Table 6.6).   
6.4.3.2.6 Mixed infection 
The prevalence of mixed infection had the same trend as other species over the studied area during the 
treatment campaign. In Kabermaido, the prevalence of mixed infection was 0.6% at baseline, while 
none was identified three months post-intervention. The prevalence rose again at nine months follow 
up reaching 1.6% which was insignificantly higher than the baseline prevalence (p=0.4). The type of 
mixed infection in Kabermaido at baseline and three months post-intervention was T. b. brucei/T. 
vivax with no T. b. rhodesiense involved.  
The prevalence of mixed infection in Dokolo at baseline was 1.7% with none being detected at three 
months follow-up, however, the prevalence increased again nine months post-intervention to 3.1%. 
The type of mixed infection at baseline was T. b. brucei/T. vivax. Eight animals were diagnosed to 
harbour mixed infection nine months post-intervention. One animal had T. b. brucei/T. congolense 
Savannah combination; two animals had T. b. rhodesiense/T. vivax combination. While the remaining 
six animals had T. b. brucei/T. vivax mixed infection. In Lira district, 2.8% and 2.1% prevalence of T. 
brucei/T. vivax mixed infection were identified at baseline and nine months post-intervention, 
respectively (Table 6.6). 
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6.4.3.3 Impact of intervention at village level 
The prevalence of different trypanosome species at village level during the treatment programme was 
compared to find out if there was a difference in the prevalence of trypanosomes in the 11 villages 
chosen for the study. Olemai village has been excluded from the analysis due to the low number of 
treated animals at three and nine months post-intervention. 
6.4.3.3.1 Prevalence of the overall parasitic events 
Figure 6.11 show the prevalence of the overall events at village level. 
 
Figure 6.11: Prevalence of the overall parasitic events at village level at the three time points (a= 






6.4.3.3.2 T. brucei s.l. infection 
Figure 6.12 show the prevalence of T. brucei s.l. at village level. 
 
Figure 6.12: Prevalence of T. brucei s.l. at village level at the three time points (a= significant 










6.4.3.3.3 T. vivax infection 
Figure 6.13 show the prevalence of T. vivax at village level. 
 
Figure 6.13: Prevalence of T. vivax at village level at the three time points (a= significant 











6.4.3.3.4 T. congolense Savannah and mixed infection 
Infections with T. congolense Savannah were identified at the three sampling time points; Figure 5.14 
shows the location where T. congolense Savannah was isolated.  
 
Figure 6.14: Map showing the village highlighted in red with T. congolense Savannah infected 
cattle at baseline and three months post-intervention 
Figure 5.14 shows that animals infected with T. congolense Savannah infections were identified in 
Abieneik village only at baseline and three months post-intervention. The baseline prevalence was 
2.5% (2/80; 95% CI: 0.3-8.7) which insignificantly (p=1) decreased to 1.5% (1/65; 95% CI: 0.04-8.3) 
three months post-intervention.  
 180 
 
Figure 6.15: Map showing the two villages highlighted in red (the size and deepness of the colour 
is related to the prevalence) with T. congolense Savannah infected animals nine months after 
treatment 
Figure 6.15 shows the villages with animals infected with T. congolense Savannah. Interestingly, 
Abieneik village was completely cleared from T. congolense Savannah infections after being infected 
at baseline and three months post-intervention. However, new cases with T. congolense Savannah 
infection were identified in new villages nine months post-intervention. The two villages with the new 
T. congolense Savannah cases were Mwatma and Awinyiipany with prevalence of 9.1% (3/33; 95% 








Mixed infections were identified from the studied villages at baseline and nine months post-
intervention. However, three months post-intervention mixed infections were cleared from the 
animals. Figures 6.16, 6.17 show the villages with mixed infections at baseline and nine months post-
intervention.  
 
Figure 6.16: Map showing the baseline prevalence of mixed infection with the size of village 
symbols graduated according to the prevalence 
Figure 6.16 shows that animals with mixed infection were identified at baseline in seven villages. The 
prevalence of mixed infection was 5% in AbuongB and Onyakede villages, while it was 3.8% in 
Okwar. A prevalence of 1.3% was detected in Abieneik and Ogengo villages; however, 2% and 2.5% 
prevalence were detected in Awinyiipany and Olemail villages, respectively. The type of mixed 
infection identified in all villages was T. b. brucei/T. vivax combination.   
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Figure 6.17: Map showing the prevalence of mixed infection at nine months post-intervention 
with the size graduated according to the prevalence 
Figure 5.17 shows that nine months post-intervention, mixed infection with trypanosome species was 
detected again after being cleared from the animals three months following the intervention. Olemai 
village was excluded due to the low treatment coverage. Nine months post-intervention, the 
prevalence of mixed infection in AbuongB village raised again reaching 1.2% which was 
insignificantly lower than the baseline prevalence (p=0.2). In Onyakede, Abieneik and Awinyiipany 
villages, mixed infection prevalence was not significantly higher than the baseline prevalence (p=1). 
However, the prevalence in Okwar village increased again to the same level as at baseline. In Olep 
village, mixed infection was detected only at nine months post-intervention with 4.8% prevalence. 
Only Awinyiipany village had one animal harbouring T. b. brucei/T. congolense Savannah 
combination. Moreover, Okwar village had two animals infected with T. b. rhodesiense/T. vivax 




6.4.3.4 Impact of the drugs used on the prevalence of infections with 
trypanosome species  
The impact of ISM and DI on the prevalence of infections with trypanosome species was studied by 
comparing the prevalence of trypanosomes at the three sampling times. Table 6.7 summarises the 
prevalence of different trypanosome infections during the campaign using the two drugs. 
Table 6.7: Impact of ISM and DI on different trypanosome species 
















































































































* The number of T. b. rhodesiense is included in the number of T. brucei s.l. infections **The number of mixed infection 
species is included in the relevant column 
The results in Table 6.7 show that at areas treated with ISM, there was a significant reduction of the 
overall parasitic events prevalence from 26.2% at baseline to 8.9% three months post-intervention 
(χ1
2=64.02, p<0.001). Moreover, the significant reduction of T. brucei s.l. (χ1
2=48.7, p<0.001), T. b. 
rhodesiense (χ1
2=7.5, p=0.006) and T. vivax (χ1
2=6.1, p=0.01) prevalence three months post-
intervention was reported in areas treated with ISM. Also, there was a significant reduction in the 
prevalence of mixed infection from 1.2% at baseline to complete absence three months later 
(p=0.001). There was no statistically significant effect of ISM on the prevalence of T. congolense 
Savannah infections.  
Areas treated with DI showed a significant reduction of the parasitic events prevalence from 27.5% at 
baseline to 2.7% three months post-intervention (χ1
2=65.2, p<0.001). The significant impact of DI on 
reducing the prevalence of T. brucei s.l. (χ1
2=39.3, p<0.001) and T. vivax (χ1
2=13, p<0.001) infections 
was clearly obvious three months post-intervention (Table 6.7). Moreover, mixed infections were 
significantly reduced from 2.8% prevalence at baseline to complete absence three months later in 
areas treated with DI (p=0.02). In contrast, ISM and DI effect on the human infective trypanosome 
species T. b. rhodesiense was statistically insignificant (p=1). This might be due to the low level of T. 
b. rhodesiense detected at baseline (1.9%).  
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6.5 Discussion 
6.5.1 Baseline results 
The aim of the study presented in this chapter was to apply the sample preparation and molecular 
approaches evaluated in Chapters IV and V in field to monitor the effect of mass treatment 
programme on the prevalence of trypanosome species. 
6.5.1.1 Overall prevalence of different trypanosome species at baseline 
in the sampled cattle  
A total of 1040 cattle were sampled and examined for trypanosomes using PCR at baseline collection. 
Overall, 26.6% were found to be infected with different trypanosome species including T. brucei s.l., 
T. vivax, T. congolense Savannah and mixed infections with overall prevalences of 20.8%, 5.7%, 0.2% 
and 1.7%, respectively. The human infective T. b. rhodesiense species was identified in 1.3% of the 
examined animals.  
Age of the animal  
Trypanosome prevalence in cattle was shown to increase with age, with the highest prevalence found 
in the adult age group (31.1%) when compared to the 1.5-3 years age category (25%) and the young 
age group (20.9%). Looking at the individual species, infections of T. brucei s.l. prevalence 
significantly increased with age with 24.5% in adults, 17% in 1.5-3 years age category and 7.8% in 
young calves. These findings agree with Kalu (1995) and Magona et al. (2004) who stated that cattle 
aged 6-9 years are more likely to be infected than younger animals. This might be attributed to the 
increased exposure to infected tsetse with age (Magona et al., 2000; Rowlands et al., 1993), only 10% 
of tsetse were reported to be feeding on year-old calves compared to 50-60% on adults (Torr and 
Mangwiro, 2000). The authors attributed this preference to the highly developed defensive mechanism 
in young animals against tsetse bites, while, the flies are more attracted to the larger and calmer adults. 
Moreover, host odours play an important role in the relative attractiveness of cattle to tsetse flies. In 
particular, young animals produce less odour stimuli that attract tsetse to the host, the odour of 500 kg 
ox is about twice as attractive as a 50 kg calf  (Torr et al., 2006).  
In contrast to T. brucei s.l.; T. vivax were found to be significantly higher in young calves (11.3%) 
compared to 6.1% and 4.5% prevalence in 1.5-3 years age group and adults, respectively. This could 
be attributed to the short lifecycle of T. vivax in tsetse flies and the mechanical transmission with other 
Tabanids leading to the rapid appearance of T. vivax than T. brucei s.l. in young age (Dale et al., 1995; 
Desquesnes and Dia, 2003). However, with increased age, T. brucei s.l. becomes more predominant 
than T. vivax which might be explained by a development of a sort of immunity in animals against T. 
vivax infection with age (Bourn and Scott, 1978; Rowlands et al., 1993). Another explanation could 
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be death of calves due to infection with the highly pathogenic T. vivax leading to removal of the 
animals from the population. 
Gender of animals  
No statistical significant difference was observed in the prevalence of the overall parasitic events and 
infections with T. brucei s.l. between male and female cattle in the current study. These findings were 
in agreement with other studies that reported the insignificant influence of animal gender in the 
prevalence of trypanosomes (Kalu, 1995; Katunguka-Rwakishaya, 1996; Wissmann, 2007). The only 
significant difference in the study was observed in the prevalence of T. vivax where male cattle were 
found to be infected with 7.3%, while, female cattle had only 3.8% prevalence. This might be due to 
the larger size of male cattle that causes more attraction for biting insects (Rowlands et al., 2001; Torr 
et al., 2006; Torr and Mangwiro, 2000).  
Body condition of the animal 
The difference in the overall parasitic events prevalence between the lean, medium and fat animals 
was significant. The prevalence in lean animals (38.9%) was significantly higher than that in fat 
animals while insignificantly higher than the prevalence in medium scored animals (28.5% and 
12.1%, respectively).  
The prevalence of T. brucei s.l. infections was significantly higher in lean animals (27.8%) compared 
to 6.1% prevalence in fat animals. However, infections with T. brucei s.l. was lower in medium scored 
animals (21%) compared to lean animals and this was statistically insignificant. The insignificant 
difference between lean and medium scored animals in the prevalence of overall parasitic events and 
T. brucei s.l. indicated that condition score is not a good indicator for the presence of trypanosome 
infection (Wissmann, 2007). This conclusion was supported by the insignificant difference in 
infections with T. vivax between condition scored animals, as T. vivax is more pathogenic to cattle 
than T. brucei s.l.  
Animal breed 
It is estimated that almost all (more than 95%) of cattle in Uganda are of Zebu or Sanga types (Ankole 
breed) (Magona and Mayende, 2002). The Ankole breed have been brought to the country recently as 
a result of a re-stocking programme (Fevre et al., 2001; Magona and Mayende, 2002; Magona et al., 
2004). The most predominant breed of cattle in the current study was Zebu cattle (87.4%) while only 
7.9% were of the Ankole breed. The results showed a significantly higher prevalence of the overall 
parasitic events in the Zebu breeds (30%) than the 17.9% prevalence in the Ankole breeds. Moreover, 
Zebu cattle were infected with T. vivax while none of the Ankole cattle were found to be infected with 
this species.  
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Regarding T. brucei s.l. infections, there was no statistical significant difference between Zebu and 
Ankole cattle with 21.8% prevalence in Zebu cattle and 16.7% in Ankole. These findings were not in 
agreement with the previously reported susceptibility of Ankole cattle to trypanosome infection 
(Magona et al., 2004; Waiswa and Katunguka-Rwakishaya, 2004). This could depend on how long the 
Ankole breeds had been in the infested area after re-stocking from trypanosome free area. However, 
Zebu cattle were reported to be more susceptible to trypanosome infection than Friesian and N’Dame 
cattle (Magona and Mayende, 2002; Naessens, 2006).    
6.5.1.2 Prevalence of different trypanosome species at district level 
The results in Table 6.4 and Figure 6.4 show that at baseline, infection with T. brucei s.l. significantly 
dominates the other species in the studied districts with an overall prevalence of 20.8%. T. brucei s.l. 
infection was followed by T. vivax and T. congolense Savannah with respective prevalence of 5.7% 
and 0.2%.  
Table 6.8 summarises the reported prevalence of infections with different trypanosome species in 
cattle sampled from different parts of Uganda with reference to the method used in diagnosis. 




































































1419 PCR 9.7% 4.9% 0.7% 0 (Fyfe, 2007) 
Central 
 
1040 PCR 20.8% 5.7% 0.2% 1.7% Current study 
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Comparing the results obtained in the current study with those previously reported in different parts in 
Uganda, T. brucei s.l. prevalence in the current study was higher than those previously reported (Table 
6.8). This higher prevalence might be attributed to the use of the highly sensitive molecular techniques 
for the detection of trypanosomes and the copy number of the PCR targets, while, other studies in the 
table (except Fyfe, 2007) used parasitological methods. Although in the study conducted by Fyfe 
(2007) molecular diagnosis was also used but the prevalence of T. brucei s.l. was lower than that 
obtained in the current study. This could be due to the different areas where studies were conducted or 
due to the use of single FTA disc for PCR reactions in Fyfe’s study. In the current work DNA was 
eluted using Chelex®100 from 10 discs which increased the chances of amplifying trypanosome DNA.  
In the current work, the prevalence of T. b. rhodesiense at baseline was 1.3% within the total sample 
population. This percentage is lower than T. b. rhodesiense reported in Uganda in other studies. An 
overall prevalence of 2.5% was reported in cattle sampled and examined by SRA-PCR in south-
eastern Uganda by Fyfe (2007), this prevalence is almost significantly higher than the obtained 
prevalence in the current study (χ1
2=3.9, p=0.05). However, 11.5% cattle were diagnosed to be 
positive for T. b. rhodesiense in south eastern Uganda (Enyaru et al., 2006; Welburn et al., 2001).  
In the current study, Dokolo district had a significantly higher prevalence of T. b. rhodesiense (2.8%) 
compared to 0.3% in Lira. The prevalence in Kabermaido in the current study was 0.3% which is 
lower than 3.3% prevalence detected in the same district in the study conducted by Enyaru et al. 
(2006). This might be due to the different sites examined or the use of different primers targeting the 
SRA gene that were developed by Radwanska et al. (2002).  
Epidemiological theory, based on mathematical modelling, predicts that the prevalence of T. b. 
rhodesiense will exceed that of T. b. brucei in non-humans with three and 3.5 fold more prevalence of 
T. b. rhodesiense in the cattle and vector population, respectively (Rogers, 1988). In the current study, 
this was not the case, in contrast, T. b. brucei was observed to be far more prevalent in cattle host. 
Coleman and Welburn (2004) collected data about the prevalence of T. b. rhodesiense and T. b. brucei 
in non-humans, they reported that the relative prevalence of T. b. rhodesiense to T. b. brucei was 0.33 
suggesting the occurrence of T. b. rhodesiense/T. b. brucei in 1:3 ratio. The discrepancy between 
theoretical predictions and empirical observations was further investigated and it was hypothesised 
that there are fitness costs associated with human serum-resistance when T. b. rhodesiense is not in the 
human host (Coleman and Welburn, 2004). Fitness is defined as the overall ability of an organism to 
survive and reproduce (Durso et al., 2004). Comparing the relative prevalence of T. b. rhodesiense to 
T. b. brucei (PTbr/PTbb) in cattle examined in Uganda with the 0.06 value in the current study, Table 6.9 




Table 6.9: Relative prevalence of T. b. rhodesiense to T. b. brucei in cattle 
Methodology of 
diagnosis 
Number of T. b. 
rhodesiense 
Number of T. b. 
brucei 
PTbr/PTbb Reference 
RFLP 15 46 0.33 (Hide et al., 1996) 
BIIT 4 6 0.67 (Mwambu and Mayende, 
1973) 
Isoenzyme analysis 14 42 0.33 (Gibson and Wellde, 1985) 
BIIT 24 109 0.12 (Robson et al., 1972b) 
BIIT 39 93 0.42 (Waiswa et al., 2003) 
PCR 18 27 0.66 (Welburn et al., 2001) 
PCR 10 79 0.13 (Enyaru et al., 2006) 
PCR 101 244 0.4 (Fyfe, 2007) 
PCR 14 216 0.06 Current study 
  
The results in Table 6.9 show that the PTbr/PTbb reported in the current study (0.06) was lower than the 
previously reported ratio. This might be attributed to the sampling of cattle in the aforementioned 
studies from endemic sleeping sickness foci where T. b. rhodesiense was identified with more 
frequency than in the current study. However, the current study agrees with the published results in 
the predominance of T. b. brucei over T. b. rhodesiense supporting the fitness cost hypothesis reported 
by Coleman and Welburn (2004).  
The prevalence of T. vivax was similar to that reported by Magona et al. (1999; 2004), Waiswa et al. 
(2003) and Waiswa and Katunguka-Rwakishaya (2004) in eastern, south-eastern and south-western 
Uganda, respectively. However, in Kampala, Clausen et al. (1998) identified only 2.1% to be infected 
with T. vivax using microscopical methods.  
The prevalence of T. congolense Savannah in the current study was 0.2% which was lower than other 
identified species. Although this result is lower than the reported studies as shown in Table 6.8 
generally, the prevalence of T. congolense Savannah in Uganda is low, ranging from 0-2.1% except 
for one study conducted by Magona et al. (2005) who reported that T. congolense was identified in 
4.2% of the parasitological examined cattle, which might be attributed to mis-calssification of other 
trypanosomes as T. congolense using microscopy.  
Mixed infections were identified either by parasitological or molecular methods in the reported studies 
summarised in Table 6.8. In the current study, the prevalence of T. brucei s.l./T. vivax mixed infection 
was 1.7%. As presented in Table 6.8 the same result was obtained by Magona et al. (1999) in south-
eastern Uganda (Buvuma islands, Lake Victoria). Lower findings of mixed T. brucei s.l./T. vivax  
infection were reported in south-eastern Uganda by Waiswa et al. (2003) and Magona et al. (2005) 
with 0.5% and 0.6%, respectively, which is explained by different diagnosis techniques and different 
locations of the studies. No mixed infection with T. brucei s.l./ T. congolense Savannah or T. vivax/T. 
congolense Savannah were diagnosed in the current study, however, T. vivax/ T. congolense Savannah 
mixed infections were reported in south-eastern Uganda by Magona et al. (2005) and in south-western 
Uganda by Waiswa and Katunguka-Rwakishaya (2004) with 0.9% and 0.2% prevalence, respectively. 
Moreover, T. brucei s.l./T. congolense mixed infections were reported in south-eastern Uganda with 
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0.2% by Waiswa et al. (2003). The identification of the aforementioned mixed infections in the 
reported study areas while the absence of such mixed combinations in the current study might be 
attributed to the different sites studied or artefacts of the parasitological methods in the visual 
differentiation of trypanosomes.  
The dominance of infections with T. brucei s.l. over other species was reported in the current work in 
all study areas. This dominance was mirrored in other results reported in Uganda by Clausen et al. 
(1998), Magona et al. (1999) and Fyfe (2007). In contrast, other studies conducted by Magona et al. 
(2004 and 2005) reported the dominance of T. vivax over other trypanosome species as mentioned in 
Table 6.8. This might be attributed to the use of parasitological diagnosis, while, the results reported 
by Fyfe (2007) showed dominance of T. brucei s.l. using PCR.     
The results were broken down to the district level to observe any differences in trypanosome 
prevalence between the three districts included in the study. The overall parasitic events prevalence 
was significantly lower in Kabermaido than in Dokolo and Lira districts. Looking at the species 
separately, infections with T. brucei s.l. were significantly higher in Dokolo than in Lira and 
Kabermaido. The results obtained in Kabermaido of T. brucei s.l. prevalence were 16.9% which 
nearly agrees with the 19% prevalence from the same district in a study conducted by Amungi (2008) 
(using the same PCR reactions for the diagnosis of T. brucei s.l.).  
As shown in the results summarised in Table 6.4, Dokolo district prevalence of T. b. rhodesiense was 
significantly higher than the other two districts. T. vivax prevalence was significantly higher in Lira; 
however, mixed infection prevalence was insignificantly higher in Lira than in Dokolo and 
Kabermaido. 
6.5.2 Post intervention follow-up results 
6.5.2.1 Impact of intervention at the three sampling time points across 
the study area 
The impact of the treatment programme at the three sampling time points across the study area is 
summarised in Table 6.5 and Figure 6.7. The results show that a significant reduction of the overall 
parasitic events, T. brucei s.l., T. vivax, T. b. rhodesiense and mixed infection prevalence was 
observed three months post-intervention indicating the success of the campaign in the study area. 
Although T. congolense Savannah prevalence was also reduced at three months follow up, this drop 
was insignificant (due to the low number of infections at baseline). Nine months post-intervention the 
prevalence of the overall parasitic events, T. brucei s.l., T. b. rhodesiense and mixed infections was 
significantly higher than the prevalence at three months follow up, however, this increase was lower 
than the prevalence at baseline.  
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The ratio of T. b. rhodesiense/T. b. brucei at baseline was 1:15 which decreased three months post-
intervention to 1:40 and then increased again to 1:16 nine months post-intervention. This finding 
indicated the re-infection of cattle with both T. b. rhodesiense and T. b. brucei. 
In contrast, the prevalence of T. vivax infection at nine months post-intervention was significantly 
higher than that reported at baseline. This could be explained due to the short lifecycle of T. vivax 
which can be completed in just one week leading to rapid re-transmission of the parasite after the 
intervention or due to increased challenge of the animals with other vectors carrying T. vivax such as 
Tabanids (Dale et al., 1995; Desquesnes and Dia, 2003).  
The same trend was noticed in T. congolense Savannah prevalence; however, the effect of the 
treatment on prevalence was not significant. This was in agreement with those reported by Fyfe 
(2007) who showed that T. congolense Savannah was detected with 0.7% prevalence at baseline; no 
cases were detected at three months follow up. However, one year post-intervention, cases were 
detected again although the prevalence remained very low (0.2%).  
The results in Table 6.5 show the prevalence of trypanosomes in animals that had not received any 
treatment. These animals could be used as a marker to estimate the impact of the intervention 
programme in the studied area. The prevalence of infection with T. brucei s.l., T. b. rhodesiense, T. 
vivax and T. congolense Savannah at three months follow up sampling was 9.6%, 0%, 2.4% and 0%, 
respectively. The prevalence of the aforementioned species was lower than the baseline correspondent 
prevalence which might indicate the decreased challenge of all the animals in the study area with 
tsetse flies due to the initial spraying coverage. However, at nine months follow up, T. brucei s.l., T. b. 
rhodesiense, T. vivax and T. congolense Savannah prevalence in the non treated animals was 
insignificantly different from the prevalence in animals subjected to intervention, indicating the 
increased challenge of all the animals with the flies due to inadequate spraying.    
The type of mixed infections identified at baseline was T. b. brucei./T. vivax with no T. b. rhodesiense 
involved in the combination. No mixed infection was detected three months post-intervention. Nine 
months post-intervention, mixed infection combination included one T. brucei s.l./ T. congolense 
Savannah and two of the remaining 14 T. brucei s.l./T. vivax included T. b. rhodesiense sub species.  
6.5.2.2 Impact of intervention at district level 
The results obtained were broken down to district level to find out if there was any difference between 
the districts included in the current study. The results in Table 6.6 show that there was a significant 
reduction of the overall parasitic events three months post-treatment in the three districts, indicating 
the success of the mass treatment in reducing trypanosome species from animals. Although there was 
a significant increase of the prevalence nine months post-intervention (compared to three months), this 
increase was insignificantly lower than the baseline prevalence. So, in the absence of sustained control 
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measures the trypanosome population returned to the baseline level meaning that the transmission is 
not interrupted by single mass treatment. This also might be attributed to the lower proportion of 
sampled animals at three and nine months follow up that had received treatment due to slaughtering, 
selling or introduction of new animals. 
Looking at the impact of the treatment programme on the prevalence of T. brucei s.l. in the three 
chosen districts, the results showed also a significant reduction three months post-intervention. Lira 
district had the significantly higher reduction in T. brucei s.l. infection than the other two districts. The 
intervention programme studied by Fyfe (2007) in south-east Uganda showed a significant reduction 
in T. brucei s.l. prevalence in Soroti and Kamuli districts three months following treatment. The 
human infective species T. b. rhodesiense was significantly reduced in Dokolo and Lira district post-
intervention; however, in Dokolo the prevalence was significantly increased again by nine months 
post-intervention to prevalence insignificantly lower than the baseline prevalence.   
Regarding T. vivax prevalence, a significant reduction was only noticed in Lira district at three months 
post-intervention. In contrast to T. brucei s.l., the re-infection of animals with T. vivax was higher than 
the prevalence at baseline. However, only Kabermaido district had a significant increase in T. vivax 
prevalence at nine months compared to baseline. This coincides with the results obtained by Fyfe 
(2007) who noticed a paradoxical increase of T. vivax prevalence in Soroti district (adjacent to 
Kabermaido district) one year post-intervention although this was statistically insignificant. Fyfe 
(2007) argued that the short development period of T. vivax within the vector might result in the rapid 
resumption of T. vivax transmission after any intervention. 
6.5.2.3 Impact of intervention at village level 
The results in Figures 6.11-6.13 show the impact of the treatment programme on the prevalence of 
trypanosomes at village level. A significant reduction of the overall parasitic events prevalence was 
detected in six villages including Omer, Awinyipany, Okwar, AbuongB, Ogengo and Onyakede 
villages. The impact of the campaign was insignificant in Mwatma and Abienek villages. 
Unexpectedly, although the proportion of animals in Olep village that had received treatment was 
94.6%, the prevalence of the overall parasitic events was insignificantly higher at three months follow 
up compared to the baseline prevalence. Nine months post-intervention, the only village that had 
continous reduction of the overall parasitic events prevalence was Amwoma village. However, re-
infection of the animals was reported in the other villages indicating the importance of continuous 
treatment of the animals accompanied with spraying to decrease the challenge with tsetse flies.  
Infection with T. brucei s.l. species was significantly reduced three and nine months post-intervention 
in Omer and Mwatma villages indicating the success of the campaign in these two villages in clearing 
the infection for nine months post-intervention. Although a reduction in T. brucei s.l. prevalence was 
noticed in Mwatma village during the study period this reduction was insignificant. In Awinyiipany, 
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Okwar, AbuongB and Ogengo villages there was a significant reduction of T. brucei s.l. infections 
three months post-intervention.  
The impact of the treatment programme on the infection with T. vivax species was only significant in 
AbuongB village at three months post-intervention. 
T. congolense Savannah was only detected in Abieneik village at baseline and three months post-
intervention. Nine months post-intervention, the infection with T. congolense Savannah was cleared 
from Abieneik village and detected in Mwatma and Awinyiipany villages. This could be due to 
movement of the animals or slaughtering of the animals that were infected in Abieneik and challenge 
of the animals at the other two districts with flies infected with T. congolense Savannah. 
6.5.2.4 Impact of the drugs used on the prevalence of trypanosome 
species infections 
Diminazine-aceturate is a curative trypanocidal drug without any reported protective period leading to 
re-infection of the treated animals if they were challenged with flies carrying trypanosomes. However, 
ISM has been reported to give a prophylactic period of 2-3 months when it is used at a dose of 1 
mg/kg body weight (Peregrine et al., 1991).  
The results in Table 6.7 show the impact of using ISM and DI on the prevalence of different 
trypanosome species. The two drugs showed a significant reduction on the prevalence of the overall 
parasitic events, T. brucei s.l., T. vivax and mixed infections. However, the percentages of reduction of 
the aforementioned species prevalence were higher using DI than using ISM. It was expected that 
cattle in areas treated with DI would be re-infected with trypanosomes at the three months follow up; 
however, this was not the case, with the drug showing a significant reduction of trypanosome species.  
Diminazine-aceturate was reported to clear the experimentally infected animals with T. vivax 24 hours 
following infection (Desquesnes, 1997). Moreover, the fast recovery of PCV in animals infected with 
T. brucei s.l. and T. congolense was reported by Van den Bossche et al. (2005) following DI 
treatment. The re-infection of animals with trypanosomes nine months post-intervention could be 
attributed to the insufficient spraying coverage, the absence of re-treatment coverage, re-infection 
from a tsetse and also the inability of the drugs to reach body tissues such as the brain where T. brucei 
s.l. is sometimes located (Waiswa et al., 2003).  
The appearance of new T. vivax infections nine months post-intervention in the current study using 
ISM and DI agrees with the reported results by Stevenson et al. (1995) who stated that T. vivax 
infections were not always cleared by ISM. They related the re-appearance of T. vivax infection 
following ISM treatment to resistance to the drug which has become increasingly common due to 
wide use of ISM to control trypanosomiasis in Africa (Stevenson et al., 1995).  
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Drug resistance against ISM and DI has been reported in different parts of Africa due to regular use of 
these drugs in treatment and prophylaxis. Resistance against ISM has been reported in cattle in 
western Ethiopia (Tewelde et al., 2004), while in Zambia resistance against both ISM and DI was 
reported by Sinyangwe et al. (2004). Development of DI resistance was reported by Rowlands et al. 
(1993) in Ethiopia after 20 days of treating the cattle with 7 mg/kg DI. Although in the current study 
relapse of trypanosomes was noticed at nine months follow up, three months post-intervention the 
reduction was significant.  
The inconsistency in the findings of the current study and the results reported by Rowlands et al., 
(1993) might be due to different geographic locations. Moreover, experimental infection of cattle with 
T. vivax revealed the relapse of infection following treatment with DI and the authors argued that this 
relapse might have resulted from drug resistance (Bengaly et al., 2001). However, drug resistance in 
Uganda against the two drugs has not been reported because these drugs are not used as regularly 
when compared to other parts of Africa. Although drug resistance in Uganda has not been reported, 
attention should be paid to avoid the unsupervised use of the limited range of trypanocidal drugs. This 
is because the unsupervised use of the limited range of drugs available for the treatment of 
trypanosomiasis could hasten the emergence of cross-resistant strains of trypanosomes, the control of 
which would be more difficult and more expensive (Connor and Halliwell, 1987). 
In conclusion, the analyses of the results indicated the success of the mass treatment programme in 
reducing the prevalence of trypanosome species from animals three months post-intervention. The re-
infection of the animal population with trypanosomes in absence of continued treatment as seen nine 
months post-intervention indicated high challenge with infected tsetse flies or possibly movement of 
infected animals into the study area. The results denote that in the absence of sustained intervention, 
the trypanosome level returned to pre-treatment levels, however with an altering of the dynamics of 
the population with T. vivax occurring more frequently. This might be attributed to the short lifecycle 
in the fly of T. vivax or increased challenge of animals with other vectors carrying T. vivax. However, 
anecdotal evidence suggested that animals included in this programme were seen to be healthier and 
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7.1.1 Mixed trypanosome infections in tsetse flies 
Natural infection rates in tsetse flies are traditionally estimated by microscopical examination of 
different parts of the fly after dissection, together with the isolation of the parasite in vivo (Hoare, 
1972). These methods are laborious and time consuming, coupled with the potential inaccuracy of 
differentiating between immature infections of T. brucei s.l. and T. congolense and mature infections 
of T. congolense and T. vivax.  
Field studies have revealed that many vertebrate species which serve as natural hosts of Glossina 
often carry mixed infections of T. brucei s.l., T. congolense species and/or T. vivax (Moloo et al., 
1982). Therefore, the frequency of mixed infections in wild flies depends on the frequency of mixed 
infections in mammalian hosts (Gibson and Ferris, 1992). Mixed infections might result from 
sequential infections (fly feeds on two infected animals) or simultaneous infections where the fly 
feeds on one animal with a mixed infection (Morlais et al., 1998b). 
Mixed species infections have been widely reported in tsetse flies with a variation in the prevalence; 
for instance, Woolhouse et al. (1996) reported only 6.2% prevalence of mixed infections in 10,000 
tsetse flies collected from Zimbabwe and examined with PCR. Lower prevalence of mixed infections 
were documented in Cameroon by Morlais et al. (1998a) who identified 2.2% mixed infections in 943 
tsetse flies using PCR. However, another study conducted in the same area reported a prevalence of 
7.1% mixed infections in 467 tsetse flies examined by PCR analysis (Morlais et al., 1998b).  
In Tanzania, Adams et al. (2006) reported a prevalence of 1% mixed infections in 2392 tsetse flies 
using PCR on midguts applied on FTA®cards. In northern Tanzania, 3741 flies were examined and 
3.4% of infections were documented to be of mixed species by Lehane et al. (2000) using PCR. In 
Kenya, 1.3% of the examined 3826 flies were harbouring mixed infections (Njiru et al., 2004b). In 
West Africa, Cote d’Ivoir, mixed infections were reported in 2.5% of the examined 811 flies using 
PCR (Masiga et al., 1996), however, a higher prevalence of 6.5% was reported in the same area by 
McNamara et al. (1995b).  
It has been also shown that it is possible for tsetse to acquire mixed infections experimentally either 
simultaneously or sequentially, a number of studies have investigated the occurrence of mixed 
infections in experimentally infected flies using an end point PCR (Gibson and Ferris, 1992; Kubi et 
al., 2005; Masiga et al., 1992; Moloo et al., 1982; Peacock et al., 2007; Reifenberg et al., 1997b). 
However, none of these studies has looked to quantify the infection load of tsetse flies with 
trypanosomes in these mixed infections. End point PCR is only qualitative and is time consuming due 
to the need for visualising the results by agarose gel. In contrast, although more expensive, qPCR 
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allows the quantification of DNA and is also less time consuming due to real time visualization of the 
results which in the long run can reduce the overall costs (Ranasinghe et al., 2008). 
As the natural infection rates of the University of Edinburgh tsetse colony range from 5 to 20% 
(MacLeod, 2005), it was decided, for preliminary work, to artificially increase the infection rates 
using glutathione (GSH). As this was a preliminary experiment to validate qPCR as an effective tool 
for the measurement of trypanosome populations in the tsetse midgut, it was felt that it would be 
better to give the trypanosomes every chance of establishing an infection (through the addition of 
GSH) rather than go down the natural infection route where many hundreds of flies would have to be 
dissected to gain similar numbers of infected midguts.  
GSH is an antioxidant and is thought to mop up free radicals produced either by the fly or as part of 
the bloodmeal breakdown during the establishment phase in the midgut (MacLeod et al., 2007). 
Previous studies had suggested that tsetse derived lectins were responsible for trypanosome death 
(Welburn et al., 1993) as the addition of the sugar glucosamine could increase infection rates 
(Maudlin and Welburn, 1987). However, it has been recently recognised that glucosamine can act as 
an antioxidant (Xing et al., 2006) and it may be that glucosamine acts in a similar way to GSH in 
mopping up free radicals (MacLeod et al., 2007). 
7.1.2 Quantitative PCR 
7.1.2.1 Principle of qPCR 
Different methods of DNA quantification are used in molecular biology such as PCR-ELISA and 
Southern hybridization. Although, the limitations of these methods include the fact they are time 
consuming, labour intensive, insufficient sensitivity, inaccurate for quantification, require the use of 
radioactivity and may result in a substantial probability of cross contamination (Reischl et al., 2002; 
Valasek and Repa, 2005). 
Recently, fluorescent real-time monitoring of amplicon accumulation has been developed to overcome 
the limitations encountered with conventional PCR reactions so that post-PCR end point analysis is 
not necessary (Heid et al., 1996). Quantitative PCR has been found to have advantages over the 
aforementioned methods, most importantly in the ability of accurate quantification of the target DNA 
with high sensitivity, allowing the detection of less than five copies of the target sequence. Moreover, 
the rapid performance and the removal of the visualization stage using gel electrophoresis makes 
qPCR quicker and less liable to contamination because handling of the samples is minimized (Klein, 
2002; Valasek and Repa, 2005). 
Quantitative PCR was pioneered by Higuchi and colleagues (1992 and 1993) who included ethidium 
bromide, as a fluorescent dye. The PCR was run under ultra-violet (UV) light thus causing the 
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ethidium bromide to fluoresce; researchers were able to visualise and record the accumulation of DNA 
with a video camera (Higuchi et al., 1992; Higuchi et al., 1993). The combination of high sensitivity 
and specificity, low contamination risk, ease of performance and speed, has made qPCR technology 
an appealing alternative to conventional methods (Espy et al., 2006). 
The quantification of the template original copy number is determined at the exponential phase of the 
reaction; at this point the reaction is able to efficiently amplify the DNA in the presence of adequate 
reactants (Figure 7.1). However, during the plateau phase, no more products are amplified due to the 
exhaustion of the ingredients and if left long enough, the PCR products will begin to degrade (Newton 
and Graham, 1997; Valasek and Repa, 2005). The crucial conceptual innovation and the key to 
understanding quantification by qPCR is the threshold cycle (Ct), which is the cycle at which the 
amplification plot crosses a fluorescence threshold (Bustin, 2006) (Figure 7.1). The Ct value is 
inversely proportional to the amount of the specific nucleic acid sequence in the original sample. 
 
Figure 7.1: A diagram showing the crossing of the fluorescence plot to a fluorescence threshold 
to determine Ct value for each sample during PCR amplification 
Although the advantages achieved by using qPCR are plentiful, several limitations are also 
encountered, including the inhibition of qPCR by compounds that occur in certain types of samples, 
for example, samples from body fluids contain inhibitors such as urea and haemoglobin (Valasek and 
Repa, 2005; Wilson, 1997). This limitation may be circumvented using alternative DNA polymerases 
(Pwo, Tth) that are resistant to particular inhibitors. Another major limitation is the use of RNA in 
gene expressions assays because RNA is more labile than DNA, therefore, isolation should be 
carefully performed to ensure both the integrity of RNA itself and the removal of contaminating 
 198 
nuclease genomic DNA and PCR inhibitors (Bustin, 2002; Bustin and Nolan, 2004; Valasek and 
Repa, 2005). 
7.1.2.2 Chemicals required for qPCR  
Monitoring the progress of DNA amplification in real-time requires specific chemicals and 
instruments. The required chemicals for qPCR consist of special fluorescent reporters; different types 
of fluorescent reporters are currently used for qPCR such as SYBR Green I, 5’-nuclease probes 
(TaqMan), molecular beacons and fluorescence resonance energy transfer (FRET) hybridization 
probes (Espy et al., 2006; Valasek and Repa, 2005). 
SYBR Green I  
SYBR Green I is an intercalating dye that binds to double stranded DNA emitting fluorescence that is 
1000-folds higher than when it is free in solution (Valasek and Repa, 2005; Wittwer et al., 1997). 
Therefore, the amount of fluorescence increases proportionally with the amount of DNA (Figure 7.2).  
.  
 
Figure 7.2: Illustration of SYBR Green I mechanism of binding (green stars represent SYBR 
Green I molecules), protocol adopted from Valasek and Repa (2005) 
Due to the higher sensitivity of the dye, it will bind to any double stranded DNA occurring in the tube, 
so that in addition to the desired target, primer dimers and other extraneous double stranded products 
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may also be detected (Valasek and Repa, 2005; Wittwer et al., 1997). In this case, the dissociation 
curve of the amplified product is analysed to determine the melting temperature that gives an 
indication if one or more products were amplified allowing us to distinguish between the amplified 
products and primer dimers or non-specific amplicons (Figure 7.3). Therefore, once the protocol has 
been optimised there should be no problem with dimer formation. 
 
Figure 7.3: Dissociation curve showing the amplified product melting temperature (82ºC) and a 
second peak at lower melting temperature (70ºC) indicating primer dimers 
Probes 
For sensitive and specific detection of amplified products, the use of FRET probes that rely on the 
transfer of light energy between two adjacent dye molecules is currently accomplished by qPCR 
technology. The intensity of emitted fluorescence using FRET probes depends on the distance 
between the dye molecules, as the distance increases, FRET decreases  (Espy et al., 2006). The 
commonly used FRET probes are hydrolysis probes (TaqMan), molecular beacons and FRET 
hybridization probes.  
TaqMan probes were the first developed 5’-nuclease probes for qPCR. They are a short DNA 
sequence (single strand) that are designed to be complementary to a specific sequence in the target; it 
contains a fluorescent dye (reporter) at the 5’ end and a quenching dye (absorbs the signal from the 
fluorescent dye) at 3’ end. The light of the fluorescent dye is not emitted as long as the quencher is 
attached to the probe, in order to remove the effect of the quenching dye to generate the light signal, 
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firstly the probe must bind to the complementary sequence at 60ºC. Secondly, at the same 
temperature, the Taq polymerase cleaves (free) the 5’ end of the probe separating the fluorescent dye 
from the quenching dye, causing accumulation of the fluorescent dye emitting the light signal which 
can be measured at any time during the PCR cycle including the hybridization step (Figure, 7.4). 
FAM, VIC, NED are examples of the fluorescent dyes and TAMRA, DABCYL and BHQ are 
examples of quencher dyes (Espy et al., 2006; Mackay, 2004; Mackay et al., 2002).   
 
Figure 7.4: TaqMan probe composition and mechanism of action (R: reported dye, Q: quencher 
dye), protocol adopted from Espy et al. (2006) 
Molecular beacons are another type of fluorescent probes used in qPCR, based on a sequence that 
binds to a complementary part in the target DNA. A fluorescent reporter is attached to the 5’ end and 
the quencher is attached to the 3’ end; in contrast to TaqMan probes, the reporter is not cleaved by the 
5’ nuclease activity. The mechanism of action of molecular beacons (Figure 7.5) depends on the 
design of the probe with a region at each end to be complementary to each other, so at low 
temperature, the ends anneal creating a hairpin structure. This close proximity leads to quenching of 
the fluorescence from the reporter dye, as the temperature increases, the probe and the target are single 
stranded and hybridization of the probe to the complementary sequence occurs leading to separation 
of the reporter from the quencher omitting light signal which can be measured at the time of 
hybridization only (Espy et al., 2006; Mackay, 2004; Mackay et al., 2002).  
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Figure 7.5: Molecular beacon before (left) and after (right) hybridization to the specific target 
(www.bio.davidson.edu/Courses/genomics/method/beacon1.gif)   
Finally, FRET hybridization probes are two DNA probes designed to anneal next to each other in a 
head-to-tail configuration on the PCR product. The upstream probe has a fluorescent dye on 3’ end 
and the downstream probe has an acceptor dye on the 5’ end. If both probes anneal to the target, 
fluorescence from the 3’ dye is absorbed by the adjacent acceptor dye which when excited will emit 
light to be detected by the qPCR machine (Figure 7.6). In the absence of target, the probes will not 
anneal and the two dyes will not associate with each other thus preventing FRET from occurring. The 
3’ end of the downstream probe is phosphorylated to prevent it from being used as a primer by Taq 
polymerase during PCR amplification. The specificity of FRET hybridization probes is extremely 
high because the two probes encompass a region of 40-50 bp (Espy et al., 2006; Mackay, 2004; 
Mackay et al., 2002). 
 
Figure 7.6: Illustration showing the mechanism of action of FRET hybridization probes 





An important requirement for qPCR technology is the use of specific instruments able to detect the 
fluorescent signal and record the progress of the PCR. Fluorescent chemicals require both a specific 
input of energy for excitation and a detection of a particular emission wavelength; for these purposes, 
the instrumentation should be able to do both simultaneously at a desired wavelength. Quantitative 
PCR machines can supply the excitation energy using a lamp, light-emitting diode (LED) or laser, the 
desired wavelength is filtered to the sample. The emission energies are filtered to obtain the 
appropriate wavelengths and detected using photo-detectors, such as cameras, which transfer the data 
to data-acquisition and analysis software. Figure 7.7, shows the basic instruction of qPCR instrument 
(Espy et al., 2006; Kubista et al., 2006; Valasek and Repa, 2005). 
 
Figure 7.7: Illustration of the basic structure of qPCR instrumentation 
(openwetware.org/images/3/31/DNA_Melting_Block_Diagram.jpg)  
7.1.2.4 Absolute and relative quantification 
Absolute quantification is used to determine the copy number of a certain gene or the load of infective 
pathogen in a sample; this is achieved by generating a standard curve from dilutions of a known 
standard. Running unknown samples in the same assay with the standard curve quantifies the DNA in 
those samples when their Ct values are compared with the standard curve (Kuhne and Oschmann, 
2002; Valasek and Repa, 2005). Relative quantification measures changes in the steady-state levels of 
the gene of interest relative to control genes (housekeeping gene) such as ß-actin and 18S rRNA 
(Dheda et al., 2004; Valasek and Repa, 2005). 
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7.1.2.5 Application of qPCR in trypanosomes and insect vectors  
The use of qPCR in quantifiying T. brucei s.l. in human blood samples was first reported by Becker et 
al. (2004). The authors developed a qPCR assay for the detection of T. brucei s.l. in blood samples 
from sleeping sickness patients collected onto FTA®cards. DNA was eluted from 10 discs using 
Chelex®100 and subjected to qPCR reaction. The authors re-designed the primers targeting the 177 bp 
repetitive DNA satellite sequence (Moser et al., 1989a) to get rid of the tendency of the primers to 
form secondary structures. The reported sensitivity of the reaction was 100 trypanosomes/ml blood, 
with an efficiency of 86%.  
In the insect vector, qPCR has been used to estimate Leishmania chagasi load in experimentally 
infected sand fly vectors (Ranasinghe et al., 2008). The authors used a TaqMan qPCR that had an 
efficiency of 75% with a sensitivity of 120 parasites. Also, qPCR reaction based on SYBR Green I 
chemistry was reported to have efficiency of 88.6% and a sensitivity of detecting 10 Plasmodium 
falciparum parasites in experimentally infected mosquito vector (Bell and Ranford-Cartwright, 2004).  
7.2 Objectives 
The aim of the work presented in this chapter is to evaluate qPCR as a tool for the quantification of T. 
b. brucei and T. congolense Savannah in tsetse midgut infection. Moreover, it aims to study 
differences in the number of each trypanosome species in the midgut of the fly in mixed infections. 
7.3 Material and Methods 
7.3.1 Quantitative PCR 
QPCR was performed in a DNA Engine Opticon 2 Continuous Fluorescence Detector (MJ Research), 
each set of reactions are able to assay 96 tubes. Standards and samples were tested in triplicate and 
expressed as mean values. Controls consisted of tubes containing the mastermix only (no template 
DNA) were also used.  
7.3.1.1 Preparation of trypanosome procyclic forms 
Procyclic forms were prepared as previously explained in Chapter IV (sections, 4.3.1.1 and 4.3.1.2).  
The number of the trypanosomes per ml was estimated using haemocytometer quantification. 
7.3.1.2 Preparation of standards for qPCR   
Standards for qPCR quantification were prepared using a ten fold serial dilution from the procyclic 
cultures after quantification of T. b. brucei and T. congolense Savannah using a haemocytometer to 
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obtain standard ranging from 4x106 to 4 parasites per ml, as the DNeasy®Blood and Tissue kits 
(Qiagen), used to prepare the DNA, recommended a concentration <5x106 cells/ml. Cultured 
procyclics were centrifuged for five minutes at 300 x g, the pellet was then resuspended in 200 µl PBS 
and 20 µl proteinase K were added and the extraction was done as previously explained in Chapter III 
(section, 3.4.3.2). 
In order to confirm the accurate quantification of the standards using the haemocytometer, DNA 
concentration was measured after extraction using a NanoDrop ND-1000 spectrophotometer (Nano-
Drop Technologies, Wilmington, DE), and the concentration was related to the assumed amount of 
DNA from one parasite which is reported to be 0.1 pg (Borst et al., 1982). After extraction of the 
DNA from T. b. brucei and T. congolense Savannah cultures, DNA concentration was measured and 
found to be 4.18x105 pg and 4.13x105 pg, respectively, these concentrations are equivalent to DNA 
from 4.18x106 and 4.13x106 parasites, respectively. 
Trypanosome standards were spiked over a fixed amount of Glossina DNA to ensure that the latter 
was not an inhibitory factor in the reaction and to mimic natural conditions in the infected flies where 
trypanosome DNA exists with Glossina DNA. Moreover, the standards were spiked with the fly DNA 
to ensure that the increase in the fluorescence in the standards resulted from the increase of 
trypanosome DNA concentration. The amount of DNA to spike the standards was calculated 
according to the average Glossina DNA in a single fly. Using the NanoDrop quantification of the 
Glossina DNA in the non-infected midguts, the average amount of DNA was 2600 ng/fly (13 ng/µl). 
However, using the Glossina qPCR on non-infected flies, the average amount of the DNA in a single 
fly was 2724 ng/fly (13.6 ng/µl). The amount calculated using Glossina qPCR was added to each 
trypanosome DNA standard. 
The Glossina DNA standards used for Glossina qPCR were prepared by 10 fold serial dilution of the 
DNA starting from a concentration of 93.4 ng/µl and four points of dilution were used.  
The cycle threshold of the reactions was detected by the Opticon software. The mean Ct and standard 
deviations were calculated for each individual standard using data from the triplicates, and graphs of 
mean Ct against standard concentration were plotted to obtain a line of best fit. 
7.3.1.3   Evaluation and optimisation of T. brucei s.l. qPCR reactions 
7.3.1.3.1 T. brucei s.l. qPCR using satellite DNA target 
QPCR amplifying 177 bp repetitive DNA sequence of T. brucei s.l. was reported by Becker et al. 
(2004) using SYBR Green I PCR core reagents kit (Applied Biosystems). The authors re-designed the 
primers to overcome 6ºC difference between the melting temperatures of the two primers. The 
sequences of the primers are Tb177F: 5’-AAC AAT GCG CAG TTA ACG CTA T-3’ and Tb177R: 
ACA TTA AAC ACT AAA GAA CAG CGT TG-3’, these primers amplify 134 bp amplicon.  
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The amplification mixture contained 1 µl DNA template, 300 nM of each primer, 0.25 units 
AmpliTaq Gold DNA polymerase, 0.1 units AmpErase [uracil-N-glycosylase (UNG)], 0.2 mM of the 
four dNTPs, 0.4 mM dUTP, 3 mM MgCl2 and 1 µl 10X SYBR Green I buffer with ROX fluorescence 
dye as a passive reference in a final volume of 10 µl. 
The qPCR reaction was performed in a DNA Engine Opticon 2 Continuous Fluorescence Detector 
(MJ Research). The reaction conditions used were 50ºC for two minutes to activate UNG, 95ºC for 10 
min then 30 cycles at 94ºC for 20 seconds and 66ºC for one minute followed by plate read for 
fluorescence acquisition. A temperature gradient between 60ºC and 95ºC was run to obtain the 
dissociation curve. Amplicons were visualised using 1% agarose gel to confirm specificity of the 
reaction. The standards and samples were run in triplicates and expressed as a mean value, non-
template controls were also used to check the presence of contamination.   
7.3.1.3.2 T. brucei s.l. qPCR using a single copy gene target  
Primers targeting the single copy glycosyl-phosphatidylinositol-specific phospholipase C (PLC gene) 
(Mensa-Wilmot et al., 1990) specific for Trypanozoon, reported by Picozzi et al. (2008) were used for 
qPCR. The sequences of the primers are PLC1: 5’- CGC TTT GTT GAG GAG CTG CAA GCA-3’ 
and PLC2: 5’- TGC CAC CGC AAA GTC GTT ATT TCG-3’, they amplify 324 bp amplicon. 
The amplification mixture contained 1 µl DNA template, 200 nM of each primer, 5 µL SYBR Green I 
ready-made master mix supplied by Qiagen (containing HotStarTaq DNA Polymerase, Quantitect 
SYBR Green I PCR Buffer [Tris-Cl, KCl, (NH4)2SO4, 2.5 mM MgCl2, pH 8.7], 0.2 mM dNTP mix, 
SYBR Green I dye, ROX dye), 0.1 units AmpErase [Uracil N-glycosylase] (Applied Biosystems). 
Water was added to a final volume of 10 µl.  
 
The reaction conditions used were 50ºC for two minutes to activate UNG, 95ºC for 15 min then 40 
cycles at 94ºC for 30 sec, 63ºC for 90 min and 72ºC for 70 sec followed by plate read for fluorescence 
acquisition. A temperature gradient between 55ºC and 95ºC was run to obtain the dissociation curve. 
Amplicons were visualised using 1% agarose gel to confirm specificity of the reaction. The standards 
and samples were run in triplicates and expressed as a mean value, non-template controls were also 
used to check the presence of contamination.  
7.3.1.4 Optimisation of T. congolense Savannah qPCR 
Primer optimisation 
Two primer sets that had been previously used for the amplification of T. congolense Savannah 
(Masiga et al., 1992; Moser et al., 1989a) were chosen for the qPCR reaction in the current study. The 
primer sets were those amplifying a satellite DNA sequence which occurs in the parasite genome as 
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5400 copies and results in amplification of 316 bp of the product. However, according to the 
guidelines for primer design to be used in qPCR, the theoretical melting temperature of the two 
primers should be within 2ºC of each other. For this reason, one base was removed from the reverse 
primer sequence to obtain 2ºC difference. The sequences for the T. congolense Savannah primers used 
for qPCR are TCS-RF: 5’-GGA CAA ACA AAT CCC GCA CA-3’ and TCS-RR: C GAG AAC GGG 
CAC TTT GCG A-3’, these primers amplified 315 bp of the target sequence (the red colored base was 
the one removed from the re-designed primers). 
For SYBR Green I chemistry, relatively low primer concentrations ranging from 50-300 nM are used 
to avoid primer-dimer formation, therefore, a primer optimisation matrix was used and for each primer 
pair; reactions were run in duplicate with the appropriate negative controls for each concentration. The 
ideal primer pair that resulted in lowest average Ct and a single product for the template when running 
a dissociation curve was chosen for the reaction. 
Reaction conditions 
Different SYBR Green I master mixes were used (Qiagen, Bio-Rad and Applied Biosystem), Bio-Rad 
kits was chosen because it resulted in lower Ct values. Each PCR reaction contained 1 µl of the 
extracted DNA, 300 nM of each primer, 5 µl iQ™SYBR®Green I supermix (Bio-Rad) that contains 
50 mM KCl, 20 mM Tris-HCl, pH 8.4, 0.2 mM of each dNTP, 0.25 units iTaq DNA polymerase, 3 
mM MgCl2, SYBR Green I, 10 nM fluorescein. Water was added to a final volume of 10 µl.  
The cycling programme was initiated with denaturation of DNA and polymerase activation at 95ºC for 
10 min followed by 30 cycles each of 94ºC for 20 sec and 60ºC for one minute followed by plate read 
for fluorescence acquisition. Dissociation curve was acquired by melting the amplified product from 
55ºC to 95ºC. Amplicons were visualised using 1% agarose gel to confirm specificity of the reaction. 
The standards and samples were run in triplicates and expressed as a mean value; non-template 
controls were also used to check for the presence of contamination.   
7.3.1.5 Optimisation of Glossina species qPCR 
7.3.1.5.1 Preparation of Glossina DNA 
DNA extraction from midguts was done using DNeasy®Blood and Tissue kits (Qiagen); midguts 
placed in micro-centrifuge tubes in 180 µl PBS were homogenised using disposable micro-tube 
pestles.  
For each sample, 20 µl proteinase K and 200 µl buffer AL were added and mixed thoroughly by 
vortexing then incubated at 56ºC for 10 min. Ethanol (96-100%) was added to the sample with the 
amount of 200 µl and mixed thoroughly by vortexing. The mixture was pipetted into DNeasy Mini 
spin column placed in a 2 ml collection tube and the flow-through was discarded after centrifugation 
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at 8000 rpm for one minute. For washing the sample, 500 µl of washing buffer AW1 was added and 
centrifuged for one minute at 8000 rpm. Another washing step was done using 500 µl of the washing 
buffer AW2 and centrifuged at 14,000 rpm for three minutes. DNA was eluted by placing the DNeasy 
Mini spin column in a clean micro-centrifuge tube and adding 200 µl of elution buffer AE directly on 
the DNeasy membrane. After incubation at room temperature for one minute, the tubes were 
centrifuged at 8000 rpm for one minute. 
7.3.1.5.2 Reaction conditions 
Primers targeting the alpha-elongation factor specific for Glossina species, reported by Mathew 
(2007) were used for qPCR. The sequences of the primers are TseAF: 5'-CGG CTG GCA CGG TGA 
TAA CAT-3' and TseAR: 5'-GCG GGA GGG TGG CAA CATT-3', they amplify 121 bp amplicon. 
The amplification mixture contained 1 µl DNA template, 300 nM of each primer, 5 µL SYBR Green I 
ready-made master mix supplied by Qiagen (containing HotStarTaq DNA Polymerase, Quantitect 
SYBR Green I PCR Buffer [Tris-Cl, KCl, (NH4)2SO4, 2.5 mM MgCl2, pH 8.7], 0.2 mM dNTP mix, 
SYBR Green I dye, ROX dye), 0.1 units AmpErase [Uracil N-glycosylase] (Applied Biosystems). 
Water was added to a final volume of 10 µl.  
The reaction conditions used were 50ºC for two minutes to activate UNG, 95ºC for 15 min then 40 
cycles at 95ºC for 45 sec, 57ºC for 45 sec and 72ºC for 45 sec, plate read for fluorescence acquisition 
was set up after the extension step following the first 15 cycles to get rid of fluorescence noise that 
occurs before the amplification of the product. A temperature gradient between 55ºC and 95ºC was 
run to obtain the dissociation curve. Amplicons were visualised using 1% agarose gel to confirm 
specificity of the reaction. The standards and samples were run in triplicates and expressed as a mean 
value, non-template controls were also used to check the presence of contamination. 
7.3.2 Optimisation of fly age and trypanosome infective dose 
Prior to application of the single and mixed infections for the qPCR and haemocytometer 
quantification, flies were infected with a wide range of parasites from one to 50,000 parasites per 
bloodmeal. This was done to optimise the infective dose that would result in an infection of 100% of 
the flies when GSH was used to increase the infection rate. 
7.3.2.1 Tsetse fly origin and maintenance 
Glossina morsitans morsitans (Westwood) were originally from the Langford colony established at 
Bristol from pupae collected from Zimbabwe in 1967; the colony has been at University of Edinburgh 
for 10 years. Tsetse flies were kept at 25oC ± 1oC, at 70% relative humidity. Pupae were collected 
from deposition trays and placed into an emergence cage. Once tsetse flies had emerged they were 
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chilled at 4oC for 10 min and at this time were separated into males and females, placed in cages and 
allowed to rest for 24 h before being infected.  
Tsetse flies were fed through an artificial silicon membrane system (Mews, 1980) three to four times a 
week. Defibrinated blood was poured on to trays on heating blocks (37oC) and covered with a silicon 
membrane, caged tsetse flies were then placed onto the membrane covered with a dark cloth and 
allowed to feed for 10 min.  
7.3.2.2 Infection of tsetse flies with procyclic forms  
Tsetse flies had their wings clipped on emergence and were allowed to rest for 24 h before being 
infected with trypanosomes. Cultured procyclics were centrifuged at 2500 rpm for 5 min and the 
culture supernatant removed, trypanosomes were then resuspended in 5 ml of ovine blood at a 
concentration of 33 to 1.67x106 /ml which is equivalent to one to 50,000 parasites per blood meal, 
respectively.  
Infective bloodmeals were supplemented with 15 mM GSH (MacLeod et al., 2007) in order to 
increase the midgut infection rate. As the infection rate in this colony is low <20% it was decided for 
practical reasons that it would be better to increase the midgut infection rate. The infective bloodmeal 
was then placed on a heated tray and covered with a silicon membrane. Tsetse were then placed on the 
membrane and allowed to feed. Flies that did not feed were removed from the experiment. 
Teneral male G. m. morsitans received an infective bloodmeal containing procyclic T. b. brucei isolate 
(BUT 135) and/or T. congolense Savannah isolate (Sikudo 124 isolated from a cow in Sikudo, Tororo 
district, Uganda, 1990) supplemented with 15 mM GSH. 
7.3.2.3 Dissection of the flies 
Tsetse flies were chilled at 4oC for 30 min then kept on ice until dissection. Flies were dissected in 
saline 15 days post-infection; midguts were homogenised in 100 µl PBS and then placed on to 
FTA®cards. 
7.3.2.4 Preparation of DNA for PCR 
Samples applied onto FTA®cards were processed by eluting DNA from 10 discs (0.2 mm) using 
Chelex®100 as previously described in Chapter IV (section, 4.3.2.2.3). The same eluate was used for 
the conventional PCR reactions on each sample. 
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7.3.2.5 Conventional PCR 
The primer sequences, reaction conditions and the size of the amplified products of TBR-PCR and 
TCS-PCR are detailed in chapters IV and V, respectively.  
7.3.3 Single and mixed infection experiment 
7.3.3.1 Infection of tsetse flies with procyclic forms 
For qPCR and haemocytometer quantification, flies were infected with 1.67x106 parasites/ml blood 
(equivalent to 50,000 parasites/bloodmeal). Dissected midguts were placed in a micro-centrifuge tube 
containing 200 µl PBS for DNA extraction. Twenty microliters were taken out for counting 
trypanosomes using haemocytometer and the remaining 180 µl was used for DNA extraction from 
midguts for qPCR. 
7.3.3.2 Dissection of the flies 
 Flies were dissected 15 days post-infection as previously described in section 7.3.2.3 of this chapter. 
7.3.3.3 Preparation of DNA for qPCR 
DNA from the dissected midguts was extracted as previously mentioned in section 7.3.1.5.1 of this 
chapter. 
7.4 Statistical analysis 
The qPCR amplification efficiency (E) determined by linear regression of the standard curve was 
calculated from the slope (s) of the standard curve using the equation: E=10-1/s -1 (Klein et al., 1999). 
The acceptable efficiency of the qPCR assay should be between 90-110%. 
Inter assay precision was calculated using the following formula (Murray et al., 1993): Inter-assay 
precision= (Standard deviation of the mean Ct of the triplicates/ Grand mean Ct of the triplicates) x 
100 
Normality of the data distribution was tested using the Anderson-Darling normality test in Minitab 
version 15 (Minitab, Inc.). The data were considered not normally distributed when p-value was 
<0.05. 
Correlation between haemocytometer and qPCR quantification and Mann-Whitney U test were 
calculated using Minitab version 15 (Minitab, Inc.). Kruskal-Wallis one way analysis of variance 
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(ANOVA) and Dunn’s multiple comparison tests were calculated using GraphPad Prism, Inc., version 
5.02. 
7.5 Results 
7.5.1 Quantitative PCR 
Prior to the application of the single and mixed experimental infections of G. m. morsitans, different 
qPCR reactions were optimised and evaluated. The reactions include specific qPCR for T. brucei s.l., 
T. congolense Savannah and Glossina species. 
7.5.1.1 Evaluation and optimisation of T. brucei s.l. qPCR 
Two reactions for the quantification of T. brucei s.l. were used in the current study. The first reaction 
was the one previously reported by Becker et al. (2004) targeting a satellite DNA sequence. The 
second reaction targeting a single copy gene was optimised in the current study to get rid of the 
pitfalls encountered using the first reaction to be used in qPCR.  
7.5.1.1.1 T. brucei s.l. qPCR using satellite DNA target 
A qPCR for quantifying T. brucei s.l. DNA in human blood samples collected on FTA®cards has been 
reported by Becker et al. (2004). The authors re-designed the primers targeting the 177 bp repetitive 
DNA satellite sequence (Moser et al., 1989a) to get rid of the tendency of the primers to form 
secondary structures.  
The qPCR performance was tested using the primers on T. b. brucei extracted DNA with a 
concentration ranging from 4x106 to 40 parasites/ml using Applied Biosystems kits. The log linear 
standard curve was obtained by plotting the Ct values of the assays versus the input parasite numbers 
obtained from five reactions (Figure 7.8). 
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Figure 7.8: Average standard curve of cycle threshold (Ct) versus log (10) of T. b. brucei 
concentration/ml using AB kits. Data points were obtained by calculating the mean Ct across 
sample sets for each standard concentration from five reactions. Vertical bars represent 
standard deviations 
Figure 7.8 shows that low Pearson correlation coefficient (R2=0.914) was obtained and this indicates 
that the efficiency of amplification was not consistent at varying template concentrations. The reaction 
efficiency was calculated from the slope and it was found to be 162.1%. 
The inter assay precision was calculated in five repeats of standards and found to be more than 10% 
(12.5-35.3%) which is higher than the acceptable range. This indicates lower reproducibility of the 
assay showing variation over the six orders of magnitude which lower the precision of the applied 
assay. 
The specificity of the reaction was determined using different concentrations of other trypanosome 
DNA including T. congolense Savannah and T. vivax, and also using different concentrations of 
Glossina DNA. The results showed cross reactivity of the primers with T. congolense Savannah, T. 
vivax and Glossina genomic material especially after running the reaction more than 25 cycles. Most 
importantly, multiple bands were observed using the T. b. brucei DNA which makes this reaction not 
ideal for qPCR quantification.  
In order to justify the use of another qPCR reaction targeting another DNA sequence in T. brucei s.l. 
genomic material, the satellite DNA primers were evaluated using other kits (BioRad and Qiagen). 
Figures 7.9 and 7.10 show the standard curves poltted from the Ct values of the assays versus the 
input parasite numbers obtained from nine reactions, each. 
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Figure 7.9: Average standard curve of cycle threshold (Ct) versus log (10) of T. b. brucei 
concentration/ml using BioRad kits. Data points were obtained by calculating the mean Ct 
across sample sets for each standard concentration from nine reactions. Vertical bars represent 
standard deviations 
Figure 7.9 shows that a high Pearson correlation coefficient (R2=0.996) was obtained and this 
indicates that the reaction was linear at varying template concentrations. However, the vertical bars 
showing standard deviations indicate variation between different runs of the standards. The reaction 
efficiency was calculated from the slope and it was found to be 117.9%. 
The inter assay precision was calculated in nine repeats of standards and found to be more than 10% 
(10.5-48.8%) which is higher than the acceptable range. This indicates lower reproducibility of the 
assay showing variation over the six orders of magnitude which lowers the precision of the assay. 
The specificity of the reaction was determined using different concentrations of other trypanosome 
DNA including T. congolense Savannah and T. vivax, and using also different concentrations of 
Glossina DNA. The results showed cross reactivity of the primers with T. congolense Savannah, T. 
vivax and Glossina genomic material especially after running the reaction more than 25 cycles. 
Moreover, multiple bands were observed using the T. b. brucei DNA which makes this reaction not 
ideal for qPCR quantification.  
Figure 7.10 shows the standard curve plotted from the Ct values of the assays versus the input parasite 
numbers obtained from nine reactions using Qiagen kits. 
 213 











0 1 2 3 4 5 6 7










Figure 7.10: Average standard curve of cycle threshold (Ct) versus log (10) of T. b. brucei 
concentration/ml using Qiagen kits. Data points were obtained by calculating the mean Ct 
across sample sets for each standard concentration from nine reactions. Vertical bars represent 
standard deviations 
The results show that a high Pearson correlation coefficient (R2=0.991) was obtained and this 
indicates that the reaction was linear at varying template concentrations. The reaction efficiency was 
calculated from the slope and it was found to be 66.5%. 
The inter assay precision was calculated in nine repeats of standards and found to be less than 10% 
(1.7-5.9%) which is within the acceptable range. This indicates the reproducibility of the assay 
showing minimal variation over the five orders of magnitude with high precision of the applied assay. 
However, the sensitivity of the reaction using Qiagen kits was 400 parasites/ml with more cycle 
numbers (40 cycles). 
The specificity of the reaction was determined using different concentrations of other trypanosome 
DNA including T. congolense Savannah and T. vivax, and using also different concentrations of 
Glossina DNA. The results showed cross reactivity of the primers with T. congolense Savannah, T. 
vivax and Glossina genomic material especially after running the reaction more than 25 cycles. Most 
importantly, multiple bands were observed using the T. b. brucei DNA and we may conclude that this 
reaction is not ideal for qPCR quantification (Figure 7.11). 
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Figure 7.11: Multiple bands obtained by T. brucei s.l. qPCR using satellite DNA target. 
Amplified product size is 134 bp and double band at more than 300 bp with multiple band 
patterns are shown. L: 100 bp ladder 
7.5.1.1.2 T. brucei s.l. qPCR using a single copy gene target  
Another qPCR reaction specific for T. brucei s.l. was optimised in the current study for the 
quantification of T. b. brucei infections in midguts. The target in this reaction is the single copy PLC 
gene specific for T. brucei s.l. (Mensa-Wilmot et al., 1990).  Figure 7.12 shows the standard curve 
plotted from running the same standards for 18 reactions.  
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Figure 7.12: Average standard curve of cycle threshold (Ct) versus log (10) of T. b. brucei 
concentration/ml. Data points were obtained by calculating the mean Ct across sample sets for 
each standard concentration from 18 reactions. Vertical bars represent standard deviations 
Figure 7.12 shows that a high Pearson correlation coefficient (R2=0.9996) was obtained and this 
indicates a linear standard curve which implies that the efficiency of amplification was consistent at 
varying template concentrations. The efficiency was calculated from the slope and it was found to be 
99.1%. 
The inter assay precision was calculated in 18 repeats of standards and found to be less than 10% (4.2-
7.6%) which is within the acceptable range. This indicates the reproducibility of the assay over six 
orders of magnitude showing minimal variation and high precision of the applied assay. 
The sensitivity of the assay was evaluated using different amounts of T. b. brucei DNA by serial 
dilution of the starting amount over 10 orders of magnitude; however, R2 value was too low indicating 
low linearity. By excluding the lower concentrations, the linearity was sufficient and the sensitivity of 
the reaction was 40 parasites/ml. 
The specificity of the reaction was determined using different concentrations of other trypanosome 
DNA including T. congolense Savannah and T. vivax, and using also different concentrations of 
Glossina DNA. The results showed that the reaction was specific for T. b. brucei DNA and there was 
no amplification noticed using the other DNA material. We conclude that the primers used were 
suitable for use in qPCR due to obtaining one single band and lack of amplification of non target 
species. 
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7.5.1.2 Optimisation of T. congolense Savannah qPCR 
Primers optimisation 
Primers used for the conventional PCR in the amplification of a satellite DNA sequence in T. 
congolense Savannah (Masiga et al., 1992; Moser et al., 1989a) were re-designed in the current study 
by excluding one base from the reverse primer sequence for use in qPCR. The primer concentration 
was optimised using different combination of the two primer sets ranging from 50 nM to 300 nM, the 
primer pair that resulted in lower Ct value were chosen to be used for the qPCR. Table 7.1 shows the 
different Ct values obtained using different primer pair concentrations. 
Table 7.1: Primer pair concentration optimisation for qPCR (red colored Ct value corresponds 
to the optimal primer pair concentration) 
Forward primer  
 50 nM 150 nM 300 nM 
50 nM 18 20.4 22 




300 nM 21 22 20 
 
Table 7.1 shows Ct value obtained using different primer pair concentrations combination for 
optimisation. The results show that using 300 nM of both primres resulted in lower Ct value compared 
to the other combinations (20); therefore this concentration was used for the subsequent reactions in 
the current study. 
Although 150 nM combination of primers resulted in lower Ct value than the chosen 300 nM 
concentration (18), it was not sufficient for amplification of lower parasite concentration and also 
resulted in background non-specific amplification. 
Reaction conditions 
BioRad kits were chosen to be used for qPCR of T. congolense Savannah genomic material because 
when compared to the other kits, lower Ct value was obtained with BioRad kits. The annealing 
temperature of the primers was evaluated with gradient temperature and temperature of 60ºC was 
found optimum. This temperature was sufficient for the annealing and extension steps as using a 





Figure 7.13 shows the standard curve plotted from running the same standards for 20 reactions. 
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Figure 7.13: Average standard curve of cycle threshold (Ct) versus log (10) of T. congolense 
Savannah concentration/ml. Data points were obtained by calculating the mean Ct across 
sample sets for each standard concentration from 20 reactions. Vertical bars represent standard 
deviations 
Figure 7.13 shows that a high Pearson correlation coefficient (R2=0.9959) was obtained and this 
indicates a linear standard curve which implies that the efficiency of amplification was consistent at 
varying template concentrations. The efficiency was calculated from the slope and it was found to be 
95.6%. 
The inter assay precision was calculated in 20 repeats of standards and found to be less than 10% (2.2-
6.9%) which is within the acceptable range. This indicates the reproducibility of the assay over six 
orders of magnitude showing minimal variation and high precision of the applied assay. 
The sensitivity of the assay was evaluated using different amounts of T. congolense Savannah DNA 
by serial dilution of the starting amount over 10 orders of magnitude; however, R2 value was too low 
indicating low linearity. By excluding the lower concentrations, the linearity was sufficient and the 
sensitivity of the reaction was found to be 40 parasites/ml. 
The specificity of the reaction was determined using different concentrations of other trypanosome 
DNA including T. b. brucei and T. vivax, and using also different concentrations of Glossina DNA. 
The results showed that the reaction was specific for T. congolense Savannah DNA and there was no 
amplification noticed using the aforementioned DNA materials. The primers used were shown to be 
more suitable for use in qPCR due to obtaining one single band. 
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7.5.1.3 Optimisation of Glossina species qPCR 
Glossina qPCR targets a two copy gene (alpha-elongation factor gene) in the tsetse genome (Degnan 
et al., 2004). The reaction was reported by Mathew (2007), however, the primer concentration of 500 
nM was shown to produce primer dimers and increased the background fluorescence. Therefore, the 
primer concentration was reduced to 300 nM which lowered the formation of primer dimers and 
removed background fluorescence.  
Also, Mathew (2007) reported the use of Q-solution in the reaction mixture; this solution changes the 
melting behaviour of DNA and can be used for PCR systems that do not work well under standard 
conditions (Qiagen, 2008). However, this solution could cause reduced efficiency or failure of a 
previously successful amplification reaction. In order to evaluate the use of Q-solution in the current 
reaction, parallel reactions with and without Q-solution were performed on replicates of the same 
standard concentration containing 93.4 ng/µl (Table 7.2). 
Table 7.2: Ct value and melting temperatures of amplified products with and without Q-
solution 
With Q-solution Without Q-solution 
Ct value Tm Ct value Tm 
39.73 76 24.79 81 
29.94 79 25.51 81 
30.64 78 25.61 81 
29.68 79 25.34 81 
31.52 78 25.23 81 
29.9 78 25.4 81 
 
The results in Table 7.2 show that using Q-solution resulted in higher Ct values compared to the 
values obtained without using Q-solution. Moreover, Q-solution changed the melting behaviour of 
DNA giving multiple Tm of the same product; while without Q-solution, Tm was constant. 
Figure 7.14 shows the standard curve plotted from running the same standards for 16 reactions using 
Glossina DNA standards. 
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Figure 7.14: Average standard curve of cycle threshold (Ct) versus log (10) of Glossina DNA 
concentration (ng)/µl. Data points were obtained by calculating the mean Ct across sample sets 
for each standard concentration from 16 reactions. Vertical bars represent standard deviations 
Figure 7.14 shows that a high Pearson correlation coefficient (R2=0.9993) was obtained and this 
indicates a linear standard curve which implies that the efficiency of amplification was consistent at 
varying template concentrations. The efficiency was calculated from the slope and it was found to be 
149%. 
The inter assay precision was calculated in 16 repeats of standards and found to be less than 10% (5.1-
8.2%) which is within the acceptable range. This indicates the reproducibility of the assay over four 
orders of magnitude showing minimal variation and high precision of the applied assay. 
The sensitivity of the assay was evaluated using different amounts of Glossina DNA by serial dilution 
of the starting amount over 10 orders of magnitude; however, R2 value was too low indicating low 
linearity. By excluding the lower six concentrations, the linearity was sufficient and the sensitivity of 
the reaction was 0.0934 ng/µl. This sensitivity was sufficient because it included the average amount 
of DNA calculated to be in a single fly (13.6 ng/µl). 
The specificity of the reaction was determined using different concentrations of trypanosome DNA 
including T. b. brucei, T. congolense Savannah and T. vivax. The results showed that the reaction was 
specific for Glossina DNA and there was no amplification noticed using the aforementioned DNA 
materials. The primers used were shown to be more suitable for use in qPCR due to obtaining one 
single band (Figure 7.15). 
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Figure 7.15: Example of amplified alpha-elongation factor gene in Glossina DNA using qPCR. 
The amplified size is 121 bp 
7.5.1.4 Normalisation of the qPCR reactions using Glossina DNA as an 
internal control 
Trypanosome DNA standards were spiked with a constant amount of Glossina DNA and the qPCR 
specific for Glossina DNA was run to quantify the amount of the spiked DNA. This aimed to evaluate 
if the fluorescence detected using T. b. brucei and T. congolense Savannah qPCR reactions was a 
result of the amplification of trypanosome DNA and not due to the presence of Glossina DNA in the 
spiked standards or the samples.  
The NanoDrop quantification of the Glossina DNA extracted from non-infected flies revealed an 
average of 2600 ng/fly (13 ng/µl), while qPCR resulted in a nearly similar amount of Glossina DNA 
with an average of 2724 ng/fly (13.6 ng/µl). 
An average Ct value of 28.7± 0.7 was obtained using all serial dilutions of T. b. brucei and T. 
congolense Savannah spiked with the constant amount of Glossina DNA. The calculated average Ct 
value was equivalent to 13.2 ng/µl of Glossina DNA.  
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7.5.2 Optimisation of fly age and trypanosome infective dose 
7.5.2.1 Age of the flies  
In the current study, the main aim was to evaluate qPCR for the quantification of T. b. brucei and T. 
congolense Savannah in single and mixed infections of tsetse. Therefore, fly age and the infective 
dose were optimised to obtain 100% infection of the flies. The age of the flies was categorised into 
three groups; group A were flies <48 hours at the day of infection; group B flies 24>48 hours at the 
day of infection and group C flies <24 hours old on the day of infection. The age groups were infected 
with a high infective dose (20,000 parasites/bloodmeal) and dissected 15 days post-infection. Table 
7.3 shows the proportion of flies infected (detected by PCR) with T. b. brucei and T. congolense 
Savannah in the different age categories. 
Table 7.3: Proportion of different age categories infected with trypanosomes (n=30) 
Age category Trypanosome species 
Group A (<48 h) Group B (24>48 h) Group C (<24 h) 
T. b. brucei 13.3% (4/30; 3.8-30.7) 33.3% (10/30; 17.3-52.8) 70% (21/30; 50.6-85.3) 
T. congolense Savannah 0 (0/30; 0-9.5) 26.7% (8/30; 12.3-45.9) 70% (21/30; 50.6-85.3) 
 
The results in Table 7.3 show the proportion of flies infected at different age categories with 
trypanosomes. The difference in the proportion of infected flies with T. b. brucei was statistically 
significant among the three age categories (χ2
2=20.9, p<0.001). The 70% proportion of infection of 
the flies less than 24 hours (group C) at the time of infection was significantly higher than the 13.3% 
proportion of group A and 33.3% proportion of infection in group B, (χ1
2=19.8, p<0.001) and 
(χ1
2=8.1, p=0.004), respectively. However, there was no statistical significant difference in the 
proportion of flies infected with T. b. brucei between group A and B (χ1
2=3.4, p=0.07). 
Regarding T. congolense Savannah, the results in Table 7.3 show that the 70% proportion of flies 
under the age category C (<24 h) was significantly higher than 26.7% of flies under the age category 
B (24>48 h) (χ1
2=11.3, p=0.001). However, none of the flies more than 48 hours old when infected 
had T. congolense Savannah infections.   
7.5.2.2 Infective dose 
The infective dose was optimised using flies of less than 24 hours age in order to obtain 100% 
infection rate. This was achieved by conducting a series of infections using infective doses ranging 
from one parasite to 5x104 parasites per bloodmeal which is equivalent to 33 to 1.67x106 /ml. The 
results of the different trials for infecting flies with T. b. brucei and T. congolense Savannah are 
summarised in Table 7.4.  
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Table 7.4: Proportion of flies infected with trypanosomes (n=30) 
Infective dose (parasites/blood meal) Trypanosome 
species one 10 100 1000 5000 10,000 20,000 50,000 









































The results in Table 7.4 show that 50,000 parasites/bloodmeal are sufficient for 100% infection rate of 
T. b. brucei and T. congolense Savannah in flies. Accordingly, in the single and mixed experimental 
infections using T. b. brucei and/or T. congolense Savannah, the flies used were of age category C 
(less than 24 hours) and the infective dose used was 50,000 parasites/bloodmeal.    
7.5.3 Single and mixed trypanosome infections in tsetse 
Five groups of G. m. morsitans were infected with T. b. brucei and T. congolense Savannah to 
evaluate qPCR in quantifying trypanosome infections of the flies when infected with single and mixed 
species. 
7.5.3.1 Comparison of qPCR and haemocytometer quantification 
Experimentally infected flies with single infection of T. congolense Savannah and T. b. brucei were 
dissected 15 days post-infection and the infection load was estimated using both haemocytometer and 
qPCR quantification. 
The correlation between using haemocytometer and qPCR quantification of T. b. brucei and T. 
congolense Savannah in single infected groups was calculated. The results revealed a significant 
correlation (p<0.001) between the two methods in quantifiying T. b. brucei (Pearson correlation= 
0.969), Figure 7.16 shows a scatterplot for the correlation between qPCR and haemocytometer 
quantification of T. b. brucei.  
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Figure 7.16: Scatterplot showing the correlation between qPCR and haemocytometer 
quantification of T. b. brucei (Tb) in midguts (numbers are presented on log 10 scale and each 
dot is the average of three replicates) 
A significant correlation (p<0.001) was detected between the haemocytometer and qPCR 
quantification of T. congolense Savannah (Pearson correlation= 0.968), Figure 7.17 shows a 
scatterplot of the correlation between qPCR and haemocytometer quantification of T. congolense 
Savannah. 
 
Figure 7.17: Scatterplot showing the correlation between qPCR and haemocytometer 
quantification of T. congolense Savannah (Tc) in midguts (numbers are presented on log 10 
scale and each dot is the average of three replicates) 
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The detection limit of qPCR and haemocytometer to T. b. brucei and T. congolense Savannah was 
compared using Mann-Whitney U test which is used for non-parametric, independent samples and 
tests the null hypothesis that the two sample medians being compared are equal. Comparing the 
medians, rather than the means, of the samples is more accurate in this study as they better represent 
the centre of a sample-set that is not normally distributed and results are not influenced by outliers. 
Figure 7.18 shows a boxplot of the log (10) number of parasites/midgut quantified using qPCR and 
haemocytometer for the two trypanosome species. 
 
Figure 7.18: Boxplot showing the median log (10) number of parasites (Tb: T. b. brucei, Tc: T. 
congolense Savannah) quantified using qPCR and haemocytometer in the single infected groups 
(Numbers are presented as log 10 scale) 
Figure 7.18 shows that the median log number of T. b. brucei quantified with qPCR was 6.79 
(6.2x106) which is insignificantly higher than the median log number of parasites (6.77=5.9x106) 
obtained using haemocytometer method (p=0.18). Moreover, the median number of T. congolense 
Savannah obtained by qPCR (6.81=6.5x106) was not significantly higher than the median number 






7.5.3.2 Infection load of Glossina species groups with single and mixed 
trypanosome infections 
7.5.3.2.1 Infection load of Glossina with T. b. brucei single and mixed 
infections 
The infection load of G. m. morsitans with T. b. brucei when in single and mixed infection was 
compared in the four fly groups. The first group of flies were infected with a single infection of T. b. 
brucei; the second group of flies were infected simultaneously with T. b. brucei/T. congolense 
Savannah; the third group of flies were infected firstly with T. b. brucei and after two days another 
feed infected with T. congolense Savannah; finally, the fourth group of flies were infected firstly with 
T. congolense Savannah followed by T. b. brucei after two days. Figure 7.19 shows a boxplot of the T. 
b. brucei quantification in the four groups. 
 
Figure 7.19: Boxplot for T. b. brucei quantification in the four groups (Tb: T. b. brucei; sim: 
simultaneous; Tc: T. congolense Savannah; seq: sequential, Numbers are presented as log 10 
scale) 
Figure 7.19 shows that the median number of T. b. brucei in the single infection group was 6.79 
(6.2x106), while it was 6.51 (3.3x106), 6.77 (5.9x106), and 1.75 (6.3x10) in simultaneous T. b. 
brucei/T. congolense Savannah, sequential T. b. brucei/T. congolense Savannah and sequential T. 
congolense Savannah/T. b. brucei infection group, respectively. The infection rate in the four groups 
was 100% for both species.  
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The data were shown to be not normally distributed; therefore, the median of the four groups was 
compared using Kruskal-Wallis U one way ANOVA which is a non-parametric test. To test the 
difference in between the four groups, Dunn’s test was used as a multiple comparison post test. The 
results show that there was a significant difference in the median of T. b. brucei number in the four 
groups (H3=74.03, p<0.001).  
There was no statistical significant difference between the median number of T. b. brucei when 
present in single infection, when fed simultaneously and when first fed in the sequential infection 
(p>0.05). However, the median number of T. b. brucei fed secondly in the sequential infection with T. 
congolense Savannah was significantly lower than the other three groups (p<0.05). 
7.5.3.2.2 Infection load of Glossina with T. congolense Savannah single and 
mixed infections 
The infection load of G. m. morsitans with T. congolense Savannah was compared in the four groups, 
the four groups were; flies with single infections, simultaneous infected flies with T. b. brucei/T. 
congolense Savannah, flies infected sequentially with T. b. brucei and after two days another feed 
infected with T. congolense Savannah, finally, flies infected sequentially with T. congolense Savannah 
followed by T. b. brucei after two days. None of the flies infected sequentially with T. b. brucei and 
after two days another feed infected with T. congolense Savannah had T. congolense Savannah 




Figure 7.20: Boxplot for T. congolense Savannah quantification in the four groups (Tb: T. b. 
brucei; sim: simultaneous; Tc: T. congolense Savannah; seq: sequential, Numbers are presented 
as log 10 scale) 
The median number of T. congolense Savannah in the single infection group was 6.81 (6.5x106); 
while it was 4.1 (1.14x104) and 6.81 (6.5x106) in the simultaneous T. b. brucei/T. congolense 
Savannah and sequential T. congolense Savannah/T. b. brucei infection group, respectively. The 
infection rate in the single, simultaneous and sequential T. congolense Savannah/T. b. brucei was 
100% for both species, while, none of the flies infected with sequential T. b. brucei/T. congolense 
Savannah was infected with T. congolense Savannah. 
The data were shown to be not normally distributed; therefore, the median of the four groups was 
compared using Kruskal-Wallis U one way ANOVA which is a non-parametric test. To test the 
difference in between the four groups, Dunn’s test was used as a multiple comparison post test. The 
results in Figure 7.20 shows that there was a significant difference in the median of T. congolense 
Savannah number in the four groups (H3=102.6, p<0.001).  
There was no statistical significant difference between the median number of T. congolense Savannah 
when present in single infection and when first fed in the sequential infection (p>0.05). However, the 
median number of T. congolense Savannah single infection and that first fed was significantly higher 
than when fed simultaneously(p<0.05). Interestingly, none of the flies fed sequentially with T. 
congolense Savannah in the second feed were found infected with T. congolense Savannah. 
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7.6 Discussion 
Quantitative PCR was used in the current study to quantify the number of trypanosomes in the midgut 
of infected flies with single and mixed infections. The aim of this work was to evaluate and 
investigate the use of qPCR in the determination of midgut populations of T. b. brucei and T. 
congolense Savannah in single and mixed infections and studying the relationship between the two 
parasites in the fly midgut. Prior to application of the single and mixed experimental infections, the 
qPCR reactions specific for T. b. brucei, T. congolense Savannah and Glossina species were optimised 
and evaluated.  
7.6.1 Evaluation and optimisation of T. brucei s.l. qPCR 
T. brucei s.l. qPCR using satellite DNA target  
SYBR Green I is an intercalating dye that binds to any double stranded DNA. Quantitative PCR using 
SYBR Green I chemistry requires a target that should have less tendency of forming secondary 
structures (primer dimers and non-specific amplifications) which affect quantification because SYBR 
Green I does not differentiate between different double stranded DNA. Therefore, if a target that tends 
to form secondary structures is used, fluorescence intensity would be collected from all double 
stranded structures resulting in inaccurate quantification.  
The qPCR reaction specific for T. brucei s.l. using the Becker’s primers showed multiple bands after 
amplification as visualised by gel electrophoresis in the current study (Figure 7.11) even though the 
authors re-designed the primers to lower the tendency of forming secondary structures. This pitfall 
impaired the quantification accuracy due to increasing the intensity of fluorescence collected from the 
multiple DNA structures. The tendency of the target which is a satellite sequence in T. brucei s.l. 
genome to produce multiple bands is due to the high copy number of the sequence in the genome 
which reaches 10,000 copies (Moser et al., 1989a). The ladder pattern was reported by Artama et al. 
(1992) who argued that it results from the primers being extended through multiple tandem copies of 
the short satellite sequence during each PCR cycle. This repetitive target is considerd ubiquitous for 
the parasites and is the most favoured for the conventional identification of Trypanozoons; however, 
for qPCR quantification this target is not ideal.  
Becker et al. (2004) reported that re-designing the primers was able to reduce the tendency of the 
primers to form secondary structures. The results of the current study are not in agreement with 
Becker et al. (2004) although the authors used a concentration range (10 to 107) higher than the 
concentration used in the current study (40 to 4x106). The possible explanation of this difference is 
that Becker et al. (2004) used bloodstream forms of the parasites diluted in human blood which has 
factors that interfere with the PCR reaction, whereas, in the current study, pure DNA from procyclic 
cultures was used.   
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Becker et al. (2004) recommended AB kits for their reaction and they obtained an efficiency of 86% 
using serial dilution of the bloodstream form in human blood. In the current study, the efficiency 
obtained using AB kits was 162.1% which is higher than the acceptable range of 90-110%. This 
difference in efficiency could be attributed to the use of pure DNA from the parasites without any 
factors interfering with the qPCR reaction. Before the optimisation of another qPCR reaction specific 
for T. brucei s.l., two other kits (BioRad and Qiagen) were used. The efficiencies of the reaction were 
117.9% and 66.5% using BioRad kits and Qiagen kits, respectively. In both cases, the efficiency was 
out side the acceptable limit of 90-110%, meaning that the amount of the product is not doubled with 
each cycle; this could be attributed to the formation of multiple structures. 
The specificity of the reaction was evaluated using different concentrations of T. congolense 
Savannah, T. vivax and Glossina DNA. The reaction showed cross reactivity with the aforementioned 
genomic materials when running more than 25 cycles and this resulted in multiple non-specific bands 
that were documented with melting curve analysis and gel visualisation. Similar results were 
previously reported by Almeida et al. (1998) who reported cross-reactivity of the primers tragetting 
the satellite sequence of T. brucei s.l. with T. vivax and T. congolense stocks they examined. 
The sensitivity of the reaction in the current study was calculated to be 40 parasites/ml with 30 
amplification cycles; however, Becker et al. (2004) reported a sensitivity of 1000 parasites/ml with 40 
amplification cycles. This strengthens the argument that mammalian DNA has an inhibitory effect on 
PCR reaction, therefore lowering the sensitivity of the reaction.   
In conclusion, it was decided to optimise a different reaction specific for T. brucei s.l. for qPCR 
quantification instead of the reaction targeting the satellite DNA sequence to avoid the drawbacks 
encountered with the reaction, especially the production of secondary structures. 
T. brucei s.l. qPCR using a single copy gene target  
The single copy PLC gene is specific for T. brucei s.l. (Mensa-Wilmot et al., 1990). This target was 
used in the current study for a qPCR reaction to quantify T. brucei s.l. in standards and G. m. 
morsitans midguts. The reaction conditions were previously reported by Picozzi et al. (2008); the 
conditions were evaluated for qPCR and optimised in the current study using serial dilutions of T. b. 
brucei DNA.  
The efficiency of the reaction was calculated to be 99.1% which indicated that the amount of product 
doubled accurately with each cycle, this efficiency is within the acceptable 90-110% PCR efficiency. 
The inter assay precision also showed a minimal variation and high precision of the applied assay 
which indicated the reproducibility of the assay over the six orders of magnitude tested.  
The sensitivity of the reaction was 40 parasites/ml and the reaction was specific for T. b. brucei with 
no production of secondary structures, which is ideal for qPCR. 
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7.6.2 Optimisation of T. congolense Savannah qPCR 
In the current study, primers specific for T. congolense Savannah targeting a satellite DNA sequence 
of 5400 copies in the genome (Masiga et al., 1992; Moser et al., 1989a) were used for qPCR. The 
primers were re-designed to match the criteria of qPCR primers, where theoretical melting 
temperature of the two primers should be within 2ºC of each other. Therefore, one base was removed 
from the reverse primer sequence to obtain 2ºC difference. A concentration of 300 nM was chosen for 
both primers; this resulted in lower Ct value.  
The reaction efficiency was 95.6% which shows sufficient doubling of the product amount with each 
cycle. The inter assay precision showed minimal variation indicating the reproducibility of the assay 
over six orders of magnitude. 
The reaction sensitivity was 40 parasites/ml and the reaction was specific for T. congolense Savannah 
with no tendency of forming secondary structures even though it occurs at a high copy number (5400). 
There was no cross reaction of the primers with T. brucei s.l. and T. vivax DNA although the presence 
of similarity in the sequence of satellite DNA of T. congolense Savannah compared with T. brucei s.l. 
and T. vivax (44% and 37%, respectively), this did not affect the sensitivity of the primers to detect the 
target sequence (Masiga et al., 1992). This was studied by Gibson et al. (1987) who introduced the 
mini-chromosomes from T. congolense Savannah into T. b. brucei using electroporation. They were 
able to detect both satellite sequences indicating that these sequences are ideal for use in 
distinguishing trypanosome species. 
7.6.3 Optimisation of Glossina species qPCR 
A quantitative PCR reaction targeting the two copy alpha-elongation factor gene specific for Glossina 
DNA was used in the current study. This reaction was previously reported by Mathew (2007), 
however the primer concentration and reaction conditions were re-optimised to eliminate primer 
dimers and non-specific background fluorescence.  
The reaction efficiency was calculated to be 149% which is more than the acceptable range of the 
efficiency meaning that the amount of product is not efficiently doubled with each cycle. Despite this 
finding, the reaction was used to confirm the presence of the Glossina DNA in constant amount in the 
standards spiked with Glossina DNA and in the experimentally infected flies. 
The inter assay precision was minimal indicating the reproducibility of the assay over the four orders 
of magnitude. The sensitivity of the assay was 0.0934 ng/µl and the reaction was specific for G. m. 
morsitans with no cross reactivity with trypanosome DNA and with the production of a single 
amplicon which is ideal for qPCR. 
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7.6.4 Normalisation of the qPCR reactions using Glossina DNA as 
an internal control 
Standards of T. b. brucei and T. congolense Savannah were spiked with a constant amount of G. m. 
morsitans DNA which is equivalent to the amount present in a single fly. This was done to mimic 
normal conditions and to ensure that the increase in fluorescence intensity was due to the increase in 
the number of parasites not due to the presence of the Glossina DNA. This was confirmed by 
obtaining the same average of Glossina DNA amount (13.2 ng/µl) from the different standard 
concentrations spiked with the same amount of Glossina DNA.  
7.6.5 Optimisation of fly age and trypanosome infective dose 
The age of G. m. morsitans and the infective dose of trypanosomes were optimised to obtain 100% 
infection rate in the flies; as the main aim of the study was to evaluate qPCR as a tool to measure 
trypanosome populations in the tsetse fly and to study the relationship between T. b. brucei and T. 
congolense Savannah when co-existing in midguts. Transmission of trypanosomes between hosts is 
entirely dependant on tsetse flies, but the flies are not easily infected due to the defence system of the 
tsetse against trypanosome invasion (Roditi and Lehane, 2008; Welburn and Maudlin, 1999). Tsetse 
were found to have midgut lectin activity that played a role in inhibiting trypanosome infections, 
feeding lectin inhibitory sugars (glucosamine) to flies along with the infective dose has shown to 
result in 100% infection rates. In the current study, GSH was used to increase the infection rate with 
an infective dose of 50,000 parasites/bloodmeal to obtain 100% infection rate to a level at which the 
relationship between the two parasites would be apparent. Glutathione is an antioxidant which protects 
trypanosomes from death induced in the fly midgut by reactive oxygen species (MacLeod et al., 
2007).   
Fly age was known to be the most significant factor by far in T. brucei s.l. and T. congolense 
infections (Welburn and Maudlin, 1999). Several laboratory studies have reported that rates of 
infection decline in older flies (Jordan, 1978; Moloo and Shaw, 1989) and several studies have 
suggested that teneral flies are most susceptible to infection (Welburn and Maudlin, 1992). Otieno et 
al. (1983) found that flies fed on an infective bloodmeal less than 8 h after emergence produced higher 
levels of midgut infections than flies fed 12-24 h after emergence. This was attributed to the 
incomplete peritrophic membrane (PM) that makes younger flies easier to infect than older flies which 
have a fully formed PM. However, the addition of glucosamine to the infective feed of both teneral 
and non-teneral flies raised midgut infections to similar levels, suggesting that a fully formed PM is 
not a barrier to infection (Welburn and Maudlin, 1992). The addition of GSH to the blood meal for the 
three age category in the current study increased the infection rate of the flies aged <24 h with T. b. 
brucei and T. congolense Savannah. Flies with age less than 24 h and an infective dose of 50,000 
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parasites/bloodmeal were therefore chosen for the subsequent experiments to obtain a high midgut 
infection rate.      
7.6.6 Single and mixed infection experiment of the flies 
G. m. morsitans were infected with T. b. brucei and T. congolense Savannah using single and mixed 
infections. The infected flies were dissected 15 days post infection and the number of parasites in 
midguts was quantified using haemocytometer and qPCR in the single infected flies. However, only 
qPCR was used to estimate the number of parasites in midguts infected with mixed infections of the 
two species due to inability to differentiate between the two species when they co-exist together. 
7.6.6.1 Comparison of qPCR and haemocytometer quantification 
Quantification of T. b. brucei and T. congolense Savannah in the midguts of G. m. morsitans with 
single infections was estimated using haemocytometer and qPCR. The results showed that the median 
number of T. b. brucei and T. congolense Savannah quantified with qPCR was insignificantly higher 
than the median number obtained using haemocytometer. Moreover, the significant correlation 
between the two methods suggested that either haemocytometer or qPCR can be used for the 
quantification of trypanosomes and both are comparable. However, qPCR was chosen in the current 
study because the sensitivity of the haemocytometer quantification was 2.5x104 parasites/ml compared 
to 40 parasites/ml for qPCR. Moreover, there was difficulty in differentiation between the two 
parasites in the mixed infected groups due to lack of experience in this field. 
Quantification of Leishmania parasites in sand flies using haemocytometer and qPCR was reported by 
Ranasinghe et al. (2008). The results showed that qPCR absolute quantification was three times higher 
than haemocytometer quantification. These results are not enough to accurately compare the two 
methods because the authors applied the quantification on only six flies. 
7.6.6.2 Trypanosome load of Glossina with single and mixed 
trypanosome species infections 
Experimental infection of different Glossina species with single and mixed trypanosome species has 
been investigated by a number of authors in order to understand the relation between the different 
trypanosomes, to understand the cycle of transmission inside the vector and to estimate the burden of 
tsetse flies in the epidemiology of trypansosomiasis. However, none of the reported studies quantified 
the number of parasites in the fly midgut. 
In the current study, the relationship between T. b. brucei and T. congolense Savannah was 
investigated by conducting single and mixed infections of G. m. morsitans and quantification of the 
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parasite number using qPCR. Figure 7.21 illustrates the median log number of T. b. brucei and T. 
congolense Savannah in single and mixed infection groups. 
 
Figure 7.21: Illustration of the median log number (actual number between brackets) of T. b. 
brucei (green) and T. congolense Savannah (red) in single and mixed infection groups of G. m. 
morsitans (Tc: T. congolense Savanna, Tb: T. b. brucei)  
The results in Figure 7.21 show that when T. b. brucei or T. congolense Savannah were fed to the flies 
once or in the first meal for the sequential mixed infection, the log number of parasites was 
consistently around 6.77 and 6.81. This could be attributed to the ability of the parasite to establish 
infection in the fly midgut when present in the first meal. This was in agreement with expectations 
from previous work that insects taking their first meal were much more easily infected by 
trypanosomes (reviewed in Welburn and Maudlin, 1999).  
Looking at the log numbers in the mixed infection groups, the log number of T. b. brucei was 
significantly higher than T. congolense Savannah when fed to the flies in the same blood meal and all 
the flies had mixed infection of the two species. When T. b. brucei was fed to the flies in the first meal 
and T. congolense Savannah in the second sequential meal, there were no T. congolense Savannah 
infections detected at all. This suggests that the presence of T. b. brucei may compromise the ability of 
T. congolense Savannah to establish within the tsetse midgut.  
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The inability of T. congolense Savannah to establish an infection when fed after T. b. brucei could be 
down to several reasons. It is thought that trypanosomes control their numbers in the tsetse midgut 
through quorum sensing (Welburn and Maudlin, 1997). This could be achieved by the secretion of a 
factor which regulates trypanosome numbers (recently reviewed by Welburn et al., 2006). So it is 
possible that T. b. brucei secretes a molecule that will have a negative effect on the establishment of T. 
congolense Savannah. As T. b. brucei has several days head start under these conditions, its numbers 
may have reached a quantity to prevent the establishment of T. congolense Savannah. However, when 
the two species were fed simultaneously it may be that not enough T. b. brucei are present to affect the 
T. congolense Savannah parasites which still manage to establish, albeit several orders of magnitude 
smaller than when T. congolense Savannah was fed singularly. Following on from this, as T. b. brucei 
can establish a small population when fed after T. congolense Savannah, this species may be less 
prone to inhibition by the presence of other trypanosome species or simply better at establishing an 
infection. This is also suggested by the results of the simultaneous infection where T. b. brucei 
managed to establish at higher numbers than T. congolense Savannah.  
Alternatively, it could be that a fly derived a factor that is responsible for the knock down of 
trypanosome numbers, with T. congolense Savannah being more susceptible than T. b. brucei. One 
thing to note is that further experiments will have to take place using different strains of T. b. brucei 
and T. congolense Savannah as the effect above could be a strain difference rather than a species 
related difference.   
Gibson and Ferris (1992) designed an experiment to infect G. m. morsitans with simultaneous and 
sequential infection using T. b. rhodesiense and T. congolense Savannah. The flies were dissected 20 
days post-infection and examined by DNA hybridisation probes specific for the two species. The 
results showed that 33.3% of the flies infected simultaneously with the two species had mixed 
infections. However, flies with sequential infection with T. b. rhodesiense/T. congolense Savannah, 
54.3% of the flies had single infection with T. b. rhodesiense and 1.1% of the flies had single T. 
congolense Savannah and mixed infection of the two species, each. In case of sequential T. 
congolense Savannah/T. b. rhodesiense, 34.4% of the flies acquired single T. congolense Savannah 
infections, while, 1.04% had single T. b. rhodesiense and mixed infection of the two species, each. 
The authors concluded that it is possible to super-infect laboratory tsetse flies with T. b. rhodesiense 
and T. congolense Savannah by sequential feeding to mimic field conditions where flies have 
unrestricted freedom to feed on infected hosts suggesting that mixed infections can be acquired 
outside the narrow window of the first feed.  
In the current work, GSH was used to boost the number of midgut infections, which would explain 
why an increased number of flies had midgut infections compared to the work of Gibson and Ferris 
(1992). This also explains why, in the current work, 100% of flies infected with T. congolense 
Savannah followed by T. b. brucei had infections of both trypanosome species, although the 
advantage of being fed first is clearly shown by the reduction in the population of T. b. brucei within 
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the fly midgut. However, similar effects were evident when T. b. brucei was fed first followed by T. 
congolense Savannah with the flies showing only T. b. brucei infections in the current work; by 
contrast only 1% of flies picked up a T. congolense Savannah infection in the work of Gibson and 
Ferris (1992). 
The hypothesis of competition between trypanosome species was previously investigated by Seed 
(1978) who reported evidence of competition between two clones of T. b. gambiense when inoculated 
simultaneously into rats. One clone outgrew the other to an extent disproportionate to the difference in 
the replication rates of the two clones when inoculated on their own. Moreover, Jamonneau et al. 
(2004) inoculated T. b. brucei/T. congolense mixed infection into mice and found that T. b. brucei 
always out competed T. congolense which systematically disappeared.      
Reifenberg et al. (1997b) simultaneously infected G. m. morsitans with T. congolense Savannah and 
T. congolense Forest and noted the exclusion of T. congolense Forest from the infection. This might 
indicate competition which could occur in the vector gut between the two species simultaneously 
ingested by the flies.  
The development of T. b. brucei in G. m. morsitans midgut did not seem to be affected by the 
presence of T. congolense in the study of Van den Bossche et al. (2004a,b). This is in agreement with 
the current study where T. b. brucei developed in flies infected with T. congolense Savannah in the 
first meal although the median number of T. b. brucei was significantly lower than the median log 
number of T. congolense Savannah (p<0.05). In contrast, Kubi et al. (2005) suggested that previous 
exposure of tsetse flies to an infected blood meal or the presence of trypanosome has no effect on a 
subsequent secondary infection.  
In conclusion, the current study suggests the possibility that a form of competition exists between T. b. 
brucei and T. congolense Savannah when they co-exist in the fly midgut. However, more research is 
required to determine the nature of such type of competition between the two species.  
7.6.7 Applications   
Investigation of tsetse infection load with trypanosomes and the relationship between the different 
species was previously done by haemocytometer counting, microscopy or conventional PCR. These 
methods were unable to accurately quantify the infection load of the flies or to estimate parasite 
numbers when they co-exist in the fly midgut. However, quantification of tsetse infection load with 
trypanosomes was reported by Peacock et al. (2007) using fluorescent markers of two T. b. brucei 
strains for studying the dynamics of infection and competition between the two strains. Although 
fluorescent trypanosomes may have some advantages over qPCR such as direct counting of 
trypanosomes, qPCR can be used on wild flies, which is obviously not the case with fluorescent 
trypanosomes. 
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The current study evaluated the use of qPCR to quantify the infection load of tsetse flies with T. b. 
brucei and T. congolense Savannah and to study the possibility of competition between the two 
species. The protocol could be used in the same manner to study the infection load of wild flies with 














































This thesis has concentrated on the molecular diagnosis of trypanosome infections obtained from a 
number of sources including cattle, wildlife and tsetse. The first two chapters formed literature 
reviews focussing on the general tools available for diagnosis of infections (Chapter I) using three 
examples of blood borne infectious parasites (Plasmodium, Leishmania and Trypanosoma cruzi) while 
Chapter II focussed on African trypanosomes as a model for blood borne parasites. The next five 
chapters formed the experimental work of this thesis and focussed on the following areas; evaluation 
of different sample preparations for trypanosome diagnosis, processing of samples from FTA®cards 
before PCR, evaluation of different PCR reactions in use for trypanosome identification, follow up of 
mass treatment campaign in Uganda and finally the application of qPCR for studying mixed infections 
in tsetse flies. 
8.1 Advantages of molecular diagnosis 
Whereas traditional in field diagnosis has relied on microscopy, evidence suggests that these 
techniques show low sensitivity, while serological tests suffer from the lack of separation of past and 
present infections. Molecular diagnosis through the use of PCR also allows infections to be 
characterised to the species/sub-species level. This is of great importance in differentiating the 
morphologically indistinct sub-species of T. brucei s.l., as T. b. rhodesiense has a zoonotic reservoir. 
In Uganda, domestic cattle play the role of the reservoir and due to the closeness between humans and 
cattle they provide an ideal stepping stone for infection of humans. Therefore, by removing the 
reservoir, the chance of human infection decreases. The advantages of molecular techniques in 
mapping an outbreak of Rhodesian sleeping sickness were shown by Fevre et al. (2001) who clearly 
demonstrated the importance of a cattle market at Brookes corner in Uganda as the focal point of the 
outbreak. Further to this, molecular characterisation of trypanosome infections has been an important 
part of several programmes to reduce the trypanosome reservoirs in cattle by using trypanocides. This 
has included the FITCA (Farming In Tsetse Controlled Areas) programme which finished in 2007 
(Fyfe, 2007) and SOS (Stamp Out Sleeping sickness) programme which is still ongoing (Chapter VI).   
8.2 Possible shortcomings of FTA®cards 
In the first experimental chapter, it became clear that FTA®cards did not show similar levels of 
sensitivity when compared with in field DNA extraction. In the current work, preparations including 
venous blood, buffy coat and DNA applied on FTA®cards and extracted DNA solutions from whole 
blood and buffy coat were compared. The sensitivities of the different sample preparations were 
compared with a gold standard which was defined as positive PCR result from amplifying 
trypanosome DNA from FTA®cards and/or positive PCR result from amplifying trypanosome 
genomic material in DNA extract. The sensitivity of amplifying trypanosome DNA from DNA 
solutions was significantly higher than the amplification of DNA from FTA®cards even when 
examining multiple FTA discs. This was expected due to the uneven distribution of the parasite DNA 
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when in contact with the matrix after cell lysis. Therefore, it was decided to focus on methods which 
could improve the homogeneity of the blood samples which formed the basis of Chapter IV.   
8.3 Processing of samples before PCR 
The introduction of FTA®cards has greatly eased the transport of samples from where they are 
collected to laboratories where they can be analysed. However, although FTA®cards claim to produce 
a homogenous sample this is not always the case and success of the PCR can be determined by where 
the punch comes from on the card (Cox, 2007). Therefore, the current work investigated several 
methods which could increase the sensitivity of the reaction. In the laboratory, trypanosome samples 
from procyclic cultures and from blood samples collected from infected mice were lysed with various 
liquids before application on to FTA®cards. Lysis of infected blood promotes the release of the DNA 
into a more homogenous solution consisting of genetic material from both the host as well as any 
infectious agents. The probability of detecting the parasitic DNA in the examined material is therefore 
increased with a more even distribution of the genomic material throughout the solution. As the results 
of the experimental trials were promising, work was then moved into the field and two studies were 
carried out using water as the lysing agent. 
A preliminary pilot study was conducted in field to obtain initial information about the logistics of 
lysis in the field; therefore, opportunistic samples were collected from 80 cattle in Uganda, in July, 
2006. From these cattle, whole and lysed blood samples were collected and 10 discs were examined 
separately from each preparation by PCR. The results of screening the discs showed that increasing 
the number of the examined discs containing lysed blood samples to 10 discs resulted in 100% 
sensitivity compared with the gold standard (defined as a positive PCR result from amplifying 
trypanosome DNA from whole blood and/or lysed blood applied on FTA®cards). The increase in the 
sensitivity would suggest that although the distribution is improved by pre-lysis, it should not be 
assumed to be a homogenous distribution; by increasing the number of screened discs it is possible to 
improve the detection of trypanosome DNA. However, this level of sensitivity required the 
examination of 9-10 discs using a separate PCR reaction on each disc which is time consuming and 
expensive. Therefore, a larger field lysis study was conducted for further evaluation of the approach. 
A large scale field study was conducted using a larger sample number (n=300) and three types of 
sample preparations, included whole blood on FTA®cards, lysed blood on FTA®cards and in situ 
DNA extraction. Examining 10 separate discs from FTA®card applied samples; the sensitivity of 
detecting positive discs containing lysed blood doubled the sensitivity of the screening protocol when 
compared to screening the same number of the discs containing whole blood. However, this 
improvement required the screening of at least 10 discs using separate PCR reactions. Therefore, to 
improve the detection of trypanosomes using only 10 discs with one PCR reaction for each species; 
DNA was eluted from FTA®card containing whole blood and lysed blood using 5% Chelex®100 resin 
aqueous suspension (Becker et al., 2004). Chelex®100 is a chelating resin that has a high affinity for 
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polyvalent metal ions, moreover, the alkalinity (pH 10-11) and the exposure to temperature result in 
the disruption of the cell membrane and denaturation of DNA into its component single strands 
facilitating PCR amplification (Sweet et al., 1996; Walsh et al., 1991). The results showed that the 
sensitivity of identifying trypanosome DNA from whole blood and lysed blood eluate was 56.4% and 
73.3%, respectively, compared to the gold standard (defined as PCR positive results from amplifying 
trypanosome DNA from samples applied to FTA®cards and/or positive PCR results from amplifying 
trypanosome genomic material in DNA extract).  
The insignificant difference between using DNA eluted from whole blood, lysed blood FTA®card 
discs and DNA extracted using kits approves the use of any of the aforementioned preparations for 
obtaining trypanosome genomic materials. The choice should be based on economic and time factors; 
in field DNA extraction using kits is both expensive and time consuming. Pre-application lysis of 
infected blood products can help create a more homogenous distribution. It is possible to elute DNA 
from FTA®cards; this approach overcomes the uneven distribution of materials across the matrix. 
Therefore the choice between these two approaches could be based on the cost, for eluted whole blood 
sample the cost is £ 2.70 and for eluted lysed blood sample the cost is £ 3.20.  
As the elution of DNA from FTA®cards showed no difference in sensitivity when compared with in 
field DNA extraction, this allowed the direct comparison of the ITS primer set with the species-
specific primer sets. This would not have been possible using individual discs from FTA®cards as the 
results would not be directly comparable as the DNA content of the cards would have been different. 
This work was completed in Chapter V.  
8.4 ITS-PCR versus species-specific PCR reactions 
There are various primer sets available to identify trypanosome infections, however, screening each 
sample with up to five PCR reactions to identify to the sub-species level is time consuming and 
expensive. When this current work commenced, Cox et al. (2005) had recently published a set of 
primers which could discriminate trypanosomes to the species level (T. brucei s.l., T. vivax, T. simiae 
and T. theileri) or to the sub-species level (T. congolense Savannah, Forest and Kilifi). This of course 
has many advantages over single species PCR particularly in the fact that “one reaction fits all”. 
Evaluation of the pan trypanosome ITS-PCR for the diagnosis of different trypanosome species 
compared to the species-specific PCR reactions was addressed in the current study. The comparison 
was based on the use of the same eluate to conduct the four PCR reactions; therefore the results would 
be comparable because the template is taken from the same eluate of the same discs from the card 
matrix. 
The results documented the significant lower sensitivity of ITS-PCR in the diagnosis of T. brucei s.l. 
than the specific reaction targeting the high copy satellite DNA sequence. Firstly, this was thought to 
be attributed to the difference in the copy number of the ITS-PCR and TBR-PCR targets. This was 
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found not to be true as using a PCR reaction (PLC) that targets a single copy gene in T. brucei s.l. 
genome resulted in a significant higher sensitivity compared to ITS-PCR. Generally, during the 
current work it was found that ITS-PCR lacked sensitivity when compared to the single species 
reactions, this was independent of trypanosome species as the same trend was seen with T. congolense 
and T. vivax.  
Due to the low sensitivity of the ITS primers set developed by Cox et al. (2005) it was decided to use 
the species-specific primers in conjunction with elution of DNA with Chelex®100 in Chapter VI to 
characterise the infection rate of trypanosomes in cattle following trypanocide treatment.  
8.5 Stamp Out Sleeping sickness mass treatment campaign 
The Chelex®100 and species-specific PCR reactions were used to evaluate and follow up the impact 
of a treatment programme conducted in central Uganda on trypanosome species. Samples collected at 
baseline (before application of treatment), three months and nine months post-intervention were 
screened for trypanosome infections using species-specific PCR reactions for T. brucei s.l., T. vivax 
and T. congolense Savannah.  
The analyses of the results indicated the success of the mass treatment programme in reducing the 
prevalence of trypanosome species from animals three months post-intervention. The re-infection of 
the animal population with trypanosomes in the absence of continued treatment as seen nine months 
post-intervention indicated continued challenge by infected tsetse flies or possibly movement of 
infected animals into the study area. The results denote that in the absence of sustained intervention, 
the trypanosome level returned to pre-treatment levels, indicating that continuous treatment and 
follow up is necessary to control the infection of the animal host and therefore to reduce the risk of 
human to get infection. 
Mixed infection of the cattle in Uganda showed a low prevalence rate that was within the range of 
0.2%-2.1% of the rate obtained with other studies. It was decided to investigate mixed infections in 
the fly vector. Although most of these infections were T. brucei s.l./T. vivax, it was decided to use T. 
b. brucei and T. congolense as both these trypanosomes inhabit the midgut of the tsetse fly, whereas T. 
vivax completes its lifecycle exclusively within the mouthparts.  
8.6 Mixed infection 
Field studies have revealed that many vertebrate species which serve as natural hosts of Glossina 
often carry mixed infections of T. brucei s.l., T. congolense species and/or T. vivax. In the current 
study, during the evaluation of SOS campaign’s impact on trypanosome infections in Uganda, the 
extenet of mixed infection was compared to other field studies in the vertebrate host. The comparison 
showed that the extent of mixed infection in the vertebrate host ranged from 0.2%-2.1%, with the 
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extent in the current study 1.7% which is in the same range. In the wild tsetse host, the extent of 
mixed infection ranged from 1.3%-7.1% in different areas. Although mixed infection is evident in 
both vertebrate and invertebrate hosts, no studies have looked at the relation between the different 
trypanosome species in the vertebrate host or vector. Except for few studies that looked at the relation 
between different species using conventional PCR reactions which give an answer of presence or 
absence of the infection. Only one study looked at quantifying the number of trypanosomes in mixed 
infection by labelling the trypanosomes with fluorescence for the quantification. The current study 
evaluated and optimised qPCR reactions to be used for quantification of trypanosomes in mixed 
infection of the vertebrate and vector host. The mixed infection of laboratory Glossina species and 
quantification of the infection conducted in Chapter VII suggests the possibility that a form of 
competition exists between T. b. brucei and T. congolense Savannah when they co-exist in the fly 
midgut. However, more research is required to determine the nature of such type of competition 
between the two species. The work did show that it was possible to accurately quantify the 
parasitaemia in tsetse flies and further studies could investigate if this technique could be applied to 
wild flies. 
8.7 Recommendations for the future of blood samples from 
animals in Africa 
Successful molecular diagnosis requires the availability of genomic material of an appropriate quality 
and concentration to be present within the sample under examination. Therefore based on the work 
presented in this thesis, blood samples should be collected onto FTA®cards where they can be easily 
transported back to the laboratory for processing. At the laboratory, material from the card should be 
eluted using Chelex®100 whereby PCR using species-specific primers should take place. Recently, 
several other ITS primer sets to diagnose trypanosome samples have been published (Adams et al., 
2006; Desquesnes, 1997; Geysen et al., 2003; Malele et al., 2003; Maslov et al., 1996; Njiru et al., 
2005) and it would be pertinent to compare these primer sets to the ITS primer set developed by Cox 
et al. (2005) and to the species-specific primer sets used in the current work. As development of an 
ITS based reaction would greatly reduce the cost and work time in processing samples.   
8.8 Final thought 
 
This thesis concentrated on molecular diagnosis of African trypanosomes. The significant finding of 
this thesis was that the FTA protocol using ITS primers described by Cox et al. (2005) has limitations 
for the diagnosis of pathogenic trypanosomes. This was done through the comparison of ITS-PCR to 
species-specific PCR reactions. As described in Section 8.7 above, a new protocol for the diagnosis of 
African trypanosomes has been put forward which should improve the diagnosis of this disease in 
cattle. Accurate determination of the prevalence of this disease is essential to the control and 
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management of pathogenic trypanosomes particularly where human infective forms are present. The 
Stamp out Sleeping Sickness campaign has been successful in reducing incidence of trypanosome 
infection in domestic cattle in Uganda. Although the knock down is only evident for three months it is 
important that the correct primer set is used to diagnose these infections. If one relied only on the ITS 
protocol described by Cox et al. (2005), then it is possible that many T. brucei s.l. infections could be 
missed. As such an area may be deemed free of this species of trypanosome, therefore control 
operations may cease too early potentially allowing human infective forms to cross over to human 
populations. Unchecked this could lead to a new epidemic of Rhodesian sleeping sickness which 
could place a high burden on a health system already overstretched by other diseases (HIV/AIDS, 
tuberculosis and malaria). 
The other significant outcome of this thesis is that it is possible to measure trypanosome populations 
in the midgut of the tsetse fly. This could have important implications when looking at infections in 
wild tsetse flies. As PCR technology has now been applied to wild tsetse populations, it has become 
apparent that many more flies could be infected than are diagnosed by microscopy. However, 
conventional PCR can not discriminate between an active infection and trypanosomes that may just of 
been imbibed with the bloodmeal. Therefore the use of qPCR to measure trypanosome populations in 
wild tsetse flies may allow the discrimination of active as opposed to non active infections. This 
protocol could be used also to quantify parasitemia of T. brucei s.l. and T. congolense Savannah and 
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